<!DOCTYPE html>
<html>
<head>
<style>
table {
  font-family: arial, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #dddddd;
  text-align: left;
  padding: 8px;
}

tr:nth-child(even) {
  background-color: #dddddd;
}
</style>
</head>
<body>
<h3>1. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TXG">10x Genomics </a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 14:00:15 GMT</td>    <td>10x Genomics, Collaborators Develop Targeted Single-Cell Gene Expression Methods - GenomeWeb</td>    <td>10x Genomics, Collaborators Develop Targeted Single-Cell Gene Expression Methods  GenomeWeb</td>    <td><a target="_blank" href="https://www.genomeweb.com/sequencing/10x-genomics-collaborators-develop-targeted-single-cell-gene-expression-methods">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 13:17:06 GMT</td>    <td>Focusing on the Genes that Matter Most: 10x Genomics Launches Targeted Gene Expression Solution - GlobeNewswire</td>    <td>Focusing on the Genes that Matter Most: 10x Genomics Launches Targeted Gene Expression Solution  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036430/0/en/Focusing-on-the-Genes-that-Matter-Most-10x-Genomics-Launches-Targeted-Gene-Expression-Solution.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>10x Genomics Q1 Revenues Increase 34 Percent - GenomeWeb</td>    <td>10x Genomics Q1 Revenues Increase 34 Percent  GenomeWeb</td>    <td><a target="_blank" href="https://www.genomeweb.com/business-news/10x-genomics-q1-revenues-increase-34-percent">Link</a></td>  </tr></table><h3>2. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ETNB">89bio</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 08 May 2020 11:44:21 GMT</td>    <td>89bio to Present at Upcoming Investor Conferences - GlobeNewswire</td>    <td>89bio to Present at Upcoming Investor Conferences  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030289/0/en/89bio-to-Present-at-Upcoming-Investor-Conferences.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 20:26:41 GMT</td>    <td>89bio Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>89bio Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032986/0/en/89bio-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 21:26:00 GMT</td>    <td>Hedge Funds Dumped 89bio, Inc. (ETNB) During The Crash - Yahoo Finance</td>    <td>Hedge Funds Dumped 89bio, Inc. (ETNB) During The Crash  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-dumped-89bio-inc-212620894.html">Link</a></td>  </tr></table><h3>3. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ABEO">Abeona Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 18:00:00 GMT</td>    <td>Market cap of Abeona Therapeutics Inc. [ABEO] reaches 250.71M – now what? - The DBT News</td>    <td>Market cap of Abeona Therapeutics Inc. [ABEO] reaches 250.71M – now what?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/market-cap-of-abeona-therapeutics-inc-abeo-reaches-250-71m-now-what/">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:21:16 GMT</td>    <td>Abeona Therapeutics Reports First Quarter Financial Results and Business Updates - GlobeNewswire</td>    <td>Abeona Therapeutics Reports First Quarter Financial Results and Business Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028855/0/en/Abeona-Therapeutics-Reports-First-Quarter-Financial-Results-and-Business-Updates.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:00:00 GMT</td>    <td>Is a Correction Looming Ahead? Abeona Therapeutics Inc. (ABEO) - The News Heater</td>    <td>Is a Correction Looming Ahead? Abeona Therapeutics Inc. (ABEO)  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/is-a-correction-looming-ahead-abeona-therapeutics-inc-abeo/">Link</a></td>  </tr></table><h3>4. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ACIU">AC Immune SA</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>AC Immune SA (NASDAQ:ACIU) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance</td>    <td>AC Immune SA (NASDAQ:ACIU) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/ac-immune-sa-nasdaq-aciu-141222141.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 11:21:21 GMT</td>    <td>AC Immune CEO to Showcase Novel Target Programs at UBS Global Healthcare Conference - GlobeNewswire</td>    <td>AC Immune CEO to Showcase Novel Target Programs at UBS Global Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034127/0/en/AC-Immune-CEO-to-Showcase-Novel-Target-Programs-at-UBS-Global-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 16:11:21 GMT</td>    <td>Is AC Immune SA’s (NASDAQ:ACIU) CEO Salary Justified? - Simply Wall St</td>    <td>Is AC Immune SA’s (NASDAQ:ACIU) CEO Salary Justified?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aciu/ac-immune/news/is-ac-immune-sas-nasdaqaciu-ceo-salary-justified/">Link</a></td>  </tr></table><h3>5. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ACAD">ACADIA Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 17:50:00 GMT</td>    <td>Why Investors Need To Watch ACADIA Pharmaceuticals Inc. (ACAD)? - The News Heater</td>    <td>Why Investors Need To Watch ACADIA Pharmaceuticals Inc. (ACAD)?  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/why-investors-need-to-watch-acadia-pharmaceuticals-inc-acad/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 10:50:00 GMT</td>    <td>ACADIA Pharmaceuticals Inc. [ACAD] Stock trading around $48.02 per share: What’s Next? - The DBT News</td>    <td>ACADIA Pharmaceuticals Inc. [ACAD] Stock trading around $48.02 per share: What’s Next?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/acadia-pharmaceuticals-inc-acad-stock-trading-around-48-02-per-share-whats-next/">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 13:00:00 GMT</td>    <td>ACADIA Pharmaceuticals to Combine CLARITY-2 and CLARITY-3 Phase 3 Studies Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder - Business Wire</td>    <td>ACADIA Pharmaceuticals to Combine CLARITY-2 and CLARITY-3 Phase 3 Studies Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200526005118/en/ACADIA-Pharmaceuticals-Combine-CLARITY-2-CLARITY-3-Phase-3">Link</a></td>  </tr></table><h3>6. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ACST">Acasti Pharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 19:30:00 GMT</td>    <td>Acasti Pharma Inc. (ACST) moved down -0.5% from 52 weeks low: Is it Too Late to Be Bullish? - State Reviewer</td>    <td>Acasti Pharma Inc. (ACST) moved down -0.5% from 52 weeks low: Is it Too Late to Be Bullish?  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/acasti-pharma-inc-acst-moved-down-0-5-from-52-weeks-low-is-it-too-late-to-be-bullish/">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 14:00:04 GMT</td>    <td>Shares in Acasti Pharma Inc. (ACST) -73.36 % down, YTD - Marketing Sentinel</td>    <td>Shares in Acasti Pharma Inc. (ACST) -73.36 % down, YTD  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/05/27/shares-in-acasti-pharma-inc-acst-73-36-down-ytd/">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>How Has Acasti Pharma Inc (ACST) Stock's Trend Affected its Rank? - InvestorsObserver</td>    <td>How Has Acasti Pharma Inc (ACST) Stock's Trend Affected its Rank?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/how-has-acasti-pharma-inc-acst-stocks-trend-affected-its-rank">Link</a></td>  </tr></table><h3>7. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AXDX">Accelerate Diagnostics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Accelerate Diagnostics Announces First Quarter Financial Results and Provides COVID-19 Business Updates - PRNewswire</td>    <td>Accelerate Diagnostics Announces First Quarter Financial Results and Provides COVID-19 Business Updates  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/accelerate-diagnostics-announces-first-quarter-financial-results-and-provides-covid-19-business-updates-301055247.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:51:00 GMT</td>    <td>How Accelerate Diagnostics (AXDX) Stock Stands Out in a Strong Industry - Yahoo Finance</td>    <td>How Accelerate Diagnostics (AXDX) Stock Stands Out in a Strong Industry  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/accelerate-diagnostics-axdx-stock-stands-125112849.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Accelerate Diagnostics: 1Q Earnings Snapshot - FOX 8 Live WVUE</td>    <td>Accelerate Diagnostics: 1Q Earnings Snapshot  FOX 8 Live WVUE</td>    <td><a target="_blank" href="https://www.fox8live.com/2020/05/07/accelerate-diagnostics-q-earnings-snapshot/">Link</a></td>  </tr></table><h3>8. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XLRN">Acceleron Pharma Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 18:58:00 GMT</td>    <td>Hedge Funds Have Never Been This Bullish On Acceleron Pharma Inc (XLRN) - Yahoo Finance</td>    <td>Hedge Funds Have Never Been This Bullish On Acceleron Pharma Inc (XLRN)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-never-bullish-acceleron-185846488.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:15:03 GMT</td>    <td>Are Insiders Selling Acceleron Pharma Inc. (NASDAQ:XLRN) Stock? - Simply Wall St</td>    <td>Are Insiders Selling Acceleron Pharma Inc. (NASDAQ:XLRN) Stock?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xlrn/acceleron-pharma/news/are-insiders-selling-acceleron-pharma-inc-nasdaqxlrn-stock/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Acceleron Pharma Inc (XLRN) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Acceleron Pharma Inc (XLRN) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/acceleron-pharma-inc-xlrn-q1-2020-earnings-call-tr.aspx">Link</a></td>  </tr></table><h3>9. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ACRX">AcelRx Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 22:50:00 GMT</td>    <td>AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase - PRNewswire</td>    <td>AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-it-will-not-further-revise-its-offer-to-acquire-tetraphase-301070465.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:30:00 GMT</td>    <td>AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase - Yahoo Finance</td>    <td>AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/acelrx-pharmaceuticals-announces-revised-merger-123000150.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 00:02:40 GMT</td>    <td>AcelRx Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference - Yahoo Finance</td>    <td>AcelRx Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/acelrx-pharmaceuticals-present-jefferies-virtual-000000858.html">Link</a></td>  </tr></table><h3>10. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ACER">Acer Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Acer Therapeutics Discusses Developing COVID-19 Clinical Program, Next Steps with the FDA and Vision for 2020 in New Video Interview on SNN Network - Yahoo Finance</td>    <td>Acer Therapeutics Discusses Developing COVID-19 Clinical Program, Next Steps with the FDA and Vision for 2020 in New Video Interview on SNN Network  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/acer-therapeutics-discusses-developing-covid-123000018.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 20:15:43 GMT</td>    <td>Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Acer Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033823/0/en/Acer-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Acer Therapeutics (ACER) to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences - StreetInsider.com</td>    <td>Acer Therapeutics (ACER) to Develop Emetine as Potential COVID-19 Treatment in Collaboration with National Center for Advancing Translational Sciences  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Acer+Therapeutics+%28ACER%29+to+Develop+Emetine+as+Potential+COVID-19+Treatment+in+Collaboration+with+National+Center+for+Advancing+Translational+Sciences/16866871.html">Link</a></td>  </tr></table><h3>11. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AKAO">Achaogen, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 02:53:00 GMT</td>    <td>Development In Pyelonephritis Drug Market Trends 2020-2025: Global Driving Directions and Top Players (Achaogen Inc, AstraZeneca Plc, Meiji Seika Pharma Co Ltd, Merck & Co Inc, More) - Cole of Duty</td>    <td>Development In Pyelonephritis Drug Market Trends 2020-2025: Global Driving Directions and Top Players (Achaogen Inc, AstraZeneca Plc, Meiji Seika Pharma Co Ltd, Merck & Co Inc, More)  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/industry-analysis/2020/06/02/development-in-pyelonephritis-drug-market-trends-2020-2025-global-driving-directions-and-top-players-achaogen-inc-astrazeneca-plc-meiji-seika-pharma-co-ltd-merck-co-inc-more/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:37:51 GMT</td>    <td>Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Report 2020 – Covering Impact of COVID-19, Financial Information, Developments, SWOT Analysis by Global Top Companies | Achaogen Inc, Adenium Biotech ApS, Aridis Pharmaceuticals LLC, AstraZeneca Plc, Bayer AG - Surfacing Magazine</td>    <td>Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Report 2020 – Covering Impact of COVID-19, Financial Information, Developments, SWOT Analysis by Global Top Companies | Achaogen Inc, Adenium Biotech ApS, Aridis Pharmaceuticals LLC, AstraZeneca Plc, Bayer AG  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/global-ventilator-associated-pneumonia-vap-therapeutics-market-report-2020-covering-impact-of-covid-19-financial-information-developments-swot-analysis-by-global-top-companies-achaogen-inc/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:17:55 GMT</td>    <td>Vaxcyte Appoints Halley E. Gilbert to Board of Directors - BioSpace</td>    <td>Vaxcyte Appoints Halley E. Gilbert to Board of Directors  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/vaxcyte-appoints-halley-e-gilbert-to-board-of-directors/">Link</a></td>  </tr></table><h3>12. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ACHV">Achieve Life Sciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Achieve Life Sciences to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 14, 2020 - PRNewswire</td>    <td>Achieve Life Sciences to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 14, 2020  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/achieve-life-sciences-to-announce-first-quarter-2020-financial-results-and-host-conference-call-and-webcast-on-may-14-2020-301052442.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 11:39:16 GMT</td>    <td>ACHIEVE LIFE SCIENCES, INC. : Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) - marketscreener.com</td>    <td>ACHIEVE LIFE SCIENCES, INC. : Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/ACHIEVE-LIFE-SCIENCES-IN-43510700/news/ACHIEVE-LIFE-SCIENCES-INC-Results-of-Operations-and-Financial-Condition-Submission-of-Matters-t-30605787/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>BRIEF-Achieve Life Sciences Reports Qtrly Loss Per Share $0.11 - Reuters</td>    <td>BRIEF-Achieve Life Sciences Reports Qtrly Loss Per Share $0.11  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-achieve-life-sciences-reports-qtrl/brief-achieve-life-sciences-reports-qtrly-loss-per-share-011-idUSFWN2CW0TH">Link</a></td>  </tr></table><h3>13. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ACRS">Aclaris Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:07:48 GMT</td>    <td>Aclaris Therapeutics Announces Publication of an Abstract of the Phase 1 Clinical Trial Results for ATI-450, an Investigational Compound, at the EULAR 2020 E-Congress - GlobeNewswire</td>    <td>Aclaris Therapeutics Announces Publication of an Abstract of the Phase 1 Clinical Trial Results for ATI-450, an Investigational Compound, at the EULAR 2020 E-Congress  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042789/0/en/Aclaris-Therapeutics-Announces-Publication-of-an-Abstract-of-the-Phase-1-Clinical-Trial-Results-for-ATI-450-an-Investigational-Compound-at-the-EULAR-2020-E-Congress.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Aclaris Therapeutics Inc. (ACRS) Soars 10.61% on June 02 - Equities.com</td>    <td>Aclaris Therapeutics Inc. (ACRS) Soars 10.61% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/aclaris-therapeutics-inc-acrs-soars-10-61-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:10:00 GMT</td>    <td>Two Stocks To Tuck Away: Aclaris Therapeutics Inc. (NASDAQ:ACRS), Immutep Limited (NASDAQ:IMMP) - State Reviewer</td>    <td>Two Stocks To Tuck Away: Aclaris Therapeutics Inc. (NASDAQ:ACRS), Immutep Limited (NASDAQ:IMMP)  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/two-stocks-to-tuck-away-aclaris-therapeutics-inc-nasdaqacrs-immutep-limited-nasdaqimmp/">Link</a></td>  </tr></table><h3>14. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ACOR">Acorda Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Acorda Therapeutics (ACOR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance</td>    <td>Acorda Therapeutics (ACOR) Reports Q1 Loss, Misses Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/acorda-therapeutics-acor-reports-q1-221510029.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Acorda (ACOR) Q1 Earnings Lag Estimates, Revenues Fall Y/Y - Yahoo Finance</td>    <td>Acorda (ACOR) Q1 Earnings Lag Estimates, Revenues Fall Y/Y  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/acorda-acor-q1-earnings-lag-172705821.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Acorda Reports First Quarter 2020 Financial Results and Provides Business Update - Yahoo Finance</td>    <td>Acorda Reports First Quarter 2020 Financial Results and Provides Business Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/acorda-reports-first-quarter-2020-200000320.html">Link</a></td>  </tr></table><h3>15. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADMS">Adamas Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Adamas Reports First Quarter 2020 Financial Results Nasdaq:ADMS - GlobeNewswire</td>    <td>Adamas Reports First Quarter 2020 Financial Results Nasdaq:ADMS  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029851/0/en/Adamas-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4345493-adamas-pharmaceuticals-inc-adms-ceo-neil-mcfarlane-on-q1-2020-results-earnings-call">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 15:07:18 GMT</td>    <td>Where Does Adamas Pharmaceuticals Inc (ADMS) Stock Fall in the Drug Manufacturers - Specialty & Generic Field? - InvestorsObserver</td>    <td>Where Does Adamas Pharmaceuticals Inc (ADMS) Stock Fall in the Drug Manufacturers - Specialty & Generic Field?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/where-does-adamas-pharmaceuticals-inc-adms-stock-fall-in-the-drug-manufacturers-specialty-generic-field">Link</a></td>  </tr></table><h3>16. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADMP">Adamis Pharmaceuticals Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 00:52:37 GMT</td>    <td>Adamis Pharmaceuticals Provides Update on SYMJEPI Products and Announces Distribution and Commercialization Agreement for SYMJEPI and ZIMHI Products - GlobeNewswire</td>    <td>Adamis Pharmaceuticals Provides Update on SYMJEPI Products and Announces Distribution and Commercialization Agreement for SYMJEPI and ZIMHI Products  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031567/0/en/Adamis-Pharmaceuticals-Provides-Update-on-SYMJEPI-Products-and-Announces-Distribution-and-Commercialization-Agreement-for-SYMJEPI-and-ZIMHI-Products.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 13:13:41 GMT</td>    <td>Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA - GlobeNewswire</td>    <td>Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2034986/0/en/Adamis-Pharmaceuticals-Resubmits-ZIMHI-New-Drug-Application-to-FDA.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Adamis Pharmaceuticals Schedules First Quarter 2020 Earnings Conference Call and Business Update - Yahoo Finance</td>    <td>Adamis Pharmaceuticals Schedules First Quarter 2020 Earnings Conference Call and Business Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/adamis-pharmaceuticals-schedules-first-quarter-130010400.html">Link</a></td>  </tr></table><h3>17. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADAP">Adaptimmune Therapeutics plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 18:20:00 GMT</td>    <td>Here's Why Adaptimmune Therapeutics Is Rocketing Higher Today - Motley Fool</td>    <td>Here's Why Adaptimmune Therapeutics Is Rocketing Higher Today  Motley FoolMizuho Said Adaptimmune Therapeutics plc (ADAP) ASCO Data 'Incrementally Supportive'  StreetInsider.comAdaptimmune doubles after #ASCO20 update on Phase 1 trial  Seeking AlphaAdaptimmune Therapeutics Makes a Big Splash at ASCO  24/7 Wall St.Adaptimmune Shares Nearly Double On Promising Cancer T-Cell Therapy Data  BenzingaView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/29/heres-why-adaptimmune-therapeutics-is-rocketing-hi.aspx">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 10:19:09 GMT</td>    <td>Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares - GlobeNewswire</td>    <td>Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041318/0/en/Adaptimmune-Therapeutics-plc-Proposes-Public-Offering-of-American-Depositary-Shares.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 05:25:13 GMT</td>    <td>Are Options Traders Betting on a Big Move in Adaptimmune Therapeutics (ADAP) Stock? - Yahoo Finance</td>    <td>Are Options Traders Betting on a Big Move in Adaptimmune Therapeutics (ADAP) Stock?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/options-traders-betting-big-move-043804975.html">Link</a></td>  </tr></table><h3>18. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADPT">Adaptive Biotechnologies</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 22:37:08 GMT</td>    <td>Adaptive Biotech revenue rises 65% to $21M, loss widens amid big COVID-19 immune partnerships - GeekWire</td>    <td>Adaptive Biotech revenue rises 65% to $21M, loss widens amid big COVID-19 immune partnerships  GeekWire</td>    <td><a target="_blank" href="https://www.geekwire.com/2020/adaptive-biotech-revenue-rises-65-21m-loss-widens-amid-big-covid-19-immune-partnerships/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Adaptive Biotechnologies Reports First Quarter 2020 Financial Results - Yahoo Finance</td>    <td>Adaptive Biotechnologies Reports First Quarter 2020 Financial Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/adaptive-biotechnologies-reports-first-quarter-200310149.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Adaptive Biotechnologies and Microsoft launch ImmuneRACE - Technology Record</td>    <td>Adaptive Biotechnologies and Microsoft launch ImmuneRACE  Technology Record</td>    <td><a target="_blank" href="https://www.technologyrecord.com/Article/adaptive-biotechnologies-and-microsoft-launch-immunerace-107714">Link</a></td>  </tr></table><h3>19. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADCT">ADC Therapeutics America SA</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>ADC Therapeutics' ADC therapeutics en-chant Wall Street: $232M upsized IPO - BioWorld Online</td>    <td>ADC Therapeutics' ADC therapeutics en-chant Wall Street: $232M upsized IPO  BioWorld Online</td>    <td><a target="_blank" href="https://www.bioworld.com/articles/435150-adc-therapeutics-adc-therapeutics-en-chant-wall-street-232m-upsized-ipo">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO - Benzinga</td>    <td>The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/general/biotech/20/05/16041357/the-daily-biotech-pulse-co-diagnostics-earnings-nantkwest-plans-pancreatic-cancer-study-adc-thera">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 22:45:24 GMT</td>    <td>Financings for May 14, 2020 | 2020-05-14 | BioWorld - BioWorld Online</td>    <td>Financings for May 14, 2020 | 2020-05-14 | BioWorld  BioWorld Online</td>    <td><a target="_blank" href="https://www.bioworld.com/articles/435099-financings-for-may-14-2020">Link</a></td>  </tr></table><h3>20. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADIL">Adial Pharmaceuticals, Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 13:30:00 GMT</td>    <td>Adial Pharmaceuticals Appoints Dr. Jack Reich to Board of Directors - Yahoo Finance</td>    <td>Adial Pharmaceuticals Appoints Dr. Jack Reich to Board of Directors  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/adial-pharmaceuticals-appoints-dr-jack-133000982.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 16:40:00 GMT</td>    <td>BRIEF-Adial Pharmaceuticals Inc says On May 26, Reached Understanding On Terms To Purchase Covid-19 IgG / IgM Rapid Test Kits - Reuters</td>    <td>BRIEF-Adial Pharmaceuticals Inc says On May 26, Reached Understanding On Terms To Purchase Covid-19 IgG / IgM Rapid Test Kits  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-adial-pharmaceuticals-inc-says-on/brief-adial-pharmaceuticals-inc-says-on-may-26-reached-understanding-on-terms-to-purchase-covid-19-igg-igm-rapid-test-kits-idUSFWN2D90PJ">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Is Adial Pharmaceuticals Inc (ADIL) a Stock to Watch This Week? - InvestorsObserver</td>    <td>Is Adial Pharmaceuticals Inc (ADIL) a Stock to Watch This Week?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-adial-pharmaceuticals-inc-adil-a-stock-to-watch-this-week">Link</a></td>  </tr></table><h3>21. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADMA">ADMA Biologics Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 18:20:32 GMT</td>    <td>For ADMA Biologics Inc. [ADMA], Jefferies sees a rise to $8. What next? - The DBT News</td>    <td>For ADMA Biologics Inc. [ADMA], Jefferies sees a rise to $8. What next?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/for-adma-biologics-inc-adma-jefferies-sees-a-rise-to-8-what-next/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 13:44:00 GMT</td>    <td>Are Options Traders Betting on a Big Move in ADMA Biologics (ADMA) Stock? - Yahoo Finance</td>    <td>Are Options Traders Betting on a Big Move in ADMA Biologics (ADMA) Stock?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/options-traders-betting-big-move-134401019.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 11:50:35 GMT</td>    <td>ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments - GlobeNewswire</td>    <td>ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029348/0/en/ADMA-Biologics-Provides-Corporate-Update-on-Supply-Chain-Robustness-and-Recent-Accomplishments.html">Link</a></td>  </tr></table><h3>22. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADRO">Aduro Biotech, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 11:52:59 GMT</td>    <td>Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement - GlobeNewswire</td>    <td>Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement  GlobeNewswireWhen is Aduro Biotech, Inc. (ADRO) going to be good investment?  Marketing Sentinel$ADRO Aduro Biotech, Chinook Therapeutics Report Definitive Merger Agreement  CML NewsAre Aduro Biotech Inc. (NASDAQ:ADRO) Prospects Worsening?  State ReviewerA Peek Into Aduro Biotech's P/E Ratio  Yahoo FinanceView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042120/0/en/Aduro-Biotech-and-Chinook-Therapeutics-Announce-Definitive-Merger-Agreement.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 11:37:00 GMT</td>    <td>BRIEF-Aduro Biotech, Chinook Therapeutics Report Definitive Merger Agreement - Reuters</td>    <td>BRIEF-Aduro Biotech, Chinook Therapeutics Report Definitive Merger Agreement  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-aduro-biotech-chinook-therapeutics/brief-aduro-biotech-chinook-therapeutics-report-definitive-merger-agreement-idUSFWN2DF07B">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 11:53:06 GMT</td>    <td>Aduro Biotech Presents Nonclinical and Phase 1 Healthy Volunteer Data for BION-1301 at the 57th ERA-EDTA Virtual Congress - GlobeNewswire</td>    <td>Aduro Biotech Presents Nonclinical and Phase 1 Healthy Volunteer Data for BION-1301 at the 57th ERA-EDTA Virtual Congress  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042130/0/en/Aduro-Biotech-Presents-Nonclinical-and-Phase-1-Healthy-Volunteer-Data-for-BION-1301-at-the-57th-ERA-EDTA-Virtual-Congress.html">Link</a></td>  </tr></table><h3>23. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADXS">Advaxis, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:10:00 GMT</td>    <td>Here's Our Rant About Advaxis, Inc. (ADXS) - The News Heater</td>    <td>Here's Our Rant About Advaxis, Inc. (ADXS)  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/heres-our-rant-about-advaxis-inc-adxs/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 12:06:39 GMT</td>    <td>Advaxis Announces Updated Positive Clinical and Biomarker Data from Ongoing Phase 1/2 ADXS-503 Trial in NSCLC - GlobeNewswire</td>    <td>Advaxis Announces Updated Positive Clinical and Biomarker Data from Ongoing Phase 1/2 ADXS-503 Trial in NSCLC  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033458/0/en/Advaxis-Announces-Updated-Positive-Clinical-and-Biomarker-Data-from-Ongoing-Phase-1-2-ADXS-503-Trial-in-NSCLC.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:26:27 GMT</td>    <td>Advaxis to Host Second Quarter Financial Results and Business Update Conference Call on Thursday, June 11, 2020 - GlobeNewswire</td>    <td>Advaxis to Host Second Quarter Financial Results and Business Update Conference Call on Thursday, June 11, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041414/0/en/Advaxis-to-Host-Second-Quarter-Financial-Results-and-Business-Update-Conference-Call-on-Thursday-June-11-2020.html">Link</a></td>  </tr></table><h3>24. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ADVM">Adverum Biotechnologies, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 15:30:34 GMT</td>    <td>Adverum Biotechnologies, Inc. (ADVM) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Adverum Biotechnologies, Inc. (ADVM) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/29/adverum-biotechnologies-inc-advm-q1-2020-earnings.aspx">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 20:25:07 GMT</td>    <td>Adverum Biotechnologies to Host a Conference Call and Webcast to Report First Quarter 2020 Financial Results and Provide Corporate Update - GlobeNewswire</td>    <td>Adverum Biotechnologies to Host a Conference Call and Webcast to Report First Quarter 2020 Financial Results and Provide Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037264/0/en/Adverum-Biotechnologies-to-Host-a-Conference-Call-and-Webcast-to-Report-First-Quarter-2020-Financial-Results-and-Provide-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 16:46:45 GMT</td>    <td>Why Adverum Biotechnologies Stock Is Soaring Today - The Motley Fool</td>    <td>Why Adverum Biotechnologies Stock Is Soaring Today  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/05/why-adverum-biotechnologies-stock-is-soaring-today.aspx">Link</a></td>  </tr></table><h3>25. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AGLE">Aeglea BioTherapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 20:18:13 GMT</td>    <td>Aeglea BioTherapeutics to Present at BIO Digital 2020 Nasdaq:AGLE - MENAFN.COM</td>    <td>Aeglea BioTherapeutics to Present at BIO Digital 2020 Nasdaq:AGLE  MENAFN.COM</td>    <td><a target="_blank" href="https://menafn.com/1100256664/Aeglea-BioTherapeutics-to-Present-at-BIO-Digital-2020-NasdaqAGLE">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:34:16 GMT</td>    <td>Aeglea BioTherapeutics Announces 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of Neurology - GlobeNewswire</td>    <td>Aeglea BioTherapeutics Announces 1-Year Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 6th Congress of the European Academy of Neurology  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038628/0/en/Aeglea-BioTherapeutics-Announces-1-Year-Data-for-Pegzilarginase-in-Patients-with-Arginase-1-Deficiency-at-the-6th-Congress-of-the-European-Academy-of-Neurology.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 20:10:00 GMT</td>    <td>Aeglea BioTherapeutics Announces Change of Location of Annual Meeting of Stockholders to Be Held June 8, 2020 - GlobeNewswire</td>    <td>Aeglea BioTherapeutics Announces Change of Location of Annual Meeting of Stockholders to Be Held June 8, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040564/0/en/Aeglea-BioTherapeutics-Announces-Change-of-Location-of-Annual-Meeting-of-Stockholders-to-Be-Held-June-8-2020.html">Link</a></td>  </tr></table><h3>26. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AERI">Aerie Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 17:10:00 GMT</td>    <td>Technical Traders Must Watch Aerie Pharmaceuticals, Inc. (AERI) - The News Heater</td>    <td>Technical Traders Must Watch Aerie Pharmaceuticals, Inc. (AERI)  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/technical-traders-must-watch-aerie-pharmaceuticals-inc-aeri/">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Was The Smart Money Right About Aerie Pharmaceuticals Inc (AERI)? - Yahoo Finance</td>    <td>Was The Smart Money Right About Aerie Pharmaceuticals Inc (AERI)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/smart-money-aerie-pharmaceuticals-inc-231553321.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Aerie Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update - Business Wire</td>    <td>Aerie Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506005835/en/Aerie-Pharmaceuticals-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr></table><h3>27. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARPO">Aerpio Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 20:33:10 GMT</td>    <td>Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients - GlobeNewswire</td>    <td>Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039771/0/en/Aerpio-Pharmaceuticals-Inc-and-Quantum-Leap-Healthcare-Collaborative-Announce-the-Selection-of-Razuprotafib-for-Evaluation-in-the-I-SPY-COVID-Trial-for-the-Treatment-of-Acute-Respi.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 17:57:00 GMT</td>    <td>How Hedge Funds Traded Aerpio Pharmaceuticals, Inc. (ARPO) During The Crash - Yahoo Finance</td>    <td>How Hedge Funds Traded Aerpio Pharmaceuticals, Inc. (ARPO) During The Crash  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-traded-aerpio-pharmaceuticals-175737543.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 15:30:00 GMT</td>    <td>Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year? - Yahoo Finance</td>    <td>Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aerpio-pharmaceuticals-arpo-outperforming-other-153003368.html">Link</a></td>  </tr></table><h3>28. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AIH">Aesthetic Medical International Holdings Group</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 02 Apr 2020 12:34:52 GMT</td>    <td>Aesthetic Medical International Holdings Group Limited Enters into Definitive Agreements to Acquire Controlling Interest in Two Treatment Centers - GlobeNewswire</td>    <td>Aesthetic Medical International Holdings Group Limited Enters into Definitive Agreements to Acquire Controlling Interest in Two Treatment Centers  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/04/02/2010760/0/en/Aesthetic-Medical-International-Holdings-Group-Limited-Enters-into-Definitive-Agreements-to-Acquire-Controlling-Interest-in-Two-Treatment-Centers.html">Link</a></td>  </tr><tr>    <td>Thu, 21 Nov 2019 08:00:00 GMT</td>    <td>Aesthetic Medical International Holdings Group Limited to Host Third Quarter 2019 Earnings Conference Call at 8:00 am ET on November 26, 2019 - GlobeNewswire</td>    <td>Aesthetic Medical International Holdings Group Limited to Host Third Quarter 2019 Earnings Conference Call at 8:00 am ET on November 26, 2019  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/11/21/1950848/0/en/Aesthetic-Medical-International-Holdings-Group-Limited-to-Host-Third-Quarter-2019-Earnings-Conference-Call-at-8-00-am-ET-on-November-26-2019.html">Link</a></td>  </tr><tr>    <td>Wed, 30 Oct 2019 07:00:00 GMT</td>    <td>AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING - GlobeNewswire</td>    <td>AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/10/30/1938012/0/en/AESTHETIC-MEDICAL-INTERNATIONAL-HOLDINGS-GROUP-LIMITED-ANNOUNCES-CLOSING-OF-INITIAL-PUBLIC-OFFERING.html">Link</a></td>  </tr></table><h3>29. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AEZS">AEterna Zentaris Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 12:29:34 GMT</td>    <td>Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results - GlobeNewswire</td>    <td>Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028397/0/en/Aeterna-Zentaris-Reports-First-Quarter-2020-Financial-and-Operating-Results.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 13:04:50 GMT</td>    <td>Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders - GlobeNewswire</td>    <td>Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030385/0/en/Aeterna-Zentaris-Announces-Virtual-2020-Annual-Meeting-of-Shareholders.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Aeterna Zentaris: 1Q Earnings Snapshot - WTOC</td>    <td>Aeterna Zentaris: 1Q Earnings Snapshot  WTOC</td>    <td><a target="_blank" href="https://www.wtoc.com/2020/05/06/aeterna-zentaris-q-earnings-snapshot/">Link</a></td>  </tr></table><h3>30. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AEMD">Aethlon Medical, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 18:51:34 GMT</td>    <td>Could The Aethlon Medical, Inc. (NASDAQ:AEMD) Ownership Structure Tell Us Something Useful? - Simply Wall St</td>    <td>Could The Aethlon Medical, Inc. (NASDAQ:AEMD) Ownership Structure Tell Us Something Useful?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/could-the-aethlon-medical-inc-nasdaqaemd-ownership-structure-tell-us-something-useful/">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 15:38:32 GMT</td>    <td>How is Aethlon Medical, Inc. (AEMD) Stock's Recent Performance Affecting Investor's Feelings? - InvestorsObserver</td>    <td>How is Aethlon Medical, Inc. (AEMD) Stock's Recent Performance Affecting Investor's Feelings?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/how-is-aethlon-medical-inc-aemd-stocks-recent-performance-affecting-investors-feelings">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 19:43:22 GMT</td>    <td>Is Aethlon Medical, Inc. (AEMD) Stock a Smart Investment? - InvestorsObserver</td>    <td>Is Aethlon Medical, Inc. (AEMD) Stock a Smart Investment?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-aethlon-medical-inc-aemd-stock-a-smart-investment">Link</a></td>  </tr></table><h3>31. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GNMX">Aevi Genomic Medicine, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 14:55:35 GMT</td>    <td>Global Genomic Medicine Market Size 2020 Analysis, Growth, Vendors, Shares, Drivers, Challenges With Forecast To 2027| BioMed Central Ltd, Cleveland Clinic., Genome Medical, Inc., Aevi Genomic Medicine, Inc., DEEP GENOMICS, Congenica Ltd - Medic Insider</td>    <td>Global Genomic Medicine Market Size 2020 Analysis, Growth, Vendors, Shares, Drivers, Challenges With Forecast To 2027| BioMed Central Ltd, Cleveland Clinic., Genome Medical, Inc., Aevi Genomic Medicine, Inc., DEEP GENOMICS, Congenica Ltd  Medic Insider</td>    <td><a target="_blank" href="https://medicinsider.com/global-genomic-medicine-market-size-2020-analysis-growth-vendors-shares-drivers-challenges-with-forecast-to-2027-biomed-central-ltd-cleveland-clinic-genome-medical-inc-aevi-genomic-me/">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>CERC: Improved Balance Sheet to Move the Pipeline Forward… - Zacks Small Cap Research</td>    <td>CERC: Improved Balance Sheet to Move the Pipeline Forward…  Zacks Small Cap Research</td>    <td><a target="_blank" href="https://scr.zacks.com/News/Press-Releases/Press-Release-Details/2020/CERC-Improved-Balance-Sheet-to-Move-the-Pipeline-Forward-article/default.aspx">Link</a></td>  </tr><tr>    <td>Mon, 03 Feb 2020 08:00:00 GMT</td>    <td>Cerecor and Aevi Genomic Medicine Complete Merger - BioSpace</td>    <td>Cerecor and Aevi Genomic Medicine Complete Merger  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/cerecor-and-aevi-genomic-medicine-complete-merger/">Link</a></td>  </tr></table><h3>32. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AFMD">Affimed N.V.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 12:12:48 GMT</td>    <td>Affimed Highlights Study Design of its AFM13 REDIRECT Trial at the ASCO 2020 Virtual Meeting - GlobeNewswire</td>    <td>Affimed Highlights Study Design of its AFM13 REDIRECT Trial at the ASCO 2020 Virtual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040910/0/en/Affimed-Highlights-Study-Design-of-its-AFM13-REDIRECT-Trial-at-the-ASCO-2020-Virtual-Meeting.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 09:12:38 GMT</td>    <td>Affimed Announces Abstracts on Innate Cell Engagers from its ROCK® Platform Accepted for Presentation at AACR Virtual Annual Meeting II - GlobeNewswire</td>    <td>Affimed Announces Abstracts on Innate Cell Engagers from its ROCK® Platform Accepted for Presentation at AACR Virtual Annual Meeting II  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034067/0/en/Affimed-Announces-Abstracts-on-Innate-Cell-Engagers-from-its-ROCK-Platform-Accepted-for-Presentation-at-AACR-Virtual-Annual-Meeting-II.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:00:00 GMT</td>    <td>Affimed NV Earnings and Growth Analysis : Stock market Insights & financial analysis - Stock Market Daily</td>    <td>Affimed NV Earnings and Growth Analysis : Stock market Insights & financial analysis  Stock Market Daily</td>    <td><a target="_blank" href="https://stockmarketdaily.co/2020/06/03/affimed-nv-earnings-and-growth-analysis/">Link</a></td>  </tr></table><h3>33. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AGEN">Agenus Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Agenus Inc. (AGEN) Plunges 7.62% on June 03 - Equities.com</td>    <td>Agenus Inc. (AGEN) Plunges 7.62% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/agenus-inc-agen-plunges-7-62-on-june-03">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Agenus First Quarter Results and Update - Yahoo Finance</td>    <td>Agenus First Quarter Results and Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/agenus-first-quarter-results-120000077.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 16:00:02 GMT</td>    <td>Agenus Inc. (AGEN) investors to reap big returns again - Marketing Sentinel</td>    <td>Agenus Inc. (AGEN) investors to reap big returns again  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/01/agenus-inc-agen-investors-to-reap-big-returns-again/">Link</a></td>  </tr></table><h3>34. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AGRX">Agile Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 20:15:50 GMT</td>    <td>Agile Therapeutics Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Agile Therapeutics Reports First Quarter 2020 Financial Results  GlobeNewswireAgile ended 1Q 2020 with nearly $94M in cash as it prepares to commercialize Twirla contraceptive  Proactive Investors USA & CanadaAgile Therapeutics Inc. (AGRX) moved down -0.36%: Agile Therapeutics Inc. Price Paint Picture of volatility  State ReviewerThings You Should Know Before Diving Into Agile Therapeutics, Inc. (AGRX)  Stocks HeraldAgile Therapeutics, Inc. (NASDAQ:AGRX) Files An 8-K Entry into a Material Definitive Agreement  Market ExclusiveView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027869/0/en/Agile-Therapeutics-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:40:00 GMT</td>    <td>Agile Therapeutics Inc. [AGRX] moved down 0.00: Why It’s Important - The DBT News</td>    <td>Agile Therapeutics Inc. [AGRX] moved down 0.00: Why It’s Important  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/agile-therapeutics-inc-agrx-moved-down-0-00-why-its-important/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 13:00:02 GMT</td>    <td>Here is a bargain stock you should look at : Agile Therapeutics, Inc. (AGRX) - Marketing Sentinel</td>    <td>Here is a bargain stock you should look at : Agile Therapeutics, Inc. (AGRX)  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/02/here-is-a-bargain-stock-you-should-look-at-agile-therapeutics-inc-agrx/">Link</a></td>  </tr></table><h3>35. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AGIO">Agios Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 30 May 2020 15:31:00 GMT</td>    <td>Why Is Agios Pharmaceuticals (AGIO) Up 25.8% Since Last Earnings Report? - Yahoo Finance</td>    <td>Why Is Agios Pharmaceuticals (AGIO) Up 25.8% Since Last Earnings Report?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-agios-pharmaceuticals-agio-25-153103311.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 11:18:53 GMT</td>    <td>Agios Announces Publication of TIBSOVO® Phase 3 Data in The Lancet Oncology Demonstrating Significant Improvement in Progression-Free Survival Compared to Placebo in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients - GlobeNewswire</td>    <td>Agios Announces Publication of TIBSOVO® Phase 3 Data in The Lancet Oncology Demonstrating Significant Improvement in Progression-Free Survival Compared to Placebo in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/19/2035513/0/en/Agios-Announces-Publication-of-TIBSOVO-Phase-3-Data-in-The-Lancet-Oncology-Demonstrating-Significant-Improvement-in-Progression-Free-Survival-Compared-to-Placebo-in-Previously-Trea.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Will Agios Pharmaceuticals Continue to Surge Higher? - Yahoo Finance</td>    <td>Will Agios Pharmaceuticals Continue to Surge Higher?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/agios-pharmaceuticals-continue-surge-higher-144902393.html">Link</a></td>  </tr></table><h3>36. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALRN">Aileron Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 14:22:00 GMT</td>    <td>The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics - Yahoo Finance</td>    <td>The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/zacks-analyst-blog-highlights-aileron-142202788.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 20:01:00 GMT</td>    <td>Aileron Therapeutics Announces Proposed Public Offering of Common Stock - Yahoo Finance</td>    <td>Aileron Therapeutics Announces Proposed Public Offering of Common Stock  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aileron-therapeutics-announces-proposed-public-200110388.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 11:00:00 GMT</td>    <td>Aileron Therapeutics Announces Positive Interim Results from Phase 1b/2 Clinical Trial of ALRN-6924 for the Prevention of Topotecan-induced Toxicities During Treatment for Small Cell Lung Cancer - Yahoo Finance</td>    <td>Aileron Therapeutics Announces Positive Interim Results from Phase 1b/2 Clinical Trial of ALRN-6924 for the Prevention of Topotecan-induced Toxicities During Treatment for Small Cell Lung Cancer  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aileron-therapeutics-announces-positive-interim-110010277.html">Link</a></td>  </tr></table><h3>37. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AIMT">Aimmune Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 18:46:06 GMT</td>    <td>Palforzia From Aimmune Therapeutics Inc - Pharmacy Times</td>    <td>Palforzia From Aimmune Therapeutics Inc  Pharmacy Times</td>    <td><a target="_blank" href="https://www.pharmacytimes.com/publications/issue/2020/may2020/palforzia-from-aimmune-therapeutics-inc">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Aimmune Therapeutics Announces First Quarter 2020 Financial Results and Provides Recent Operational Highlights - Business Wire</td>    <td>Aimmune Therapeutics Announces First Quarter 2020 Financial Results and Provides Recent Operational Highlights  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200511005824/en/Aimmune-Therapeutics-Announces-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:50:00 GMT</td>    <td>What's Behind Aimmune Therapeutics, Inc. (AIMT) Volatile Ride? - The News Heater</td>    <td>What's Behind Aimmune Therapeutics, Inc. (AIMT) Volatile Ride?  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/whats-behind-aimmune-therapeutics-inc-aimt-volatile-ride/">Link</a></td>  </tr></table><h3>38. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AKTX">Akari Therapeutics Plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 15:53:17 GMT</td>    <td>Akari Therapeutics Receives Positive EMA Opinion on Orphan Designation for Nomacopan for Bullous Pemphigoid - GlobeNewswire</td>    <td>Akari Therapeutics Receives Positive EMA Opinion on Orphan Designation for Nomacopan for Bullous Pemphigoid  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037179/0/en/Akari-Therapeutics-Receives-Positive-EMA-Opinion-on-Orphan-Designation-for-Nomacopan-for-Bullous-Pemphigoid.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 11:07:36 GMT</td>    <td>Akari Therapeutics Reports First Quarter 2020 Financial Results and Highlights Recent Clinical Progress - GlobeNewswire</td>    <td>Akari Therapeutics Reports First Quarter 2020 Financial Results and Highlights Recent Clinical Progress  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040810/0/en/Akari-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Highlights-Recent-Clinical-Progress.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 11:27:00 GMT</td>    <td>BRIEF-Akari Therapeutics Reports Qtrly Loss Per Share $0.00 - Reuters</td>    <td>BRIEF-Akari Therapeutics Reports Qtrly Loss Per Share $0.00  Reuters</td>    <td><a target="_blank" href="https://in.reuters.com/article/brief-akari-therapeutics-reports-qtrly-l/brief-akari-therapeutics-reports-qtrly-loss-per-share-0-00-idINASA00S0B">Link</a></td>  </tr></table><h3>39. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AKCA">Akcea Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Akcea Announces Appointment of New Chief Financial Officer - PRNewswire</td>    <td>Akcea Announces Appointment of New Chief Financial Officer  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/akcea-announces-appointment-of-new-chief-financial-officer-301059792.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Akcea Therapeutics Canada Confirms Letter of Intent with Pan-Canadian Pharmaceutical Alliance for TEGSEDI™ (inotersen injection) - Yahoo Finance</td>    <td>Akcea Therapeutics Canada Confirms Letter of Intent with Pan-Canadian Pharmaceutical Alliance for TEGSEDI™ (inotersen injection)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/akcea-therapeutics-canada-confirms-letter-120000739.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Akcea Therapeutics, Inc. (AKCA) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Akcea Therapeutics, Inc. (AKCA) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/06/akcea-therapeutics-inc-akca-q1-2020-earnings-call.aspx">Link</a></td>  </tr></table><h3>40. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AKBA">Akebia Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 20:30:00 GMT</td>    <td>Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Manchestertimes</td>    <td>Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Manchestertimes</td>    <td><a target="_blank" href="https://www.manchestertimes.com/news/business/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4/article_7d17fe88-db4c-5a6f-9456-2932cce32857.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Akebia Therapeutics Announces Change to Virtual Annual Meeting of Stockholders - PRNewswire</td>    <td>Akebia Therapeutics Announces Change to Virtual Annual Meeting of Stockholders  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-change-to-virtual-annual-meeting-of-stockholders-301063709.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Akebia Therapeutics: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Akebia Therapeutics: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Akebia-Therapeutics-1Q-Earnings-Snapshot-15247316.php">Link</a></td>  </tr></table><h3>41. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AKRO">Akero Therapeutics, Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Akero Therapeutics Reports First Quarter 2020 Financial Results - PRNewswire</td>    <td>Akero Therapeutics Reports First Quarter 2020 Financial Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/akero-therapeutics-reports-first-quarter-2020-financial-results-301058822.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 20:05:00 GMT</td>    <td>Akero Therapeutics To Present At The Jefferies Virtual Healthcare Conference - PRNewswire</td>    <td>Akero Therapeutics To Present At The Jefferies Virtual Healthcare Conference  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/akero-therapeutics-to-present-at-the-jefferies-virtual-healthcare-conference-301065404.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Akero Therapeutics Inc (AKRO) Upgraded to Buy: Here's What You Should Know - Yahoo Finance</td>    <td>Akero Therapeutics Inc (AKRO) Upgraded to Buy: Here's What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/akero-therapeutics-inc-akro-upgraded-160004686.html">Link</a></td>  </tr></table><h3>42. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AKER">Akers Biosciences Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 21:37:52 GMT</td>    <td>Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - GlobeNewswire</td>    <td>Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2035286/0/en/Akers-Biosciences-Closes-4-8-Million-Registered-Direct-Offering-Priced-At-the-Market-under-Nasdaq-Rules.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 13:47:29 GMT</td>    <td>Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP - GlobeNewswire</td>    <td>Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033608/0/en/Akers-Biosciences-and-Premas-Biotech-Announce-Successful-Completion-of-Vaccine-Prototype-Obtained-First-Images-of-VLP.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K) - marketscreener.com</td>    <td>AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/AKERS-BIOSCIENCES-INC-47080603/news/AKERS-BIOSCIENCES-INC-Entry-into-a-Material-Definitive-Agreement-Other-Events-Financial-Statem-30608610/">Link</a></td>  </tr></table><h3>43. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AKRX">Akorn, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Akorn Seeks Bankruptcy After Failed Takeover, FDA Warnings - Yahoo Finance</td>    <td>Akorn Seeks Bankruptcy After Failed Takeover, FDA Warnings  Yahoo FinanceAkorn files for bankruptcy after failed takeover, FDA warnings  Crain's Chicago BusinessAkorn, Inc. − Generic Pharmaceutical Files Chapter 11 with $1bn of Debt Citing "Overhang" of Terminated Merger with Fresenius Kabi AG and Related Litigation; Prepetition Lenders to Serve as Stalking Horse in Sales Process | Daily Bankrupt Company Updates  Bankrupt Company NewsAkorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term Success  PRNewswireAkorn Files For Chapter 11  Contract PharmaView Full Coverage on Google News</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/akorn-files-bankruptcy-failed-takeover-043654699.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 17:39:57 GMT</td>    <td>Akorn Inc. Chapter 11 Looks Imminent - Seeking Alpha</td>    <td>Akorn Inc. Chapter 11 Looks Imminent  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4348037-akorn-inc-chapter-11-looks-imminent">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 20:00:02 GMT</td>    <td>Akorn, Inc. (AKRX) investors to reap big returns again - Marketing Sentinel</td>    <td>Akorn, Inc. (AKRX) investors to reap big returns again  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/05/28/akorn-inc-akrx-investors-to-reap-big-returns-again/">Link</a></td>  </tr></table><h3>44. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALBO">Albireo Pharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Recap: Albireo Pharma Q1 Earnings - Yahoo Finance</td>    <td>Recap: Albireo Pharma Q1 Earnings  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/recap-albireo-pharma-q1-earnings-114538727.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Albireo Pharma, Inc. (NASDAQ:ALBO) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance</td>    <td>Albireo Pharma, Inc. (NASDAQ:ALBO) Just Reported And Analysts Have Been Cutting Their Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/albireo-pharma-inc-nasdaq-albo-102505972.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:07:53 GMT</td>    <td>Albireo to Present at 2020 Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>Albireo to Present at 2020 Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038558/0/en/Albireo-to-Present-at-2020-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr></table><h3>45. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALDR">Alder BioPharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 10:03:53 GMT</td>    <td>Pituitary ACTH Hypersecretion Drug Market 2020 | Strategic Assessment by Top Players like Alder Biopharmaceuticals Inc., Corcept Therapeutics Incorporated, Cortendo AB, Cyclacel Pharmaceuticals, Inc., ElexoPharm GmbH, Ipsen SA, Isis Pharmaceuticals, Inc., Novartis AG, Orphagen Pharmaceuticals, Inc., Pfizer Inc., and More… - Medic Insider</td>    <td>Pituitary ACTH Hypersecretion Drug Market 2020 | Strategic Assessment by Top Players like Alder Biopharmaceuticals Inc., Corcept Therapeutics Incorporated, Cortendo AB, Cyclacel Pharmaceuticals, Inc., ElexoPharm GmbH, Ipsen SA, Isis Pharmaceuticals, Inc., Novartis AG, Orphagen Pharmaceuticals, Inc., Pfizer Inc., and More…  Medic Insider</td>    <td><a target="_blank" href="https://medicinsider.com/pituitary-acth-hypersecretion-drug-market-2020-strategic-assessment-by-top-players-like-alder-biopharmaceuticals-inc-corcept-therapeutics-incorporated-cortendo-ab-cyclacel-pharmaceuticals-inc/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:26:16 GMT</td>    <td>Neoleukin Therapeutics Announces Appointment of Erin Lavelle to Board of Directors - GlobeNewswire</td>    <td>Neoleukin Therapeutics Announces Appointment of Erin Lavelle to Board of Directors  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041426/0/en/Neoleukin-Therapeutics-Announces-Appointment-of-Erin-Lavelle-to-Board-of-Directors.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 18:52:08 GMT</td>    <td>Migraine Treatment Market 2020, Major key companies Analysis like Cefaly Technology, Aegis Theraputics, LLC, Electrocore, Inc, Aerial BioPharma LLC, ALDER BIOPHARMACEUTICALS, INC - Medic Insider</td>    <td>Migraine Treatment Market 2020, Major key companies Analysis like Cefaly Technology, Aegis Theraputics, LLC, Electrocore, Inc, Aerial BioPharma LLC, ALDER BIOPHARMACEUTICALS, INC  Medic Insider</td>    <td><a target="_blank" href="https://medicinsider.com/migraine-treatment-market-2020-major-key-companies-analysis-like-cefaly-technology-aegis-theraputics-llc-electrocore-inc-aerial-biopharma-llc-alder-biopharmaceuticals-inc/">Link</a></td>  </tr></table><h3>46. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALDX">Aldeyra Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 11:00:00 GMT</td>    <td>Aldeyra Therapeutics to Advance ADX-1612, an Investigational New HSP90 Inhibitor with Potential Nanomolar Potency Against SARS-CoV-2, to Clinical Testing for COVID-19; ADX-629 Accepted for BARDA CoronaWatch Meeting - Business Wire</td>    <td>Aldeyra Therapeutics to Advance ADX-1612, an Investigational New HSP90 Inhibitor with Potential Nanomolar Potency Against SARS-CoV-2, to Clinical Testing for COVID-19; ADX-629 Accepted for BARDA CoronaWatch Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200520005228/en/Aldeyra-Therapeutics-Advance-ADX-1612-Investigational-New-HSP90">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Aldeyra Therapeutics Reports First-Quarter 2020 Financial Results and Announces New Clinical Programs - Business Wire</td>    <td>Aldeyra Therapeutics Reports First-Quarter 2020 Financial Results and Announces New Clinical Programs  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005225/en/Aldeyra-Therapeutics-Reports-First-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 16:00:00 GMT</td>    <td>Aldeyra Therapeutics Inc (ALDX) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance</td>    <td>Aldeyra Therapeutics Inc (ALDX) Upgraded to Strong Buy: Here's What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aldeyra-therapeutics-inc-aldx-upgraded-160004443.html">Link</a></td>  </tr></table><h3>47. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALEC">Alector, Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:01:00 GMT</td>    <td>Alector to Present at the Goldman Sachs 41st Annual Global Healthcare Conference - Yahoo Finance</td>    <td>Alector to Present at the Goldman Sachs 41st Annual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/alector-present-goldman-sachs-41st-200110787.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 12:00:00 GMT</td>    <td>Alector Reports 2020 First Quarter Financial Results and Business Highlights - GlobeNewswire</td>    <td>Alector Reports 2020 First Quarter Financial Results and Business Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032652/0/en/Alector-Reports-2020-First-Quarter-Financial-Results-and-Business-Highlights.html">Link</a></td>  </tr><tr>    <td>Sat, 16 May 2020 07:00:00 GMT</td>    <td>Analysts Have Made A Financial Statement On Alector, Inc.'s (NASDAQ:ALEC) First-Quarter Report - Yahoo Finance</td>    <td>Analysts Have Made A Financial Statement On Alector, Inc.'s (NASDAQ:ALEC) First-Quarter Report  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-made-financial-statement-alector-120541463.html">Link</a></td>  </tr></table><h3>48. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALXN">Alexion Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 21:50:00 GMT</td>    <td>Alexion Pharmaceuticals (ALXN) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance</td>    <td>Alexion Pharmaceuticals (ALXN) Stock Sinks As Market Gains: What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/alexion-pharmaceuticals-alxn-stock-sinks-215009917.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 17:05:00 GMT</td>    <td>Hedge Funds Have Never Been This Bullish On Alexion Pharmaceuticals, Inc. (ALXN) - Yahoo Finance</td>    <td>Hedge Funds Have Never Been This Bullish On Alexion Pharmaceuticals, Inc. (ALXN)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-never-bullish-alexion-170557048.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 14:00:05 GMT</td>    <td>Alexion Pharmaceuticals, Inc. (ALXN): What is good about stock? - Marketing Sentinel</td>    <td>Alexion Pharmaceuticals, Inc. (ALXN): What is good about stock?  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/02/alexion-pharmaceuticals-inc-alxn-what-is-good-about-stock/">Link</a></td>  </tr></table><h3>49. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALIM">Alimera Sciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:15:34 GMT</td>    <td>Alimera to Present at the June 2020 Virtual Summer Investor Summit - GlobeNewswire</td>    <td>Alimera to Present at the June 2020 Virtual Summer Investor Summit  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042857/0/en/Alimera-to-Present-at-the-June-2020-Virtual-Summer-Investor-Summit.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 10:23:06 GMT</td>    <td>Some Alimera Sciences (NASDAQ:ALIM) Shareholders Have Taken A Painful 92% Share Price Drop - Simply Wall St</td>    <td>Some Alimera Sciences (NASDAQ:ALIM) Shareholders Have Taken A Painful 92% Share Price Drop  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alim/alimera-sciences/news/some-alimera-sciences-nasdaqalim-shareholders-have-taken-a-painful-92-share-price-drop/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 13:20:49 GMT</td>    <td>Global Retinal Vein Occlusion Market Key Trends 2020: By Regeneron Pharmaceuticals, Inc., Topcon Corporation, Merck & Co., Inc., Carl Zeiss AG, Alimera Sciences, Annexin Pharmaceuticals - Cole of Duty</td>    <td>Global Retinal Vein Occlusion Market Key Trends 2020: By Regeneron Pharmaceuticals, Inc., Topcon Corporation, Merck & Co., Inc., Carl Zeiss AG, Alimera Sciences, Annexin Pharmaceuticals  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/military-news/2020/06/02/global-retinal-vein-occlusion-market-key-trends-2020-by-regeneron-pharmaceuticals-inc-topcon-corporation-merck-co-inc-carl-zeiss-ag-alimera-sciences-annexin-pharmaceuticals/">Link</a></td>  </tr></table><h3>50. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALKS">Alkermes plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Alkermes Announces Upcoming Presentation at the Bank of America Securities Virtual Health Care Conference - Yahoo Finance</td>    <td>Alkermes Announces Upcoming Presentation at the Bank of America Securities Virtual Health Care Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/alkermes-announces-upcoming-presentation-bank-200000830.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 11:00:00 GMT</td>    <td>Alkermes Highlights New Data From Schizophrenia Portfolio at the American Society of Clinical Psychopharmacology 2020 Annual Meeting - PRNewswire</td>    <td>Alkermes Highlights New Data From Schizophrenia Portfolio at the American Society of Clinical Psychopharmacology 2020 Annual Meeting  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/alkermes-highlights-new-data-from-schizophrenia-portfolio-at-the-american-society-of-clinical-psychopharmacology-2020-annual-meeting-301065586.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 11:08:00 GMT</td>    <td>Alkermes (ALKS) Reports Publication of Data from ALPINE Study in Patients With Schizophrenia - StreetInsider.com</td>    <td>Alkermes (ALKS) Reports Publication of Data from ALPINE Study in Patients With Schizophrenia  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Alkermes+%28ALKS%29+Reports+Publication+of+Data+from+ALPINE+Study+in+Patients+With+Schizophrenia/16909186.html">Link</a></td>  </tr></table><h3>51. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALLK">Allakos Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:01:00 GMT</td>    <td>Allakos Initiates Patient Recruitment for AK002 Registrational Studies - GlobeNewswire</td>    <td>Allakos Initiates Patient Recruitment for AK002 Registrational Studies  GlobeNewswire</td>    <td><a target="_blank" href="http://www.globenewswire.com/news-release/2020/06/03/2042884/0/en/Allakos-Initiates-Patient-Recruitment-for-AK002-Registrational-Studies.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:06:00 GMT</td>    <td>Form 8-K Allakos Inc. For: Jun 03 - StreetInsider.com</td>    <td>Form 8-K Allakos Inc. For: Jun 03  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/SEC+Filings/Form+8-K+Allakos+Inc.+For%3A+Jun+03/16965565.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>All You Need to Know About Allakos Inc (ALLK) Rating Upgrade to Buy - Yahoo Finance</td>    <td>All You Need to Know About Allakos Inc (ALLK) Rating Upgrade to Buy  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/know-allakos-inc-allk-rating-160004306.html">Link</a></td>  </tr></table><h3>52. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALNA">Allena Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 12:07:40 GMT</td>    <td>Allena Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>Allena Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038568/0/en/Allena-Pharmaceuticals-to-Present-at-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 20:00:03 GMT</td>    <td>Allena Pharmaceuticals, Inc. (ALNA) investors to reap big returns again - Marketing Sentinel</td>    <td>Allena Pharmaceuticals, Inc. (ALNA) investors to reap big returns again  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/02/allena-pharmaceuticals-inc-alna-investors-to-reap-big-returns-again/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:15:00 GMT</td>    <td>Allena Pharmaceuticals Announces $15.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Yahoo Finance</td>    <td>Allena Pharmaceuticals Announces $15.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/allena-pharmaceuticals-announces-15-0-171510948.html">Link</a></td>  </tr></table><h3>53. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALLO">Allogene Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 01:07:44 GMT</td>    <td>Allogene Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewswire</td>    <td>Allogene Therapeutics Announces Pricing of Public Offering of Common Stock  GlobeNewswireWhy Allogene Therapeutics Is Trading Lower Today  Yahoo FinanceAllogene Therapeutics (ALLO) Announces Proposed $450M Common Offering  StreetInsider.comASCO20: Allogene CAR T 'shelf life' mulled as early phase I results rival autologous  BioWorld OnlineAllogene Therapeutics Announces Commencement of Public Offering of Common Stock  Global Banking And Finance ReviewView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2041863/0/en/Allogene-Therapeutics-Announces-Pricing-of-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:35:35 GMT</td>    <td>Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation - GlobeNewswire</td>    <td>Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042922/0/en/Allogene-Therapeutics-Announces-June-2020-Virtual-Investor-Conference-Participation.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 11:46:47 GMT</td>    <td>Allogene Therapeutics Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Allogene Therapeutics Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028334/0/en/Allogene-Therapeutics-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>54. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALNY">Alnylam Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Is Alnylam Pharmaceuticals a Buy? - Motley Fool</td>    <td>Is Alnylam Pharmaceuticals a Buy?  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/21/is-alnylam-pharmaceuticals-a-buy.aspx">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 11:00:00 GMT</td>    <td>Alnylam Announces U.S. Food and Drug Administration Has Granted Priority Review of the Lumasiran New Drug Application for the Treatment of Primary Hyperoxaluria Type 1 - Business Wire</td>    <td>Alnylam Announces U.S. Food and Drug Administration Has Granted Priority Review of the Lumasiran New Drug Application for the Treatment of Primary Hyperoxaluria Type 1  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200526005203/en/Alnylam-Announces-U.S.-Food-Drug-Administration-Granted">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Alnylam Pharmaceuticals Inc (ALNY) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Alnylam Pharmaceuticals Inc (ALNY) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/06/alnylam-pharmaceuticals-inc-alny-q1-2020-earnings.aspx">Link</a></td>  </tr></table><h3>55. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALPN">Alpine Immune Sciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Alpine Immune Sciences Reports First Quarter 2020 Financial Results and Provides Company Update - Business Wire</td>    <td>Alpine Immune Sciences Reports First Quarter 2020 Financial Results and Provides Company Update  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200514005697/en/Alpine-Immune-Sciences-Reports-Quarter-2020-Financial">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 10:42:06 GMT</td>    <td>Alpine Immune Sciences (NASDAQ:ALPN) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway - Simply Wall St</td>    <td>Alpine Immune Sciences (NASDAQ:ALPN) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alpn/alpine-immune-sciences/news/alpine-immune-sciences-nasdaqalpn-may-not-be-profitable-but-it-seems-to-be-managing-its-debt-just-fine-anyway/">Link</a></td>  </tr><tr>    <td>Sat, 16 May 2020 07:00:00 GMT</td>    <td>Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance</td>    <td>Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported Earnings, And Analysts Cut Their Target Price  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/alpine-immune-sciences-inc-nasdaq-121101069.html">Link</a></td>  </tr></table><h3>56. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALT">Altimmune, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 11:21:00 GMT</td>    <td>Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19 - GlobeNewswire</td>    <td>Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041361/0/en/Altimmune-Launches-Clinical-Trial-of-T-COVIDTM-an-Investigational-Intranasal-Immune-Modulator-for-the-Treatment-of-Patients-with-Early-COVID-19.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 21:26:17 GMT</td>    <td>Altimmune Announces First Quarter 2020 Financial Results and Provides a Business Update - GlobeNewswire</td>    <td>Altimmune Announces First Quarter 2020 Financial Results and Provides a Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033072/0/en/Altimmune-Announces-First-Quarter-2020-Financial-Results-and-Provides-a-Business-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 14:39:02 GMT</td>    <td>Is Altimmune Inc (ALT) Stock a Smart Investment? - InvestorsObserver</td>    <td>Is Altimmune Inc (ALT) Stock a Smart Investment?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-altimmune-inc-alt-stock-a-smart-investment">Link</a></td>  </tr></table><h3>57. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ALZH">Alzheon, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 07 Jan 2020 08:00:00 GMT</td>    <td>Alzheon Announces Appointment of Peter N. Laivins as Head of Commercial Strategy and Planning - Business Wire</td>    <td>Alzheon Announces Appointment of Peter N. Laivins as Head of Commercial Strategy and Planning  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200107005196/en/Alzheon-Announces-Appointment-Peter-N.-Laivins-Head">Link</a></td>  </tr><tr>    <td>Wed, 06 Nov 2019 08:00:00 GMT</td>    <td>Alzheon Publication Defines New Path for 2nd Generation Anti-Amyloid Drugs for Alzheimer's Disease, Supporting Launch of Phase 3 Study with ALZ-801 Oral Tablet - Business Wire</td>    <td>Alzheon Publication Defines New Path for 2nd Generation Anti-Amyloid Drugs for Alzheimer's Disease, Supporting Launch of Phase 3 Study with ALZ-801 Oral Tablet  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20191106005355/en/Alzheon-Publication-Defines-New-Path-2nd-Generation">Link</a></td>  </tr><tr>    <td>Mon, 02 Dec 2019 08:00:00 GMT</td>    <td>Alzheon Announces Scientific Presentation at 12th Clinical Trials on Alzheimer's Disease (CTAD) Conference Taking Place on December 4-7 in San Diego, USA - Business Wire</td>    <td>Alzheon Announces Scientific Presentation at 12th Clinical Trials on Alzheimer's Disease (CTAD) Conference Taking Place on December 4-7 in San Diego, USA  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20191202005122/en/Alzheon-Announces-Scientific-Presentation-12th-Clinical-Trials">Link</a></td>  </tr></table><h3>58. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AMAG">AMAG Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 21:19:50 GMT</td>    <td>AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million - GlobeNewswire</td>    <td>AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037319/0/en/AMAG-Pharmaceuticals-Completes-Sale-of-its-Rights-to-Intrarosa-to-Millicent-Pharma-for-up-to-125-Million.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 11:07:49 GMT</td>    <td>AMAG Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>AMAG Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030942/0/en/AMAG-Pharmaceuticals-Announces-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 12:00:00 GMT</td>    <td>AMAG Pharmaceuticals to Participate in Jefferies Virtual Global Healthcare Conference - Yahoo Finance</td>    <td>AMAG Pharmaceuticals to Participate in Jefferies Virtual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/amag-pharmaceuticals-participate-jefferies-virtual-120010674.html">Link</a></td>  </tr></table><h3>59. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AMRN">Amarin Corporation plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 17:38:00 GMT</td>    <td>Hedge Funds Aren’t Done Buying Amarin Corporation plc (AMRN) - Yahoo Finance</td>    <td>Hedge Funds Aren’t Done Buying Amarin Corporation plc (AMRN)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-aren-t-done-173828016.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:00:02 GMT</td>    <td>Amarin Corporation plc (NASDAQ:AMRN) has great growth outlook for 2020 - Marketing Sentinel</td>    <td>Amarin Corporation plc (NASDAQ:AMRN) has great growth outlook for 2020  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/03/amarin-corporation-plc-nasdaqamrn-has-great-growth-outlook-for-2020/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 11:21:07 GMT</td>    <td>Amarin Plans to Increase VASCEPA® (icosapent ethyl) Promotion and Education - GlobeNewswire</td>    <td>Amarin Plans to Increase VASCEPA® (icosapent ethyl) Promotion and Education  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041354/0/en/Amarin-Plans-to-Increase-VASCEPA-icosapent-ethyl-Promotion-and-Education.html">Link</a></td>  </tr></table><h3>60. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AMGN">Amgen Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 01:42:00 GMT</td>    <td>Amgen Inc. (AMGN) Management Presents at Jefferies 2020 Virtual Healthcare Conference (Transcript) - Seeking Alpha</td>    <td>Amgen Inc. (AMGN) Management Presents at Jefferies 2020 Virtual Healthcare Conference (Transcript)  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4351626-amgen-inc-amgn-management-presents-jefferies-2020-virtual-healthcare-conference-transcript">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 02:52:00 GMT</td>    <td>Oppenheimer Stick to Their Buy Rating for Amgen Inc - Investing.com</td>    <td>Oppenheimer Stick to Their Buy Rating for Amgen Inc  Investing.com</td>    <td><a target="_blank" href="https://www.investing.com/news/oppenheimer-stick-to-their-buy-rating-for-amgen-inc-2187928">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:10:00 GMT</td>    <td>Amgen Inc. (AMGN) move down -1.41% this morning: AMGN Price downtrend Looks Real - State Reviewer</td>    <td>Amgen Inc. (AMGN) move down -1.41% this morning: AMGN Price downtrend Looks Real  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/amgen-inc-amgn-move-down-1-41-this-morning-amgn-price-downtrend-looks-real/">Link</a></td>  </tr></table><h3>61. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FOLD">Amicus Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:09:16 GMT</td>    <td>Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates - GlobeNewswire</td>    <td>Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029312/0/en/Amicus-Therapeutics-Announces-First-Quarter-2020-Financial-Results-and-Corporate-Updates.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 09:30:00 GMT</td>    <td>why Amicus Therapeutics Inc. [FOLD] is a Good Choice for Investors After New Price Target of $17.95 - The DBT News</td>    <td>why Amicus Therapeutics Inc. [FOLD] is a Good Choice for Investors After New Price Target of $17.95  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/why-amicus-therapeutics-inc-fold-is-a-good-choice-for-investors-after-new-price-target-of-17-95/">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Amicus Therapeutics Inc (FOLD) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Amicus Therapeutics Inc (FOLD) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/09/amicus-therapeutics-inc-fold-q1-2020-earnings-call.aspx">Link</a></td>  </tr></table><h3>62. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AMPH">Amphastar Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 20:05:00 GMT</td>    <td>Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference - Yahoo Finance</td>    <td>Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/amphastar-pharmaceuticals-present-jefferies-virtual-200510115.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:11:46 GMT</td>    <td>Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020 - GlobeNewswire</td>    <td>Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029883/0/en/Amphastar-Pharmaceuticals-Reports-Financial-Results-for-the-Three-Months-Ended-March-31-2020.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Amphastar Pharmaceuticals Inc (AMPH) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Amphastar Pharmaceuticals Inc (AMPH) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/amphastar-pharmaceuticals-inc-amph-q1-2020-earning.aspx">Link</a></td>  </tr></table><h3>63. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ANAB">AnaptysBio, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>AnaptysBio Announces First Quarter 2020 Financial Results and Provides Pipeline Updates - GlobeNewswire</td>    <td>AnaptysBio Announces First Quarter 2020 Financial Results and Provides Pipeline Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028827/0/en/AnaptysBio-Announces-First-Quarter-2020-Financial-Results-and-Provides-Pipeline-Updates.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Earnings Update: AnaptysBio, Inc. (NASDAQ:ANAB) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance</td>    <td>Earnings Update: AnaptysBio, Inc. (NASDAQ:ANAB) Just Reported And Analysts Are Boosting Their Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/earnings-anaptysbio-inc-nasdaq-anab-163800937.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 10:26:33 GMT</td>    <td>How Many AnaptysBio, Inc. (NASDAQ:ANAB) Shares Did Insiders Buy, In The Last Year? - Simply Wall St</td>    <td>How Many AnaptysBio, Inc. (NASDAQ:ANAB) Shares Did Insiders Buy, In The Last Year?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anab/anaptysbio/news/how-many-anaptysbio-inc-nasdaqanab-shares-did-insiders-buy-in-the-last-year/">Link</a></td>  </tr></table><h3>64. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AVXL">Anavex Life Sciences Corp.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:10:23 GMT</td>    <td>Anavex Life Sciences Reports Fiscal 2020 Second Quarter Financial Results And Provides Business Updates - GlobeNewswire</td>    <td>Anavex Life Sciences Reports Fiscal 2020 Second Quarter Financial Results And Provides Business Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029267/0/en/Anavex-Life-Sciences-Reports-Fiscal-2020-Second-Quarter-Financial-Results-And-Provides-Business-Updates.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B) - Yahoo Finance</td>    <td>Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/anavex-life-sciences-announces-initiation-110010180.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Anavex Life Sciences to Announce Fiscal 2020 Second Quarter Financial Results on Thursday, May 7th, 2020Conference Call and Webcast To be Held Thursday, May 7 2020 4:30pm Eastern Time - BioSpace</td>    <td>Anavex Life Sciences to Announce Fiscal 2020 Second Quarter Financial Results on Thursday, May 7th, 2020Conference Call and Webcast To be Held Thursday, May 7 2020 4:30pm Eastern Time  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/anavex-life-sciences-to-announce-fiscal-2020-second-quarter-financial-results-on-thursday-may-7th-2020conference-call-and-webcast-to-be-held-thursday-may-7-2020-4-30pm-eastern-time/">Link</a></td>  </tr></table><h3>65. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ANCN">Anchiano Therapeutics Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 20:12:51 GMT</td>    <td>Anchiano Therapeutics Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Anchiano Therapeutics Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031382/0/en/Anchiano-Therapeutics-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 12:26:24 GMT</td>    <td>Genesis Prize co-founder appointed chairman of Anchiano Therapeutics - The Jerusalem Post</td>    <td>Genesis Prize co-founder appointed chairman of Anchiano Therapeutics  The Jerusalem Post</td>    <td><a target="_blank" href="https://www.jpost.com/health-science/genesis-prize-co-founder-appointed-chairman-of-anchiano-therapeutics-629532">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 22:19:54 GMT</td>    <td>Anchiano Appoints Steve DiPalma as Chief Financial Officer - GlobeNewswire</td>    <td>Anchiano Appoints Steve DiPalma as Chief Financial Officer  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2028022/0/en/Anchiano-Appoints-Steve-DiPalma-as-Chief-Financial-Officer.html">Link</a></td>  </tr></table><h3>66. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ANIP">ANI Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:30:00 GMT</td>    <td>ANI Pharmaceuticals Provides Update on Recent Regulatory Filing - Southernminn.com</td>    <td>ANI Pharmaceuticals Provides Update on Recent Regulatory Filing  Southernminn.com</td>    <td><a target="_blank" href="https://www.southernminn.com/around_the_web/news/article_7382aa6b-3525-52c8-963e-3e5f163c5f42.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 13:07:00 GMT</td>    <td>BRIEF-ANI Pharmaceuticals Says Making Progress To Address Items Identified In FDA's Refusal To File Letter Relating To Cortrophin Gel sNDA Filing - Reuters</td>    <td>BRIEF-ANI Pharmaceuticals Says Making Progress To Address Items Identified In FDA's Refusal To File Letter Relating To Cortrophin Gel sNDA Filing  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-ani-pharmaceuticals-says-making-pr/brief-ani-pharmaceuticals-says-making-progress-to-address-items-identified-in-fdas-refusal-to-file-letter-relating-to-cortrophin-gel-snda-filing-idUSFWN2DE0G6">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO - PRNewswire</td>    <td>ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/ani-pharmaceuticals-reports-first-quarter-2020-results-and-appoints-interim-ceo-301054540.html">Link</a></td>  </tr></table><h3>67. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ANVS">Annovis Bio, Inc. </a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 10:51:06 GMT</td>    <td>Annovis Bio Issued European Patent for Method of Treating Alzheimer's Disease with ANVS401 - GlobeNewswire</td>    <td>Annovis Bio Issued European Patent for Method of Treating Alzheimer's Disease with ANVS401  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042066/0/en/Annovis-Bio-Issued-European-Patent-for-Method-of-Treating-Alzheimer-s-Disease-with-ANVS401.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 11:00:56 GMT</td>    <td>Annovis Bio 2020 Annual Meeting of Stockholders to Be Held on June 3, 2020 - GlobeNewswire</td>    <td>Annovis Bio 2020 Annual Meeting of Stockholders to Be Held on June 3, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041334/0/en/Annovis-Bio-2020-Annual-Meeting-of-Stockholders-to-Be-Held-on-June-3-2020.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 10:51:00 GMT</td>    <td>BRIEF-Annovis Bio Issued European Patent For Method Of Treating Alzheimer’s Disease - Reuters</td>    <td>BRIEF-Annovis Bio Issued European Patent For Method Of Treating Alzheimer’s Disease  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-annovis-bio-issued-european-patent/brief-annovis-bio-issued-european-patent-for-method-of-treating-alzheimers-disease-idUSFWN2DF071">Link</a></td>  </tr></table><h3>68. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ANPC">AnPac Bio-Medical Science Co., Ltd</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:52:00 GMT</td>    <td>BRIEF-Anpac Bio-Medical Science Co Says Jinqiu Tang Appointed CFO - Reuters</td>    <td>BRIEF-Anpac Bio-Medical Science Co Says Jinqiu Tang Appointed CFO  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-anpac-bio-medical-science-co-says/brief-anpac-bio-medical-science-co-says-jinqiu-tang-appointed-cfo-idUSASA00SIB">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 10:48:10 GMT</td>    <td>AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States - GlobeNewswire</td>    <td>AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030915/0/en/AnPac-Bio-Granted-New-Patent-in-Novel-Medical-Device-for-Disease-Detection-in-the-United-States.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:16:24 GMT</td>    <td>AnPac Bio Announces Appointment of New Chief Financial Officer - GlobeNewswire</td>    <td>AnPac Bio Announces Appointment of New Chief Financial Officer  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042596/0/en/AnPac-Bio-Announces-Appointment-of-New-Chief-Financial-Officer.html">Link</a></td>  </tr></table><h3>69. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-APLS">Apellis Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:28:59 GMT</td>    <td>Apellis Pharmaceuticals Announces Private Placement of Convertible Senior Notes - GlobeNewswire</td>    <td>Apellis Pharmaceuticals Announces Private Placement of Convertible Senior Notes  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029330/0/en/Apellis-Pharmaceuticals-Announces-Private-Placement-of-Convertible-Senior-Notes.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Apellis Pharmaceuticals to Present at the BofA Securities 2020 Health Care Conference - Yahoo Finance</td>    <td>Apellis Pharmaceuticals to Present at the BofA Securities 2020 Health Care Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/apellis-pharmaceuticals-present-bofa-securities-110010835.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:11:45 GMT</td>    <td>Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire</td>    <td>Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029884/0/en/Apellis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html">Link</a></td>  </tr></table><h3>70. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AGTC">Applied Genetic Technologies Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 14:50:00 GMT</td>    <td>Why Applied Genetic Technologies (AGTC) Stock Might be a Great Pick - Yahoo Finance</td>    <td>Why Applied Genetic Technologies (AGTC) Stock Might be a Great Pick  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-applied-genetic-technologies-agtc-145002550.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Applied Genetic Technologies Corporation (AGTC) Soars 4.18% on June 02 - Equities.com</td>    <td>Applied Genetic Technologies Corporation (AGTC) Soars 4.18% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/applied-genetic-technologies-corporation-agtc-soars-4-18-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 11:06:55 GMT</td>    <td>AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 13, 2020 - GlobeNewswire</td>    <td>AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 13, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028297/0/en/AGTC-to-Host-Third-Quarter-Financial-Results-Conference-Call-and-Webcast-on-May-13-2020.html">Link</a></td>  </tr></table><h3>71. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-APLT">Applied Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:00:00 GMT</td>    <td>Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference - Yahoo Finance</td>    <td>Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/applied-therapeutics-present-goldman-sachs-110010956.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Applied Therapeutics - Genetic Engineering & Biotechnology News</td>    <td>Applied Therapeutics  Genetic Engineering & Biotechnology News</td>    <td><a target="_blank" href="https://www.genengnews.com/covid-19-candidates/covid-19-keeping-an-eye-on/applied-therapeutics/">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 04:19:30 GMT</td>    <td>Applied Therapeutics Taps Chuck Silberstein as Chief Financial Officer - Xconomy</td>    <td>Applied Therapeutics Taps Chuck Silberstein as Chief Financial Officer  Xconomy</td>    <td><a target="_blank" href="https://xconomy.com/new-york/2020/05/28/applied-therapeutics-taps-chuck-silberstein-as-chief-financial-officer/">Link</a></td>  </tr></table><h3>72. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-APRE">Aprea Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:27:53 GMT</td>    <td>Aprea Therapeutics Completes Full Enrollment of Phase 3 Clinical Trial in TP53 Mutant Myelodysplastic Syndromes (MDS) - BioSpace</td>    <td>Aprea Therapeutics Completes Full Enrollment of Phase 3 Clinical Trial in TP53 Mutant Myelodysplastic Syndromes (MDS)  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/aprea-therapeutics-completes-full-enrollment-of-phase-3-clinical-trial-in-tp53-mutant-myelodysplastic-syndromes-mds-/">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 11:38:42 GMT</td>    <td>Aprea Therapeutics Reports First Quarter 2020 Financial Results and Provides Update on Business Operations - GlobeNewswire</td>    <td>Aprea Therapeutics Reports First Quarter 2020 Financial Results and Provides Update on Business Operations  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034161/0/en/Aprea-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Update-on-Business-Operations.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Why Aprea Therapeutics (APRE) Stock Might be a Great Pick - Yahoo Finance</td>    <td>Why Aprea Therapeutics (APRE) Stock Might be a Great Pick  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-aprea-therapeutics-apre-stock-145702178.html">Link</a></td>  </tr></table><h3>73. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-APRI">Apricus Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:30:09 GMT</td>    <td>Erectile Dysfunction (ED) Drugs Market: Next-level Analysis of COVID 19 Effect on Key Players: Apricus Biosciences Inc., SK Chemicals Co. Ltd., Dong-A Pharmaceutical Co. Ltd. - News Distinct</td>    <td>Erectile Dysfunction (ED) Drugs Market: Next-level Analysis of COVID 19 Effect on Key Players: Apricus Biosciences Inc., SK Chemicals Co. Ltd., Dong-A Pharmaceutical Co. Ltd.  News Distinct</td>    <td><a target="_blank" href="https://www.newsdistinct.com/erectile-dysfunction-ed-drugs-market-next-level-analysis-of-covid-19-effect-on-key-players-apricus-biosciences-inc-s-k-chemicals-co-ltd-dong-a-pharmaceutical-co-ltd/">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 05:24:02 GMT</td>    <td>Erectile Dysfunction (ED) Drugs Market 2020-2026 | Apricus Biosciences Inc., Cristalia Produtos Quimicos Farmaceuticos Ltd., Bayer AG - Cole of Duty</td>    <td>Erectile Dysfunction (ED) Drugs Market 2020-2026 | Apricus Biosciences Inc., Cristalia Produtos Quimicos Farmaceuticos Ltd., Bayer AG  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/05/26/erectile-dysfunction-ed-drugs-market-2020-2026-apricus-biosciences-inc-cristalia-produtos-quimicos-farmaceuticos-ltd-bayer-ag/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 17:02:00 GMT</td>    <td>Erectile Dysfunction Drugs Market to Witness Huge Growth by 2020-2025 Focusing on Leading Players are Apricus Biosciences Inc.,Cristalia Produtos Quimicos Farmaceuticos Ltd.,Bayer AG,Dong-A Pharmaceutical Co. Ltd.,Meda Pharmaceuticals - 3rd Watch News</td>    <td>Erectile Dysfunction Drugs Market to Witness Huge Growth by 2020-2025 Focusing on Leading Players are Apricus Biosciences Inc.,Cristalia Produtos Quimicos Farmaceuticos Ltd.,Bayer AG,Dong-A Pharmaceutical Co. Ltd.,Meda Pharmaceuticals  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/1121211/erectile-dysfunction-drugs-market-to-witness-huge-growth-by-2020-2025-focusing-on-leading-players-are-apricus-biosciences-inc-cristalia-produtos-quimicos-farmaceuticos-ltd-bayer-agdong-a-pharmaceut/">Link</a></td>  </tr></table><h3>74. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-APVO">Aptevo Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Aptevo Therapeutics Reports First Quarter 2020 Financial Results - Yahoo Finance</td>    <td>Aptevo Therapeutics Reports First Quarter 2020 Financial Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aptevo-therapeutics-reports-first-quarter-130000006.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:30:38 GMT</td>    <td>APTEVO THERAPEUTICS INC. : Submission of Matters to a Vote of Security Holders (form 8-K) - marketscreener.com</td>    <td>APTEVO THERAPEUTICS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/APTEVO-THERAPEUTICS-INC-29774500/news/APTEVO-THERAPEUTICS-INC-Submission-of-Matters-to-a-Vote-of-Security-Holders-form-8-K-30706611/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Aptevo Therapeutics Inc. [APVO] fell -16.51% so far this year. What now? - The DBT News</td>    <td>Aptevo Therapeutics Inc. [APVO] fell -16.51% so far this year. What now?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/05/12/aptevo-therapeutics-inc-apvo-fell-16-51-so-far-this-year-what-now/">Link</a></td>  </tr></table><h3>75. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-APTX">Aptinyx Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 20:15:50 GMT</td>    <td>Aptinyx Reports First Quarter 2020 Financial Results and Highlights - GlobeNewswire</td>    <td>Aptinyx Reports First Quarter 2020 Financial Results and Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033840/0/en/Aptinyx-Reports-First-Quarter-2020-Financial-Results-and-Highlights.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Aptinyx Inc. (APTX) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance</td>    <td>Aptinyx Inc. (APTX) Moves to Strong Buy: Rationale Behind the Upgrade  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aptinyx-inc-aptx-moves-strong-160004686.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 12:49:00 GMT</td>    <td>Some Analysts Just Cut Their Aptinyx Inc. (NASDAQ:APTX) Estimates - Yahoo Finance</td>    <td>Some Analysts Just Cut Their Aptinyx Inc. (NASDAQ:APTX) Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-just-cut-aptinyx-inc-124900040.html">Link</a></td>  </tr></table><h3>76. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-APTO">Aptose Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:59:22 GMT</td>    <td>Aptose Biosciences Announces Results of Annual Meeting of Shareholders - GlobeNewswire</td>    <td>Aptose Biosciences Announces Results of Annual Meeting of Shareholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042612/0/en/Aptose-Biosciences-Announces-Results-of-Annual-Meeting-of-Shareholders.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Aptose Biosciences: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Aptose Biosciences: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Aptose-Biosciences-1Q-Earnings-Snapshot-15248623.php">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 20:36:44 GMT</td>    <td>Aptose Biosciences Establishes New At-The-Market Facility - GlobeNewswire</td>    <td>Aptose Biosciences Establishes New At-The-Market Facility  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027936/0/en/Aptose-Biosciences-Establishes-New-At-The-Market-Facility.html">Link</a></td>  </tr></table><h3>77. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AQST">Aquestive Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 21:38:31 GMT</td>    <td>Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals' Apomorphine Sublingual Film Therapy Receives FDA Approval - GlobeNewswire</td>    <td>Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals' Apomorphine Sublingual Film Therapy Receives FDA Approval  GlobeNewswireAquestive Therapeutics Inc. (AQST) Advances Royalty Monetization Plan as Sunovion Pharmaceuticals' Apomorphine Sublingual Film Therapy Receives FDA Approval  StreetInsider.comU.S. FDA Approves Parkinson's Treatment From Sunovion Pharma  The New York TimesParkinson's patients no longer need to rely on a needle for apomorphine antidote for 'off' episodes after new FDA approval  Endpoints NewsView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037338/0/en/Aquestive-Therapeutics-Advances-Royalty-Monetization-Plan-as-Sunovion-Pharmaceuticals-Apomorphine-Sublingual-Film-Therapy-Receives-FDA-Approval.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 19:53:04 GMT</td>    <td>Aquestive Therapeutics (NASDAQ:AQST) Shareholders Have Enjoyed A 24% Share Price Gain - Simply Wall St</td>    <td>Aquestive Therapeutics (NASDAQ:AQST) Shareholders Have Enjoyed A 24% Share Price Gain  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aqst/aquestive-therapeutics/news/aquestive-therapeutics-nasdaqaqst-shareholders-have-enjoyed-a-24-share-price-gain/">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 13:42:00 GMT</td>    <td>Implied Volatility Surging for Aquestive Therapeutics (AQST) Stock Options - Yahoo Finance</td>    <td>Implied Volatility Surging for Aquestive Therapeutics (AQST) Stock Options  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/implied-volatility-surging-aquestive-therapeutics-134201298.html">Link</a></td>  </tr></table><h3>78. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AQXP">Aquinox Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 06 Aug 2019 07:00:00 GMT</td>    <td>Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement - GlobeNewswire</td>    <td>Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement  GlobeNewswireCancer-fighting startup Neoleukin merging with Aquinox in $40M deal, 8 months after UW spinout  GeekWireAquinox, Neoleukin Therapeutics Announce Merger Agreement  Contract PharmaAguinox Pharma down 15% on merger with Neoleukin  Seeking AlphaView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/08/06/1897411/0/en/Aquinox-Pharmaceuticals-and-Neoleukin-Therapeutics-announce-merger-agreement.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Neoleukin (NLTX) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance</td>    <td>Neoleukin (NLTX) Moves to Strong Buy: Rationale Behind the Upgrade  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/neoleukin-nltx-moves-strong-buy-160004939.html">Link</a></td>  </tr><tr>    <td>Fri, 09 Aug 2019 07:00:00 GMT</td>    <td>Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction - GlobeNewswire</td>    <td>Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/08/09/1899908/0/en/Neoleukin-Therapeutics-and-Aquinox-Pharmaceuticals-Complete-Merger-Transaction.html">Link</a></td>  </tr></table><h3>79. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARDM">Aradigm Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 03:28:00 GMT</td>    <td>Tularaemia Treatment Market 2025 Insights Analysis and 7 Company Profiles (Aradigm Corp, Arno Therapeutics Inc, DynPort Vaccine Company LLC, Emergent BioSolutions Inc, More) - 3rd Watch News</td>    <td>Tularaemia Treatment Market 2025 Insights Analysis and 7 Company Profiles (Aradigm Corp, Arno Therapeutics Inc, DynPort Vaccine Company LLC, Emergent BioSolutions Inc, More)  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/industry-analytics/1142889/tularaemia-treatment-market-2025-insights-analysis-and-7-company-profiles-aradigm-corp-arno-therapeutics-inc-dynport-vaccine-company-llc-emergent-biosolutions-inc-more/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:21:36 GMT</td>    <td>Global Sustained Release Drugs Market is slated to grow rapidly in the coming years | Orbis Biosciences, Inc., Lonza, Aradigm Corporation, Alkermes, Johnson & Johnson Services, Inc, Pfizer Inc - Farmers Ledger</td>    <td>Global Sustained Release Drugs Market is slated to grow rapidly in the coming years | Orbis Biosciences, Inc., Lonza, Aradigm Corporation, Alkermes, Johnson & Johnson Services, Inc, Pfizer Inc  Farmers Ledger</td>    <td><a target="_blank" href="https://www.farmersledger.com/global-sustained-release-drugs-market-is-slated-to-grow-rapidly-in-the-coming-years-orbis-biosciences-inc-lonza-aradigm-corporation-alkermes-johnson-johnson-services-inc-pfizer-inc/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 19:13:00 GMT</td>    <td>COVID19-Update:Drug Delivery Technology Market 2020 by Manufacturers, Regions, Type and Application, COVID-19 Impact Analysis 2027 – DBMR Updates - 3rd Watch News</td>    <td>COVID19-Update:Drug Delivery Technology Market 2020 by Manufacturers, Regions, Type and Application, COVID-19 Impact Analysis 2027 – DBMR Updates  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/1159089/covid19-updatedrug-delivery-technology-market-2020-by-manufacturers-regions-type-and-application-covid-19-impact-analysis-2027-dbmr-updates/">Link</a></td>  </tr></table><h3>80. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PETX">Aratana Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 11:42:00 GMT</td>    <td>Pet Veterinary Drug Market by Growth, Demand & Opportunities & Forecast To 2027 | AdvaVet, Advaxis Inc., Amgen Inc., Aratana Therapeutics, Inc., Boehringer Ingelheim International GmbH - BіоPhаrmа Dіvе</td>    <td>Pet Veterinary Drug Market by Growth, Demand & Opportunities & Forecast To 2027 | AdvaVet, Advaxis Inc., Amgen Inc., Aratana Therapeutics, Inc., Boehringer Ingelheim International GmbH  BіоPhаrmа Dіvе</td>    <td><a target="_blank" href="https://www.biopharmapress.com/pet-veterinary-drug-market-by-growth-demand-opportunities-forecast-to-2027-advavet-advaxis-inc-amgen-inc-aratana-therapeutics-inc-boehringer-ingelheim-international-gmbh/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 14:39:25 GMT</td>    <td>COVID-19 Impact on Pet Cancer Therapeutics Market To Grow in the Coming Years, New Research Explores Factors Responsible | Top Key Players Aratana Therapeutics, Inc., AB Science, Boehinger Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc., VetDC, Inc. - Surfacing Magazine</td>    <td>COVID-19 Impact on Pet Cancer Therapeutics Market To Grow in the Coming Years, New Research Explores Factors Responsible | Top Key Players Aratana Therapeutics, Inc., AB Science, Boehinger Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc., VetDC, Inc.  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/covid-19-impact-on-pet-cancer-therapeutics-market-to-grow-in-the-coming-years-new-research-explores-factors-responsible-top-key-players-aratana-therapeutics-inc-ab-science-boehinger-ingelheim-i/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 18:02:00 GMT</td>    <td>Veterinary Pharmaceuticals Market Growth, Drivers, Challenges, Trends And Market Dynamics Forecast 2027| Dechra Pharmaceuticals, Virbac, Ceva Sante Animale, Aratana Therapeutics - News Distinct</td>    <td>Veterinary Pharmaceuticals Market Growth, Drivers, Challenges, Trends And Market Dynamics Forecast 2027| Dechra Pharmaceuticals, Virbac, Ceva Sante Animale, Aratana Therapeutics  News Distinct</td>    <td><a target="_blank" href="https://www.newsdistinct.com/veterinary-pharmaceuticals-market/">Link</a></td>  </tr></table><h3>81. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARAV">Aravive, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 20:20:48 GMT</td>    <td>Aravive Reports First Quarter 2020 Financial Results and Provides Recent Corporate Updates - GlobeNewswire</td>    <td>Aravive Reports First Quarter 2020 Financial Results and Provides Recent Corporate Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028821/0/en/Aravive-Reports-First-Quarter-2020-Financial-Results-and-Provides-Recent-Corporate-Updates.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Aravive To Present at The 2020 RBC Capital Markets Global Healthcare Conference - Yahoo Finance</td>    <td>Aravive To Present at The 2020 RBC Capital Markets Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aravive-present-2020-rbc-capital-120010396.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Aravive: 1Q Earnings Snapshot - Albany Times Union</td>    <td>Aravive: 1Q Earnings Snapshot  Albany Times Union</td>    <td><a target="_blank" href="https://www.timesunion.com/business/article/Aravive-1Q-Earnings-Snapshot-15252868.php">Link</a></td>  </tr></table><h3>82. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ABUS">Arbutus Biopharma Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 17:40:00 GMT</td>    <td>Arbutus Biopharma Corporation [ABUS] Stock trading around $2.09 per share: What’s Next? - The DBT News</td>    <td>Arbutus Biopharma Corporation [ABUS] Stock trading around $2.09 per share: What’s Next?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/arbutus-biopharma-corporation-abus-stock-trading-around-2-09-per-share-whats-next/">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Forecast: Analysts Think Arbutus Biopharma Corporation's (NASDAQ:ABUS) Business Prospects Have Improved Drastically - Yahoo Finance</td>    <td>Forecast: Analysts Think Arbutus Biopharma Corporation's (NASDAQ:ABUS) Business Prospects Have Improved Drastically  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/forecast-analysts-think-arbutus-biopharma-100549620.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Moving Average Crossover Alert: Arbutus Biopharma - Yahoo Finance</td>    <td>Moving Average Crossover Alert: Arbutus Biopharma  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/moving-average-crossover-alert-arbutus-151903178.html">Link</a></td>  </tr></table><h3>83. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ABIO">ARCA biopharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:27:35 GMT</td>    <td>ARCA Biopharma Announces $9.4 Million Registered Direct Offering - GlobeNewswire</td>    <td>ARCA Biopharma Announces $9.4 Million Registered Direct Offering  GlobeNewswireArca Biopharma (ABIO) Announces $9.4 Million Registered Direct Offering of Common Stock, Warrants  StreetInsider.comARCA biopharma, Inc. (NASDAQ:ABIO) Files An 8-K Unregistered Sales of Equity Securities  Market ExclusiveDo ARCA biopharma, Inc. (ABIO) beta value of 3.46 signposts another twist?  The InvestChronicleARCA Biopharma Inc. (NASDAQ:ABIO) Is Developing AB201Program As A Possible COVID-19 Treatment  BP JournalView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041463/0/en/ARCA-Biopharma-Announces-9-4-Million-Registered-Direct-Offering.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:11:01 GMT</td>    <td>ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering - GlobeNewswire</td>    <td>ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2043031/0/en/ARCA-biopharma-Announces-Closing-of-6-1-Million-Registered-Direct-Offering.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 15:40:00 GMT</td>    <td>Arca Biopharma Rallies 200% On COVID-19 Plans - Benzinga</td>    <td>Arca Biopharma Rallies 200% On COVID-19 Plans  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/general/biotech/20/05/16128864/arca-biopharma-rallies-200-on-covid-19-plans">Link</a></td>  </tr></table><h3>84. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARCT">Arcturus Therapeutics Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 17:49:20 GMT</td>    <td>Why Arcturus Therapeutics Stock Is Plunging Today - The Motley Fool</td>    <td>Why Arcturus Therapeutics Stock Is Plunging Today  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/27/why-arcturus-therapeutics-stock-is-plunging-today.aspx">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 18:11:45 GMT</td>    <td>Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine - TheStreet</td>    <td>Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine  TheStreet</td>    <td><a target="_blank" href="https://realmoney.thestreet.com/investing/arcturus-therapeutics-has-a-candidate-for-a-covid-19-vaccine-15334962">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Arcturus Therapeutics Announces First Quarter 2020 Financial Results and Provides a Corporate Update - GlobeNewswire</td>    <td>Arcturus Therapeutics Announces First Quarter 2020 Financial Results and Provides a Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029824/0/en/Arcturus-Therapeutics-Announces-First-Quarter-2020-Financial-Results-and-Provides-a-Corporate-Update.html">Link</a></td>  </tr></table><h3>85. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARQT">Arcutis Biotherapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 13:09:27 GMT</td>    <td>Ayisha Jeter Joins Arcutis as Vice President of Market Access - GlobeNewswire</td>    <td>Ayisha Jeter Joins Arcutis as Vice President of Market Access  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041511/0/en/Ayisha-Jeter-Joins-Arcutis-as-Vice-President-of-Market-Access.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 20:08:10 GMT</td>    <td>Arcutis Announces First Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire</td>    <td>Arcutis Announces First Quarter 2020 Financial Results and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032238/0/en/Arcutis-Announces-First-Quarter-2020-Financial-Results-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 07:00:00 GMT</td>    <td>Do Analysts Agree on Arcutis Biotherapeutics Inc (ARQT) Stock's Target Price? - InvestorsObserver</td>    <td>Do Analysts Agree on Arcutis Biotherapeutics Inc (ARQT) Stock's Target Price?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/do-analysts-agree-on-arcutis-biotherapeutics-inc-arqt-stocks-target-price">Link</a></td>  </tr></table><h3>86. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARDX">Ardelyx, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 03:40:45 GMT</td>    <td>Ardelyx Inc (NASDAQ:ARDX) CEO Sells $169,528.24 in Stock - MarketBeat</td>    <td>Ardelyx Inc (NASDAQ:ARDX) CEO Sells $169,528.24 in Stock  MarketBeat</td>    <td><a target="_blank" href="https://www.marketbeat.com/instant-alerts/nasdaq-ardx-insider-buying-and-selling/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights - PRNewswire</td>    <td>Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/ardelyx-reports-first-quarter-2020-financial-results-and-recent-business-highlights-301055187.html">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>Analysts Are Upgrading Ardelyx, Inc. (NASDAQ:ARDX) After Its Latest Results - Yahoo Finance</td>    <td>Analysts Are Upgrading Ardelyx, Inc. (NASDAQ:ARDX) After Its Latest Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-upgrading-ardelyx-inc-nasdaq-121636506.html">Link</a></td>  </tr></table><h3>87. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARNA">Arena Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 19:25:12 GMT</td>    <td>Hedge Funds Aren’t Done Buying Arena Pharmaceuticals, Inc. (ARNA) - Yahoo Finance</td>    <td>Hedge Funds Aren’t Done Buying Arena Pharmaceuticals, Inc. (ARNA)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-aren-t-done-191354832.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 20:01:00 GMT</td>    <td>Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares - PRNewswire</td>    <td>Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/arena-pharmaceuticals-announces-completion-of-public-offering-of-common-stock-and-exercise-in-full-of-underwriters-option-to-purchase-additional-shares-301068721.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:11:13 GMT</td>    <td>Is Arena Pharmaceuticals, Inc. (ARNA) a Stock to Watch This Week? - InvestorsObserver</td>    <td>Is Arena Pharmaceuticals, Inc. (ARNA) a Stock to Watch This Week?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-arena-pharmaceuticals-inc-arna-a-stock-to-watch-this-week">Link</a></td>  </tr></table><h3>88. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARGX">argenx SE</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>argenx SE (ARGX) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>argenx SE (ARGX) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/14/argenx-se-argx-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 18:48:16 GMT</td>    <td>Here's Why argenx Stock Is Soaring Today - The Motley Fool</td>    <td>Here's Why argenx Stock Is Soaring Today  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/26/heres-why-argenx-stock-is-soaring-today.aspx">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 05:15:07 GMT</td>    <td>argenx reports first quarter 2020 financial results and provides business update - GlobeNewswire</td>    <td>argenx reports first quarter 2020 financial results and provides business update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033183/0/en/argenx-reports-first-quarter-2020-financial-results-and-provides-business-update.html">Link</a></td>  </tr></table><h3>89. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARDS">Aridis Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Aridis Pharmaceuticals Announces First Quarter 2020 Results - PRNewswire</td>    <td>Aridis Pharmaceuticals Announces First Quarter 2020 Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/aridis-pharmaceuticals-announces-first-quarter-2020-results-301058036.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 16:08:00 GMT</td>    <td>Will Aridis Pharmaceuticals Continue to Surge Higher? - Yahoo Finance</td>    <td>Will Aridis Pharmaceuticals Continue to Surge Higher?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aridis-pharmaceuticals-continue-surge-higher-160804297.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 21:28:00 GMT</td>    <td>BRIEF-Aridis Pharmaceuticals Announces Q1 Results - Reuters</td>    <td>BRIEF-Aridis Pharmaceuticals Announces Q1 Results  Reuters</td>    <td><a target="_blank" href="https://uk.reuters.com/article/brief-aridis-pharmaceuticals-announces-q/brief-aridis-pharmaceuticals-announces-q1-results-idUKASA00PRR">Link</a></td>  </tr></table><h3>90. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARQL">ArQule, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 17:51:38 GMT</td>    <td>RAC Gamma Serine/Threonine Protein Kinas MARKET LATEST TRENDING REPORT IS BOOMING GLOBALLY BY TOP LEADING PLAYERS – ArQule Inc, AstraZeneca Plc - Cole of Duty</td>    <td>RAC Gamma Serine/Threonine Protein Kinas MARKET LATEST TRENDING REPORT IS BOOMING GLOBALLY BY TOP LEADING PLAYERS – ArQule Inc, AstraZeneca Plc  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/market-reports/2020/06/02/rac-gamma-serine-threonine-protein-kinas-market-latest-trending-report-is-booming-globally-by-top-leading-players-arqule-inc-astrazeneca-plc/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:47:35 GMT</td>    <td>June 2020 Global Bile Duct Cancer Drug Market Research Report 2020 with COVID-19 Pandemic Analysis by Major Players Ariad Pharmaceuticals Inc., ArQule Inc., Array BioPharma Inc., Arrien Pharmaceuticals LLC, Aslan Pharmaceuticals Pte. Ltd. - Surfacing Magazine</td>    <td>June 2020 Global Bile Duct Cancer Drug Market Research Report 2020 with COVID-19 Pandemic Analysis by Major Players Ariad Pharmaceuticals Inc., ArQule Inc., Array BioPharma Inc., Arrien Pharmaceuticals LLC, Aslan Pharmaceuticals Pte. Ltd.  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/june-2020-global-bile-duct-cancer-drug-market-research-report-2020-with-covid-19-pandemic-analysis-by-major-players-ariad-pharmaceuticals-inc-arqule-inc-array-biopharma-inc-arrien-pharmaceutical/">Link</a></td>  </tr><tr>    <td>Mon, 09 Dec 2019 08:00:00 GMT</td>    <td>Merck to Acquire ArQule, Advancing Leadership in Oncology - Business Wire</td>    <td>Merck to Acquire ArQule, Advancing Leadership in Oncology  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20191209005234/en/Merck-Acquire-ArQule-Advancing-Leadership-Oncology">Link</a></td>  </tr></table><h3>91. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARRY">Array BioPharma Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:51:12 GMT</td>    <td>Array BioPharma Inc. (ARRY:NASDAQ) - Stocks Newswire</td>    <td>Array BioPharma Inc. (ARRY:NASDAQ)  Stocks Newswire</td>    <td><a target="_blank" href="https://stocksnewswire.com/2020/06/02/array-biopharma-continues-to-grow/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 10:57:43 GMT</td>    <td>Coronavirus (COVID – 19) Imapct On Global Dilated Cardiomyopathy Therapeutic Market 2020 Analysis By Top Players | Array BioPharma, Inc., AstraZeneca plc., Celladon Corporation - Cole of Duty</td>    <td>Coronavirus (COVID – 19) Imapct On Global Dilated Cardiomyopathy Therapeutic Market 2020 Analysis By Top Players | Array BioPharma, Inc., AstraZeneca plc., Celladon Corporation  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/06/03/coronavirus-covid-19-imapct-on-global-dilated-cardiomyopathy-therapeutic-market-2020-analysis-by-top-players-array-biopharma-inc-astrazeneca-plc-celladon-corporation/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 16:22:00 GMT</td>    <td>Chronic Low Back Pain Market to Witness Huge Growth by 2027 | Astellas Pharma Inc., Grunenthal GmbH, Orion Oyj, Pfizer Inc., Regeneron Pharmaceuticals, Inc, Array BioPharma Inc - 3rd Watch News</td>    <td>Chronic Low Back Pain Market to Witness Huge Growth by 2027 | Astellas Pharma Inc., Grunenthal GmbH, Orion Oyj, Pfizer Inc., Regeneron Pharmaceuticals, Inc, Array BioPharma Inc  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/1139004/chronic-low-back-pain-market-to-witness-huge-growth-by-2027-astellas-pharma-inc-grunenthal-gmbh-orion-oyj-pfizer-inc-regeneron-pharmaceuticals-inc-array-biopharma-inc/">Link</a></td>  </tr></table><h3>92. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARWR">Arrowhead Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sun, 24 May 2020 20:48:11 GMT</td>    <td>Is Arrowhead Pharmaceuticals a Buy? - The Motley Fool</td>    <td>Is Arrowhead Pharmaceuticals a Buy?  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/24/is-arrowhead-pharmaceuticals-a-buy.aspx">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Arrowhead Pharmaceuticals Reports Fiscal 2020 Second Quarter Results - Business Wire</td>    <td>Arrowhead Pharmaceuticals Reports Fiscal 2020 Second Quarter Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507006032/en/Arrowhead-Pharmaceuticals-Reports-Fiscal-2020-Quarter-Results">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 11:30:00 GMT</td>    <td>Arrowhead Pharmaceuticals to Participate in Upcoming June 2020 Conferences - Business Wire</td>    <td>Arrowhead Pharmaceuticals to Participate in Upcoming June 2020 Conferences  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200528005083/en/Arrowhead-Pharmaceuticals-Participate-Upcoming-June-2020-Conferences">Link</a></td>  </tr></table><h3>93. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ASNS">Arsanis, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Arsanis Inc (XFOR) Moves to Buy: Rationale Behind the Upgrade - Zacks.com</td>    <td>Arsanis Inc (XFOR) Moves to Buy: Rationale Behind the Upgrade  Zacks.com</td>    <td><a target="_blank" href="https://www.zacks.com/stock/news/923404/arsanis-inc-xfor-moves-to-buy-rationale-behind-the-upgrade">Link</a></td>  </tr><tr>    <td>Tue, 27 Nov 2018 08:00:00 GMT</td>    <td>Arsanis and X4 Pharmaceuticals Agree to Merger - GlobeNewswire</td>    <td>Arsanis and X4 Pharmaceuticals Agree to Merger  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2018/11/27/1657289/0/en/Arsanis-and-X4-Pharmaceuticals-Agree-to-Merger.html">Link</a></td>  </tr><tr>    <td>Wed, 13 Mar 2019 07:00:00 GMT</td>    <td>X4 Pharmaceuticals Completes Merger with Arsanis - Business Wire</td>    <td>X4 Pharmaceuticals Completes Merger with Arsanis  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20190313005525/en/X4-Pharmaceuticals-Completes-Merger-Arsanis">Link</a></td>  </tr></table><h3>94. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ARVN">Arvinas, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 11:07:27 GMT</td>    <td>Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTAC® Protein Degrader ARV-110 in Patients with Metastatic Castration-Resistant Prostate Cancer - GlobeNewswire</td>    <td>Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTAC® Protein Degrader ARV-110 in Patients with Metastatic Castration-Resistant Prostate Cancer  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040817/0/en/Arvinas-Releases-Updated-Dose-Escalation-Data-from-Clinical-Trial-of-PROTAC-Protein-Degrader-ARV-110-in-Patients-with-Metastatic-Castration-Resistant-Prostate-Cancer.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Arvinas, Inc. (ARVN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance</td>    <td>Arvinas, Inc. (ARVN) Upgraded to Buy: Here's What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/arvinas-inc-arvn-upgraded-buy-160004237.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:30:01 GMT</td>    <td>Arvinas Inc. (ARVN) latest performance of -1.78% is not what was on cards - News Daemon</td>    <td>Arvinas Inc. (ARVN) latest performance of -1.78% is not what was on cards  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/03/arvinas-inc-arvn-latest-performance-of-1-78-is-not-what-was-on-cards/">Link</a></td>  </tr></table><h3>95. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ASND">Ascendis Pharma A/S</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 19:46:00 GMT</td>    <td>Should You Avoid Ascendis Pharma A/S (ASND)? - Yahoo Finance</td>    <td>Should You Avoid Ascendis Pharma A/S (ASND)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/avoid-ascendis-pharma-asnd-194636563.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Ascendis Pharma A/S Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 19 - Yahoo Finance</td>    <td>Ascendis Pharma A/S Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 19  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/ascendis-pharma-announces-first-quarter-200110881.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 09:28:12 GMT</td>    <td>Will the Ascendis Pharma A/s share price run continue? - Stockopedia</td>    <td>Will the Ascendis Pharma A/s share price run continue?  Stockopedia</td>    <td><a target="_blank" href="https://www.stockopedia.com/articles/will-the-ascendis-pharma-as-share-price-run-continue-54618/">Link</a></td>  </tr></table><h3>96. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ASLN">ASLAN Pharmaceuticals Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 09:47:07 GMT</td>    <td>ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030846/0/en/ASLAN-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Mon, 13 Apr 2020 09:25:51 GMT</td>    <td>UPDATE - ASLAN Pharmaceuticals Temporarily Pauses Recruitment of New Patients Into ASLAN004 Study Due to COVID-19 - GlobeNewswire</td>    <td>UPDATE - ASLAN Pharmaceuticals Temporarily Pauses Recruitment of New Patients Into ASLAN004 Study Due to COVID-19  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/04/13/2014950/0/en/UPDATE-ASLAN-Pharmaceuticals-Temporarily-Pauses-Recruitment-of-New-Patients-Into-ASLAN004-Study-Due-to-COVID-19.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 04:41:00 GMT</td>    <td>Impact of Covid-19 on Macrophage Stimulating Protein Receptor Market is slated to grow rapidly in the forthcoming years with key Players Advenchen Laboratories LLC, Aslan Pharmaceuticals Pte Ltd, Bristol-Myers Squibb Company, etc - 3rd Watch News</td>    <td>Impact of Covid-19 on Macrophage Stimulating Protein Receptor Market is slated to grow rapidly in the forthcoming years with key Players Advenchen Laboratories LLC, Aslan Pharmaceuticals Pte Ltd, Bristol-Myers Squibb Company, etc  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/industry/991191/impact-of-covid-19-on-macrophage-stimulating-protein-receptor-market-is-slated-to-grow-rapidly-in-the-forthcoming-years-with-key-players-advenchen-laboratories-llc-aslan-pharmaceuticals-pte-ltd-bris/">Link</a></td>  </tr></table><h3>97. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ASMB">Assembly Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 20:18:00 GMT</td>    <td>Assembly Biosciences Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire</td>    <td>Assembly Biosciences Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041765/0/en/Assembly-Biosciences-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Assembly Biosciences: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Assembly Biosciences: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Assembly-Biosciences-1Q-Earnings-Snapshot-15255967.php">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 12:02:20 GMT</td>    <td>Assembly Biosciences Announces Management Transition Nasdaq:ASMB - GlobeNewswire</td>    <td>Assembly Biosciences Announces Management Transition Nasdaq:ASMB  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039338/0/en/Assembly-Biosciences-Announces-Management-Transition.html">Link</a></td>  </tr></table><h3>98. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ASRT">Assertio Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 12:09:36 GMT</td>    <td>Assertio Therapeutics Announces First-Quarter 2020 Results Nasdaq:ASRT - GlobeNewswire</td>    <td>Assertio Therapeutics Announces First-Quarter 2020 Results Nasdaq:ASRT  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031046/0/en/Assertio-Therapeutics-Announces-First-Quarter-2020-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 22:30:00 GMT</td>    <td>Assertio Therapeutics Inc. (NASDAQ:ASRT): A Stocks With Stellar Fundamentals? - State Reviewer</td>    <td>Assertio Therapeutics Inc. (NASDAQ:ASRT): A Stocks With Stellar Fundamentals?  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/assertio-therapeutics-inc-nasdaqasrt-a-stocks-with-stellar-fundamentals/">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Recap: Assertio Therapeutics Q1 Earnings - Yahoo Finance</td>    <td>Recap: Assertio Therapeutics Q1 Earnings  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/recap-assertio-therapeutics-q1-earnings-121746932.html">Link</a></td>  </tr></table><h3>99. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ASTC">Astrotech Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Astrotech Reports Third Quarter of Fiscal Year 2020 Financial Results - Benzinga</td>    <td>Astrotech Reports Third Quarter of Fiscal Year 2020 Financial Results  BenzingaAstrotech Corporation [ASTC] moved up 13.89: Why It’s Important  The DBT NewsIs It Right Time to Be Bullish on Astrotech Corporation (NASDAQ:ASTC), Sonic Automotive Inc. (NYSE:SAH)?  State ReviewerWait For The Pullback To Buy Forescout Technologies Inc. (FSCT) and Astrotech Corporation (ASTC)  BOV NewsView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.benzinga.com/pressreleases/20/05/ac16023518/astrotech-reports-third-quarter-of-fiscal-year-2020-financial-results">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Is It Crazy To Buy Astrotech Corporation (NASDAQ:ASTC) And Mesa Air Group Inc. (NASDAQ:MESA) - State Reviewer</td>    <td>Is It Crazy To Buy Astrotech Corporation (NASDAQ:ASTC) And Mesa Air Group Inc. (NASDAQ:MESA)  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/05/07/is-it-crazy-to-buy-astrotech-corporation-nasdaqastc-and-mesa-air-group-inc-nasdaqmesa/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Astrotech Corporation (ASTC) price jumped close to $3.34 early on Monday: What’s Next? - State Reviewer</td>    <td>Astrotech Corporation (ASTC) price jumped close to $3.34 early on Monday: What’s Next?  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/05/12/astrotech-corporation-astc-price-jumped-close-to-3-34-early-on-monday-whats-next/">Link</a></td>  </tr></table><h3>100. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ATRA">Atara Biotherapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Atara Biotherapeutics Announces First Quarter 2020 Financial Results and Operational Progress - Business Wire</td>    <td>Atara Biotherapeutics Announces First Quarter 2020 Financial Results and Operational Progress  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506006020/en/Atara-Biotherapeutics-Announces-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Atara Biotherapeutics to Present Late-Breaking ATA188 Data in Progressive Multiple Sclerosis at 2020 European Academy of Neurology (EAN) Virtual Congress - Yahoo Finance</td>    <td>Atara Biotherapeutics to Present Late-Breaking ATA188 Data in Progressive Multiple Sclerosis at 2020 European Academy of Neurology (EAN) Virtual Congress  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/atara-biotherapeutics-present-breaking-ata188-123000504.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 11:00:00 GMT</td>    <td>Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at the 2020 European Academy of Neurology Virtual Congress - Business Wire</td>    <td>Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at the 2020 European Academy of Neurology Virtual Congress  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200526005266/en/Atara-Biotherapeutics-Presents-Data-Demonstrating-Safety-Sustained">Link</a></td>  </tr></table><h3>101. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ATNX">Athenex, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 10:12:00 GMT</td>    <td>Athenex, Inc. (NASDAQ:ATNX) Insiders Increased Their Holdings - Yahoo Finance</td>    <td>Athenex, Inc. (NASDAQ:ATNX) Insiders Increased Their Holdings  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/athenex-inc-nasdaq-atnx-insiders-101233056.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 11:10:17 GMT</td>    <td>Athenex, Inc. Reports First Quarter Ended March 31, 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Athenex, Inc. Reports First Quarter Ended March 31, 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029270/0/en/Athenex-Inc-Reports-First-Quarter-Ended-March-31-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Athenex, Inc. (ATNX) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Athenex, Inc. (ATNX) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/09/athenex-inc-atnx-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr></table><h3>102. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ATHX">Athersys, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Athersys Inc. (ATHX) Plunges 6.73% on June 03 - Equities.com</td>    <td>Athersys Inc. (ATHX) Plunges 6.73% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/athersys-inc-athx-plunges-6-73-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Athersys enrolls first patients in MultiStem cell therapy study to combat coronavirus-induced ARDS - Crain's Cleveland Business</td>    <td>Athersys enrolls first patients in MultiStem cell therapy study to combat coronavirus-induced ARDS  Crain's Cleveland Business</td>    <td><a target="_blank" href="https://www.crainscleveland.com/health-care/athersys-enrolls-first-patients-multistem-cell-therapy-study-combat-coronavirus-induced">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 19:00:03 GMT</td>    <td>Short term estimates and forecasts for Athersys, Inc. (ATHX) - Marketing Sentinel</td>    <td>Short term estimates and forecasts for Athersys, Inc. (ATHX)  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/01/short-term-estimates-and-forecasts-for-athersys-inc-athx/">Link</a></td>  </tr></table><h3>103. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ATOS">Atossa Genetics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Atossa Genetics (ATOS) Announces Successful In vitro Testing Results of COVID-19 Drug - StreetInsider.com</td>    <td>Atossa Genetics (ATOS) Announces Successful In vitro Testing Results of COVID-19 Drug  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Atossa+Genetics+%28ATOS%29+Announces+Successful+In+vitro+Testing+Results+of+COVID-19+Drug/16910267.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Atossa Genetics (ATOS) Receives FDA Feedback on Two Ongoing Programs - StreetInsider.com</td>    <td>Atossa Genetics (ATOS) Receives FDA Feedback on Two Ongoing Programs  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Atossa+Genetics+%28ATOS%29+Receives+FDA+Feedback+on+Two+Ongoing+Programs/16847940.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:50:00 GMT</td>    <td>Global Estrogen Receptor Beta market 2019 ? 2025 analysis examined in new market research report - Jewish Life News</td>    <td>Global Estrogen Receptor Beta market 2019 ? 2025 analysis examined in new market research report  Jewish Life News</td>    <td><a target="_blank" href="https://jewishlifenews.com/uncategorized/global-estrogen-receptor-beta-market-2019-2025-analysis-examined-in-new-market-research-report/">Link</a></td>  </tr></table><h3>104. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BCEL">Atreca, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 20:37:54 GMT</td>    <td>Atreca Reports First Quarter 2020 Financial Results and Recent Corporate Developments - GlobeNewswire</td>    <td>Atreca Reports First Quarter 2020 Financial Results and Recent Corporate Developments  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033904/0/en/Atreca-Reports-First-Quarter-2020-Financial-Results-and-Recent-Corporate-Developments.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 12:12:51 GMT</td>    <td>Atreca Announces Appointment of Kristine M. Ball to its Board of Directors - GlobeNewswire</td>    <td>Atreca Announces Appointment of Kristine M. Ball to its Board of Directors  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2036999/0/en/Atreca-Announces-Appointment-of-Kristine-M-Ball-to-its-Board-of-Directors.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 21:05:49 GMT</td>    <td>Atreca Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program - GlobeNewswire</td>    <td>Atreca Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033036/0/en/Atreca-Announces-Poster-Presentation-at-the-American-Society-of-Clinical-Oncology-ASCO-2020-Virtual-Scientific-Program.html">Link</a></td>  </tr></table><h3>105. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LIFE">aTyr Pharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 12:29:26 GMT</td>    <td>aTyr Pharma to Webcast Conference Call Reporting First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>aTyr Pharma to Webcast Conference Call Reporting First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028391/0/en/aTyr-Pharma-to-Webcast-Conference-Call-Reporting-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 20:07:54 GMT</td>    <td>aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19 - GlobeNewswire</td>    <td>aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032250/0/en/aTyr-Pharma-Announces-First-Quarter-2020-Results-and-Provides-Corporate-Update-on-ATYR1923-Clinical-Trials-in-Pulmonary-Sarcoidosis-and-COVID-19.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Atyr Pharma (LIFE) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance</td>    <td>Atyr Pharma (LIFE) Q1 Earnings and Revenues Surpass Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/atyr-pharma-life-q1-earnings-212509388.html">Link</a></td>  </tr></table><h3>106. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BOLD">Audentes Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 16:05:00 GMT</td>    <td>Gene Therapy Products Market Outlook : Post Covid Investors Eye Bigger-than-expected | Top key Players –... - Azizsalon News</td>    <td>Gene Therapy Products Market Outlook : Post Covid Investors Eye Bigger-than-expected | Top key Players –...  Azizsalon News</td>    <td><a target="_blank" href="https://azizsalon.com/gene-therapy-products-market-outlook-post-covid-investors-eye-bigger-than-expected-top-key-players-novartis-ag-achieve-life-sciences-inc-spark-therapeutics-inc-abeona-therapeutics/">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 23:43:28 GMT</td>    <td>May 15, 2020 - Casdin Capital, LLC Buys Blueprint Medicines Corp, Twist Bioscience Corp, Gilead Sciences Inc, Sells Audentes Therapeutics Inc, Illumina Inc, Deciphera Pharmaceuticals Inc - GuruFocus.com</td>    <td>May 15, 2020 - Casdin Capital, LLC Buys Blueprint Medicines Corp, Twist Bioscience Corp, Gilead Sciences Inc, Sells Audentes Therapeutics Inc, Illumina Inc, Deciphera Pharmaceuticals Inc  GuruFocus.com</td>    <td><a target="_blank" href="https://www.gurufocus.com/news/1138808/casdin-capital-llc-buys-blueprint-medicines-corp-twist-bioscience-corp-gilead-sciences-inc-sells-audentes-therapeutics-inc-illumina-inc-deciphera-pharmaceuticals-inc">Link</a></td>  </tr><tr>    <td>Sat, 23 May 2020 01:41:43 GMT</td>    <td>May 22, 2020 - Opaleye Management Inc. Buys Protara Therapeutics Inc, Eton Pharmaceuticals Inc, Kala Pharmaceuticals Inc, Sells Epizyme Inc, Turning Point Therapeutics Inc, Audentes Therapeutics Inc - GuruFocus.com</td>    <td>May 22, 2020 - Opaleye Management Inc. Buys Protara Therapeutics Inc, Eton Pharmaceuticals Inc, Kala Pharmaceuticals Inc, Sells Epizyme Inc, Turning Point Therapeutics Inc, Audentes Therapeutics Inc  GuruFocus.com</td>    <td><a target="_blank" href="https://www.gurufocus.com/news/1145457/opaleye-management-inc-buys-protara-therapeutics-inc-eton-pharmaceuticals-inc-kala-pharmaceuticals-inc-sells-epizyme-inc-turning-point-therapeutics-inc-audentes-therapeutics-inc">Link</a></td>  </tr></table><h3>107. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AUPH">Aurinia Pharmaceuticals Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 10:05:00 GMT</td>    <td>Aurinia Announces Results of Annual General Meeting - Business Wire</td>    <td>Aurinia Announces Results of Annual General Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200603005265/en/Aurinia-Announces-Results-Annual-General-Meeting">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 01:48:18 GMT</td>    <td>Aurinia Pharmaceuticals Inc (AUPH) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Aurinia Pharmaceuticals Inc (AUPH) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/19/aurinia-pharmaceuticals-inc-auph-q1-2020-earnings.aspx">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Aurinia Pharmaceuticals Inc. (TSE:AUP) Released Earnings Last Week And Analysts Lifted Their Price Target To US$32.00 - Yahoo Finance</td>    <td>Aurinia Pharmaceuticals Inc. (TSE:AUP) Released Earnings Last Week And Analysts Lifted Their Price Target To US$32.00  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aurinia-pharmaceuticals-inc-tse-aup-101040279.html">Link</a></td>  </tr></table><h3>108. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EARS">Auris Medical Holding AG</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 16 Apr 2020 11:14:25 GMT</td>    <td>Auris Medical Provides Business Update and Reports Second Half and Full Year 2019 Financial Results - GlobeNewswire</td>    <td>Auris Medical Provides Business Update and Reports Second Half and Full Year 2019 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/04/16/2017177/0/en/Auris-Medical-Provides-Business-Update-and-Reports-Second-Half-and-Full-Year-2019-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 30 Dec 2019 08:00:00 GMT</td>    <td>Auris Medical Announces Formation of New Subsidiary for Development Projects in Tinnitus and Hearing Loss - GlobeNewswire</td>    <td>Auris Medical Announces Formation of New Subsidiary for Development Projects in Tinnitus and Hearing Loss  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/12/30/1964964/0/en/Auris-Medical-Announces-Formation-of-New-Subsidiary-for-Development-Projects-in-Tinnitus-and-Hearing-Loss.html">Link</a></td>  </tr><tr>    <td>Tue, 25 Feb 2020 08:00:00 GMT</td>    <td>Auris Medical Highlights Publication of Study Results Demonstrating Betahistine's Antiepileptogenic and Anticonvulsant Activity in Murine Model - GlobeNewswire</td>    <td>Auris Medical Highlights Publication of Study Results Demonstrating Betahistine's Antiepileptogenic and Anticonvulsant Activity in Murine Model  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/02/25/1990054/0/en/Auris-Medical-Highlights-Publication-of-Study-Results-Demonstrating-Betahistine-s-Antiepileptogenic-and-Anticonvulsant-Activity-in-Murine-Model.html">Link</a></td>  </tr></table><h3>109. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AUTL">Autolus Therapeutics plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 11:00:00 GMT</td>    <td>Autolus Therapeutics to host Investor Conference Calls through June - GlobeNewswire</td>    <td>Autolus Therapeutics to host Investor Conference Calls through June  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038500/0/en/Autolus-Therapeutics-to-host-Investor-Conference-Calls-through-June.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 10:33:40 GMT</td>    <td>Broker Revenue Forecasts For Autolus Therapeutics plc (NASDAQ:AUTL) Are Surging Higher - Simply Wall St</td>    <td>Broker Revenue Forecasts For Autolus Therapeutics plc (NASDAQ:AUTL) Are Surging Higher  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-autl/autolus-therapeutics/news/broker-revenue-forecasts-for-autolus-therapeutics-plc-nasdaqautl-are-surging-higher/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 11:09:19 GMT</td>    <td>Autolus Therapeutics Reports First Quarter 2020 Financial Results and Operational Progress - GlobeNewswire</td>    <td>Autolus Therapeutics Reports First Quarter 2020 Financial Results and Operational Progress  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029310/0/en/Autolus-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Operational-Progress.html">Link</a></td>  </tr></table><h3>110. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AVDL">Avadel Pharmaceuticals plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:27:13 GMT</td>    <td>Avadel Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>Avadel Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041448/0/en/Avadel-Pharmaceuticals-to-Present-at-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 11:07:50 GMT</td>    <td>Avadel Pharmaceuticals Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Avadel Pharmaceuticals Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030941/0/en/Avadel-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Avadel Pharmaceuticals plc (AVDL) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Avadel Pharmaceuticals plc (AVDL) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/11/avadel-pharmaceuticals-plc-avdl-q1-2020-earnings-c.aspx">Link</a></td>  </tr></table><h3>111. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AVTR">Avantor</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Avantor® Announces Pricing of Secondary Offering - Yahoo Finance</td>    <td>Avantor® Announces Pricing of Secondary Offering  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/avantor-announces-pricing-secondary-offering-023300425.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 09:40:00 GMT</td>    <td>Avantor Inc. [AVTR] is 4.63% higher this YTD. Is it still time to buy? - The DBT News</td>    <td>Avantor Inc. [AVTR] is 4.63% higher this YTD. Is it still time to buy?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/avantor-inc-avtr-is-4-63-higher-this-ytd-is-it-still-time-to-buy/">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 13:20:43 GMT</td>    <td>Avantor to Present at the Virtual Bank of America Securities 2020 Healthcare Conference - WFMZ Allentown</td>    <td>Avantor to Present at the Virtual Bank of America Securities 2020 Healthcare Conference  WFMZ Allentown</td>    <td><a target="_blank" href="https://www.wfmz.com/news/pr_newswire/pr_newswire_stocks/avantor-to-present-at-the-virtual-bank-of-america-securities-2020-healthcare-conference/article_ebe0dc7f-79df-527c-b7af-45ab53467ffb.html">Link</a></td>  </tr></table><h3>112. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AVDR">Avedro</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 07 Aug 2019 07:00:00 GMT</td>    <td>Glaukos and Avedro Announce Definitive Acquisition Agreement - Business Wire</td>    <td>Glaukos and Avedro Announce Definitive Acquisition Agreement  Business WireAvedro, Inc. Announces Second Quarter 2019 Financial Results  GlobeNewswireGlaukos to acquire Avedro in all-stock transaction  HealioGlaukos to Acquire Avedro  InvisionMagGlaukos to Buy Avedro  Orange County Business JournalView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20190807005773/en/Glaukos-Avedro-Announce-Definitive-Acquisition-Agreement">Link</a></td>  </tr><tr>    <td>Fri, 09 Aug 2019 07:00:00 GMT</td>    <td>Glaukos Continues its Evolution with Avedro Acquisition - Medical Device and Diagnostics Industry</td>    <td>Glaukos Continues its Evolution with Avedro Acquisition  Medical Device and Diagnostics Industry</td>    <td><a target="_blank" href="https://www.mddionline.com/glaukos-continues-its-evolution-avedro-acquisition">Link</a></td>  </tr><tr>    <td>Thu, 21 Nov 2019 08:00:00 GMT</td>    <td>Glaukos Completes Acquisition of Avedro, Inc. - Business Wire</td>    <td>Glaukos Completes Acquisition of Avedro, Inc.  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20191121005534/en/Glaukos-Completes-Acquisition-Avedro">Link</a></td>  </tr></table><h3>113. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ATXI">Avenue Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights - Yahoo Finance</td>    <td>Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/avenue-therapeutics-reports-first-quarter-113010255.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:50:51 GMT</td>    <td>Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders - GlobeNewswire</td>    <td>Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040923/0/en/Avenue-Therapeutics-to-Host-Virtual-Annual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 14:31:00 GMT</td>    <td>Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne - Yahoo Finance</td>    <td>Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/zacks-com-featured-highlights-minerva-143102280.html">Link</a></td>  </tr></table><h3>114. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AVEO">AVEO Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Why You Shouldn't Bet Against AVEO Pharmaceuticals (AVEO) Stock - Yahoo Finance</td>    <td>Why You Shouldn't Bet Against AVEO Pharmaceuticals (AVEO) Stock  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-shouldnt-bet-against-aveo-125012406.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 13:41:56 GMT</td>    <td>Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options - Nasdaq</td>    <td>Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/implied-volatility-surging-for-aveo-pharmaceuticals-aveo-stock-options-2020-06-01">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 12:50:01 GMT</td>    <td>Pay Attention to this Trade Activity as AVEO Pharmaceuticals Inc. (AVEO) last week performance was -19.01% - News Daemon</td>    <td>Pay Attention to this Trade Activity as AVEO Pharmaceuticals Inc. (AVEO) last week performance was -19.01%  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/02/pay-attention-to-this-trade-activity-as-aveo-pharmaceuticals-inc-aveo-last-week-performance-was-19-01/">Link</a></td>  </tr></table><h3>115. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CDMO">Avid Bioservices, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:05:00 GMT</td>    <td>Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock - Yahoo Finance</td>    <td>Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/avid-bioservices-declares-quarterly-dividend-200510879.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 12:29:36 GMT</td>    <td>Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing - GlobeNewswire</td>    <td>Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028396/0/en/Avid-Bioservices-and-Aragen-Bioscience-Enter-Agreement-to-Offer-Biotechnology-and-Pharmaceutical-Clients-Integrated-Solution-for-Cell-Line-and-Process-Development-through-Commercia.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>BRIEF-Avid Bioservices Says PPP Loan Was Paid In Full To Lender On May 12 - Reuters</td>    <td>BRIEF-Avid Bioservices Says PPP Loan Was Paid In Full To Lender On May 12  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-avid-bioservices-says-ppp-loan-was/brief-avid-bioservices-says-ppp-loan-was-paid-in-full-to-lender-on-may-12-idUSFWN2CX17U">Link</a></td>  </tr></table><h3>116. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AVRO">AVROBIO, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>AVROBIO Reports 1Q 2020 Financial Results and Provides Business Update - Business Wire</td>    <td>AVROBIO Reports 1Q 2020 Financial Results and Provides Business Update  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005205/en/AVROBIO-Reports-1Q-2020-Financial-Results-Business">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>AVROBIO Reports Updated Clinical Data from Investigational Gene Therapy Programs for Fabry Disease and Cystinosis - Business Wire</td>    <td>AVROBIO Reports Updated Clinical Data from Investigational Gene Therapy Programs for Fabry Disease and Cystinosis  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200513005165/en/AVROBIO-Reports-Updated-Clinical-Data-Investigational-Gene">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>AVROBIO and Magenta Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies - Business Wire</td>    <td>AVROBIO and Magenta Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506005265/en/AVROBIO-Magenta-Therapeutics-Announce-Collaboration-Evaluate-Targeted">Link</a></td>  </tr></table><h3>117. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AXLA">Axcella Health</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 15:30:00 GMT</td>    <td>Has Axcella Health (AXLA) Outpaced Other Medical Stocks This Year? - Yahoo Finance</td>    <td>Has Axcella Health (AXLA) Outpaced Other Medical Stocks This Year?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/axcella-health-axla-outpaced-other-153003186.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 16:09:00 GMT</td>    <td>Will Axcella Health Continue to Surge Higher? - Yahoo Finance</td>    <td>Will Axcella Health Continue to Surge Higher?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/axcella-health-continue-surge-higher-160904032.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Why Micro-Cap Biopharma Axcella Health Is Surging Higher - Benzinga</td>    <td>Why Micro-Cap Biopharma Axcella Health Is Surging Higher  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/general/biotech/20/05/15966569/why-micro-cap-biopharma-axcella-health-is-surging-higher">Link</a></td>  </tr></table><h3>118. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AXGN">AxoGen, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 11:00:00 GMT</td>    <td>Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General Counsel and Chief Compliance Officer - GlobeNewswire</td>    <td>Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General Counsel and Chief Compliance Officer  GlobeNewswire</td>    <td><a target="_blank" href="http://www.globenewswire.com/news-release/2020/06/01/2041358/0/en/Axogen-Inc-Announces-Planned-Retirement-of-Greg-Freitag-and-Appoints-Brad-Ottinger-as-General-Counsel-and-Chief-Compliance-Officer.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:03:25 GMT</td>    <td>Axogen, Inc. Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Axogen, Inc. Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028796/0/en/Axogen-Inc-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Axogen, Inc. to Present at the Jefferies Virtual Healthcare Conference - Yahoo Finance</td>    <td>Axogen, Inc. to Present at the Jefferies Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/axogen-inc-present-jefferies-virtual-110010744.html">Link</a></td>  </tr></table><h3>119. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AXON">Axovant Sciences Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 16:00:00 GMT</td>    <td>Axovant (AXGT) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance</td>    <td>Axovant (AXGT) Moves to Strong Buy: Rationale Behind the Upgrade  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/axovant-axgt-moves-strong-buy-160004372.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 19:02:43 GMT</td>    <td>Assessing Axovant Gene Therapies - Seeking Alpha</td>    <td>Assessing Axovant Gene Therapies  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4351347-assessing-axovant-gene-therapies">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Top Ranked Momentum Stocks to Buy for May 5th - Yahoo Finance</td>    <td>Top Ranked Momentum Stocks to Buy for May 5th  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/top-ranked-momentum-stocks-buy-145502361.html">Link</a></td>  </tr></table><h3>120. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AXSM">Axsome Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 11:14:00 GMT</td>    <td>Axsome Therapeutics to Host 2020 Annual Meeting of Stockholders Virtually - GlobeNewswire</td>    <td>Axsome Therapeutics to Host 2020 Annual Meeting of Stockholders Virtually  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038481/0/en/Axsome-Therapeutics-to-Host-2020-Annual-Meeting-of-Stockholders-Virtually.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 18:48:19 GMT</td>    <td>Is Axsome Therapeutics a Buy? - The Motley Fool</td>    <td>Is Axsome Therapeutics a Buy?  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/26/is-axsome-therapeutics-a-buy.aspx">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 11:05:59 GMT</td>    <td>Axsome Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire</td>    <td>Axsome Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030268/0/en/Axsome-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Business-Update.html">Link</a></td>  </tr></table><h3>121. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AYLA">Ayala Pharmaceuticals</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:01:00 GMT</td>    <td>Ayala Pharmaceuticals to Present at Upcoming Investor Conferences - Yahoo Finance</td>    <td>Ayala Pharmaceuticals to Present at Upcoming Investor Conferences  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/ayala-pharmaceuticals-present-upcoming-investor-120110347.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 20:07:34 GMT</td>    <td>Ayala Pharmaceuticals Announces Closing of Initial Public Offering - GlobeNewswire</td>    <td>Ayala Pharmaceuticals Announces Closing of Initial Public Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032223/0/en/Ayala-Pharmaceuticals-Announces-Closing-of-Initial-Public-Offering.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 23:00:44 GMT</td>    <td>Ayala Pharmaceuticals Announces Pricing of Initial Public Offering - GlobeNewswire</td>    <td>Ayala Pharmaceuticals Announces Pricing of Initial Public Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2030078/0/en/Ayala-Pharmaceuticals-Announces-Pricing-of-Initial-Public-Offering.html">Link</a></td>  </tr></table><h3>122. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AYTU">Aytu BioScience, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 20:01:00 GMT</td>    <td>Aytu BioScience Announces $15 Million Debt Retirement - Yahoo Finance</td>    <td>Aytu BioScience Announces $15 Million Debt Retirement  Yahoo FinanceAytu BioScience Inc. [AYTU] is 53.21% higher this YTD. Is it still time to buy?  The DBT NewsAYTU BIOSCIENCE, INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)  marketscreener.comIs Aytu Bioscience Inc (AYTU) Stock Worth a Buy Monday?  InvestorsObserverAYTU BIOSCIENCE, INC. (OTCMKTS:AYTU) Files An 8-K Entry into a Material Definitive Agreement  Market ExclusiveView Full Coverage on Google News</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aytu-bioscience-announces-15-million-200100609.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:00:00 GMT</td>    <td>Aytu BioScience Announces Emergency Use Authorization of COVID-19 IgG/IgM Rapid Test - Yahoo Finance</td>    <td>Aytu BioScience Announces Emergency Use Authorization of COVID-19 IgG/IgM Rapid Test  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aytu-bioscience-announces-emergency-authorization-120000355.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 15:30:00 GMT</td>    <td>Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year? - Yahoo Finance</td>    <td>Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/aytu-bioscience-aytu-outpaced-other-153003636.html">Link</a></td>  </tr></table><h3>123. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-AZRX">AzurRx BioPharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>AzurRx BioPharma Receives Approximately $721000 for its 2019 CIR (French Research Tax Credit) - GlobeNewswire</td>    <td>AzurRx BioPharma Receives Approximately $721000 for its 2019 CIR (French Research Tax Credit)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027495/0/en/AzurRx-BioPharma-Receives-Approximately-721-000-for-its-2019-CIR-French-Research-Tax-Credit.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 19:08:00 GMT</td>    <td>Here is What Hedge Funds Think About AzurRx BioPharma, Inc. (AZRX) - Yahoo Finance</td>    <td>Here is What Hedge Funds Think About AzurRx BioPharma, Inc. (AZRX)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-think-azurrx-biopharma-190834573.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 22:40:00 GMT</td>    <td>AzurRx BioPharma, Inc. (NASDAQ:AZRX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - Market Exclusive</td>    <td>AzurRx BioPharma, Inc. (NASDAQ:AZRX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Market Exclusive</td>    <td><a target="_blank" href="https://marketexclusive.com/azurrx-biopharma-inc-nasdaqazrx-files-an-8-k-notice-of-delisting-or-failure-to-satisfy-a-continued-listing-rule-or-standard-transfer-of-listing-2/2020/06/">Link</a></td>  </tr></table><h3>124. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BEAM">Beam Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Beam Therapeutics Taking Novel Approach to Gene Therapy - Yahoo Finance</td>    <td>Beam Therapeutics Taking Novel Approach to Gene Therapy  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/beam-therapeutics-taking-novel-approach-222126259.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 10:34:18 GMT</td>    <td>Beam Therapeutics Reports Additional Data at ASGCT Annual Meeting and First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Beam Therapeutics Reports Additional Data at ASGCT Annual Meeting and First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031728/0/en/Beam-Therapeutics-Reports-Additional-Data-at-ASGCT-Annual-Meeting-and-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 10:32:18 GMT</td>    <td>Beam Therapeutics to Present at Jefferies 2020 Virtual Healthcare Conference - GlobeNewswire</td>    <td>Beam Therapeutics to Present at Jefferies 2020 Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038448/0/en/Beam-Therapeutics-to-Present-at-Jefferies-2020-Virtual-Healthcare-Conference.html">Link</a></td>  </tr></table><h3>125. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BGNE">BeiGene, Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 16:32:00 GMT</td>    <td>Leerink Partners Stick to Their Buy Rating for BeiGene, Ltd. - Investing.com</td>    <td>Leerink Partners Stick to Their Buy Rating for BeiGene, Ltd.  Investing.com</td>    <td><a target="_blank" href="https://www.investing.com/news/leerink-partners-stick-to-their-buy-rating-for-beigene-ltd-2191155">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 11:30:09 GMT</td>    <td>BeiGene Announces the Approval of BRUKINSA™ (Zanubrutinib) in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell Lymphoma - GlobeNewswire</td>    <td>BeiGene Announces the Approval of BRUKINSA™ (Zanubrutinib) in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell Lymphoma  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042805/0/en/BeiGene-Announces-the-Approval-of-BRUKINSA-Zanubrutinib-in-China-for-Patients-with-Relapsed-Refractory-Chronic-Lymphocytic-Leukemia-or-Small-Lymphocytic-Lymphoma-and-Relapsed-Refra.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 11:06:26 GMT</td>    <td>BeiGene to Present at the Bernstein 36th Annual Strategic Decisions Conference - GlobeNewswire</td>    <td>BeiGene to Present at the Bernstein 36th Annual Strategic Decisions Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036242/0/en/BeiGene-to-Present-at-the-Bernstein-36th-Annual-Strategic-Decisions-Conference.html">Link</a></td>  </tr></table><h3>126. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BLPH">Bellerophon Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 20:05:29 GMT</td>    <td>Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewswire</td>    <td>Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2035235/0/en/Bellerophon-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 12:32:28 GMT</td>    <td>Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse® Inhaled Nitric Oxide Therapy to Treat COVID-19 - GlobeNewswire</td>    <td>Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse® Inhaled Nitric Oxide Therapy to Treat COVID-19  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031087/0/en/Bellerophon-Therapeutics-Announces-FDA-Clears-Initiation-of-Phase-3-Study-for-INOpulse-Inhaled-Nitric-Oxide-Therapy-to-Treat-COVID-19.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Bellerophon Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Registered Direct Offering - Yahoo Finance</td>    <td>Bellerophon Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Registered Direct Offering  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/bellerophon-therapeutics-announces-pricing-public-110010780.html">Link</a></td>  </tr></table><h3>127. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BLCM">Bellicum Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 21:09:00 GMT</td>    <td>Bellicum Pharmaceuticals Inc. (BLCM) Soars 14.29% on June 01 - Equities.com</td>    <td>Bellicum Pharmaceuticals Inc. (BLCM) Soars 14.29% on June 01  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/bellicum-pharmaceuticals-inc-blcm-soars-14-29-on-june-01">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 10:18:00 GMT</td>    <td>BRIEF-Bellicum Pharma - M.D. Anderson To Resume Selected Research, Manufacturing Activities - Reuters</td>    <td>BRIEF-Bellicum Pharma - M.D. Anderson To Resume Selected Research, Manufacturing Activities  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-bellicum-pharma-md-anderson-to-res/brief-bellicum-pharma-md-anderson-to-resume-selected-research-manufacturing-activities-idUSFWN2DF0TW">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 11:03:00 GMT</td>    <td>What Kind Of Investor Owns Most Of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM)? - Simply Wall St</td>    <td>What Kind Of Investor Owns Most Of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM)?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blcm/bellicum-pharmaceuticals/news/what-kind-of-investor-owns-most-of-bellicum-pharmaceuticals-inc-nasdaqblcm/">Link</a></td>  </tr></table><h3>128. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BNTC">Benitec Biopharma Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Benitec Biopharma's Redomiciliation to the United States – Global Legal Chronicle - Global Legal Chronicle</td>    <td>Benitec Biopharma's Redomiciliation to the United States – Global Legal Chronicle  Global Legal Chronicle</td>    <td><a target="_blank" href="https://www.globallegalchronicle.com/benitec-biopharmas-redomiciliation-to-the-united-states/">Link</a></td>  </tr><tr>    <td>Wed, 18 Mar 2020 07:00:00 GMT</td>    <td>Benitec Biopharma : COVID-19 information relating to Scheme Meeting - marketscreener.com</td>    <td>Benitec Biopharma : COVID-19 information relating to Scheme Meeting  marketscreener.com</td>    <td><a target="_blank" href="https://m.marketscreener.com/BENITEC-BIOPHARMA-LIMITED-10353433/news/Benitec-Biopharma-COVID-19-information-relating-to-Scheme-Meeting-30181136/">Link</a></td>  </tr><tr>    <td>Mon, 30 Sep 2019 07:00:00 GMT</td>    <td>Benitec Biopharma Limited Announces US$2.25 Million Registered Direct Offering - PRNewswire</td>    <td>Benitec Biopharma Limited Announces US$2.25 Million Registered Direct Offering  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/benitec-biopharma-limited-announces-us2-25-million-registered-direct-offering-300927688.html">Link</a></td>  </tr></table><h3>129. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BYSI">BeyondSpring, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:15:18 GMT</td>    <td>BeyondSpring E-Poster Presented at 2020 ASCO Virtual Scientific Program - GlobeNewswire</td>    <td>BeyondSpring E-Poster Presented at 2020 ASCO Virtual Scientific Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042178/0/en/BeyondSpring-E-Poster-Presented-at-2020-ASCO-Virtual-Scientific-Program.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 18:01:46 GMT</td>    <td>BeyondSpring Announces Data & Safety Monitoring Board Recommendation for Plinabulin to Continue NSCLC Phase 3 Dublin-3 Study Without Modification - BioSpace</td>    <td>BeyondSpring Announces Data & Safety Monitoring Board Recommendation for Plinabulin to Continue NSCLC Phase 3 Dublin-3 Study Without Modification  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/beyondspring-announces-data-and-safety-monitoring-board-recommendation-for-plinabulin-to-continue-nsclc-phase-3-dublin-3-study-without-modification/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 17:25:50 GMT</td>    <td>Where Does Wall Street Think Beyondspring Inc (BYSI) Stock Will Go? - InvestorsObserver</td>    <td>Where Does Wall Street Think Beyondspring Inc (BYSI) Stock Will Go?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/where-does-wall-street-think-beyondspring-inc-bysi-stock-will-go">Link</a></td>  </tr></table><h3>130. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BCYC">Bicycle Therapeutics Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Bicycle Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - BioSpace</td>    <td>Bicycle Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/bicycle-therapeutics-reports-first-quarter-2020-financial-results-and-provides-corporate-update-/">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Bicycle Therapeutics to Present Trials in Progress Poster for BT5528 at the 2020 American Society of Clinical Oncology Virtual Meeting - Business Wire</td>    <td>Bicycle Therapeutics to Present Trials in Progress Poster for BT5528 at the 2020 American Society of Clinical Oncology Virtual Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200513005856/en/Bicycle-Therapeutics-Present-Trials-Progress-Poster-BT5528">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Bicycle Therapeutics Announces Publication of BT5528 Mechanism of Action in AACR Journal Molecular Cancer Therapeutics - Business Wire</td>    <td>Bicycle Therapeutics Announces Publication of BT5528 Mechanism of Action in AACR Journal Molecular Cancer Therapeutics  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005437/en/Bicycle-Therapeutics-Announces-Publication-BT5528-Mechanism-Action">Link</a></td>  </tr></table><h3>131. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BASI">Bioanalytical Systems, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 10:28:14 GMT</td>    <td>Bioanalytical Systems, Inc. (NASDAQ:BASI) Insiders Increased Their Holdings - Simply Wall St</td>    <td>Bioanalytical Systems, Inc. (NASDAQ:BASI) Insiders Increased Their Holdings  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/bioanalytical-systems-inc-nasdaqbasi-insiders-increased-their-holdings/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>BASi Releases Earnings for Second Quarter of Fiscal 2020 - GlobeNewswire</td>    <td>BASi Releases Earnings for Second Quarter of Fiscal 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033514/0/en/BASi-Releases-Earnings-for-Second-Quarter-of-Fiscal-2020.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 12:37:40 GMT</td>    <td>Diane Tutko Francisco, Ph.D., Joins Inotiv to Lead Client Experience Team - GlobeNewswire</td>    <td>Diane Tutko Francisco, Ph.D., Joins Inotiv to Lead Client Experience Team  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027545/0/en/Diane-Tutko-Francisco-Ph-D-Joins-Inotiv-to-Lead-Client-Experience-Team.html">Link</a></td>  </tr></table><h3>132. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ORPN">Bioblast Pharma Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 Feb 2019 08:00:00 GMT</td>    <td>Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics - GlobeNewswire</td>    <td>Bioblast Pharma Announces Sale of its Trehalose Clinical Development Programs to Seelos Therapeutics  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/02/19/1734172/0/en/Bioblast-Pharma-Announces-Sale-of-its-Trehalose-Clinical-Development-Programs-to-Seelos-Therapeutics.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 06:14:37 GMT</td>    <td>Spinal Muscular Atrophy Medicine Market Analysis Reveals Explosive Growth By 2027 - Cole of Duty</td>    <td>Spinal Muscular Atrophy Medicine Market Analysis Reveals Explosive Growth By 2027  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/industry-analysis/2020/05/26/spinal-muscular-atrophy-medicine-market-analysis-reveals-explosive-growth-by-2027/">Link</a></td>  </tr><tr>    <td>Mon, 19 Nov 2018 08:00:00 GMT</td>    <td>Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors - GlobeNewswire</td>    <td>Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2018/11/19/1654089/0/en/Bioblast-Pharma-Ltd-Announces-Entry-Into-Merger-Agreement-to-Acquire-Enlivex-Therapeutics-Ltd-to-Advance-Clinical-Stage-Immunotherapeutic-Drug-Pipeline-for-the-Treatment-of-Life-Th.html">Link</a></td>  </tr></table><h3>133. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BCRX">BioCryst Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 13:19:40 GMT</td>    <td>Tech Today: BioCryst raises $115M, grants stock to 5 hires; G1 secures $100M; Charles & Covard new CEO; Akoustis names sales exec - WRAL Tech Wire</td>    <td>Tech Today: BioCryst raises $115M, grants stock to 5 hires; G1 secures $100M; Charles & Covard new CEO; Akoustis names sales exec  WRAL Tech Wire</td>    <td><a target="_blank" href="https://www.wraltechwire.com/2020/06/02/tech-today-biocryst-raises-115m-grants-stock-to-5-hires-g1-secures-100m-charles-akoustis-names-sales-exec/">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 20:14:11 GMT</td>    <td>BioCryst Commences Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire</td>    <td>BioCryst Commences Public Offering of Common Stock and Pre-Funded Warrants  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039714/0/en/BioCryst-Commences-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 20:12:39 GMT</td>    <td>BioCryst Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Completion of Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire</td>    <td>BioCryst Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Completion of Public Offering of Common Stock and Pre-Funded Warrants  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041731/0/en/BioCryst-Announces-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares-and-Completion-of-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html">Link</a></td>  </tr></table><h3>134. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BDSI">BioDelivery Sciences International, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Biodelivery Sciences International Inc (BDSI) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Biodelivery Sciences International Inc (BDSI) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/09/biodelivery-sciences-international-inc-bdsi-q1-202.aspx">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>BioDelivery Sciences Reports Strong Q1 2020 Results Nasdaq:BDSI - GlobeNewswire</td>    <td>BioDelivery Sciences Reports Strong Q1 2020 Results Nasdaq:BDSI  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029830/0/en/BioDelivery-Sciences-Reports-Strong-Q1-2020-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 12:32:15 GMT</td>    <td>BioDelivery Sciences Appoints Jeff Bailey Interim CEO - GlobeNewswire</td>    <td>BioDelivery Sciences Appoints Jeff Bailey Interim CEO  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031096/0/en/BioDelivery-Sciences-Appoints-Jeff-Bailey-Interim-CEO.html">Link</a></td>  </tr></table><h3>135. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BFRA">Biofrontera AG</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 16:11:44 GMT</td>    <td>Results of the 2020 Annual General Meeting of Biofrontera AG - GlobeNewswire</td>    <td>Results of the 2020 Annual General Meeting of Biofrontera AG  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040415/0/en/Results-of-the-2020-Annual-General-Meeting-of-Biofrontera-AG.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 14:30:51 GMT</td>    <td>Biofrontera reports Q1 2020 financial results Nasdaq:BFRA - GlobeNewswire</td>    <td>Biofrontera reports Q1 2020 financial results Nasdaq:BFRA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/19/2035788/0/en/Biofrontera-reports-Q1-2020-financial-results.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 08:06:35 GMT</td>    <td>Biofrontera dismisses case against DUSA Pharmaceuticals, Inc. in California state court - GlobeNewswire</td>    <td>Biofrontera dismisses case against DUSA Pharmaceuticals, Inc. in California state court  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032459/0/en/Biofrontera-dismisses-case-against-DUSA-Pharmaceuticals-Inc-in-California-state-court.html">Link</a></td>  </tr></table><h3>136. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BIIB">Biogen Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 07:00:00 GMT</td>    <td>Hedge Funds Are Betting On Biogen Inc. (BIIB) - Yahoo Finance</td>    <td>Hedge Funds Are Betting On Biogen Inc. (BIIB)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-betting-biogen-inc-165517524.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 18:19:46 GMT</td>    <td>Is Biogen Inc (BIIB) Stock a Good Buy? - InvestorsObserver</td>    <td>Is Biogen Inc (BIIB) Stock a Good Buy?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-biogen-inc-biib-stock-a-good-buy">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:32:24 GMT</td>    <td>Zacks.com featured highlights include: Canadian Solar, Biogen, Graphic Packaging and Vistra Energy - Nasdaq</td>    <td>Zacks.com featured highlights include: Canadian Solar, Biogen, Graphic Packaging and Vistra Energy  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/zacks.com-featured-highlights-include%3A-canadian-solar-biogen-graphic-packaging-and-vistra">Link</a></td>  </tr></table><h3>137. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BLFS">BioLife Solutions, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>BioLife Solutions to Report First Quarter 2020 Financial Results and Provide Business Update on May 14th, 2020 - P&T Community</td>    <td>BioLife Solutions to Report First Quarter 2020 Financial Results and Provide Business Update on May 14th, 2020  P&T Community</td>    <td><a target="_blank" href="https://www.ptcommunity.com/wire/biolife-solutions-report-first-quarter-2020-financial-results-and-provide-business-update-may">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 06:48:24 GMT</td>    <td>Biolife Solutions Inc (BLFS) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Biolife Solutions Inc (BLFS) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/14/biolife-solutions-inc-blfs-q1-2020-earnings-call-t.aspx">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Why Earnings Season Could Be Great for BioLife Solutions (BLFS) - Yahoo Finance</td>    <td>Why Earnings Season Could Be Great for BioLife Solutions (BLFS)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-earnings-season-could-great-142002873.html">Link</a></td>  </tr></table><h3>138. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BLRX">BioLineRx Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 12:40:00 GMT</td>    <td>BioLineRx Announces $9.0 Million Registered Direct Offering - PRNewswire</td>    <td>BioLineRx Announces $9.0 Million Registered Direct Offering  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/biolinerx-announces-9-0-million-registered-direct-offering-301065124.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>BioLineRx Reports First Quarter 2020 Financial Results and Provides Corporate Update - PRNewswire</td>    <td>BioLineRx Reports First Quarter 2020 Financial Results and Provides Corporate Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/biolinerx-reports-first-quarter-2020-financial-results-and-provides-corporate-update-301062454.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>BioLineRx to Report First Quarter 2020 Results on May 20, 2020 - PRNewswire</td>    <td>BioLineRx to Report First Quarter 2020 Results on May 20, 2020  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/biolinerx-to-report-first-quarter-2020-results-on-may-20-2020-301060030.html">Link</a></td>  </tr></table><h3>139. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BMRN">BioMarin Pharmaceutical Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sun, 31 May 2020 20:01:00 GMT</td>    <td>BioMarin Provides Highlights of 4 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A - PRNewswire</td>    <td>BioMarin Provides Highlights of 4 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A  PRNewswireWhy four years is important for BioMarin, hemophilia patients - San Francisco Business Times  San Francisco Business TimesBioMarin Provides Positive Gene Therapy Update For Severe Hemophilia A  Yahoo FinanceBioMarin Pharma (BMRN) Highlights 4-Yrs of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia  StreetInsider.comView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/biomarin-provides-highlights-of-4-years-of-clinical-data-from-ongoing-phase-12-study-of-valoctocogene-roxaparvovec-gene-therapy-for-severe-hemophilia-a-301068247.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:30:00 GMT</td>    <td>BioMarin to Participate in Two Upcoming Virtual Investor Conferences - PRNewswire</td>    <td>BioMarin to Participate in Two Upcoming Virtual Investor Conferences  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301069809.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 08:35:23 GMT</td>    <td>BioMarin Pharmaceutical Inc. : The underlying trend is in force again - marketscreener.com</td>    <td>BioMarin Pharmaceutical Inc. : The underlying trend is in force again  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/BIOMARIN-PHARMACEUTICAL-I-8587/news-strategies/The-underlying-trend-is-in-force-again-30714240/">Link</a></td>  </tr></table><h3>140. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BNGO">Bionano Genomics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 16:00:00 GMT</td>    <td>What Makes Bionano Genomics, Inc. (BNGO) a New Strong Buy Stock - Yahoo Finance</td>    <td>What Makes Bionano Genomics, Inc. (BNGO) a New Strong Buy Stock  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/makes-bionano-genomics-inc-bngo-160004896.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 20:37:52 GMT</td>    <td>Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020 - GlobeNewswire</td>    <td>Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033906/0/en/Bionano-Genomics-to-Report-First-Quarter-2020-Financial-Results-on-June-18-2020.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 12:07:46 GMT</td>    <td>Bionano to Participate in Maxim Group's Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on Testing - GlobeNewswire</td>    <td>Bionano to Participate in Maxim Group's Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on Testing  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039349/0/en/Bionano-to-Participate-in-Maxim-Group-s-Covid-19-Virtual-Conference-Series-The-Role-of-Cell-Therapy-and-Clarity-on-Testing.html">Link</a></td>  </tr></table><h3>141. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BVXV">BiondVax Pharmaceuticals Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>BiondVax Announces Receipt of $4.2 Million Through Exercise of Warrants - PRNewswire</td>    <td>BiondVax Announces Receipt of $4.2 Million Through Exercise of Warrants  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/biondvax-announces-receipt-of-4-2-million-through-exercise-of-warrants-301062491.html">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>How BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) Can Impact Your Portfolio Volatility - Yahoo Finance</td>    <td>How BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) Can Impact Your Portfolio Volatility  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/biondvax-pharmaceuticals-ltd-nasdaq-bvxv-124702603.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Market Reactions to Biondvax Pharmaceuticals Ltd - ADR (BVXV) Stock Getting a Bearish Rating - InvestorsObserver</td>    <td>Market Reactions to Biondvax Pharmaceuticals Ltd - ADR (BVXV) Stock Getting a Bearish Rating  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/market-reactions-to-biondvax-pharmaceuticals-ltd-adr-bvxv-stock-getting-a-bearish-rating">Link</a></td>  </tr></table><h3>142. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BNTX">BioNTech SE</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:57:00 GMT</td>    <td>How BioNTech (BNTX) Stock Stands Out in a Strong Industry - Yahoo Finance</td>    <td>How BioNTech (BNTX) Stock Stands Out in a Strong Industry  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/biontech-bntx-stock-stands-strong-125712591.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 08:49:27 GMT</td>    <td>BioNTech SE (BNTX) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>BioNTech SE (BNTX) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/13/biontech-se-bntx-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 10:02:08 GMT</td>    <td>BioNTech to Report First Quarter 2020 Financial Results and Operational Update on May 12, 2020 - GlobeNewswire</td>    <td>BioNTech to Report First Quarter 2020 Financial Results and Operational Update on May 12, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027332/0/en/BioNTech-to-Report-First-Quarter-2020-Financial-Results-and-Operational-Update-on-May-12-2020.html">Link</a></td>  </tr></table><h3>143. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BPTH">Bio-Path Holdings, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 11:21:26 GMT</td>    <td>Bio-Path Holdings Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Bio-Path Holdings Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034121/0/en/Bio-Path-Holdings-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 21:05:40 GMT</td>    <td>Bio-Path Holdings to Present at the 2020 American Society of Clinical Oncology Annual Meeting - GlobeNewswire</td>    <td>Bio-Path Holdings to Present at the 2020 American Society of Clinical Oncology Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033045/0/en/Bio-Path-Holdings-to-Present-at-the-2020-American-Society-of-Clinical-Oncology-Annual-Meeting.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Bio-Path Holdings to Announce First Quarter 2020 Financial Results on May 15, 2020 - Yahoo Finance</td>    <td>Bio-Path Holdings to Announce First Quarter 2020 Financial Results on May 15, 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/bio-path-holdings-announce-first-120010129.html">Link</a></td>  </tr></table><h3>144. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BSGM">BioSig Technologies, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:50:32 GMT</td>    <td>BioSig Technologies Expands Intellectual Property Portfolio Nasdaq:BSGM - GlobeNewswire</td>    <td>BioSig Technologies Expands Intellectual Property Portfolio Nasdaq:BSGM  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2043106/0/en/BioSig-Technologies-Expands-Intellectual-Property-Portfolio.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:24:00 GMT</td>    <td>BRIEF-Biosig Technologies Expands Intellectual Property Portfolio - Reuters</td>    <td>BRIEF-Biosig Technologies Expands Intellectual Property Portfolio  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-biosig-technologies-expands-intell/brief-biosig-technologies-expands-intellectual-property-portfolio-idUSFWN2DG0NV">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 09:33:00 GMT</td>    <td>Relative Strength Alert: Will the Biosig Technologies Inc (NAQ:BSGM) share price keep rising? - Yahoo Finance UK</td>    <td>Relative Strength Alert: Will the Biosig Technologies Inc (NAQ:BSGM) share price keep rising?  Yahoo Finance UK</td>    <td><a target="_blank" href="https://uk.finance.yahoo.com/news/relative-strength-alert-biosig-technologies-093302648.html">Link</a></td>  </tr></table><h3>145. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BSTC">BioSpecifics Technologies Corp</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 16 May 2020 07:00:00 GMT</td>    <td>One Analyst Thinks BioSpecifics Technologies Corp.'s (NASDAQ:BSTC) Revenues Are Under Threat - Yahoo Finance</td>    <td>One Analyst Thinks BioSpecifics Technologies Corp.'s (NASDAQ:BSTC) Revenues Are Under Threat  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/one-analyst-thinks-biospecifics-technologies-123006361.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:11:00 GMT</td>    <td>BioSpecifics Technologies Corp (BSTC) Plunges 5.16% on June 01 - Equities.com</td>    <td>BioSpecifics Technologies Corp (BSTC) Plunges 5.16% on June 01  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/biospecifics-technologies-corp-bstc-plunges-5-16-on-june-01">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>BioSpecifics Reports First Quarter 2020 Financial and Operating Results - BioSpace</td>    <td>BioSpecifics Reports First Quarter 2020 Financial and Operating Results  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/biospecifics-reports-first-quarter-2020-financial-and-operating-results/">Link</a></td>  </tr></table><h3>146. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TECH">Bio-Techne Corp</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 04 May 2020 07:00:00 GMT</td>    <td>Bio-Techne Corporation Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next - Yahoo Finance</td>    <td>Bio-Techne Corporation Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/bio-techne-corporation-just-beat-172645163.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 11:00:00 GMT</td>    <td>Bio-Techne To Present At The Jefferies Virtual Healthcare Conference - PRNewswire</td>    <td>Bio-Techne To Present At The Jefferies Virtual Healthcare Conference  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-jefferies-virtual-healthcare-conference-301065384.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>A Rising Share Price Has Us Looking Closely At Bio-Techne Corporation's (NASDAQ:TECH) P/E Ratio - Yahoo Finance</td>    <td>A Rising Share Price Has Us Looking Closely At Bio-Techne Corporation's (NASDAQ:TECH) P/E Ratio  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/rising-share-price-us-looking-153244724.html">Link</a></td>  </tr></table><h3>147. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BTAI">BioXcel Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 11:03:52 GMT</td>    <td>BioXcel Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast - GlobeNewswire</td>    <td>BioXcel Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027377/0/en/BioXcel-Therapeutics-to-Host-First-Quarter-2020-Operating-and-Financial-Results-Conference-Call-and-Webcast.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 11:12:13 GMT</td>    <td>BioXcel Therapeutics Announces Completion of Patient Enrollment in Phase 3 SERENITY Trials with BXCL501 - GlobeNewswire</td>    <td>BioXcel Therapeutics Announces Completion of Patient Enrollment in Phase 3 SERENITY Trials with BXCL501  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033382/0/en/BioXcel-Therapeutics-Announces-Completion-of-Patient-Enrollment-in-Phase-3-SERENITY-Trials-with-BXCL501.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>BioXcel Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update - BioSpace</td>    <td>BioXcel Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/bioxcel-therapeutics-reports-first-quarter-2020-financial-results-and-provides-business-update/">Link</a></td>  </tr></table><h3>148. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BCAC">Bison Capital Acquisition Corp.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 15 May 2019 07:00:00 GMT</td>    <td>BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC. - GlobeNewswire</td>    <td>BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC.  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/05/15/1825107/0/en/BISON-CAPITAL-ACQUISITION-CORP-ANNOUNCES-CLOSING-OF-ITS-BUSINESS-COMBINATION-WITH-XYNOMIC-PHARMACEUTICALS-INC.html">Link</a></td>  </tr><tr>    <td>Mon, 12 Aug 2019 07:00:00 GMT</td>    <td>Bison Capital Acquisition Corp.'s $350 Million Merger with Xynomic Pharmaceuticals, Inc. - Global Legal Chronicle</td>    <td>Bison Capital Acquisition Corp.'s $350 Million Merger with Xynomic Pharmaceuticals, Inc.  Global Legal Chronicle</td>    <td><a target="_blank" href="https://www.globallegalchronicle.com/bison-capital-acquisition-corp-s-350-million-merger-with-xynomic-pharmaceuticals-inc/">Link</a></td>  </tr><tr>    <td>Mon, 29 Apr 2019 07:00:00 GMT</td>    <td>Bison Capital Acquisition Corp. Announces Record and Meeting Dates for the Special Meeting of Shareholders to Approve Business Combination with Xynomic Pharmaceuticals, Inc. - GlobeNewswire</td>    <td>Bison Capital Acquisition Corp. Announces Record and Meeting Dates for the Special Meeting of Shareholders to Approve Business Combination with Xynomic Pharmaceuticals, Inc.  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/04/29/1811928/0/en/Bison-Capital-Acquisition-Corp-Announces-Record-and-Meeting-Dates-for-the-Special-Meeting-of-Shareholders-to-Approve-Business-Combination-with-Xynomic-Pharmaceuticals-Inc.html">Link</a></td>  </tr></table><h3>149. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BDTX">Black Diamond Therapeutics, Inc. </a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 11:47:10 GMT</td>    <td>Black Diamond Therapeutics to Present at the Bank of America Global Research Health Care Conference 2020 - GlobeNewswire</td>    <td>Black Diamond Therapeutics to Present at the Bank of America Global Research Health Care Conference 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028348/0/en/Black-Diamond-Therapeutics-to-Present-at-the-Bank-of-America-Global-Research-Health-Care-Conference-2020.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 11:52:34 GMT</td>    <td>Black Diamond Therapeutics Reports First Quarter 2020 Financial Results and Corporate Update - GlobeNewswire</td>    <td>Black Diamond Therapeutics Reports First Quarter 2020 Financial Results and Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031815/0/en/Black-Diamond-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Black Diamond Therapeutics, Inc. (BDTX) Shares March Higher, Can It Continue? - Yahoo Finance</td>    <td>Black Diamond Therapeutics, Inc. (BDTX) Shares March Higher, Can It Continue?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/black-diamond-therapeutics-inc-bdtx-131001757.html">Link</a></td>  </tr></table><h3>150. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BLUE">bluebird bio, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:05:00 GMT</td>    <td>bluebird bio Announces That Its 2020 Annual Meeting of Stockholders Will Be Held in Virtual Format - Business Wire</td>    <td>bluebird bio Announces That Its 2020 Annual Meeting of Stockholders Will Be Held in Virtual Format  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200603005781/en/bluebird-bio-Announces-2020-Annual-Meeting-Stockholders">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>bluebird bio Provides Operational and Business Update and Reports First Quarter 2020 Financial Results - Business Wire</td>    <td>bluebird bio Provides Operational and Business Update and Reports First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200511005289/en/bluebird-bio-Operational-Business-Update-Reports-Quarter">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>bluebird bio Inc. (BLUE) Soars 1.16% on June 02 - Equities.com</td>    <td>bluebird bio Inc. (BLUE) Soars 1.16% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/bluebird-bio-inc-blue-soars-1-16-on-june-02">Link</a></td>  </tr></table><h3>151. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BPMC">Blueprint Medicines Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Blueprint Medicines Receives Complete Response Letter from FDA for Avapritinib New Drug Application for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor - PRNewswire</td>    <td>Blueprint Medicines Receives Complete Response Letter from FDA for Avapritinib New Drug Application for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor  PRNewswireBRIEF-Blueprint Medicines Receives Complete Response Letter From FDA For Avapritinib NDA For The Treatment Of Fourth-Line Gastrointestinal Stromal Tumor  ReutersBlueprint Medicines (BPMC) Receives CRL from FDA for Avapritinib NDA for Treatment of Fourth-Line Gastrointestinal Stromal Tumor  StreetInsider.comU.S. FDA Declines to Approve Blueprint's Therapy for Type of Stomach Cancer  The New York TimesFDA Issues Complete Response Letter for Avapritinib in Fourth-Line GIST  OncLiveView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/blueprint-medicines-receives-complete-response-letter-from-fda-for-avapritinib-new-drug-application-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor-301059932.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:00:00 GMT</td>    <td>Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewswire</td>    <td>Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/blueprint-medicines-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301069617.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 13:49:00 GMT</td>    <td>Hedge Funds Are Done Buying Blueprint Medicines Corporation (BPMC) - Yahoo Finance</td>    <td>Hedge Funds Are Done Buying Blueprint Medicines Corporation (BPMC)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-done-buying-blueprint-134908543.html">Link</a></td>  </tr></table><h3>152. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BCLI">Brainstorm Cell Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 10:00:00 GMT</td>    <td>BrainStorm to Participate in BIO Digital 2020 English English - PRNewswire</td>    <td>BrainStorm to Participate in BIO Digital 2020 English English  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/il/news-releases/brainstorm-to-participate-in-bio-digital-2020-301069948.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 10:00:00 GMT</td>    <td>BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020 - PRNewswire</td>    <td>BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/il/news-releases/brainstorm-announces-that-pivotal-phase-3-trial-remains-on-track-for-topline-data-in-q4-2020-301069123.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 10:31:43 GMT</td>    <td>BrainStorm Announces Financial Results for the First Quarter of 2020 and Provides a Corporate Update - GlobeNewswire</td>    <td>BrainStorm Announces Financial Results for the First Quarter of 2020 and Provides a Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029237/0/en/BrainStorm-Announces-Financial-Results-for-the-First-Quarter-of-2020-and-Provides-a-Corporate-Update.html">Link</a></td>  </tr></table><h3>153. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BWAY">Brainsway Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 11:41:04 GMT</td>    <td>BrainsWay Strengthens Senior Leadership Team with Appointment of Christopher Boyer as Vice President of Global Marketing - GlobeNewswire</td>    <td>BrainsWay Strengthens Senior Leadership Team with Appointment of Christopher Boyer as Vice President of Global Marketing  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036294/0/en/BrainsWay-Strengthens-Senior-Leadership-Team-with-Appointment-of-Christopher-Boyer-as-Vice-President-of-Global-Marketing.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 11:47:01 GMT</td>    <td>BrainsWay Enhances Senior Leadership with Promotion and New Executive Addition - GlobeNewswire</td>    <td>BrainsWay Enhances Senior Leadership with Promotion and New Executive Addition  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028323/0/en/BrainsWay-Enhances-Senior-Leadership-with-Promotion-and-New-Executive-Addition.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:10:00 GMT</td>    <td>BRAINSWAY LTD/S ADR Did they just beat EPS? - Stock Market Daily</td>    <td>BRAINSWAY LTD/S ADR Did they just beat EPS?  Stock Market Daily</td>    <td><a target="_blank" href="https://stockmarketdaily.co/2020/06/03/brainsway-ltd-s-adr-did-they-just-beat-eps/">Link</a></td>  </tr></table><h3>154. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BBIO">BridgeBio Pharma</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 20:42:35 GMT</td>    <td>BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference - GlobeNewswire</td>    <td>BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028907/0/en/BridgeBio-Pharma-Inc-To-Present-At-Upcoming-Investor-Conference.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 20:04:24 GMT</td>    <td>BridgeBio Pharma, Inc. Reports First Quarter 2020 Financial Results and Business Update - GlobeNewswire</td>    <td>BridgeBio Pharma, Inc. Reports First Quarter 2020 Financial Results and Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032968/0/en/BridgeBio-Pharma-Inc-Reports-First-Quarter-2020-Financial-Results-and-Business-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 20:36:58 GMT</td>    <td>BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire</td>    <td>BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027946/0/en/BridgeBio-Pharma-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html">Link</a></td>  </tr></table><h3>155. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BRKR">Bruker Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 13:56:00 GMT</td>    <td>Bruker Rides on PCI Sales, Coronavirus-Led Supply Issues Hurt - Yahoo Finance</td>    <td>Bruker Rides on PCI Sales, Coronavirus-Led Supply Issues Hurt  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/bruker-rides-pci-sales-coronavirus-135601703.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 10:28:11 GMT</td>    <td>Bruker introduces breakthrough MALDI-2 source on timsTOF fleX, and further innovations in CCS-enabled 4D proteomics on timsTOF - News-Medical.Net</td>    <td>Bruker introduces breakthrough MALDI-2 source on timsTOF fleX, and further innovations in CCS-enabled 4D proteomics on timsTOF  News-Medical.Net</td>    <td><a target="_blank" href="https://www.news-medical.net/news/20200603/Bruker-introduces-breakthrough-MALDI-2-source-on-timsTOF-fleX-and-further-innovations-in-CCS-enabled-4D-proteomics-on-timsTOF.aspx">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 07:00:00 GMT</td>    <td>Bruker Alicona to host webinar on form and roughness measurement - Powder Metallurgy Review magazine</td>    <td>Bruker Alicona to host webinar on form and roughness measurement  Powder Metallurgy Review magazine</td>    <td><a target="_blank" href="https://www.pm-review.com/bruker-alicona-to-host-webinar-on-form-and-roughness-measurement/">Link</a></td>  </tr></table><h3>156. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CABA">Cabaletta Bio</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 12:04:08 GMT</td>    <td>Cabaletta Bio Announces Expansion of Sponsored Research Agreement with the University of Pennsylvania - GlobeNewswire</td>    <td>Cabaletta Bio Announces Expansion of Sponsored Research Agreement with the University of Pennsylvania  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040157/0/en/Cabaletta-Bio-Announces-Expansion-of-Sponsored-Research-Agreement-with-the-University-of-Pennsylvania.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 17:10:00 GMT</td>    <td>Philadelphia biotech company expands successful partnership with Penn - Philadelphia Business Journal</td>    <td>Philadelphia biotech company expands successful partnership with Penn  Philadelphia Business Journal</td>    <td><a target="_blank" href="https://www.bizjournals.com/philadelphia/news/2020/05/28/university-of-pennsylvania-cabaletta-bio-cell-gene.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 16:00:00 GMT</td>    <td>Cabaletta Bio, Inc. (CABA) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance</td>    <td>Cabaletta Bio, Inc. (CABA) Moves to Strong Buy: Rationale Behind the Upgrade  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cabaletta-bio-inc-caba-moves-160004083.html">Link</a></td>  </tr></table><h3>157. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CALA">Calithera Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 11:09:14 GMT</td>    <td>Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire</td>    <td>Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042076/0/en/Calithera-Biosciences-Announces-New-Employment-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Calithera Biosciences Reports First Quarter 2020 Financial Results and Recent Highlights - GlobeNewswire</td>    <td>Calithera Biosciences Reports First Quarter 2020 Financial Results and Recent Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029899/0/en/Calithera-Biosciences-Reports-First-Quarter-2020-Financial-Results-and-Recent-Highlights.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 11:08:54 GMT</td>    <td>If You Had Bought Calithera Biosciences (NASDAQ:CALA) Stock Three Years Ago, You’d Be Sitting On A 65% Loss, Today - Simply Wall St</td>    <td>If You Had Bought Calithera Biosciences (NASDAQ:CALA) Stock Three Years Ago, You’d Be Sitting On A 65% Loss, Today  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cala/calithera-biosciences/news/if-you-had-bought-calithera-biosciences-nasdaqcala-stock-three-years-ago-youd-be-sitting-on-a-65-loss-today/">Link</a></td>  </tr></table><h3>158. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CAPR">Capricor Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 17:08:00 GMT</td>    <td>Here is What Hedge Funds Think About Capricor Therapeutics, Inc. (CAPR) - Yahoo Finance</td>    <td>Here is What Hedge Funds Think About Capricor Therapeutics, Inc. (CAPR)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-think-capricor-therapeutics-170830375.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 20:15:28 GMT</td>    <td>Capricor Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Capricor Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033829/0/en/Capricor-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Capricor Therapeutics to Present First Quarter 2020 Financial Results and Recent Corporate Update on May 14 - Yahoo Finance</td>    <td>Capricor Therapeutics to Present First Quarter 2020 Financial Results and Recent Corporate Update on May 14  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/capricor-therapeutics-present-first-quarter-203010927.html">Link</a></td>  </tr></table><h3>159. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CARA">Cara Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Cara Therapeutics Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Cara Therapeutics Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031384/0/en/Cara-Therapeutics-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 11:10:28 GMT</td>    <td>Cara Therapeutics to Present at the Virtual BofA Securities 2020 Health Care Conference - GlobeNewswire</td>    <td>Cara Therapeutics to Present at the Virtual BofA Securities 2020 Health Care Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029263/0/en/Cara-Therapeutics-to-Present-at-the-Virtual-BofA-Securities-2020-Health-Care-Conference.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance</td>    <td>Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cara-therapeutics-cara-reports-q1-215509859.html">Link</a></td>  </tr></table><h3>160. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CASI">CASI Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 11:00:00 GMT</td>    <td>CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference - PRNewswire</td>    <td>CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/casi-pharmaceuticals-to-present-at-the-jefferies-2020-healthcare-conference-301068743.html">Link</a></td>  </tr><tr>    <td>Sun, 31 May 2020 21:38:00 GMT</td>    <td>Do Hedge Funds Love CASI Pharmaceuticals Inc (CASI)? - Yahoo Finance</td>    <td>Do Hedge Funds Love CASI Pharmaceuticals Inc (CASI)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-love-casi-pharmaceuticals-213821055.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>CASI Pharmaceuticals Announces First Quarter 2020 Financial Results - PRNewswire</td>    <td>CASI Pharmaceuticals Announces First Quarter 2020 Financial Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-first-quarter-2020-financial-results-301056419.html">Link</a></td>  </tr></table><h3>161. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CSTL">Castle Biosciences</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Castle Biosciences Announces Change of Location of Annual Meeting of Stockholders to Be Held June 4, 2020 - Business Wire</td>    <td>Castle Biosciences Announces Change of Location of Annual Meeting of Stockholders to Be Held June 4, 2020  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200522005041/en/Castle-Biosciences-Announces-Change-Location-Annual-Meeting">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Castle Biosciences Announces First Quarter 2020 Results - Business Wire</td>    <td>Castle Biosciences Announces First Quarter 2020 Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200511005730/en/Castle-Biosciences-Announces-Quarter-2020-Results">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Castle Biosciences Inc (CSTL) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Castle Biosciences Inc (CSTL) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/castle-biosciences-inc-cstl-q1-2020-earnings-call.aspx">Link</a></td>  </tr></table><h3>162. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CATB">Catabasis Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress - Business Wire</td>    <td>Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005585/en/Catabasis-Pharmaceuticals-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 10:27:30 GMT</td>    <td>Before You Buy Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), Consider Its Volatility - Simply Wall St</td>    <td>Before You Buy Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), Consider Its Volatility  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/before-you-buy-catabasis-pharmaceuticals-inc-nasdaqcatb-consider-its-volatility-3/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>BRIEF-Catabasis Pharma Reports First Quarter Loss Per Share Of $0.50 - Reuters</td>    <td>BRIEF-Catabasis Pharma Reports First Quarter Loss Per Share Of $0.50  Reuters</td>    <td><a target="_blank" href="https://uk.reuters.com/article/brief-catabasis-pharma-reports-first-qua/brief-catabasis-pharma-reports-first-quarter-loss-per-share-of-050-idUKASA00PSG">Link</a></td>  </tr></table><h3>163. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CBIO">Catalyst Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 12:09:25 GMT</td>    <td>Catalyst Biosciences Reports First Quarter 2020 Operating & Financial Results and Provides a Corporate Update - GlobeNewswire</td>    <td>Catalyst Biosciences Reports First Quarter 2020 Operating & Financial Results and Provides a Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031053/0/en/Catalyst-Biosciences-Reports-First-Quarter-2020-Operating-Financial-Results-and-Provides-a-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>BRIEF-Catalyst Biosciences Reports Q1 Loss Per Share $0.28 - Reuters</td>    <td>BRIEF-Catalyst Biosciences Reports Q1 Loss Per Share $0.28  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-catalyst-biosciences-reports-q1-lo/brief-catalyst-biosciences-reports-q1-loss-per-share-028-idUSASA00PBU">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Is Catalyst Biosciences Inc (CBIO) Stock About to Get Hot Thursday? - InvestorsObserver</td>    <td>Is Catalyst Biosciences Inc (CBIO) Stock About to Get Hot Thursday?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-catalyst-biosciences-inc-cbio-stock-about-to-get-hot-thursday">Link</a></td>  </tr></table><h3>164. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CPRX">Catalyst Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:27:24 GMT</td>    <td>Catalyst Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>Catalyst Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041452/0/en/Catalyst-Pharmaceuticals-to-Present-at-the-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 20:33:51 GMT</td>    <td>Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031471/0/en/Catalyst-Pharmaceuticals-Announces-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 08:47:43 GMT</td>    <td>Catalyst Pharmaceuticals Inc (CPRX) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Catalyst Pharmaceuticals Inc (CPRX) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/catalyst-pharmaceuticals-inc-cprx-q1-2020-earnings.aspx">Link</a></td>  </tr></table><h3>165. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CELG">Celgene Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:24:00 GMT</td>    <td>SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bristol-Myers Squibb Company - BMY.RT - Yahoo Finance</td>    <td>SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bristol-Myers Squibb Company - BMY.RT  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-202417754.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 17:37:00 GMT</td>    <td>Cancer Nanotherapy Market 2020 To Receive Overwhelming Hike in Future | Leading Players are Celgene Corporation, Galen Limited, Pacira BioSciences, Inc, Johnson & Johnson Services, Inc - 3rd Watch News</td>    <td>Cancer Nanotherapy Market 2020 To Receive Overwhelming Hike in Future | Leading Players are Celgene Corporation, Galen Limited, Pacira BioSciences, Inc, Johnson & Johnson Services, Inc  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/1139934/cancer-nanotherapy-market-2020-to-receive-overwhelming-hike-in-future-leading-players-are-celgene-corporation-galen-limited-pacira-biosciences-inc-johnson-johnson-services-inc/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 07:12:51 GMT</td>    <td>GLOBAL STEM CELL MARKET 2020-2026 | LEADING PLAYERS ADVANCED CELL TECHNOLOGY INC, OSIRIS THERAPEUTICS INC, CELGENE CORPORATION, BIOTIME, INC., CYNATA, STEMCELL TECHNOLOGIES INC., CELLULAR ENGINEERING TECHNOLOGIES INC – Distinct Analysis & Reports - News Distinct</td>    <td>GLOBAL STEM CELL MARKET 2020-2026 | LEADING PLAYERS ADVANCED CELL TECHNOLOGY INC, OSIRIS THERAPEUTICS INC, CELGENE CORPORATION, BIOTIME, INC., CYNATA, STEMCELL TECHNOLOGIES INC., CELLULAR ENGINEERING TECHNOLOGIES INC – Distinct Analysis & Reports  News Distinct</td>    <td><a target="_blank" href="https://www.newsdistinct.com/global-stem-cell-market-2020-2026-leading-players-advanced-cell-technology-inc-osiris-therapeutics-inc-celgene-corporation-biotime-inc-cynata-stemcell-technologies-inc-cellular-engineering/">Link</a></td>  </tr></table><h3>166. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CLDX">Celldex Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 19:22:00 GMT</td>    <td>Hedge Funds Are Dumping Celldex Therapeutics, Inc. (CLDX) - Yahoo Finance</td>    <td>Hedge Funds Are Dumping Celldex Therapeutics, Inc. (CLDX)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-dumping-celldex-therapeutics-192258372.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Celldex Therapeutics Inc. (CLDX) Soars 4.14% on June 02 - Equities.com</td>    <td>Celldex Therapeutics Inc. (CLDX) Soars 4.14% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/celldex-therapeutics-inc-cldx-soars-4-14-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Is Celldex Therapeutics, Inc. (CLDX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance</td>    <td>Is Celldex Therapeutics, Inc. (CLDX) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/celldex-therapeutics-inc-cldx-stock-153003220.html">Link</a></td>  </tr></table><h3>167. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-APOP">Cellect Biotechnology Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Cellect Biotechnology's ApoGraft™ to Empower Cellular Treatment of COVID-19 Related Pulmonary Diseases - PRNewswire</td>    <td>Cellect Biotechnology's ApoGraft™ to Empower Cellular Treatment of COVID-19 Related Pulmonary Diseases  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cellect-biotechnologys-apograft-to-empower-cellular-treatment-of-covid-19-related-pulmonary-diseases-301060683.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Cellect Biotechnology Announces Positive Data Demonstrating Robust Engraftment Using ApoGraft was Featured in Bone Marrow Transplantation; Primary Data Points Were Submitted to the FDA During Investigational New Drug Approval Process - PRNewswire</td>    <td>Cellect Biotechnology Announces Positive Data Demonstrating Robust Engraftment Using ApoGraft was Featured in Bone Marrow Transplantation; Primary Data Points Were Submitted to the FDA During Investigational New Drug Approval Process  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cellect-biotechnology-announces-positive-data-demonstrating-robust-engraftment-using-apograft-was-featured-in-bone-marrow-transplantation-primary-data-points-were-submitted-to-the-fda-during-investigational-new-drug-approval-proc-301056409.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Cellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progress Despite Adjusted Operations Due to COVID-19 - PRNewswire</td>    <td>Cellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progress Despite Adjusted Operations Due to COVID-19  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cellect-biotechnology-reports-first-quarter-2020-financial-and-operating-results-continues-to-demonstrate-significant-progress-despite-adjusted-operations-due-to-covid-19-301063900.html">Link</a></td>  </tr></table><h3>168. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CLRB">Cellectar Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 13:13:44 GMT</td>    <td>Cellectar Biosciences Announces Pricing of $20 Million Underwritten Public Offering - GlobeNewswire</td>    <td>Cellectar Biosciences Announces Pricing of $20 Million Underwritten Public Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042969/0/en/Cellectar-Biosciences-Announces-Pricing-of-20-Million-Underwritten-Public-Offering.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:21:06 GMT</td>    <td>CELLECTAR BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - marketscreener.com</td>    <td>CELLECTAR BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/CELLECTAR-BIOSCIENCES-IN-44979166/news/CELLECTAR-BIOSCIENCES-INC-Regulation-FD-Disclosure-Financial-Statements-and-Exhibits-form-8-K-30716095/">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 14:10:00 GMT</td>    <td>Here’s How Hedge Funds Traded Cellectar Biosciences, Inc. (CLRB) During The Crash - Yahoo Finance</td>    <td>Here’s How Hedge Funds Traded Cellectar Biosciences, Inc. (CLRB) During The Crash  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-traded-cellectar-biosciences-141017636.html">Link</a></td>  </tr></table><h3>169. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CLLS">Cellectis S.A.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Cellectis SA (CLLS) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Cellectis SA (CLLS) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/09/cellectis-sa-clls-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:42:33 GMT</td>    <td>Cellectis Provides Business Update and Reports Financial Results for First Quarter 2020 - GlobeNewswire</td>    <td>Cellectis Provides Business Update and Reports Financial Results for First Quarter 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028908/0/en/Cellectis-Provides-Business-Update-and-Reports-Financial-Results-for-First-Quarter-2020.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:30:00 GMT</td>    <td>Is Cellectis (CLLS) Outperforming Other Medical Stocks This Year? - Yahoo Finance</td>    <td>Is Cellectis (CLLS) Outperforming Other Medical Stocks This Year?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cellectis-clls-outperforming-other-medical-153003873.html">Link</a></td>  </tr></table><h3>170. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CBMG">Cellular Biomedicine Group, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 12:00:00 GMT</td>    <td>Cellular Biomedicine Group (CBMG) Announces 2020 Annual Meeting of Stockholders - WFMZ Allentown</td>    <td>Cellular Biomedicine Group (CBMG) Announces 2020 Annual Meeting of Stockholders  WFMZ Allentown</td>    <td><a target="_blank" href="https://www.wfmz.com/news/pr_newswire/pr_newswire_business/cellular-biomedicine-group-cbmg-announces-2020-annual-meeting-of-stockholders/article_853a58ec-097c-5499-a002-086b1901e9e9.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Cellular Biomedicine Group Reports Q1 2020 Financial Results and Business Highlights - PRNewswire</td>    <td>Cellular Biomedicine Group Reports Q1 2020 Financial Results and Business Highlights  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cellular-biomedicine-group-reports-q1-2020-financial-results-and-business-highlights-301054303.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 21:20:00 GMT</td>    <td>Hedge Funds Are Warming Up To Cellular Biomedicine Group, Inc. (CBMG) - Yahoo Finance</td>    <td>Hedge Funds Are Warming Up To Cellular Biomedicine Group, Inc. (CBMG)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-warming-cellular-biomedicine-212015294.html">Link</a></td>  </tr></table><h3>171. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CLSN">Celsion Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 12:17:39 GMT</td>    <td>Celsion Corporation Reports First Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire</td>    <td>Celsion Corporation Reports First Quarter 2020 Financial Results and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034203/0/en/Celsion-Corporation-Reports-First-Quarter-2020-Financial-Results-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 13:04:57 GMT</td>    <td>Celsion Corporation to Hold First Quarter 2020 Financial Results Conference Call on Friday, May 15, 2020 - GlobeNewswire</td>    <td>Celsion Corporation to Hold First Quarter 2020 Financial Results Conference Call on Friday, May 15, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030380/0/en/Celsion-Corporation-to-Hold-First-Quarter-2020-Financial-Results-Conference-Call-on-Friday-May-15-2020.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:09:52 GMT</td>    <td>Is Celsion Corporation (CLSN) Stock a Good Buy? - InvestorsObserver</td>    <td>Is Celsion Corporation (CLSN) Stock a Good Buy?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-celsion-corporation-clsn-stock-a-good-buy-2">Link</a></td>  </tr></table><h3>172. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CYAD">Celyad SA</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 25 May 2020 07:00:00 GMT</td>    <td>All You Need to Know About Celyad SA (CYAD) Rating Upgrade to Strong Buy - Yahoo Finance</td>    <td>All You Need to Know About Celyad SA (CYAD) Rating Upgrade to Strong Buy  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/know-celyad-sa-cyad-rating-160004517.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 10:00:00 GMT</td>    <td>Celyad SA (CYAD) Reports Update on Allogeneic CAR-T Franchise Including CYAD-101 & shRNA Platform - StreetInsider.com</td>    <td>Celyad SA (CYAD) Reports Update on Allogeneic CAR-T Franchise Including CYAD-101 & shRNA Platform  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Celyad+SA+%28CYAD%29+Reports+Update+on+Allogeneic+CAR-T+Franchise+Including+CYAD-101+%26+shRNA+Platform/16952215.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Celyad SA (CYAD) Names Dr. Maria Koehler and Mr. Dominic Piscitelli to Board - StreetInsider.com</td>    <td>Celyad SA (CYAD) Names Dr. Maria Koehler and Mr. Dominic Piscitelli to Board  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Celyad+SA+%28CYAD%29+Names+Dr.+Maria+Koehler+and+Mr.+Dominic+Piscitelli+to+Board/16838998.html">Link</a></td>  </tr></table><h3>173. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CNTG">Centogene B.V.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 Nov 2019 08:00:00 GMT</td>    <td>CENTOGENE Announces Pricing of Initial Public Offering - GlobeNewswire</td>    <td>CENTOGENE Announces Pricing of Initial Public Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/11/07/1942850/0/en/CENTOGENE-Announces-Pricing-of-Initial-Public-Offering.html">Link</a></td>  </tr><tr>    <td>Mon, 28 Oct 2019 07:00:00 GMT</td>    <td>CENTOGENE Announces Proposed Initial Public Offering of Common Shares - GlobeNewswire</td>    <td>CENTOGENE Announces Proposed Initial Public Offering of Common Shares  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/10/28/1936314/0/en/CENTOGENE-Announces-Proposed-Initial-Public-Offering-of-Common-Shares.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 08:17:21 GMT</td>    <td>Global Thymidine Kinase-2 Deficiency Treatment Market To Witness Astonishing Growth By 2026 With Key Players Like Modis Therapeutics, CENTOGENE AG, GeneDx, NeuroVive Pharmaceuticals AB, Gino Cortopassi, Khondrion BV, Mitobridge, Inc., Reata Pharmaceuticals, Inc - Surfacing Magazine</td>    <td>Global Thymidine Kinase-2 Deficiency Treatment Market To Witness Astonishing Growth By 2026 With Key Players Like Modis Therapeutics, CENTOGENE AG, GeneDx, NeuroVive Pharmaceuticals AB, Gino Cortopassi, Khondrion BV, Mitobridge, Inc., Reata Pharmaceuticals, Inc  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/global-thymidine-kinase-2-deficiency-treatment-market-vigorous-growth-2019-2026centogene-ag-genedx-neurovive-pharmaceuticals-ab-gino-cortopassi-khondrion-bv-mitobridge-inc-reata-pharmaceutica/">Link</a></td>  </tr></table><h3>174. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CNTX">Centrexion Therapeutics Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 03 Dec 2019 08:00:00 GMT</td>    <td>Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975 - GlobeNewswire</td>    <td>Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/12/03/1955486/0/en/Centrexion-Therapeutics-Announces-Issuance-of-U-S-Composition-of-Matter-Patent-for-Lead-Pipeline-Candidate-CNTX-4975.html">Link</a></td>  </tr><tr>    <td>Wed, 04 Sep 2019 07:00:00 GMT</td>    <td>CORRECTION - Centrexion Therapeutics Nasdaq:CNTX - GlobeNewswire</td>    <td>CORRECTION - Centrexion Therapeutics Nasdaq:CNTX  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/09/04/1910987/0/en/CORRECTION-Centrexion-Therapeutics.html">Link</a></td>  </tr><tr>    <td>Fri, 08 Nov 2019 08:00:00 GMT</td>    <td>Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 American College of Rheumatology Annual Meeting and the 2019 American Academy of Physical Medicine and Rehabilitation Annual Assembly - GlobeNewswire</td>    <td>Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 American College of Rheumatology Annual Meeting and the 2019 American Academy of Physical Medicine and Rehabilitation Annual Assembly  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/11/08/1944003/0/en/Centrexion-Therapeutics-Announces-CNTX-4975-Data-Presentations-at-the-2019-American-College-of-Rheumatology-Annual-Meeting-and-the-2019-American-Academy-of-Physical-Medicine-and-Re.html">Link</a></td>  </tr></table><h3>175. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CERC">Cerecor Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:45:27 GMT</td>    <td>Biomarker Study Finds Levels of Novel Cytokine Highly Correlated To COVID-19 Severity and Mortality - HospiMedica</td>    <td>Biomarker Study Finds Levels of Novel Cytokine Highly Correlated To COVID-19 Severity and Mortality  HospiMedica</td>    <td><a target="_blank" href="https://www.hospimedica.com/covid-19/articles/294782740/biomarker-study-finds-levels-of-novel-cytokine-highly-correlated-to-covid-19-severity-and-mortality.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 10:31:46 GMT</td>    <td>Cerecor Reports Q1 2020 Results and Update Nasdaq:CERC - GlobeNewswire</td>    <td>Cerecor Reports Q1 2020 Results and Update Nasdaq:CERC  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029235/0/en/Cerecor-Reports-Q1-2020-Results-and-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 11:13:53 GMT</td>    <td>Cerecor and Myriad Genetics Announce that Levels of LIGHT, a Novel Cytokine, Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker Study - GlobeNewswire</td>    <td>Cerecor and Myriad Genetics Announce that Levels of LIGHT, a Novel Cytokine, Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker Study  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038489/0/en/Cerecor-and-Myriad-Genetics-Announce-that-Levels-of-LIGHT-a-Novel-Cytokine-Were-Highly-Correlated-with-Disease-Severity-and-Mortality-in-COVID-19-ARDS-Biomarker-Study.html">Link</a></td>  </tr></table><h3>176. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CSBR">Champions Oncology, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 11:05:00 GMT</td>    <td>If You Had Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago You'd Have Made 278% - Yahoo Finance</td>    <td>If You Had Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago You'd Have Made 278%  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/had-bought-champions-oncology-nasdaq-110511040.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 10:32:31 GMT</td>    <td>Patient Derived Xenograft or PDX Models Market 2020-2027 Covid-19 Impact on Major Companies – Champions Oncology Inc., Charles River Laboratories International Inc., Oncodesign, Bioduro (Us), Hera Biolabs, etc. - Cole of Duty</td>    <td>Patient Derived Xenograft or PDX Models Market 2020-2027 Covid-19 Impact on Major Companies – Champions Oncology Inc., Charles River Laboratories International Inc., Oncodesign, Bioduro (Us), Hera Biolabs, etc.  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/military-news/2020/06/03/patient-derived-xenograft-or-pdx-models-market-2020-2027-covid-19-impact-on-major-companies-champions-oncology-inc-charles-river-laboratories-international-inc-oncodesign-bioduro-us-hera-bio/">Link</a></td>  </tr><tr>    <td>Sun, 31 May 2020 17:40:05 GMT</td>    <td>Patient Derived Xenografts Market Key Players are Bioduro, Champion Oncology, Inc, Charles River, Crown Bioscience Inc, EPO Berlin-Buch GmbH - Surfacing Magazine</td>    <td>Patient Derived Xenografts Market Key Players are Bioduro, Champion Oncology, Inc, Charles River, Crown Bioscience Inc, EPO Berlin-Buch GmbH  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/patient-derived-xenografts-market-key-players-are-bioduro-champion-oncology-inc-charles-river-crown-bioscience-inc-epo-berlin-buch-gmbh/">Link</a></td>  </tr></table><h3>177. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CKPT">Checkpoint Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Checkpoint Therapeutics to Host Virtual Annual Meeting of Stockholders - GlobeNewswire</td>    <td>Checkpoint Therapeutics to Host Virtual Annual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/22/2037587/0/en/Checkpoint-Therapeutics-to-Host-Virtual-Annual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Checkpoint Therapeutics CEO On Tapping Into A $25 Billion Cancer Treatment Market - Yahoo Finance</td>    <td>Checkpoint Therapeutics CEO On Tapping Into A $25 Billion Cancer Treatment Market  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/checkpoint-therapeutics-ceo-tapping-25-123349080.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 17:42:00 GMT</td>    <td>Hedge Funds Are Warming Up To Checkpoint Therapeutics, Inc. (CKPT) - Yahoo Finance</td>    <td>Hedge Funds Are Warming Up To Checkpoint Therapeutics, Inc. (CKPT)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-warming-checkpoint-therapeutics-174226880.html">Link</a></td>  </tr></table><h3>178. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CEMI">Chembio Diagnostics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:14:43 GMT</td>    <td>Chembio Diagnostics Strengthens Commercial Organization Nasdaq:CEMI - GlobeNewswire</td>    <td>Chembio Diagnostics Strengthens Commercial Organization Nasdaq:CEMI  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042198/0/en/Chembio-Diagnostics-Strengthens-Commercial-Organization.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 11:14:14 GMT</td>    <td>Chembio Diagnostics Announces US Distribution Agreement to Expand Reach of DPP COVID-19 Serological Test with Thermo Fisher Scientific's Healthcare Channel - GlobeNewswire</td>    <td>Chembio Diagnostics Announces US Distribution Agreement to Expand Reach of DPP COVID-19 Serological Test with Thermo Fisher Scientific's Healthcare Channel  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2034847/0/en/Chembio-Diagnostics-Announces-US-Distribution-Agreement-to-Expand-Reach-of-DPP-COVID-19-Serological-Test-with-Thermo-Fisher-Scientific-s-Healthcare-Channel.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 14:32:22 GMT</td>    <td>Chembio Diagnostics Announces Closing of Public Offering of Common Stock - GlobeNewswire</td>    <td>Chembio Diagnostics Announces Closing of Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031211/0/en/Chembio-Diagnostics-Announces-Closing-of-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr></table><h3>179. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CCXI">ChemoCentryx, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:30:00 GMT</td>    <td>ChemoCentryx Phase III ADVOCATE Trial of Avacopan in ANCA-Associated Vasculitis Highlighted in Oral Plenary Presentations at EULAR and ERA-EDTA Congresses - GlobeNewswire</td>    <td>ChemoCentryx Phase III ADVOCATE Trial of Avacopan in ANCA-Associated Vasculitis Highlighted in Oral Plenary Presentations at EULAR and ERA-EDTA Congresses  GlobeNewswire</td>    <td><a target="_blank" href="http://www.globenewswire.com/news-release/2020/06/03/2042821/0/en/ChemoCentryx-Phase-III-ADVOCATE-Trial-of-Avacopan-in-ANCA-Associated-Vasculitis-Highlighted-in-Oral-Plenary-Presentations-at-EULAR-and-ERA-EDTA-Congresses.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 20:13:26 GMT</td>    <td>ChemoCentryx Reports First Quarter 2020 Financial Results and Recent Highlights - GlobeNewswire</td>    <td>ChemoCentryx Reports First Quarter 2020 Financial Results and Recent Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031437/0/en/ChemoCentryx-Reports-First-Quarter-2020-Financial-Results-and-Recent-Highlights.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>ChemoCentryx Inc (CCXI) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>ChemoCentryx Inc (CCXI) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/chemocentryx-inc-ccxi-q1-2020-earnings-call-transc.aspx">Link</a></td>  </tr></table><h3>180. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CHFS">CHF Solutions, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 20:43:03 GMT</td>    <td>CHF Solutions, Inc. Announces Adjournment of Annual Meeting of Stockholders - GlobeNewswire</td>    <td>CHF Solutions, Inc. Announces Adjournment of Annual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/22/2037823/0/en/CHF-Solutions-Inc-Announces-Adjournment-of-Annual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 12:15:06 GMT</td>    <td>CHF Solutions, Inc. Announces 34 Percent Increase in Revenue for First Quarter 2020 Over Previous Year and Provides Company Update - GlobeNewswire</td>    <td>CHF Solutions, Inc. Announces 34 Percent Increase in Revenue for First Quarter 2020 Over Previous Year and Provides Company Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031875/0/en/CHF-Solutions-Inc-Announces-34-Percent-Increase-in-Revenue-for-First-Quarter-2020-Over-Previous-Year-and-Provides-Company-Update.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance</td>    <td>CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/chf-solutions-inc-reports-inducement-203510597.html">Link</a></td>  </tr></table><h3>181. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CHMA">Chiasma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Chiasma Inc (CHMA) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Chiasma Inc (CHMA) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/chiasma-inc-chma-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:12:05 GMT</td>    <td>Chiasma Reports First Quarter 2020 Financial Results Nasdaq:CHMA - GlobeNewswire</td>    <td>Chiasma Reports First Quarter 2020 Financial Results Nasdaq:CHMA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029870/0/en/Chiasma-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 04:04:00 GMT</td>    <td>Chiasma, Inc. (CHMA) CEO Raj Kannan on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Chiasma, Inc. (CHMA) CEO Raj Kannan on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4345872-chiasma-inc-chma-ceo-raj-kannan-on-q1-2020-results-earnings-call-transcript">Link</a></td>  </tr></table><h3>182. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CMRX">Chimerix, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Chimerix Inc. (CMRX) Soars 1.82% on June 03 - Equities.com</td>    <td>Chimerix Inc. (CMRX) Soars 1.82% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/chimerix-inc-cmrx-soars-1-82-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Revenue Downgrade: Here's What Analysts Forecast For Chimerix, Inc. (NASDAQ:CMRX) - Yahoo Finance</td>    <td>Revenue Downgrade: Here's What Analysts Forecast For Chimerix, Inc. (NASDAQ:CMRX)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/revenue-downgrade-heres-analysts-forecast-104702851.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Chimerix Inc. (CMRX) Soars 7.46% on May 14 - Equities.com</td>    <td>Chimerix Inc. (CMRX) Soars 7.46% on May 14  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/chimerix-inc-cmrx-soars-7-46-on-may-14">Link</a></td>  </tr></table><h3>183. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CBPO">China Biologic Products Holdings, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 18:38:45 GMT</td>    <td>Is China Biologic Products Holdings Inc (CBPO) Stock a Good Buy on Wednesday? - InvestorsObserver</td>    <td>Is China Biologic Products Holdings Inc (CBPO) Stock a Good Buy on Wednesday?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-china-biologic-products-holdings-inc-cbpo-stock-a-good-buy-on-wednesday">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 12:30:00 GMT</td>    <td>China Biologic Products to Report First Quarter 2020 Financial Results - StreetInsider.com</td>    <td>China Biologic Products to Report First Quarter 2020 Financial Results  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/PRNewswire/China+Biologic+Products+to+Report+First+Quarter+2020+Financial+Results/16869541.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 20:45:00 GMT</td>    <td>China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction - PRNewswire</td>    <td>China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/china-biologic-comments-on-the-xinjiang-deyuan-and-shuanglin-transaction-301062805.html">Link</a></td>  </tr></table><h3>184. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CDTX">Cidara Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 20:37:06 GMT</td>    <td>Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) - GlobeNewswire</td>    <td>Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027953/0/en/Cidara-Therapeutics-Announces-New-Clinical-and-Preclinical-Data-for-Rezafungin-and-Influenza-AVCs-from-the-European-Congress-of-Clinical-Microbiology-and-Infectious-Diseases-ECCMID.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 12:56:05 GMT</td>    <td>Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation - GlobeNewswire</td>    <td>Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036400/0/en/Cidara-Therapeutics-Doses-First-Patient-in-Pivotal-Phase-3-ReSPECT-Trial-of-Rezafungin-for-Prevention-of-Invasive-Fungal-Disease-in-Patients-Undergoing-Allogeneic-Blood-and-Marrow-.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Cidara Therapeutics: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Cidara Therapeutics: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Cidara-Therapeutics-1Q-Earnings-Snapshot-15268180.php">Link</a></td>  </tr></table><h3>185. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CTXR">Citius Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Should You Be Concerned About Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Historical Volatility? - Yahoo Finance</td>    <td>Should You Be Concerned About Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Historical Volatility?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/concerned-citius-pharmaceuticals-inc-nasdaq-104944581.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Citius Pharmaceuticals Issues May 2020 Shareholder Letter - Yahoo Finance</td>    <td>Citius Pharmaceuticals Issues May 2020 Shareholder Letter  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/citius-pharmaceuticals-issues-may-2020-120000749.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:28:02 GMT</td>    <td>Citius Pharmaceuticals Inc. (CTXR) Open at price of $0.8925: A Brand-New Opportunity for Investors - News Daemon</td>    <td>Citius Pharmaceuticals Inc. (CTXR) Open at price of $0.8925: A Brand-New Opportunity for Investors  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/03/citius-pharmaceuticals-inc-ctxr-open-at-price-of-0-8925-a-brand-new-opportunity-for-investors/">Link</a></td>  </tr></table><h3>186. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CLSD">Clearside Biomedical, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 08 May 2020 11:06:25 GMT</td>    <td>Clearside Biomedical Announces First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Clearside Biomedical Announces First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030280/0/en/Clearside-Biomedical-Announces-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Clearside Biomedical Inc (CLSD) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance</td>    <td>Clearside Biomedical Inc (CLSD) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/clearside-biomedical-inc-clsd-reports-124512981.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance</td>    <td>Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/clearside-biomedical-inc-clsd-report-163004223.html">Link</a></td>  </tr></table><h3>187. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CMTA">Clementia Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 04:51:00 GMT</td>    <td>Global Fibrodysplasia Ossificans Progressiva Drug Market 2020 Growth Factors – AstraZeneca Plc, Regeneron Pharmaceuticals Inc - Jewish Life News</td>    <td>Global Fibrodysplasia Ossificans Progressiva Drug Market 2020 Growth Factors – AstraZeneca Plc, Regeneron Pharmaceuticals Inc  Jewish Life News</td>    <td><a target="_blank" href="https://jewishlifenews.com/uncategorized/global-fibrodysplasia-ossificans-progressiva-drug-market-2020-growth-factors-astrazeneca-plc-regeneron-pharmaceuticals-inc/">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Global Fibrodysplasia Ossificans Progressive Drugs 2020 – AstraZeneca Plc, Blueprint Medicines Corp., Clementia Pharmaceuticals Inc., Daiichi Sankyo Company Ltd., La Jolla Pharmaceutical Company - Bandera County Courier</td>    <td>Global Fibrodysplasia Ossificans Progressive Drugs 2020 – AstraZeneca Plc, Blueprint Medicines Corp., Clementia Pharmaceuticals Inc., Daiichi Sankyo Company Ltd., La Jolla Pharmaceutical Company  Bandera County Courier</td>    <td><a target="_blank" href="https://www.bccourier.com/global-fibrodysplasia-ossificans-progressive-drugs-2020-astrazeneca-plc-blueprint-medicines-corp-clementia-pharmaceuticals-inc-daiichi-sankyo-company-ltd-la-jolla-pharmaceutical-company/">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:13:52 GMT</td>    <td>Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market worth Observing Growth by 2027 | Pfizer Inc., AstraZeneca, Limited, Regeneron Pharmaceuticals, Inc, Clementia Pharmaceuticals, Oncodesign, Daiichi Sankyo Company, Novartis AG - Surfacing Magazine</td>    <td>Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market worth Observing Growth by 2027 | Pfizer Inc., AstraZeneca, Limited, Regeneron Pharmaceuticals, Inc, Clementia Pharmaceuticals, Oncodesign, Daiichi Sankyo Company, Novartis AG  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/fibrodysplasia-ossificans-progressiva-fop-treatment-market-worth-observing-growth-by-2027-pfizer-inc-astrazeneca-limited-regeneron-pharmaceuticals-inc-clementia-pharmaceuticals-oncodesign/">Link</a></td>  </tr></table><h3>188. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CBLI">Cleveland BioLabs, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:05:00 GMT</td>    <td>Cleveland BioLabs Closes $3.175 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules - Yahoo Finance</td>    <td>Cleveland BioLabs Closes $3.175 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cleveland-biolabs-closes-3-175-200500679.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:30:00 GMT</td>    <td>Cleveland BioLabs Announces $3.175 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Yahoo Finance</td>    <td>Cleveland BioLabs Announces $3.175 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cleveland-biolabs-announces-3-175-123000128.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Cleveland BioLabs Reports First Quarter 2020 Financial Results and Development Progress - Yahoo Finance</td>    <td>Cleveland BioLabs Reports First Quarter 2020 Financial Results and Development Progress  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cleveland-biolabs-reports-first-quarter-130000578.html">Link</a></td>  </tr></table><h3>189. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CLVS">Clovis Oncology, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Clovis Oncology Needs a Savior - Yahoo Finance</td>    <td>Clovis Oncology Needs a Savior  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/clovis-oncology-needs-savior-182429230.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 20:00:02 GMT</td>    <td>Investor confidence shakens after Clovis Oncology, Inc. (NASDAQ:CLVS) share prices loss $0 - Marketing Sentinel</td>    <td>Investor confidence shakens after Clovis Oncology, Inc. (NASDAQ:CLVS) share prices loss $0  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/01/investor-confidence-shakens-after-clovis-oncology-inc-nasdaqclvs-share-prices-loss-0/">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Clovis Oncology Announces Pricing of Public Offering of Common Stock - Yahoo Finance</td>    <td>Clovis Oncology Announces Pricing of Public Offering of Common Stock  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/clovis-oncology-announces-pricing-public-000500335.html">Link</a></td>  </tr></table><h3>190. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CNSP">CNS Pharmaceuticals</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 04 May 2020 07:00:00 GMT</td>    <td>CNS Pharmaceuticals Announces Trading Halt - BioSpace</td>    <td>CNS Pharmaceuticals Announces Trading Halt  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/cns-pharmaceuticals-announces-trading-halt/">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 14:45:04 GMT</td>    <td>CNS Pharmaceuticals Announces Sponsored Research Agreement with MD Anderson for Potential Cancer Treatment Technologies - BioSpace</td>    <td>CNS Pharmaceuticals Announces Sponsored Research Agreement with MD Anderson for Potential Cancer Treatment Technologies  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/cns-pharmaceuticals-announces-sponsored-research-agreement-with-md-anderson-for-potential-cancer-treatment-technologies/">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>CNS Provides Additional Comments Regarding Trading Halt - PRNewswire</td>    <td>CNS Provides Additional Comments Regarding Trading Halt  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cns-provides-additional-comments-regarding-trading-halt-301056441.html">Link</a></td>  </tr></table><h3>191. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-COCP">Cocrystal Pharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 11:12:57 GMT</td>    <td>Cocrystal Pharma Reports First Quarter 2020 Financial Results and Provides Updates on Antiviral Programs - GlobeNewswire</td>    <td>Cocrystal Pharma Reports First Quarter 2020 Financial Results and Provides Updates on Antiviral Programs  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033400/0/en/Cocrystal-Pharma-Reports-First-Quarter-2020-Financial-Results-and-Provides-Updates-on-Antiviral-Programs.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 12:11:34 GMT</td>    <td>Cocrystal Pharma Provides COVID-19 Impact Update on Development Programs - GlobeNewswire</td>    <td>Cocrystal Pharma Provides COVID-19 Impact Update on Development Programs  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031060/0/en/Cocrystal-Pharma-Provides-COVID-19-Impact-Update-on-Development-Programs.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Why Cocrystal Pharma, Inc.'s (NASDAQ:COCP) CEO Pay Matters To You - Yahoo Finance</td>    <td>Why Cocrystal Pharma, Inc.'s (NASDAQ:COCP) CEO Pay Matters To You  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-cocrystal-pharma-inc-nasdaq-103601282.html">Link</a></td>  </tr></table><h3>192. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CWBR">CohBar, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 13:11:36 GMT</td>    <td>CohBar to Hold 2020 Annual Shareholder Meeting and Investor Update June 16, 2020 - GlobeNewswire</td>    <td>CohBar to Hold 2020 Annual Shareholder Meeting and Investor Update June 16, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042251/0/en/CohBar-to-Hold-2020-Annual-Shareholder-Meeting-and-Investor-Update-June-16-2020.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 13:08:28 GMT</td>    <td>CohBar's Chief Operating Officer Jon Stern Plans to Step Down from Management Role - GlobeNewswire</td>    <td>CohBar's Chief Operating Officer Jon Stern Plans to Step Down from Management Role  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032733/0/en/CohBar-s-Chief-Operating-Officer-Jon-Stern-Plans-to-Step-Down-from-Management-Role.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>CohBar, Inc. (CWBR) CEO Steve Engle on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>CohBar, Inc. (CWBR) CEO Steve Engle on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4347904-cohbar-inc-cwbr-ceo-steve-engle-on-q1-2020-results-earnings-call-transcript">Link</a></td>  </tr></table><h3>193. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-COHR">Coherent, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Coherent Inc. (COHR) Soars 3.79% on June 03 - Equities.com</td>    <td>Coherent Inc. (COHR) Soars 3.79% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/coherent-inc-cohr-soars-3-79-on-june-03">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Coherent, Inc. Announces Live Webcast of Second Quarter Fiscal Year 2020 Results - PRNewswire</td>    <td>Coherent, Inc. Announces Live Webcast of Second Quarter Fiscal Year 2020 Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/coherent-inc-announces-live-webcast-of-second-quarter-fiscal-year-2020-results-301059754.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 20:05:00 GMT</td>    <td>Coherent, Inc. Reports Second Fiscal Quarter Results - PRNewswire</td>    <td>Coherent, Inc. Reports Second Fiscal Quarter Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/coherent-inc-reports-second-fiscal-quarter-results-301066407.html">Link</a></td>  </tr></table><h3>194. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CHRS">Coherus BioSciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Coherus BioSciences Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Coherus BioSciences Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029931/0/en/Coherus-BioSciences-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 12:44:00 GMT</td>    <td>Hedge Funds Aren’t Done Buying Coherus Biosciences Inc (CHRS) - Yahoo Finance</td>    <td>Hedge Funds Aren’t Done Buying Coherus Biosciences Inc (CHRS)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-aren-t-done-124458991.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Coherus BioSciences Inc (CHRS) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Coherus BioSciences Inc (CHRS) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/coherus-biosciences-inc-chrs-q1-2020-earnings-call.aspx">Link</a></td>  </tr></table><h3>195. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-COLL">Collegium Pharmaceutical, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Collegium Pharmaceutical Inc. (COLL) Soars 3.55% on June 03 - Equities.com</td>    <td>Collegium Pharmaceutical Inc. (COLL) Soars 3.55% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/collegium-pharmaceutical-inc-coll-soars-3-55-on-june-03">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Collegium Pharmaceutical Inc (COLL) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Collegium Pharmaceutical Inc (COLL) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/collegium-pharmaceutical-inc-coll-q1-2020-earnings.aspx">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 03:40:45 GMT</td>    <td>Joseph Ciaffoni Sells 70,676 Shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) Stock - MarketBeat</td>    <td>Joseph Ciaffoni Sells 70,676 Shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) Stock  MarketBeat</td>    <td><a target="_blank" href="https://www.marketbeat.com/instant-alerts/nasdaq-coll-insider-buying-and-selling/">Link</a></td>  </tr></table><h3>196. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CGEN">Compugen Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 18:00:02 GMT</td>    <td>Compugen Ltd. (CGEN) investors to reap big returns again - Marketing Sentinel</td>    <td>Compugen Ltd. (CGEN) investors to reap big returns again  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/03/compugen-ltd-cgen-investors-to-reap-big-returns-again/">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Compugen Ltd. (CGEN) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Compugen Ltd. (CGEN) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/06/compugen-ltd-cgen-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:50:00 GMT</td>    <td>Is It Right Time to Be Bullish on Compugen Ltd. (NASDAQ:CGEN), Virgin Galactic Holdings Inc. (NYSE:SPCE)? - State Reviewer</td>    <td>Is It Right Time to Be Bullish on Compugen Ltd. (NASDAQ:CGEN), Virgin Galactic Holdings Inc. (NYSE:SPCE)?  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/is-it-right-time-to-be-bullish-on-compugen-ltd-nasdaqcgen-virgin-galactic-holdings-inc-nysespce/">Link</a></td>  </tr></table><h3>197. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CNAT">Conatus Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 12:03:35 GMT</td>    <td>Histogen Announces Successful Completion of its Merger with Conatus Pharmaceuticals - GlobeNewswire</td>    <td>Histogen Announces Successful Completion of its Merger with Conatus Pharmaceuticals  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039308/0/en/Histogen-Announces-Successful-Completion-of-its-Merger-with-Conatus-Pharmaceuticals.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 12:13:44 GMT</td>    <td>Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Histogen and the Required Reverse Stock Split - GlobeNewswire</td>    <td>Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Histogen and the Required Reverse Stock Split  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2034905/0/en/Leading-Independent-Proxy-Advisory-Firms-Recommend-Conatus-Pharmaceuticals-Shareholders-Vote-in-Favor-of-its-Merger-with-Histogen-and-the-Required-Reverse-Stock-Split.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:12:15 GMT</td>    <td>The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reconvene on May 21, 2020 - GlobeNewswire</td>    <td>The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reconvene on May 21, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029863/0/en/The-Conatus-Pharmaceuticals-Special-Meeting-of-Stockholders-Seeking-Approval-for-Proposed-Merger-with-Histogen-Inc-will-Reconvene-on-May-21-2020.html">Link</a></td>  </tr></table><h3>198. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CNCE">Concert Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Concert Pharmaceuticals Inc. (CNCE) Plunges 6.55% on June 03 - Equities.com</td>    <td>Concert Pharmaceuticals Inc. (CNCE) Plunges 6.55% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/concert-pharmaceuticals-inc-cnce-plunges-6-55-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 11:00:00 GMT</td>    <td>Concert Pharmaceuticals to Webcast Fireside Chat at Jefferies Virtual Global Healthcare Conference - Yahoo Finance</td>    <td>Concert Pharmaceuticals to Webcast Fireside Chat at Jefferies Virtual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/concert-pharmaceuticals-webcast-fireside-chat-110000980.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Concert Pharmaceuticals to Webcast Presentation at UBS Virtual Healthcare Conference - Yahoo Finance</td>    <td>Concert Pharmaceuticals to Webcast Presentation at UBS Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/concert-pharmaceuticals-webcast-presentation-ubs-110000920.html">Link</a></td>  </tr></table><h3>199. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CNMD">CONMED Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 20:05:00 GMT</td>    <td>CONMED Corporation Announces Quarterly Cash Dividend - Business Wire</td>    <td>CONMED Corporation Announces Quarterly Cash Dividend  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200521005623/en/CONMED-Corporation-Announces-Quarterly-Cash-Dividend">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>CONMED Corporation Announces That 2020 Annual Meeting of Shareholders Will Be Virtual-Only Meeting Due to COVID-19 - Business Wire</td>    <td>CONMED Corporation Announces That 2020 Annual Meeting of Shareholders Will Be Virtual-Only Meeting Due to COVID-19  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200511005215/en/CONMED-Corporation-Announces-2020-Annual-Meeting-Shareholders">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 15:31:00 GMT</td>    <td>Why Is Conmed (CNMD) Down 0.7% Since Last Earnings Report? - Yahoo Finance</td>    <td>Why Is Conmed (CNMD) Down 0.7% Since Last Earnings Report?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-conmed-cnmd-down-0-153103400.html">Link</a></td>  </tr></table><h3>200. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CNST">Constellation Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 13:00:00 GMT</td>    <td>Constellation Pharmaceuticals to Participate in Investor Conference - Yahoo Finance</td>    <td>Constellation Pharmaceuticals to Participate in Investor Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/constellation-pharmaceuticals-participate-investor-conference-130010098.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 18:24:11 GMT</td>    <td>Constellation Pharmaceuticals to Participate in Two Investor Conferences - GlobeNewswire</td>    <td>Constellation Pharmaceuticals to Participate in Two Investor Conferences  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027822/0/en/Constellation-Pharmaceuticals-to-Participate-in-Two-Investor-Conferences.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 16:12:17 GMT</td>    <td>Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610 - GlobeNewswire</td>    <td>Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040447/0/en/Constellation-Pharmaceuticals-to-Host-Analyst-Investor-Event-to-Discuss-Update-of-MANIFEST-Clinical-Trial-for-CPI-0610.html">Link</a></td>  </tr></table><h3>201. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CFRX">ContraFect Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 11:33:50 GMT</td>    <td>ContraFect Corporation Announces Private Placement of Common Stock and Warrants to Pfizer Inc. - GlobeNewswire</td>    <td>ContraFect Corporation Announces Private Placement of Common Stock and Warrants to Pfizer Inc.  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038529/0/en/ContraFect-Corporation-Announces-Private-Placement-of-Common-Stock-and-Warrants-to-Pfizer-Inc.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 20:25:10 GMT</td>    <td>ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants - GlobeNewswire</td>    <td>ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037278/0/en/ContraFect-Corporation-Announces-Proposed-Public-Offering-of-Common-Stock-and-Warrants.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 11:47:47 GMT</td>    <td>ContraFect Announces Four Abstracts Published in the 30th ECCMID Abstract Book - GlobeNewswire</td>    <td>ContraFect Announces Four Abstracts Published in the 30th ECCMID Abstract Book  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030999/0/en/ContraFect-Announces-Four-Abstracts-Published-in-the-30th-ECCMID-Abstract-Book.html">Link</a></td>  </tr></table><h3>202. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CTRV">ContraVir Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sun, 31 May 2020 15:31:18 GMT</td>    <td>Global Herpes Zoste Drug Market 2020 – Impact of COVID-19, Future Growth Analysis and Challenges | Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd, ContraVir Pharmaceuticals, Inc. - Surfacing Magazine</td>    <td>Global Herpes Zoste Drug Market 2020 – Impact of COVID-19, Future Growth Analysis and Challenges | Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd, ContraVir Pharmaceuticals, Inc.  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/global-herpes-zoste-drug-market-2020-impact-of-covid-19-future-growth-analysis-and-challenges-astellas-pharma-inc-beijing-minhai-biotechnology-co-ltd-contravir-pharmaceuticals-inc/">Link</a></td>  </tr><tr>    <td>Mon, 22 Jul 2019 07:00:00 GMT</td>    <td>ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA” - GlobeNewswire</td>    <td>ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/07/22/1885994/0/en/ContraVir-Pharmaceuticals-Announces-Name-Change-to-Hepion-Pharmaceuticals-Inc-Trading-Symbol-Change-to-HEPA.html">Link</a></td>  </tr><tr>    <td>Tue, 18 Jun 2019 07:00:00 GMT</td>    <td>ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering - GlobeNewswire</td>    <td>ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/06/18/1870316/0/en/ContraVir-Pharmaceuticals-Inc-Announces-Pricing-of-15-6-Million-Public-Offering.html">Link</a></td>  </tr></table><h3>203. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CRBP">Corbus Pharmaceuticals Holdings, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 15:00:00 GMT</td>    <td>Corbus Pharmaceuticals Holdings Inc. [CRBP] is 36.63% higher this YTD. Is it still time to buy? - The DBT News</td>    <td>Corbus Pharmaceuticals Holdings Inc. [CRBP] is 36.63% higher this YTD. Is it still time to buy?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/01/corbus-pharmaceuticals-holdings-inc-crbp-is-36-63-higher-this-ytd-is-it-still-time-to-buy/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:20:00 GMT</td>    <td>Growth Myths About Corbus Pharmaceuticals Holdings, Inc. (CRBP) You Probably Still Believe - The News Heater</td>    <td>Growth Myths About Corbus Pharmaceuticals Holdings, Inc. (CRBP) You Probably Still Believe  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/growth-myths-about-corbus-pharmaceuticals-holdings-inc-crbp-you-probably-still-believe-2/">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 12:06:57 GMT</td>    <td>Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2020 E-Congress - GlobeNewswire</td>    <td>Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2020 E-Congress  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/22/2037567/0/en/Corbus-Pharmaceuticals-Announces-Publication-of-Two-Abstracts-at-EULAR-2020-E-Congress.html">Link</a></td>  </tr></table><h3>204. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CORT">Corcept Therapeutics Incorporated</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Corcept Therapeutics Incorporated (CORT) Soars 1.26% on June 03 - Equities.com</td>    <td>Corcept Therapeutics Incorporated (CORT) Soars 1.26% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/corcept-therapeutics-incorporated-cort-soars-1-26-on-june-03">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:30:00 GMT</td>    <td>Has Corcept Therapeutics (CORT) Outpaced Other Medical Stocks This Year? - Yahoo Finance</td>    <td>Has Corcept Therapeutics (CORT) Outpaced Other Medical Stocks This Year?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/corcept-therapeutics-cort-outpaced-other-153003438.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 20:16:20 GMT</td>    <td>Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual Meeting - GlobeNewswire</td>    <td>Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033850/0/en/Corcept-Therapeutics-to-Present-Data-at-the-American-Society-of-Clinical-Oncology-Annual-Meeting.html">Link</a></td>  </tr></table><h3>205. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CORV">Correvio Pharma Corp.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 15:42:00 GMT</td>    <td>ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp. - Yahoo Finance</td>    <td>ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/advanz-pharma-corp-limited-closes-154200463.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Correvio Announces Results from Annual General and Special Meeting of Securityholders - PRNewswire</td>    <td>Correvio Announces Results from Annual General and Special Meeting of Securityholders  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/correvio-announces-results-from-annual-general-and-special-meeting-of-securityholders-301060356.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 15:00:04 GMT</td>    <td>Think You Need A Good Stock? Look At This Correvio Pharma Corp. (NASDAQ:CORV) Analysis - Stocks Register</td>    <td>Think You Need A Good Stock? Look At This Correvio Pharma Corp. (NASDAQ:CORV) Analysis  Stocks Register</td>    <td><a target="_blank" href="https://stocksregister.com/2020/06/02/think-you-need-a-good-stock-look-at-this-correvio-pharma-corp-nasdaqcorv-analysis/">Link</a></td>  </tr></table><h3>206. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CRTX">Cortexyme</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Cortexyme Publishes Data on P. Gingivalis Ability to Infect Neurons, Drive Alzheimer's-Like Pathology in the Journal of Alzheimer's Disease - Business Wire</td>    <td>Cortexyme Publishes Data on P. Gingivalis Ability to Infect Neurons, Drive Alzheimer's-Like Pathology in the Journal of Alzheimer's Disease  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506005314/en/Cortexyme-Publishes-Data-P.-Gingivalis-Ability-Infect">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Cortexyme to Present at the BofA Securities 2020 Health Care Conference on May 13, 2020 - Business Wire</td>    <td>Cortexyme to Present at the BofA Securities 2020 Health Care Conference on May 13, 2020  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005244/en/Cortexyme-Present-BofA-Securities-2020-Health-Care">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Cortexyme Announces First Quarter 2020 Financial Results and Provides Business Update - Business Wire</td>    <td>Cortexyme Announces First Quarter 2020 Financial Results and Provides Business Update  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005876/en/Cortexyme-Announces-Quarter-2020-Financial-Results-Business">Link</a></td>  </tr></table><h3>207. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CRVS">Corvus Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Corvus Pharmaceuticals Inc. (CRVS) Soars 2.78% on June 03 - Equities.com</td>    <td>Corvus Pharmaceuticals Inc. (CRVS) Soars 2.78% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/corvus-pharmaceuticals-inc-crvs-soars-2-78-on-june-03">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 21:26:22 GMT</td>    <td>Corvus Pharmaceuticals to Present Data on Refinement of the Adenosine Gene Signature and Ciforadenant in Renal Cell Cancer at the ASCO20 Virtual Scientific Program - GlobeNewswire</td>    <td>Corvus Pharmaceuticals to Present Data on Refinement of the Adenosine Gene Signature and Ciforadenant in Renal Cell Cancer at the ASCO20 Virtual Scientific Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033077/0/en/Corvus-Pharmaceuticals-to-Present-Data-on-Refinement-of-the-Adenosine-Gene-Signature-and-Ciforadenant-in-Renal-Cell-Cancer-at-the-ASCO20-Virtual-Scientific-Program.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:12:31 GMT</td>    <td>Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature's Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant - GlobeNewswire</td>    <td>Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature's Ability to Identify Patients Likely to Respond to Treatment with Ciforadenant  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040862/0/en/Corvus-Pharmaceuticals-Presents-Updated-Clinical-Data-Supporting-and-Refining-the-Adenosine-Gene-Signature-s-Ability-to-Identify-Patients-Likely-to-Respond-to-Treatment-with-Cifora.html">Link</a></td>  </tr></table><h3>208. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CRNX">Crinetics Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 08 May 2020 13:07:43 GMT</td>    <td>Crinetics Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Crinetics Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030387/0/en/Crinetics-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Is Crinetics Pharmaceuticals (CRNX) Stock a Solid Choice Right Now? - Yahoo Finance</td>    <td>Is Crinetics Pharmaceuticals (CRNX) Stock a Solid Choice Right Now?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/crinetics-pharmaceuticals-crnx-stock-solid-125112591.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>BRIEF-Crinetics Pharmaceuticals Reports First Quarter 2020 Financial Results And Provides Corporate Update - Reuters</td>    <td>BRIEF-Crinetics Pharmaceuticals Reports First Quarter 2020 Financial Results And Provides Corporate Update  Reuters</td>    <td><a target="_blank" href="https://uk.reuters.com/article/brief-crinetics-pharmaceuticals-reports/brief-crinetics-pharmaceuticals-reports-first-quarter-2020-financial-results-and-provides-corporate-update-idUKASA00P58">Link</a></td>  </tr></table><h3>209. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CRSP">CRISPR Therapeutics AG</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 12:31:07 GMT</td>    <td>CRISPR Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire</td>    <td>CRISPR Therapeutics to Participate in Upcoming Investor Conferences  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038619/0/en/CRISPR-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 12:37:45 GMT</td>    <td>CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2020 Annual Meeting - GlobeNewswire</td>    <td>CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2020 Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034249/0/en/CRISPR-Therapeutics-Announces-Presentations-at-the-American-Association-for-Cancer-Research-2020-Annual-Meeting.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 15:31:00 GMT</td>    <td>Why Is CRISPR Therapeutics AG (CRSP) Up 22.9% Since Last Earnings Report? - Yahoo Finance</td>    <td>Why Is CRISPR Therapeutics AG (CRSP) Up 22.9% Since Last Earnings Report?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-crispr-therapeutics-ag-crsp-153103000.html">Link</a></td>  </tr></table><h3>210. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CTIC">CTI BioPharma Corp.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 11:00:00 GMT</td>    <td>CTI BioPharma to Present at the Jefferies 2020 Healthcare Conference on Thursday, Jun. 4 - PRNewswire</td>    <td>CTI BioPharma to Present at the Jefferies 2020 Healthcare Conference on Thursday, Jun. 4  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-jefferies-2020-healthcare-conference-on-thursday-jun-4-301066429.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 11:00:00 GMT</td>    <td>CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial - PRNewswire</td>    <td>CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cti-biopharma-announces-enrollment-of-first-patient-in-covid-19-pre-vent-phase-3-clinical-trial-301068348.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>CTI BioPharma Reports First Quarter 2020 Financial Results - PRNewswire</td>    <td>CTI BioPharma Reports First Quarter 2020 Financial Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cti-biopharma-reports-first-quarter-2020-financial-results-301055212.html">Link</a></td>  </tr></table><h3>211. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CUE">Cue Biopharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 May 2020 20:07:09 GMT</td>    <td>Cue Biopharma Reports First Quarter 2020 Results, Updates of CUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights - GlobeNewswire</td>    <td>Cue Biopharma Reports First Quarter 2020 Results, Updates of CUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/19/2035958/0/en/Cue-Biopharma-Reports-First-Quarter-2020-Results-Updates-of-CUE-101-Phase-1-Dose-Escalation-Study-and-Recent-Business-Highlights.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 12:14:39 GMT</td>    <td>Cue Biopharma to Host Business Update Call and Webcast - GlobeNewswire</td>    <td>Cue Biopharma to Host Business Update Call and Webcast  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031830/0/en/Cue-Biopharma-to-Host-Business-Update-Call-and-Webcast.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:42:18 GMT</td>    <td>Market Reactions to Cue Biopharma Inc (CUE) Stock Getting a Bullish Rating - InvestorsObserver</td>    <td>Market Reactions to Cue Biopharma Inc (CUE) Stock Getting a Bullish Rating  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/market-reactions-to-cue-biopharma-inc-cue-stock-getting-a-bullish-rating">Link</a></td>  </tr></table><h3>212. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CPIX">Cumberland Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results - PRNewswire</td>    <td>Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-to-announce-first-quarter-2020-financial-results-301060309.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Cumberland Pharmaceuticals, Inc. to Host Earnings Call - Yahoo Finance</td>    <td>Cumberland Pharmaceuticals, Inc. to Host Earnings Call  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cumberland-pharmaceuticals-inc-host-earnings-183000167.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 22:00:00 GMT</td>    <td>Is Cumberland Pharmaceuticals (CPIX) A Good Stock To Buy Now? - Yahoo Finance</td>    <td>Is Cumberland Pharmaceuticals (CPIX) A Good Stock To Buy Now?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cumberland-pharmaceuticals-cpix-good-stock-220055547.html">Link</a></td>  </tr></table><h3>213. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CRIS">Curis, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Curis Reports First Quarter 2020 Financial Results - PRNewswire</td>    <td>Curis Reports First Quarter 2020 Financial Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/curis-reports-first-quarter-2020-financial-results-301057781.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Curis to Release First Quarter 2020 Financial Results and Hold Conference Call on May 12, 2020 - Yahoo Finance</td>    <td>Curis to Release First Quarter 2020 Financial Results and Hold Conference Call on May 12, 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/curis-release-first-quarter-2020-120000855.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 21:09:00 GMT</td>    <td>Curis Inc. (CRIS) Soars 3.11% on May 28 - Equities.com</td>    <td>Curis Inc. (CRIS) Soars 3.11% on May 28  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/curis-inc-cris-soars-3-11-on-may-28">Link</a></td>  </tr></table><h3>214. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CUTR">Cutera, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Cutera, Inc. Announces First Quarter 2020 Financial Results - Yahoo Finance</td>    <td>Cutera, Inc. Announces First Quarter 2020 Financial Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cutera-inc-announces-first-quarter-200100966.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Bearish: Analysts Just Cut Their Cutera, Inc. (NASDAQ:CUTR) Revenue and EPS estimates - Yahoo Finance</td>    <td>Bearish: Analysts Just Cut Their Cutera, Inc. (NASDAQ:CUTR) Revenue and EPS estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/bearish-analysts-just-cut-cutera-172827360.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Cutera: 1Q Earnings Snapshot | Business - Lincoln Journal Star</td>    <td>Cutera: 1Q Earnings Snapshot | Business  Lincoln Journal Star</td>    <td><a target="_blank" href="https://journalstar.com/business/cutera-1q-earnings-snapshot/article_07ee9f15-1a09-5316-9660-c446be84d970.html">Link</a></td>  </tr></table><h3>215. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CYCC">Cyclacel Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 20:07:50 GMT</td>    <td>Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032253/0/en/Cyclacel-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:00:01 GMT</td>    <td>Cyclacel Pharmaceuticals, Inc. (CYCC) drops -7.04%, marking lose by bears - Marketing Sentinel</td>    <td>Cyclacel Pharmaceuticals, Inc. (CYCC) drops -7.04%, marking lose by bears  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/01/cyclacel-pharmaceuticals-inc-cycc-drops-7-04-marking-lose-by-bears/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 21:20:21 GMT</td>    <td>CYCLACEL PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com</td>    <td>CYCLACEL PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/news/CYCLACEL-PHARMACEUTICALS-INC-Management-s-Discussion-and-Analysis-of-Financial-Condition-and-Resu--30591091/">Link</a></td>  </tr></table><h3>216. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CBAY">CymaBay Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 09:48:46 GMT</td>    <td>CymaBay Therapeutics Inc (CBAY) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>CymaBay Therapeutics Inc (CBAY) Q1 2020 Earnings Call Transcript  The Motley FoolA Look Into CymaBay Therapeutics Price Over Earnings  Yahoo FinanceCymaBay Therapeutics' stock more than doubles amid hopes FDA will lift hold on NASH treatment  MarketWatchCymaBay Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswireAre Investors Unfairly Punishing CymaBay Therapeutics Inc. (NASDAQ:CBAY)?  State ReviewerView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/cymabay-therapeutics-inc-cbay-q1-2020-earnings-cal.aspx">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 14:22:00 GMT</td>    <td>The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics - Yahoo Finance</td>    <td>The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/zacks-analyst-blog-highlights-aileron-142202788.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 13:30:03 GMT</td>    <td>CymaBay Therapeutics Inc. (CBAY) plunge -1.81% in a week: will this be a lucky break through? - News Daemon</td>    <td>CymaBay Therapeutics Inc. (CBAY) plunge -1.81% in a week: will this be a lucky break through?  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/02/cymabay-therapeutics-inc-cbay-plunge-1-81-in-a-week-will-this-be-a-lucky-break-through/">Link</a></td>  </tr></table><h3>217. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CYTK">Cytokinetics, Incorporated</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Cytokinetics to Hold Annual Meeting of Stockholders - GlobeNewswire</td>    <td>Cytokinetics to Hold Annual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029816/0/en/Cytokinetics-to-Hold-Annual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Cytokinetics Incorporated (CYTK) Soars 1% on June 02 - Equities.com</td>    <td>Cytokinetics Incorporated (CYTK) Soars 1% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/cytokinetics-incorporated-cytk-soars-1-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:03:02 GMT</td>    <td>Cytokinetics Reports First Quarter 2020 Financial Results Nasdaq:CYTK - GlobeNewswire</td>    <td>Cytokinetics Reports First Quarter 2020 Financial Results Nasdaq:CYTK  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028781/0/en/Cytokinetics-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>218. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CTMX">CytomX Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 13:46:00 GMT</td>    <td>Is CytomX Therapeutics (CTMX) Stock a Solid Choice Right Now? - Yahoo Finance</td>    <td>Is CytomX Therapeutics (CTMX) Stock a Solid Choice Right Now?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cytomx-therapeutics-ctmx-stock-solid-134601551.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 21:26:19 GMT</td>    <td>CytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program - GlobeNewswire</td>    <td>CytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033073/0/en/CytomX-Therapeutics-Announces-Details-of-Presentations-at-the-American-Society-of-Clinical-Oncology-ASCO20-Virtual-Scientific-Program.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 21:38:33 GMT</td>    <td>Pomerantz Law Firm Announces the Filing of a Class Action against CytomX Therapeutics Inc. and Certain Officers – CTMX - GlobeNewswire</td>    <td>Pomerantz Law Firm Announces the Filing of a Class Action against CytomX Therapeutics Inc. and Certain Officers – CTMX  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037339/0/en/Pomerantz-Law-Firm-Announces-the-Filing-of-a-Class-Action-against-CytomX-Therapeutics-Inc-and-Certain-Officers-CTMX.html">Link</a></td>  </tr></table><h3>219. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CYTR">CytRx Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>CytRx Corporation Highlights Latest Positive Event From its Licensed Drug Aldoxorubicin - Yahoo Finance</td>    <td>CytRx Corporation Highlights Latest Positive Event From its Licensed Drug Aldoxorubicin  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/cytrx-corporation-highlights-latest-positive-130000788.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 13:00:00 GMT</td>    <td>CytRx Corporation Highlights Orphazyme's Rolling Submission of its New Drug Application with the US FDA for Arimoclomol in Niemann-Pick Disease Type-C - PRNewswire</td>    <td>CytRx Corporation Highlights Orphazyme's Rolling Submission of its New Drug Application with the US FDA for Arimoclomol in Niemann-Pick Disease Type-C  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cytrx-corporation-highlights-orphazymes-rolling-submission-of-its-new-drug-application-with-the-us-fda-for-arimoclomol-in-niemann-pick-disease-type-c-301068174.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 07:00:00 GMT</td>    <td>CytRx Corporation Highlights Orphazyme's Receipt of FDA Fast Track Designation for the Development of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS) - PRNewswire</td>    <td>CytRx Corporation Highlights Orphazyme's Receipt of FDA Fast Track Designation for the Development of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS)  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/cytrx-corporation-highlights-orphazymes-receipt-of-fda-fast-track-designation-for-the-development-of-arimoclomol-in-amyotrophic-lateral-sclerosis-als-301064522.html">Link</a></td>  </tr></table><h3>220. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DARE">Dare Bioscience, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 12:10:37 GMT</td>    <td>Daré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Daré's Novel Pipeline of Women's Health Programs - GlobeNewswire</td>    <td>Daré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Daré's Novel Pipeline of Women's Health Programs  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031025/0/en/Dar%C3%A9-Bioscience-and-Health-Decisions-Form-Strategic-Partnership-to-Accelerate-the-Development-of-Dar%C3%A9-s-Novel-Pipeline-of-Women-s-Health-Programs.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:00:05 GMT</td>    <td>Why Buy stock in Dare Bioscience, Inc. (DARE)? - Marketing Sentinel</td>    <td>Why Buy stock in Dare Bioscience, Inc. (DARE)?  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/05/26/why-buy-stock-in-dare-bioscience-inc-dare/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 12:11:25 GMT</td>    <td>Daré Bioscience to Host First Quarter 2020 Financial Results and Company Update Conference Call and Webcast on May 14, 2020 - GlobeNewswire</td>    <td>Daré Bioscience to Host First Quarter 2020 Financial Results and Company Update Conference Call and Webcast on May 14, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029361/0/en/Dar%C3%A9-Bioscience-to-Host-First-Quarter-2020-Financial-Results-and-Company-Update-Conference-Call-and-Webcast-on-May-14-2020.html">Link</a></td>  </tr></table><h3>221. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DBVT">DBV Technologies S.A.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Some DBV Technologies (EPA:DBV) Shareholders Have Taken A Painful 83% Share Price Drop - Simply Wall St</td>    <td>Some DBV Technologies (EPA:DBV) Shareholders Have Taken A Painful 83% Share Price Drop  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/some-dbv-technologies-epadbv-shareholders-have-taken-a-painful-83-share-price-drop/">Link</a></td>  </tr><tr>    <td>Thu, 30 Apr 2020 20:08:04 GMT</td>    <td>DBV Technologies Reports March 31, 2020 Cash Position Paris Stock Exchange:DBV - GlobeNewswire</td>    <td>DBV Technologies Reports March 31, 2020 Cash Position Paris Stock Exchange:DBV  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/04/30/2025701/0/en/DBV-Technologies-Reports-March-31-2020-Cash-Position.html">Link</a></td>  </tr><tr>    <td>Mon, 16 Mar 2020 20:33:53 GMT</td>    <td>DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years - GlobeNewswire</td>    <td>DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/03/16/2001453/0/en/DBV-Technologies-Provides-Update-on-Viaskin-Peanut-BLA-for-Children-Ages-4-11-Years.html">Link</a></td>  </tr></table><h3>222. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DCPH">Deciphera Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Deciphera Pharmaceuticals, Inc. Announces First Quarter 2020 Financial Results - Business Wire</td>    <td>Deciphera Pharmaceuticals, Inc. Announces First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200505005839/en/Deciphera-Pharmaceuticals-Announces-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/06/deciphera-pharmaceuticals-inc-dcph-q1-2020-earning.aspx">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Analysts Just Trimmed Their Revenue Forecasts By 14% - Yahoo Finance</td>    <td>Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Analysts Just Trimmed Their Revenue Forecasts By 14%  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/deciphera-pharmaceuticals-inc-nasdaq-dcph-105356777.html">Link</a></td>  </tr></table><h3>223. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DMPI">DelMar Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:00:00 GMT</td>    <td>DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Cancer Research Virtual Annual Meeting II - PRNewswire</td>    <td>DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Cancer Research Virtual Annual Meeting II  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/delmar-pharmaceuticals-to-present-updates-of-two-phase-2-clinical-trials-of-val-083-at-the-2020-american-association-for-cancer-research-virtual-annual-meeting-ii-301068192.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate Updates - PRNewswire</td>    <td>DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate Updates  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/delmar-pharmaceuticals-announces-fiscal-third-quarter-2020-financial-results-and-recent-corporate-updates-301058312.html">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>Is DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) A Volatile Stock? - Yahoo Finance</td>    <td>Is DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) A Volatile Stock?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/delmar-pharmaceuticals-inc-nasdaq-dmpi-142914446.html">Link</a></td>  </tr></table><h3>224. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DNLI">Denali Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 20:33:17 GMT</td>    <td>Denali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational Medicine - GlobeNewswire</td>    <td>Denali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational Medicine  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039765/0/en/Denali-Therapeutics-Announces-Publication-of-Two-New-Papers-Describing-Its-Blood-Brain-Barrier-Delivery-Technology-in-Science-Translational-Medicine.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:47:20 GMT</td>    <td>Denali Therapeutics Reports First Quarter 2020 Financial Results and Provides COVID-19 Response Update - GlobeNewswire</td>    <td>Denali Therapeutics Reports First Quarter 2020 Financial Results and Provides COVID-19 Response Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029984/0/en/Denali-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-COVID-19-Response-Update.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Denali Therapeutics Inc (DNLI) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance</td>    <td>Denali Therapeutics Inc (DNLI) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/denali-therapeutics-inc-dnli-reports-002012003.html">Link</a></td>  </tr></table><h3>225. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DERM">Dermira, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:17:55 GMT</td>    <td>Vaxcyte Appoints Halley E. Gilbert to Board of Directors - BioSpace</td>    <td>Vaxcyte Appoints Halley E. Gilbert to Board of Directors  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/vaxcyte-appoints-halley-e-gilbert-to-board-of-directors/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 04:43:14 GMT</td>    <td>Axillary Hyperhidrosis Drug Market Survey Report (COVID-19 impact) 2020-26: Brickell Biotech Inc, Dermira Inc, Dr. August Wolff GmbH & Co KG Arzneimittle - Surfacing Magazine</td>    <td>Axillary Hyperhidrosis Drug Market Survey Report (COVID-19 impact) 2020-26: Brickell Biotech Inc, Dermira Inc, Dr. August Wolff GmbH & Co KG Arzneimittle  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/axillary-hyperhidrosis-drug-market-survey-report-covid-19-impact-2020-26-brickell-biotech-inc-dermira-inc-dr-august-wolff-gmbh-co-kg-arzneimittle/">Link</a></td>  </tr><tr>    <td>Fri, 10 Jan 2020 08:00:00 GMT</td>    <td>Lilly Announces Agreement to Acquire Dermira - PRNewswire</td>    <td>Lilly Announces Agreement to Acquire Dermira  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/lilly-announces-agreement-to-acquire-dermira-300984850.html">Link</a></td>  </tr></table><h3>226. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DMAC">DiaMedica Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020 - Business Wire</td>    <td>DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200519005684/en/DiaMedica-Therapeutics-Present-17th-Annual-Craig-Hallum-Institutional">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020 - Yahoo Finance</td>    <td>DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/diamedica-therapeutics-report-first-quarter-203000053.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results - Business Wire</td>    <td>DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200513005761/en/DiaMedica-Announces-Positive-Results-Top-Line-Data-Phase">Link</a></td>  </tr></table><h3>227. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DRNA">Dicerna Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 20:05:00 GMT</td>    <td>Dicerna to Participate in Jefferies Virtual Global Healthcare Conference - Business Wire</td>    <td>Dicerna to Participate in Jefferies Virtual Global Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200526005017/en/Dicerna-Participate-Jefferies-Virtual-Global-Healthcare-Conference">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 20:30:00 GMT</td>    <td>Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire</td>    <td>Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200601005705/en/Dicerna-Reports-Inducement-Grants-Nasdaq-Listing-Rule">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>Dicerna Pharmaceuticals, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next - Yahoo Finance</td>    <td>Dicerna Pharmaceuticals, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/dicerna-pharmaceuticals-inc-just-reported-132310663.html">Link</a></td>  </tr></table><h3>228. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DFFN">Diffusion Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:26:10 GMT</td>    <td>Diffusion Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement - GlobeNewswire</td>    <td>Diffusion Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041433/0/en/Diffusion-Pharmaceuticals-Regains-Compliance-with-NASDAQ-Minimum-Bid-Price-Requirement.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 17:19:44 GMT</td>    <td>Diffusion Pharmaceuticals Inc. Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market - GlobeNewswire</td>    <td>Diffusion Pharmaceuticals Inc. Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036606/0/en/Diffusion-Pharmaceuticals-Inc-Announces-Closing-of-12-0-Million-Registered-Direct-Offering-Priced-At-the-Market.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:03:58 GMT</td>    <td>Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program - GlobeNewswire</td>    <td>Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038598/0/en/Diffusion-Pharmaceuticals-Receives-Accelerated-FDA-Response-to-Proposed-TSC-COVID-19-Clinical-Trial-Program.html">Link</a></td>  </tr></table><h3>229. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DRAD">Digirad Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 20:16:14 GMT</td>    <td>Digirad Corporation Announces Closing of $5.0 Million Underwritten Public Offering - GlobeNewswire</td>    <td>Digirad Corporation Announces Closing of $5.0 Million Underwritten Public Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040556/0/en/Digirad-Corporation-Announces-Closing-of-5-0-Million-Underwritten-Public-Offering.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 16:21:31 GMT</td>    <td>Digirad Corporation Announces Pricing of $5.0 Million Underwritten Public Offering - GlobeNewswire</td>    <td>Digirad Corporation Announces Pricing of $5.0 Million Underwritten Public Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038826/0/en/Digirad-Corporation-Announces-Pricing-of-5-0-Million-Underwritten-Public-Offering.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 10:14:28 GMT</td>    <td>Digirad Corporation Reports Financial Results for the First Quarter Ended March 31, 2020 - GlobeNewswire</td>    <td>Digirad Corporation Reports Financial Results for the First Quarter Ended March 31, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034088/0/en/Digirad-Corporation-Reports-Financial-Results-for-the-First-Quarter-Ended-March-31-2020.html">Link</a></td>  </tr></table><h3>230. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DOVA">Dova Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 23 May 2020 07:00:00 GMT</td>    <td>GLOBAL LIVER CIRRHOSIS DRUG MARKET 2020 RISING TREND INCLUDING KEY PLAYERS PROFILE LIKE GILEAD SCIENCES, INC., INTERCEPT PHARMACEUTICALS, INC., DOVA PHARMACEUTICALS, GLAXOSMITHKLINE PLC, REGENERON PHARMACEUTICALS – 3w Market News Reports - 3rd Watch News</td>    <td>GLOBAL LIVER CIRRHOSIS DRUG MARKET 2020 RISING TREND INCLUDING KEY PLAYERS PROFILE LIKE GILEAD SCIENCES, INC., INTERCEPT PHARMACEUTICALS, INC., DOVA PHARMACEUTICALS, GLAXOSMITHKLINE PLC, REGENERON PHARMACEUTICALS – 3w Market News Reports  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/962146/global-liver-cirrhosis-drug-market-2020-rising-trend-including-key-players-profile-like-gilead-sciences-inc-intercept-pharmaceuticals-inc-dova-pharmaceuticals-glaxosmithkline-plc-regeneron-ph/">Link</a></td>  </tr><tr>    <td>Tue, 12 Nov 2019 08:00:00 GMT</td>    <td>Sobi Successfully Completes Acquisition of Dova Pharmaceuticals - BioSpace</td>    <td>Sobi Successfully Completes Acquisition of Dova Pharmaceuticals  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/sobi-successfully-completes-acquisition-of-dova-pharmaceuticals/">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Provention Bio Announces Changes to its Board of Directors - PRNewswire</td>    <td>Provention Bio Announces Changes to its Board of Directors  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/provention-bio-announces-changes-to-its-board-of-directors-301062264.html">Link</a></td>  </tr></table><h3>231. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DRRX">DURECT Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs - Yahoo Finance</td>    <td>DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/durect-corporation-announces-first-quarter-200500006.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:30:00 GMT</td>    <td>DURECT Corporation Announces Positive Topline Data from Phase 1b Study of DUR-928 in NASH - PRNewswire</td>    <td>DURECT Corporation Announces Positive Topline Data from Phase 1b Study of DUR-928 in NASH  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/durect-corporation-announces-positive-topline-data-from-phase-1b-study-of-dur-928-in-nash-301064994.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:09:00 GMT</td>    <td>DURECT Corporation (DRRX) Soars 4.7% on June 01 - Equities.com</td>    <td>DURECT Corporation (DRRX) Soars 4.7% on June 01  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/durect-corporation-drrx-soars-4-7-on-june-01">Link</a></td>  </tr></table><h3>232. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DVAX">Dynavax Technologies Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 20:05:26 GMT</td>    <td>Dynavax Technologies Announces Proposed Public Offering of Common Stock - GlobeNewswire</td>    <td>Dynavax Technologies Announces Proposed Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037256/0/en/Dynavax-Technologies-Announces-Proposed-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Why Dynavax Technologies Is Jumping Today - Motley Fool</td>    <td>Why Dynavax Technologies Is Jumping Today  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/19/why-dynavax-technologies-is-jumping-today.aspx">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 20:05:00 GMT</td>    <td>Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Yahoo Finance</td>    <td>Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/dynavax-technologies-announces-closing-80-200510582.html">Link</a></td>  </tr></table><h3>233. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EGRX">Eagle Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Eagle Pharmaceuticals Inc. (EGRX) Plunges 5.57% on June 03 - Equities.com</td>    <td>Eagle Pharmaceuticals Inc. (EGRX) Plunges 5.57% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/eagle-pharmaceuticals-inc-egrx-plunges-5-57-on-june-03">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 20:05:00 GMT</td>    <td>Eagle Pharmaceuticals Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders - Business Wire</td>    <td>Eagle Pharmaceuticals Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200522005309/en/Eagle-Pharmaceuticals-Announces-Change-Virtual-Format-2020">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Eagle Pharmaceuticals to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference - Business Wire</td>    <td>Eagle Pharmaceuticals to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005875/en/Eagle-Pharmaceuticals-Present-2020-RBC-Capital-Markets">Link</a></td>  </tr></table><h3>234. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EDAP">EDAP TMS S.A.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 17:36:00 GMT</td>    <td>EDAP TMS S.A. (EDAP): Are Hedge Funds Right About This Stock? - Yahoo Finance</td>    <td>EDAP TMS S.A. (EDAP): Are Hedge Funds Right About This Stock?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/edap-tms-edap-hedge-funds-173631269.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 20:52:21 GMT</td>    <td>EDAP ANNOUNCES EXCLUSIVE WORLDWIDE DISTRIBUTION RIGHTS TO EXACT IMAGING'S MICRO-ULTRASOUND TECHNOLOGIES - GlobeNewswire</td>    <td>EDAP ANNOUNCES EXCLUSIVE WORLDWIDE DISTRIBUTION RIGHTS TO EXACT IMAGING'S MICRO-ULTRASOUND TECHNOLOGIES  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032285/0/en/EDAP-ANNOUNCES-EXCLUSIVE-WORLDWIDE-DISTRIBUTION-RIGHTS-TO-EXACT-IMAGING-S-MICRO-ULTRASOUND-TECHNOLOGIES.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 20:47:50 GMT</td>    <td>EDAP Reports First Quarter 2020 Results and Provides Operational Update - GlobeNewswire</td>    <td>EDAP Reports First Quarter 2020 Results and Provides Operational Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033019/0/en/EDAP-Reports-First-Quarter-2020-Results-and-Provides-Operational-Update.html">Link</a></td>  </tr></table><h3>235. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EDGE">Edge Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:08:27 GMT</td>    <td>Pluristem Joins Forces with CRISPR-IL National Consortium to Advance Development of Cutting-Edge Genome Editing Solutions for Life Science Products - GlobeNewswire</td>    <td>Pluristem Joins Forces with CRISPR-IL National Consortium to Advance Development of Cutting-Edge Genome Editing Solutions for Life Science Products  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042782/0/en/Pluristem-Joins-Forces-with-CRISPR-IL-National-Consortium-to-Advance-Development-of-Cutting-Edge-Genome-Editing-Solutions-for-Life-Science-Products.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 20:12:19 GMT</td>    <td>Emerald Health Therapeutics Closes $2.1 Million Prospectus Sale TSX Venture Exchange:EMH - GlobeNewswire</td>    <td>Emerald Health Therapeutics Closes $2.1 Million Prospectus Sale TSX Venture Exchange:EMH  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042569/0/en/Emerald-Health-Therapeutics-Closes-2-1-Million-Prospectus-Sale.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Aneurysmal Subarachnoid Hemorrhage Drugs Market to Record an Exponential Growth Along with Edge Therapeutics, Inc, Mylan NV, Arbor Pharmaceuticals Inc, etc – by 2027 - 3rd Watch News</td>    <td>Aneurysmal Subarachnoid Hemorrhage Drugs Market to Record an Exponential Growth Along with Edge Therapeutics, Inc, Mylan NV, Arbor Pharmaceuticals Inc, etc – by 2027  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/749608/aneurysmal-subarachnoid-hemorrhage-drugs-market-to-record-an-exponential-growth-along-with-edge-therapeutics-inc-mylan-n-v-arbor-pharmaceuticals-inc-etc-by-2027/">Link</a></td>  </tr></table><h3>236. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EDIT">Editas Medicine, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:09:27 GMT</td>    <td>Editas Medicine Announces First Quarter 2020 Results and Update - GlobeNewswire</td>    <td>Editas Medicine Announces First Quarter 2020 Results and Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029304/0/en/Editas-Medicine-Announces-First-Quarter-2020-Results-and-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 11:02:00 GMT</td>    <td>Why Editas Medicine Is Now the CRISPR Stock to Really Watch - Nasdaq</td>    <td>Why Editas Medicine Is Now the CRISPR Stock to Really Watch  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/why-editas-medicine-is-now-the-crispr-stock-to-really-watch-2020-06-03">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 13:24:40 GMT</td>    <td>Editas Medicine Presents Pre-Clinical Data Supporting the use of CRISPR-Cas12a to Edit Induced Pluripotent Stem Cells for the Development of Engineered Cell Immunotherapies - GlobeNewswire</td>    <td>Editas Medicine Presents Pre-Clinical Data Supporting the use of CRISPR-Cas12a to Edit Induced Pluripotent Stem Cells for the Development of Engineered Cell Immunotherapies  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034284/0/en/Editas-Medicine-Presents-Pre-Clinical-Data-Supporting-the-use-of-CRISPR-Cas12a-to-Edit-Induced-Pluripotent-Stem-Cells-for-the-Development-of-Engineered-Cell-Immunotherapies.html">Link</a></td>  </tr></table><h3>237. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EIDX">Eidos Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 08 May 2020 20:44:42 GMT</td>    <td>Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business Update - GlobeNewswire</td>    <td>Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030585/0/en/Eidos-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Business-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 07:00:00 GMT</td>    <td>Eidos Therapeutics (NASDAQ:EIDX) Lifted to "Buy" at Zacks Investment Research - MarketBeat</td>    <td>Eidos Therapeutics (NASDAQ:EIDX) Lifted to "Buy" at Zacks Investment Research  MarketBeat</td>    <td><a target="_blank" href="https://www.marketbeat.com/instant-alerts/nasdaq-eidx-a-buy-or-sell-right-now/">Link</a></td>  </tr><tr>    <td>Wed, 26 Feb 2020 08:00:00 GMT</td>    <td>Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business Update - GlobeNewswire</td>    <td>Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/02/26/1991408/0/en/Eidos-Therapeutics-Reports-Fourth-Quarter-and-Year-End-2019-Financial-Results-and-Business-Update.html">Link</a></td>  </tr></table><h3>238. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EIGR">Eiger BioPharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 30 May 2020 03:26:58 GMT</td>    <td>Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020 - BioSpace</td>    <td>Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/eiger-biopharmaceuticals-inc-to-hold-virtual-annual-meeting-of-stockholders-on-june-15-2020/">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy™ (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies - PRNewswire</td>    <td>Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy™ (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-announces-fda-acceptance-of-nda-for-filing-with-priority-review-of-zokinvy-lonafarnib-for-treatment-of-progeria-and-progeroid-laminopathies-301062068.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update - PRNewswire</td>    <td>Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-reports-first-quarter-2020-financial-results-and-provides-business-update-301055094.html">Link</a></td>  </tr></table><h3>239. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ECOR">electroCore, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 12:12:11 GMT</td>    <td>electroCore, Inc. to Present at Little Grapevine's G1 Microcap Virtual Conference - GlobeNewswire</td>    <td>electroCore, Inc. to Present at Little Grapevine's G1 Microcap Virtual Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040882/0/en/electroCore-Inc-to-Present-at-Little-Grapevine-s-G1-Microcap-Virtual-Conference.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 20:16:26 GMT</td>    <td>electroCore Announces First Quarter Financial Results Nasdaq:ECOR - GlobeNewswire</td>    <td>electroCore Announces First Quarter Financial Results Nasdaq:ECOR  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033844/0/en/electroCore-Announces-First-Quarter-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>electroCore, Inc. (ECOR) CEO Dan Goldberger on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>electroCore, Inc. (ECOR) CEO Dan Goldberger on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4347811-electrocore-inc-ecor-ceo-dan-goldberger-on-q1-2020-results-earnings-call-transcript">Link</a></td>  </tr></table><h3>240. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ELOX">Eloxx Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Eloxx Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results and Provides Business Update - GlobeNewswire</td>    <td>Eloxx Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029831/0/en/Eloxx-Pharmaceuticals-Reports-First-Quarter-2020-Financial-and-Operating-Results-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Eloxx Pharmaceuticals, Inc. (ELOX) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Eloxx Pharmaceuticals, Inc. (ELOX) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/eloxx-pharmaceuticals-inc-elox-q1-2020-earnings-ca.aspx">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 16:48:00 GMT</td>    <td>Hedge Funds Are Selling Eloxx Pharmaceuticals, Inc. (ELOX) - Yahoo Finance</td>    <td>Hedge Funds Are Selling Eloxx Pharmaceuticals, Inc. (ELOX)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-selling-eloxx-pharmaceuticals-164855656.html">Link</a></td>  </tr></table><h3>241. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ENTA">Enanta Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 20:03:00 GMT</td>    <td>Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET - Business Wire</td>    <td>Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506005569/en/Enanta-Pharmaceuticals-Reports-Financial-Results-Fiscal-Quarter">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Were Hedge Funds Right About Enanta Pharmaceuticals Inc (ENTA)? - Yahoo Finance</td>    <td>Were Hedge Funds Right About Enanta Pharmaceuticals Inc (ENTA)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/were-hedge-funds-enanta-pharmaceuticals-014321714.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Why Enanta Pharmaceuticals (ENTA) Stock Might be a Great Pick - Yahoo Finance</td>    <td>Why Enanta Pharmaceuticals (ENTA) Stock Might be a Great Pick  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-enanta-pharmaceuticals-enta-stock-125312853.html">Link</a></td>  </tr></table><h3>242. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ENDP">Endo International plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Endo International plc Announces Proposed Exchange Offers And Consent Solicitations - BioSpace</td>    <td>Endo International plc Announces Proposed Exchange Offers And Consent Solicitations  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/endo-international-plc-announces-proposed-exchange-offers-and-consent-solicitations/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 18:00:04 GMT</td>    <td>Here is a bargain stock you should look at : Endo International plc (ENDP) - Marketing Sentinel</td>    <td>Here is a bargain stock you should look at : Endo International plc (ENDP)  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/02/here-is-a-bargain-stock-you-should-look-at-endo-international-plc-endp/">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Was The Smart Money Right About Endo International plc (ENDP)? - Yahoo Finance</td>    <td>Was The Smart Money Right About Endo International plc (ENDP)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/smart-money-endo-international-plc-140523082.html">Link</a></td>  </tr></table><h3>243. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NDRA">ENDRA Life Sciences Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results - Yahoo Finance</td>    <td>ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/endra-life-sciences-provides-business-200000510.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>ENDRA Life Sciences Strengthens IP Portfolio with Issuance of Additional Patents for its Innovative Fatty Liver Imaging Probe - Yahoo Finance</td>    <td>ENDRA Life Sciences Strengthens IP Portfolio with Issuance of Additional Patents for its Innovative Fatty Liver Imaging Probe  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/endra-life-sciences-strengthens-ip-120000328.html">Link</a></td>  </tr><tr>    <td>Sat, 16 May 2020 07:00:00 GMT</td>    <td>ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>ENDRA Life Sciences, Inc. (NDRA) CEO Francois Michelon on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4348229-endra-life-sciences-inc-ndra-ceo-francois-michelon-on-q1-2020-results-earnings-call">Link</a></td>  </tr></table><h3>244. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ENOB">Enochian Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Enochian Biosciences: Fiscal 3Q Earnings Snapshot - The Pioneer</td>    <td>Enochian Biosciences: Fiscal 3Q Earnings Snapshot  The Pioneer</td>    <td><a target="_blank" href="https://www.bigrapidsnews.com/business/article/Enochian-Biosciences-Fiscal-3Q-Earnings-Snapshot-15265226.php">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>BRIEF-Enochian Biosciences Announces Three Scientific Presentations On Potential HIV and HBV Cures - Reuters</td>    <td>BRIEF-Enochian Biosciences Announces Three Scientific Presentations On Potential HIV and HBV Cures  Reuters</td>    <td><a target="_blank" href="https://uk.reuters.com/article/brief-enochian-biosciences-announces-thr/brief-enochian-biosciences-announces-three-scientific-presentations-on-potential-hiv-and-hbv-cures-idUKFWN2CV0O3">Link</a></td>  </tr><tr>    <td>Mon, 06 Jan 2020 08:00:00 GMT</td>    <td>Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer, announces the appointment of two board members: - GlobeNewswire</td>    <td>Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer, announces the appointment of two board members:  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/01/06/1966379/0/en/Enochian-Biosciences-a-company-focused-on-gene-modified-cellular-therapy-in-infectious-disease-and-cancer-announces-the-appointment-of-two-board-members.html">Link</a></td>  </tr></table><h3>245. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ETTX">Entasis Therapeutics Holdings Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 20:11:57 GMT</td>    <td>Entasis Therapeutics Reports First Quarter 2020 Financial Results and Business Update - GlobeNewswire</td>    <td>Entasis Therapeutics Reports First Quarter 2020 Financial Results and Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029876/0/en/Entasis-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Business-Update.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 17:10:48 GMT</td>    <td>Market's View on Entasis Therapeutics Holdings Inc (ETTX) Stock's Price & Volume Trends - InvestorsObserver</td>    <td>Market's View on Entasis Therapeutics Holdings Inc (ETTX) Stock's Price & Volume Trends  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/markets-view-on-entasis-therapeutics-holdings-inc-ettx-stocks-price-volume-trends">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Analysts Suggest Buying These 2 Falling Knives - Yahoo Finance</td>    <td>Analysts Suggest Buying These 2 Falling Knives  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-suggest-buying-2-falling-153438918.html">Link</a></td>  </tr></table><h3>246. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ENTX">Entera Bio Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 12:47:58 GMT</td>    <td>Entera Bio to Report Interim Data From EB613 Phase 2 Trial and First Quarter 2020 Business and Financial Results on May 21, 2020 - GlobeNewswire</td>    <td>Entera Bio to Report Interim Data From EB613 Phase 2 Trial and First Quarter 2020 Business and Financial Results on May 21, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029438/0/en/Entera-Bio-to-Report-Interim-Data-From-EB613-Phase-2-Trial-and-First-Quarter-2020-Business-and-Financial-Results-on-May-21-2020.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 10:32:27 GMT</td>    <td>Entera Bio Ltd Announces Interim Biomarker Data From Phase 2 Clinical Trial of EB613 and First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Entera Bio Ltd Announces Interim Biomarker Data From Phase 2 Clinical Trial of EB613 and First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2036888/0/en/Entera-Bio-Ltd-Announces-Interim-Biomarker-Data-From-Phase-2-Clinical-Trial-of-EB613-and-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Entera Bio shares sink on interim phase II osteoporosis data - BioWorld Online</td>    <td>Entera Bio shares sink on interim phase II osteoporosis data  BioWorld Online</td>    <td><a target="_blank" href="https://www.bioworld.com/articles/435284-entera-bio-shares-sink-on-interim-phase-ii-osteoporosis-data">Link</a></td>  </tr></table><h3>247. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NVST">Envista Holdings</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Is a Surprise Coming for Envista Holdings (NVST) This Earnings Season? - Yahoo Finance</td>    <td>Is a Surprise Coming for Envista Holdings (NVST) This Earnings Season?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/surprise-coming-envista-holdings-nvst-155203050.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:50:00 GMT</td>    <td>Envista Holdings Corporation [NVST] Revenue clocked in at $2.64 billion, down -27.33% YTD: What’s Next? - The DBT News</td>    <td>Envista Holdings Corporation [NVST] Revenue clocked in at $2.64 billion, down -27.33% YTD: What’s Next?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/envista-holdings-corporation-nvst-revenue-clocked-in-at-2-64-billion-down-27-33-ytd-whats-next/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Envista Holdings Corporation (NVST) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Envista Holdings Corporation (NVST) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/14/envista-holdings-corporation-nvst-q1-2020-earnings.aspx">Link</a></td>  </tr></table><h3>248. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EPZM">Epizyme, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:13:01 GMT</td>    <td>EPIZYME, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) - marketscreener.com</td>    <td>EPIZYME, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/EPIZYME-INC-13314771/news/EPIZYME-INC-Submission-of-Matters-to-a-Vote-of-Security-Holders-form-8-K-30715409/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:30:00 GMT</td>    <td>Epizyme (EPZM) Down 4.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance</td>    <td>Epizyme (EPZM) Down 4.4% Since Last Earnings Report: Can It Rebound?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/epizyme-epzm-down-4-4-153003034.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Epizyme to Present Data from Tazemetostat Clinical Program during the 2020 ASCO Virtual Scientific Program - Business Wire</td>    <td>Epizyme to Present Data from Tazemetostat Clinical Program during the 2020 ASCO Virtual Scientific Program  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200513005860/en/Epizyme-Present-Data-Tazemetostat-Clinical-Program-2020">Link</a></td>  </tr></table><h3>249. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EQ">Equillium, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 20:27:02 GMT</td>    <td>Equillium Reports First Quarter 2020 Financial Results Nasdaq:EQ - GlobeNewswire</td>    <td>Equillium Reports First Quarter 2020 Financial Results Nasdaq:EQ  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032989/0/en/Equillium-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:12:30 GMT</td>    <td>Equillium to Present at 2020 RBC Capital Markets Virtual Global Healthcare Conference - GlobeNewswire</td>    <td>Equillium to Present at 2020 RBC Capital Markets Virtual Global Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029930/0/en/Equillium-to-Present-at-2020-RBC-Capital-Markets-Virtual-Global-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:27:00 GMT</td>    <td>BRIEF-Equillium Says Executive Chairman Voluntarily Agreed To 65% Reduction In Base Salary - Reuters</td>    <td>BRIEF-Equillium Says Executive Chairman Voluntarily Agreed To 65% Reduction In Base Salary  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-equillium-says-executive-chairman/brief-equillium-says-executive-chairman-voluntarily-agreed-to-65-reduction-in-base-salary-idUSFWN2DE0G3">Link</a></td>  </tr></table><h3>250. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ERYP">Erytech Pharma S.A.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 16:00:00 GMT</td>    <td>Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's What You Should Know - Yahoo Finance</td>    <td>Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/erytech-pharma-sa-sponsored-adr-160004234.html">Link</a></td>  </tr><tr>    <td>Mon, 04 May 2020 07:00:00 GMT</td>    <td>Is ERYTECH Pharma (EPA:ERYP) Using Debt In A Risky Way? - Yahoo Finance</td>    <td>Is ERYTECH Pharma (EPA:ERYP) Using Debt In A Risky Way?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/erytech-pharma-epa-eryp-using-064122246.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4347019-erytech-pharma-s-eryp-ceo-gil-beyen-on-q1-2020-results-earnings-call-transcript">Link</a></td>  </tr></table><h3>251. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ESPR">Esperion Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 20:21:01 GMT</td>    <td>Esperion Reports First Quarter 2020 Financial Results and Provides Company Update - GlobeNewswire</td>    <td>Esperion Reports First Quarter 2020 Financial Results and Provides Company Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028812/0/en/Esperion-Reports-First-Quarter-2020-Financial-Results-and-Provides-Company-Update.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Analysts Are Upgrading Esperion Therapeutics, Inc. (NASDAQ:ESPR) After Its Latest Results - Yahoo Finance</td>    <td>Analysts Are Upgrading Esperion Therapeutics, Inc. (NASDAQ:ESPR) After Its Latest Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-upgrading-esperion-therapeutics-inc-184946440.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Esperion Therapeutics: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Esperion Therapeutics: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Esperion-Therapeutics-1Q-Earnings-Snapshot-15251931.php">Link</a></td>  </tr></table><h3>252. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EPIX">ESSA Pharma Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting - PRNewswire</td>    <td>ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/essa-pharma-presents-therapeutic-potential-of-epi-7386-at-2020-virtual-american-urological-association-aua-annual-meeting-301059903.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 11:00:00 GMT</td>    <td>ESSA Pharma to Present at Jefferies Virtual Healthcare Conference - PRNewswire</td>    <td>ESSA Pharma to Present at Jefferies Virtual Healthcare Conference  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-jefferies-virtual-healthcare-conference-301065634.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020 - BioSpace</td>    <td>ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/essa-pharma-provides-corporate-update-and-reports-financial-results-for-fiscal-second-quarter-ended-march-31-2020/">Link</a></td>  </tr></table><h3>253. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ETON">Eton Pharmaceutcials, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 20:42:41 GMT</td>    <td>Eton Pharmaceuticals to Report First Quarter Financial Results on Thursday, May 14, 2020 - GlobeNewswire</td>    <td>Eton Pharmaceuticals to Report First Quarter Financial Results on Thursday, May 14, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028903/0/en/Eton-Pharmaceuticals-to-Report-First-Quarter-Financial-Results-on-Thursday-May-14-2020.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance</td>    <td>Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/eton-pharmaceuticals-inc-eton-reports-212509016.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Eton Pharmaceuticals Inc (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance</td>    <td>Eton Pharmaceuticals Inc (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/eton-pharmaceuticals-inc-eton-may-163004660.html">Link</a></td>  </tr></table><h3>254. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EVLO">Evelo Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 11:08:33 GMT</td>    <td>Evelo Biosciences to Present at Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>Evelo Biosciences to Present at Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040068/0/en/Evelo-Biosciences-to-Present-at-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 16:00:00 GMT</td>    <td>Evelo Biosciences, Inc. (EVLO) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance</td>    <td>Evelo Biosciences, Inc. (EVLO) Upgraded to Strong Buy: What Does It Mean for the Stock?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/evelo-biosciences-inc-evlo-upgraded-160004420.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 16:34:00 GMT</td>    <td>Evelo Biosciences, Inc. (EVLO): Hedge Fund Sentiment Unchanged - Yahoo Finance</td>    <td>Evelo Biosciences, Inc. (EVLO): Hedge Fund Sentiment Unchanged  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/evelo-biosciences-inc-evlo-hedge-163425829.html">Link</a></td>  </tr></table><h3>255. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EVFM">Evofem Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 16:31:00 GMT</td>    <td>Why Evofem Biosciences Is Down Today - Motley Fool</td>    <td>Why Evofem Biosciences Is Down Today  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/06/03/why-evofem-biosciences-is-down-today.aspx">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 20:01:00 GMT</td>    <td>Evofem Announces Proposed Public Offering of Common Stock - PRNewswire</td>    <td>Evofem Announces Proposed Public Offering of Common Stock  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/evofem-announces-proposed-public-offering-of-common-stock-301069639.html">Link</a></td>  </tr><tr>    <td>Sun, 31 May 2020 21:15:00 GMT</td>    <td>Is Evofem Biosciences, Inc. (EVFM) A Good Buy According To Hedge Funds? - Yahoo Finance</td>    <td>Is Evofem Biosciences, Inc. (EVFM) A Good Buy According To Hedge Funds?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/evofem-biosciences-inc-evfm-good-211533224.html">Link</a></td>  </tr></table><h3>256. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EVOK">Evoke Pharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 12:37:52 GMT</td>    <td>Evoke Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA Resubmission - GlobeNewswire</td>    <td>Evoke Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA Resubmission  GlobeNewswireEvoke Pharma (EVOK) Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA Resubmission  StreetInsider.comEVOKE PHARMA, INC. (NASDAQ:EVOK) Files An 8-K Other Events  Market ExclusiveEvoke Pharma Inc. (EVOK) Gain 8.02% YTD: Chances Are, Buyers Will Win the Tug-of-War  State ReviewerView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036390/0/en/Evoke-Receives-FDA-Conditional-Acceptance-of-Gimoti-Brand-Name-Following-NDA-Resubmission.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 12:35:46 GMT</td>    <td>Evoke Pharma Reports First Quarter 2020 Financial Results and Changes its 2020 Annual Meeting of Stockholders to a Virtual Format - GlobeNewswire</td>    <td>Evoke Pharma Reports First Quarter 2020 Financial Results and Changes its 2020 Annual Meeting of Stockholders to a Virtual Format  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031905/0/en/Evoke-Pharma-Reports-First-Quarter-2020-Financial-Results-and-Changes-its-2020-Annual-Meeting-of-Stockholders-to-a-Virtual-Format.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 17:34:44 GMT</td>    <td>How Does Evoke Pharma Inc (EVOK) Stock Rank on Wall Street? - InvestorsObserver</td>    <td>How Does Evoke Pharma Inc (EVOK) Stock Rank on Wall Street?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/how-does-evoke-pharma-inc-evok-stock-rank-on-wall-street">Link</a></td>  </tr></table><h3>257. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EOLS">Evolus, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 14:20:00 GMT</td>    <td>Evolus, Inc. (EOLS): All the Basics You Need to Know - The News Heater</td>    <td>Evolus, Inc. (EOLS): All the Basics You Need to Know  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/evolus-inc-eols-all-the-basics-you-need-to-know/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>What You Need To Know About The Evolus, Inc. (NASDAQ:EOLS) Analyst Downgrade Today - Yahoo Finance</td>    <td>What You Need To Know About The Evolus, Inc. (NASDAQ:EOLS) Analyst Downgrade Today  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/know-evolus-inc-nasdaq-eols-135048140.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 09:49:26 GMT</td>    <td>Evolus, Inc. (EOLS) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Evolus, Inc. (EOLS) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/evolus-inc-eols-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr></table><h3>258. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EXAS">Exact Sciences Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 19:01:00 GMT</td>    <td>Hedge Funds Cashing Out Of EXACT Sciences Corporation (EXAS) - Yahoo Finance</td>    <td>Hedge Funds Cashing Out Of EXACT Sciences Corporation (EXAS)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-cashing-exact-sciences-190103081.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Exact Sciences Announces First Quarter 2020 Results - PRNewswire</td>    <td>Exact Sciences Announces First Quarter 2020 Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/exact-sciences-announces-first-quarter-2020-results-301054271.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:30:00 GMT</td>    <td>Here's How One Should Trade Exact Sciences Corporation (EXAS) Now - The News Heater</td>    <td>Here's How One Should Trade Exact Sciences Corporation (EXAS) Now  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/heres-how-one-should-trade-exact-sciences-corporation-exas-now/">Link</a></td>  </tr></table><h3>259. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XGN">Exagen</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:25:00 GMT</td>    <td>Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus - Northeast Mississippi Daily Journal</td>    <td>Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus  Northeast Mississippi Daily Journal</td>    <td><a target="_blank" href="https://www.djournal.com/exagen-inc-announces-clinical-trial-conducted-at-major-academic-center-in-distinguishing-type-1-and/article_e7b11028-062d-5b3a-9049-1f8672507d6a.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 20:13:51 GMT</td>    <td>Exagen Inc. Reports First Quarter 2020 Results Nasdaq:XGN - GlobeNewswire</td>    <td>Exagen Inc. Reports First Quarter 2020 Results Nasdaq:XGN  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031419/0/en/Exagen-Inc-Reports-First-Quarter-2020-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:38:00 GMT</td>    <td>BRIEF-Exagen Inc Announces Clinical Trial Conducted At Major Academic Center In Distinguishing Type 1 And Type 2 Lupus - Reuters</td>    <td>BRIEF-Exagen Inc Announces Clinical Trial Conducted At Major Academic Center In Distinguishing Type 1 And Type 2 Lupus  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-exagen-inc-announces-clinical-tria/brief-exagen-inc-announces-clinical-trial-conducted-at-major-academic-center-in-distinguishing-type-1-and-type-2-lupus-idUSASA00SL7">Link</a></td>  </tr></table><h3>260. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EXEL">Exelixis, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:05:42 GMT</td>    <td>Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in June - Valdosta Daily Times</td>    <td>Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in June  Valdosta Daily Times</td>    <td><a target="_blank" href="https://www.valdostadailytimes.com/news/business/exelixis-to-webcast-fireside-chats-as-part-of-virtual-investor-conferences-in-june/article_62569193-d85e-56ce-8b88-79f23afb23ce.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 08:13:43 GMT</td>    <td>Finding long-term winners: 5 things in favour of Exelixis Inc - Stockopedia</td>    <td>Finding long-term winners: 5 things in favour of Exelixis Inc  Stockopedia</td>    <td><a target="_blank" href="https://www.stockopedia.com/articles/finding-long-term-winners-5-things-in-favour-of-exelixis-inc-52928/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:05:32 GMT</td>    <td>What Is the Outlook For Exelixis, Inc. (NASDAQ:EXEL) Like For Short-Term? - Stocks Register</td>    <td>What Is the Outlook For Exelixis, Inc. (NASDAQ:EXEL) Like For Short-Term?  Stocks Register</td>    <td><a target="_blank" href="https://stocksregister.com/2020/06/03/what-is-the-outlook-for-exelixis-inc-nasdaqexel-like-for-short-term/">Link</a></td>  </tr></table><h3>261. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EYEG">Eyegate Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 10:55:00 GMT</td>    <td>EyeGate Pharma to Present at Jefferies 2020 Virtual Healthcare Conference - Yahoo Finance</td>    <td>EyeGate Pharma to Present at Jefferies 2020 Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/eyegate-pharma-present-jefferies-2020-105500064.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>EyeGate Pharma Reports First Quarter 2020 Financial Results and Provides Business Update - Yahoo Finance</td>    <td>EyeGate Pharma Reports First Quarter 2020 Financial Results and Provides Business Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/eyegate-pharma-reports-first-quarter-201500031.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 23:02:00 GMT</td>    <td>Anterior Uveitis Drug Market 2020 | COVID19 Impact Analysis | Top Companies: Aciont Inc., Aldeyra Therapeutics, Inc., EyeGate Pharmaceuticals, More - News Distinct</td>    <td>Anterior Uveitis Drug Market 2020 | COVID19 Impact Analysis | Top Companies: Aciont Inc., Aldeyra Therapeutics, Inc., EyeGate Pharmaceuticals, More  News Distinct</td>    <td><a target="_blank" href="https://www.newsdistinct.com/anterior-uveitis-drug-market-2020-covid19-impact-analysis-top-companies-aciont-inc-aldeyra-therapeutics-inc-eyegate-pharmaceuticals-more/">Link</a></td>  </tr></table><h3>262. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EYEN">Eyenovia, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 20:27:00 GMT</td>    <td>Eyenovia Reports First Quarter 2020 Financial Results Nasdaq:EYEN - GlobeNewswire</td>    <td>Eyenovia Reports First Quarter 2020 Financial Results Nasdaq:EYEN  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032973/0/en/Eyenovia-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4347391-eyenovia-inc-eyen-ceo-sean-ianchulev-on-q1-2020-results-earnings-call-transcript">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Form 424B3 EYENOVIA, INC. - StreetInsider.com</td>    <td>Form 424B3 EYENOVIA, INC.  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/SEC+Filings/Form+424B3+EYENOVIA%2C+INC./16879152.html">Link</a></td>  </tr></table><h3>263. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EYPT">EyePoint Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 16:50:00 GMT</td>    <td>Should You Buy EyePoint Pharmaceuticals, Inc. (EYPT)? - Yahoo Finance</td>    <td>Should You Buy EyePoint Pharmaceuticals, Inc. (EYPT)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/buy-eyepoint-pharmaceuticals-inc-eypt-165001926.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 11:14:25 GMT</td>    <td>EyePoint Pharmaceuticals Presents Data Showcasing DEXYCU® at the American Society of Cataract and Refractive Surgery 2020 Virtual Annual Meeting - GlobeNewswire</td>    <td>EyePoint Pharmaceuticals Presents Data Showcasing DEXYCU® at the American Society of Cataract and Refractive Surgery 2020 Virtual Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2034836/0/en/EyePoint-Pharmaceuticals-Presents-Data-Showcasing-DEXYCU-at-the-American-Society-of-Cataract-and-Refractive-Surgery-2020-Virtual-Annual-Meeting.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 10:39:12 GMT</td>    <td>COVID-19's Timing Could Not Have Been Worse For EyePoint Pharmaceuticals - Seeking Alpha</td>    <td>COVID-19's Timing Could Not Have Been Worse For EyePoint Pharmaceuticals  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4351440-covidminus-19s-timing-not-worse-for-eyepoint-pharmaceuticals">Link</a></td>  </tr></table><h3>264. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FATE">Fate Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 20:15:55 GMT</td>    <td>Fate Therapeutics Announces Changes to its Board of Directors - GlobeNewswire</td>    <td>Fate Therapeutics Announces Changes to its Board of Directors  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027865/0/en/Fate-Therapeutics-Announces-Changes-to-its-Board-of-Directors.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Fate Therapeutics Inc (FATE) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Fate Therapeutics Inc (FATE) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/fate-therapeutics-inc-fate-q1-2020-earnings-call-t.aspx">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Fate Therapeutics Announces FDA Clearance of IND Application for FT538, First CRISPR-edited, iPSC-derived Cell Therapy - Yahoo Finance</td>    <td>Fate Therapeutics Announces FDA Clearance of IND Application for FT538, First CRISPR-edited, iPSC-derived Cell Therapy  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/fate-therapeutics-announces-fda-clearance-120010161.html">Link</a></td>  </tr></table><h3>265. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FENC">Fennec Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 10:01:40 GMT</td>    <td>Fennec Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire</td>    <td>Fennec Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033310/0/en/Fennec-Pharmaceuticals-Announces-First-Quarter-2020-Financial-Results-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 10:04:42 GMT</td>    <td>Fennec Announces Exercise and Closing of Underwriters' Option to Purchase Additional Shares - GlobeNewswire</td>    <td>Fennec Announces Exercise and Closing of Underwriters' Option to Purchase Additional Shares  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030209/0/en/Fennec-Announces-Exercise-and-Closing-of-Underwriters-Option-to-Purchase-Additional-Shares.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 10:02:12 GMT</td>    <td>Fennec Announces Closing of Public Offering Toronto Stock Exchange:FRX - GlobeNewswire</td>    <td>Fennec Announces Closing of Public Offering Toronto Stock Exchange:FRX  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027329/0/en/Fennec-Announces-Closing-of-Public-Offering.html">Link</a></td>  </tr></table><h3>266. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FCSC">Fibrocell Science Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 16:24:00 GMT</td>    <td>Cell And Gene Therapy Consumables Market to Witness Huge Growth by 2027 | Amgen Inc., ATLANTA BIOLOGICALS, bluebird bio, Inc., Cook Medical, Dendreon Pharmaceuticals LLC, Fibrocell Science, Inc., General Electric, Kolon TissueGene, Inc., Orchard Therapeutics plc, Pfizer, Inc - 3rd Watch News</td>    <td>Cell And Gene Therapy Consumables Market to Witness Huge Growth by 2027 | Amgen Inc., ATLANTA BIOLOGICALS, bluebird bio, Inc., Cook Medical, Dendreon Pharmaceuticals LLC, Fibrocell Science, Inc., General Electric, Kolon TissueGene, Inc., Orchard Therapeutics plc, Pfizer, Inc  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/1139006/cell-and-gene-therapy-consumables-market-to-witness-huge-growth-by-2027-amgen-inc-atlanta-biologicals-bluebird-bio-inc-cook-medical-dendreon-pharmaceuticals-llc-fibrocell-science-inc-gene/">Link</a></td>  </tr><tr>    <td>Sun, 31 May 2020 11:28:42 GMT</td>    <td>Covid-19 Impact On Autologous Stem Cell and Non-Stem Cell Based Therapies Market Key Opportunities, Challenges by 2027 | Vericel Corporation, Fibrocell Science, Inc., Genzyme Corporation, BrainStorm Cell Therapeutics, Regeneus Ltd - Surfacing Magazine</td>    <td>Covid-19 Impact On Autologous Stem Cell and Non-Stem Cell Based Therapies Market Key Opportunities, Challenges by 2027 | Vericel Corporation, Fibrocell Science, Inc., Genzyme Corporation, BrainStorm Cell Therapeutics, Regeneus Ltd  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/covid-19-impact-on-autologous-stem-cell-and-non-stem-cell-based-therapies-market-key-opportunities-challenges-by-2027-vericel-corporation-fibrocell-science-inc-genzyme-corporation-brainstorm-c/">Link</a></td>  </tr><tr>    <td>Thu, 12 Sep 2019 07:00:00 GMT</td>    <td>Castle Creek Pharmaceutical Holdings to Acquire Fibrocell - GlobeNewswire</td>    <td>Castle Creek Pharmaceutical Holdings to Acquire Fibrocell  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/09/12/1915187/0/en/Castle-Creek-Pharmaceutical-Holdings-to-Acquire-Fibrocell.html">Link</a></td>  </tr></table><h3>267. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FGEN">FibroGen, Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 18:09:48 GMT</td>    <td>FibroGen Inc (NASDAQ: FGEN) Q1 2020 Earnings Call Transcript - AlphaStreet</td>    <td>FibroGen Inc (NASDAQ: FGEN) Q1 2020 Earnings Call Transcript  AlphaStreet</td>    <td><a target="_blank" href="https://news.alphastreet.com/fibrogen-inc-nasdaq-fgen-q1-2020-earnings-call-transcript/">Link</a></td>  </tr><tr>    <td>Sun, 31 May 2020 14:30:06 GMT</td>    <td>When Will FibroGen, Inc. (NASDAQ:FGEN) Breakeven? - Simply Wall St</td>    <td>When Will FibroGen, Inc. (NASDAQ:FGEN) Breakeven?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-fgen/fibrogen/news/when-will-fibrogen-inc-nasdaqfgen-breakeven/">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 11:00:00 GMT</td>    <td>FibroGen to Present at Upcoming Investor Conferences - Yahoo Finance</td>    <td>FibroGen to Present at Upcoming Investor Conferences  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/fibrogen-present-upcoming-investor-conferences-110010969.html">Link</a></td>  </tr></table><h3>268. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FPRX">Five Prime Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Five Prime Therapeutics Inc. (FPRX) Plunges 7.39% on June 03 - Equities.com</td>    <td>Five Prime Therapeutics Inc. (FPRX) Plunges 7.39% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/five-prime-therapeutics-inc-fprx-plunges-7-39-on-june-03">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Five Prime Therapeutics Reports First Quarter 2020 Results - Business Wire</td>    <td>Five Prime Therapeutics Reports First Quarter 2020 Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005703/en/Prime-Therapeutics-Reports-Quarter-2020-Results">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Is Five Prime Therapeutics (FPRX) Stock a Solid Choice Right Now? - Yahoo Finance</td>    <td>Is Five Prime Therapeutics (FPRX) Stock a Solid Choice Right Now?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/five-prime-therapeutics-fprx-stock-133701538.html">Link</a></td>  </tr></table><h3>269. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FLKS">Flex Pharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 20:15:58 GMT</td>    <td>Salarius Pharmaceuticals Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Salarius Pharmaceuticals Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033866/0/en/Salarius-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Fri, 12 Jul 2019 07:00:00 GMT</td>    <td>Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting - Business Wire</td>    <td>Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20190712005428/en/Flex-Pharma-Announces-Approval-Merger-Related-Proposals-Special">Link</a></td>  </tr><tr>    <td>Mon, 15 Jul 2019 07:00:00 GMT</td>    <td>Flex Pharma shareholders OK reverse-merger after drug failure - Boston Business Journal</td>    <td>Flex Pharma shareholders OK reverse-merger after drug failure  Boston Business Journal</td>    <td><a target="_blank" href="https://www.bizjournals.com/boston/news/2019/07/15/flex-pharma-shareholders-ok-reverse-merger-after.html">Link</a></td>  </tr></table><h3>270. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FLXN">Flexion Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 18:30:00 GMT</td>    <td>Is Flexion Therapeutics, Inc. (FLXN) A 'Must-Own' Growth Stock? - The News Heater</td>    <td>Is Flexion Therapeutics, Inc. (FLXN) A 'Must-Own' Growth Stock?  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/is-flexion-therapeutics-inc-flxn-a-must-own-growth-stock/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Flexion Therapeutics Inc. (FLXN) Soars 7.12% on June 02 - Equities.com</td>    <td>Flexion Therapeutics Inc. (FLXN) Soars 7.12% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/flexion-therapeutics-inc-flxn-soars-7-12-on-june-02">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 13:17:51 GMT</td>    <td>Flexion Therapeutics Announces Virtual Poster Presentations for FX201, an Intra-Articular Gene Therapy Candidate for the Treatment of Osteoarthritis, at the American Society of Gene & Cell Therapy Annual Meeting - GlobeNewswire</td>    <td>Flexion Therapeutics Announces Virtual Poster Presentations for FX201, an Intra-Articular Gene Therapy Candidate for the Treatment of Osteoarthritis, at the American Society of Gene & Cell Therapy Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027596/0/en/Flexion-Therapeutics-Announces-Virtual-Poster-Presentations-for-FX201-an-Intra-Articular-Gene-Therapy-Candidate-for-the-Treatment-of-Osteoarthritis-at-the-American-Society-of-Gene-.html">Link</a></td>  </tr></table><h3>271. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FLDM">Fluidigm Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 20:04:35 GMT</td>    <td>Fluidigm to Present at Upcoming Health Care Investor Conferences - GlobeNewswire</td>    <td>Fluidigm to Present at Upcoming Health Care Investor Conferences  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032970/0/en/Fluidigm-to-Present-at-Upcoming-Health-Care-Investor-Conferences.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Fluidigm Announces First Quarter 2020 Financial Results Nasdaq:FLDM - GlobeNewswire</td>    <td>Fluidigm Announces First Quarter 2020 Financial Results Nasdaq:FLDM  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029882/0/en/Fluidigm-Announces-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services - GlobeNewswire</td>    <td>Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029849/0/en/Fluidigm-Expands-Accessibility-of-Mass-Cytometry-and-Imaging-Mass-Cytometry-Technology-with-New-Therapeutic-Insights-Services.html">Link</a></td>  </tr></table><h3>272. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FONR">Fonar Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 00:52:45 GMT</td>    <td>FONAR Announces Fiscal 2020 3rd Quarter and Nine Months Financial Results; Company Balance Sheet Remains Strong Amid COVID-19 Crisis - GlobeNewswire</td>    <td>FONAR Announces Fiscal 2020 3rd Quarter and Nine Months Financial Results; Company Balance Sheet Remains Strong Amid COVID-19 Crisis  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031572/0/en/FONAR-Announces-Fiscal-2020-3rd-Quarter-and-Nine-Months-Financial-Results-Company-Balance-Sheet-Remains-Strong-Amid-COVID-19-Crisis.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Has FONAR Corporation’s (NASDAQ:FONR) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Simply Wall St</td>    <td>Has FONAR Corporation’s (NASDAQ:FONR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/healthcare/nasdaq-fonr/fonar/news/has-fonar-corporations-nasdaqfonr-impressive-stock-performance-got-anything-to-do-with-its-fundamentals/">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 15:24:29 GMT</td>    <td>Medical Imaging Market 2020 : Fonar Corporation, Toshiba Corporation, Medtronic, Philips Healthcare - Cole of Duty</td>    <td>Medical Imaging Market 2020 : Fonar Corporation, Toshiba Corporation, Medtronic, Philips Healthcare  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/market-reports/2020/05/28/medical-imaging-market-2020-fonar-corporation-toshiba-corporation-medtronic-philips-healthcare/">Link</a></td>  </tr></table><h3>273. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FBIO">Fortress Biotech, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:32:28 GMT</td>    <td>Fortress Biotech to Host Virtual Annual Meeting of Stockholders - GlobeNewswire</td>    <td>Fortress Biotech to Host Virtual Annual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042231/0/en/Fortress-Biotech-to-Host-Virtual-Annual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Fortress Biotech Inc. (FBIO) Soars 5.69% on June 02 - Equities.com</td>    <td>Fortress Biotech Inc. (FBIO) Soars 5.69% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/fortress-biotech-inc-fbio-soars-5-69-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 01:38:08 GMT</td>    <td>Fortress Biotech Announces Pricing of Series A Preferred Stock Offering - GlobeNewswire</td>    <td>Fortress Biotech Announces Pricing of Series A Preferred Stock Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039039/0/en/Fortress-Biotech-Announces-Pricing-of-Series-A-Preferred-Stock-Offering.html">Link</a></td>  </tr></table><h3>274. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FTSV">Forty Seven, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 11:01:14 GMT</td>    <td>iTeos Therapeutics Appoints Ann D. Rhoads to Board of Directors - GlobeNewswire</td>    <td>iTeos Therapeutics Appoints Ann D. Rhoads to Board of Directors  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041341/0/en/iTeos-Therapeutics-Appoints-Ann-D-Rhoads-to-Board-of-Directors.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 22:41:15 GMT</td>    <td>May 22, 2020 - Glazer Capital, Llc Buys WABCO Holdings Inc, Forty Seven Inc, Allergan PLC, Sells Mosaic Acquisition Corp, Tallgrass Energy LP, PAE Inc - GuruFocus.com</td>    <td>May 22, 2020 - Glazer Capital, Llc Buys WABCO Holdings Inc, Forty Seven Inc, Allergan PLC, Sells Mosaic Acquisition Corp, Tallgrass Energy LP, PAE Inc  GuruFocus.com</td>    <td><a target="_blank" href="https://www.gurufocus.com/news/1145330/glazer-capital-llc-buys-wabco-holdings-inc-forty-seven-inc-allergan-plc-sells-mosaic-acquisition-corp-tallgrass-energy-lp-pae-inc">Link</a></td>  </tr><tr>    <td>Sun, 31 May 2020 11:26:15 GMT</td>    <td>LEUKOCYTE SURFACE ANTIGEN CD47 Market Size (COVID-19 Impact) 2020-26: Celgene Corp, Forty Seven Inc, Surface Oncology Inc - Bandera County Courier</td>    <td>LEUKOCYTE SURFACE ANTIGEN CD47 Market Size (COVID-19 Impact) 2020-26: Celgene Corp, Forty Seven Inc, Surface Oncology Inc  Bandera County Courier</td>    <td><a target="_blank" href="https://www.bccourier.com/leukocyte-surface-antigen-cd47-market-size-covid-19-impact-2020-26-celgene-corp-forty-seven-inc-surface-oncology-inc/">Link</a></td>  </tr></table><h3>275. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FWP">Forward Pharma A/S</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 21:14:11 GMT</td>    <td>Forward Pharma Announces New Date for the EP2801355 Appeal Hearing due to COVID-19 - GlobeNewswire</td>    <td>Forward Pharma Announces New Date for the EP2801355 Appeal Hearing due to COVID-19  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032294/0/en/Forward-Pharma-Announces-New-Date-for-the-EP2801355-Appeal-Hearing-due-to-COVID-19.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 16:38:38 GMT</td>    <td>Forward Pharma up 10% on extended timeline for patent appeal - Seeking Alpha</td>    <td>Forward Pharma up 10% on extended timeline for patent appeal  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/news/3573999-forward-pharma-up-10-on-extended-timeline-for-patent-appeal">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Is Forward Pharma A/S (FWP) a good stock to buy now? - News RTS</td>    <td>Is Forward Pharma A/S (FWP) a good stock to buy now?  News RTS</td>    <td><a target="_blank" href="https://newsrts.com/2020/05/15/is-forward-pharma-a-s-fwp-a-good-stock-to-buy-now/">Link</a></td>  </tr></table><h3>276. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FREQ">Frequency Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Frequency Therapeutics Provides Business Updates and Reports First Quarter 2020 Financial Results - Business Wire</td>    <td>Frequency Therapeutics Provides Business Updates and Reports First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200514005055/en/Frequency-Therapeutics-Business-Updates-Reports-Quarter-2020">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 07:07:32 GMT</td>    <td>Frequency Therapeutics: FX-322 Top Line Data From Exploratory Study Proves Promising - Seeking Alpha</td>    <td>Frequency Therapeutics: FX-322 Top Line Data From Exploratory Study Proves Promising  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4351165-frequency-therapeutics-fxminus-322-top-line-data-from-exploratory-study-proves-promising">Link</a></td>  </tr><tr>    <td>Sun, 17 May 2020 07:00:00 GMT</td>    <td>Forecast: Analysts Think Frequency Therapeutics, Inc.'s (NASDAQ:FREQ) Business Prospects Have Improved Drastically - Yahoo Finance</td>    <td>Forecast: Analysts Think Frequency Therapeutics, Inc.'s (NASDAQ:FREQ) Business Prospects Have Improved Drastically  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/forecast-analysts-think-frequency-therapeutics-131821266.html">Link</a></td>  </tr></table><h3>277. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HUGE">FSD Pharma Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 06:30:00 GMT</td>    <td>FSD Pharma Receives U.S. FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis - Business Wire</td>    <td>FSD Pharma Receives U.S. FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis  Business WireFSD Pharma Jumps 200% After FDA Nod For Initiating Proof-Of-Concept Study Of COVID-19 Treatment  BenzingaFSD Pharma wins FDA nod to design Phase 2a clinical trial of its lead candidate micro-PEA to treat coronavirus patients  Proactive Investors USA & CanadaFSD Pharma rockets on FDA approval of FSD-201 trial to treat COVID-19 patients  Seeking AlphaFSD Pharma Inc (HUGE) Up Over 200% After FDA Approval for COVID19 Phase 2a Trial  InvestorsObserverView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005990/en/FSD-Pharma-Receives-U.S.-FDA-Approval-Design">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:47:00 GMT</td>    <td>Mid-day market update: Gold falls 2%; FSD Pharma shares spike higher - FXStreet</td>    <td>Mid-day market update: Gold falls 2%; FSD Pharma shares spike higher  FXStreet</td>    <td><a target="_blank" href="https://www.fxstreet.com/analysis/mid-day-market-update-gold-falls-2-fsd-pharma-shares-spike-higher-202006031647">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>FSD Pharma Reports First Quarter 2020 Financial Results - Business Wire</td>    <td>FSD Pharma Reports First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200514005889/en/FSD-Pharma-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr></table><h3>278. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FULC">Fulcrum Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 11:08:07 GMT</td>    <td>Fulcrum Therapeutics to Present at the BofA Securities 2020 Health Care Conference - GlobeNewswire</td>    <td>Fulcrum Therapeutics to Present at the BofA Securities 2020 Health Care Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030928/0/en/Fulcrum-Therapeutics-to-Present-at-the-BofA-Securities-2020-Health-Care-Conference.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Fulcrum Therapeutics : Corporation Overview Presentation - marketscreener.com</td>    <td>Fulcrum Therapeutics : Corporation Overview Presentation  marketscreener.com</td>    <td><a target="_blank" href="https://m.marketscreener.com/FULCRUM-THERAPEUTICS-INC-62037838/news/Fulcrum-Therapeutics-Corporation-Overview-Presentation-30602501/">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results - Yahoo Finance</td>    <td>Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/fulcrum-therapeutics-reports-recent-business-110010691.html">Link</a></td>  </tr></table><h3>279. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GTHX">G1 Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 20:01:00 GMT</td>    <td>G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital - GlobeNewswire</td>    <td>G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041737/0/en/G1-Therapeutics-Announces-Flexible-Credit-Financing-for-Up-to-100-Million-with-Hercules-Capital.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:03:40 GMT</td>    <td>G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update - GlobeNewswire</td>    <td>G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028788/0/en/G1-Therapeutics-Provides-First-Quarter-2020-Corporate-and-Financial-Update.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 14:49:03 GMT</td>    <td>G1 Therapeutics, Inc. (GTHX) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>G1 Therapeutics, Inc. (GTHX) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/07/g1-therapeutics-inc-gthx-q1-2020-earnings-call-tra.aspx">Link</a></td>  </tr></table><h3>280. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GLPG">Galapagos NV</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Galapagos NV (GLPG) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Galapagos NV (GLPG) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/09/galapagos-nv-glpg-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>H.C. Wainwright Sticks to Their Buy Rating for Galapagos NV - Yahoo Finance</td>    <td>H.C. Wainwright Sticks to Their Buy Rating for Galapagos NV  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/h-c-wainwright-sticks-buy-105219028.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>On track for clinical read-outs and commercial readiness in 2020 - GlobeNewswire</td>    <td>On track for clinical read-outs and commercial readiness in 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029853/0/en/On-track-for-clinical-read-outs-and-commercial-readiness-in-2020.html">Link</a></td>  </tr></table><h3>281. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GALT">Galectin Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 12:10:33 GMT</td>    <td>Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2020, and Provides Business Update - GlobeNewswire</td>    <td>Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2020, and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031029/0/en/Galectin-Therapeutics-Reports-Financial-Results-for-the-Quarter-Ended-March-31-2020-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 10:49:41 GMT</td>    <td>What Percentage Of Galectin Therapeutics, Inc. (NASDAQ:GALT) Shares Do Insiders Own? - Simply Wall St</td>    <td>What Percentage Of Galectin Therapeutics, Inc. (NASDAQ:GALT) Shares Do Insiders Own?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-galt/galectin-therapeutics/news/what-percentage-of-galectin-therapeutics-inc-nasdaqgalt-shares-do-insiders-own/">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>BRIEF-Galectin Therapeutics Says Nash-Rx Clinical Trial Protocol Filed With FDA First Patient Currently Expected To Be Enrolled In Q2 2020 - Reuters</td>    <td>BRIEF-Galectin Therapeutics Says Nash-Rx Clinical Trial Protocol Filed With FDA First Patient Currently Expected To Be Enrolled In Q2 2020  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-galectin-therapeutics-says-nash-rx/brief-galectin-therapeutics-says-nash-rx-clinical-trial-protocol-filed-with-fda-first-patient-currently-expected-to-be-enrolled-in-q2-2020-idUSFWN2CT0GC">Link</a></td>  </tr></table><h3>282. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GRTX">Galera Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 11:15:02 GMT</td>    <td>Galera Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates - GlobeNewswire</td>    <td>Galera Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031772/0/en/Galera-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Business-Updates.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 20:24:27 GMT</td>    <td>Galera Therapeutics to Host Virtual KOL Event on Cisplatin-Induced Chronic Kidney Disease - GlobeNewswire</td>    <td>Galera Therapeutics to Host Virtual KOL Event on Cisplatin-Induced Chronic Kidney Disease  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2035239/0/en/Galera-Therapeutics-to-Host-Virtual-KOL-Event-on-Cisplatin-Induced-Chronic-Kidney-Disease.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Galera Therapeutics Announces New Data from the Phase 2b Trial - MyChesCo</td>    <td>Galera Therapeutics Announces New Data from the Phase 2b Trial  MyChesCo</td>    <td><a target="_blank" href="https://www.mychesco.com/a/news/health-medical/cancer/galera-therapeutics-announces-new-data-from-the-phase-2b-trial/">Link</a></td>  </tr></table><h3>283. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GLMD">Galmed Pharmaceuticals Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results - PRNewswire</td>    <td>Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/il/news-releases/galmed-pharmaceuticals-provides-business-update-and-reports-first-quarter-2020-financial-results-301059265.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Galmed Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Business Update on Thursday May 14 - Yahoo Finance</td>    <td>Galmed Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Business Update on Thursday May 14  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/galmed-pharmaceuticals-report-first-quarter-123000655.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Galmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Galmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4347690-galmed-pharmaceuticals-ltd-glmd-ceo-allen-baharaff-on-q1-2020-results-earnings-call">Link</a></td>  </tr></table><h3>284. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GMDA">Gamida Cell Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Gamida Cell Announces Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies - Business Wire</td>    <td>Gamida Cell Announces Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies  Business WireBone marrow co Gamida Cell reports positive Phase III results  GlobesGamida Cell Ltd. (GMDA) Reports Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies  StreetInsider.comOmidubicel Succeeds in Phase 3 Trial in High-Risk Hematologic Malignancies  OncLiveIs Gamida Cell Ltd. (NASDAQ:GMDA) Worth A Bite? GMDA 200 SMA stands at 50.58%  State ReviewerView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005264/en/Gamida-Cell-Announces-Positive-Topline-Data-Phase">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Gamida Cell raises $60m at 24% discount - Globes - Globes</td>    <td>Gamida Cell raises $60m at 24% discount - Globes  Globes</td>    <td><a target="_blank" href="https://en.globes.co.il/en/article-gamida-cell-raises-60m-at-24-discount-1001329121">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 13:01:00 GMT</td>    <td>Gamida Cell Announces Full Exercise of Underwriters' Option to Purchase Additional Shares - Business Wire</td>    <td>Gamida Cell Announces Full Exercise of Underwriters' Option to Purchase Additional Shares  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200526005436/en/Gamida-Cell-Announces-Full-Exercise-Underwriters%E2%80%99-Option">Link</a></td>  </tr></table><h3>285. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GEMP">Gemphire Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 13:47:54 GMT</td>    <td>Global Hypercholesterolemia Treatment Market 2020 | Know the Companies List Could Potentially Benefit or Loose out From the Impact of COVID-19 | Top Companies: CymaBay Therapeutics Inc, Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc, Regeneron Pharmaceuticals Inc, etc. | InForGrowth - Farmers Ledger</td>    <td>Global Hypercholesterolemia Treatment Market 2020 | Know the Companies List Could Potentially Benefit or Loose out From the Impact of COVID-19 | Top Companies: CymaBay Therapeutics Inc, Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc, Regeneron Pharmaceuticals Inc, etc. | InForGrowth  Farmers Ledger</td>    <td><a target="_blank" href="https://www.farmersledger.com/global-hypercholesterolemia-treatment-market-2020-know-the-companies-list-could-potentially-benefit-or-loose-out-from-the-impact-of-covid-19-top-companies-cymabay-therapeutics-inc-daewoong-co-lt/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 07:40:32 GMT</td>    <td>Homozygous Familial Hypercholesterolemia Treatment Market Survey Report (COVID-19 impact) 2020-26: Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc - Surfacing Magazine</td>    <td>Homozygous Familial Hypercholesterolemia Treatment Market Survey Report (COVID-19 impact) 2020-26: Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/homozygous-familial-hypercholesterolemia-treatment-market-survey-report-covid-19-impact-2020-26-daewoong-co-ltd-gemphire-therapeutics-inc-lipimetix-development-inc/">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 13:11:00 GMT</td>    <td>New Strong Buy Stocks For May 27th - Yahoo Finance</td>    <td>New Strong Buy Stocks For May 27th  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/strong-buy-stocks-may-27th-131101625.html">Link</a></td>  </tr></table><h3>286. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GENE">Genetic Technologies Ltd</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 07:00:00 GMT</td>    <td>Wall Street's Analysis on Genetic Technologies Limited (GENE) Stock's Recent Behavior - InvestorsObserver</td>    <td>Wall Street's Analysis on Genetic Technologies Limited (GENE) Stock's Recent Behavior  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/wall-streets-analysis-on-genetic-technologies-limited-gene-stocks-recent-behavior">Link</a></td>  </tr><tr>    <td>Sun, 17 May 2020 07:00:00 GMT</td>    <td>BRIEF-Genetic Technologies Says Nasdaq Hearing Panel Grants Full Extension For Continued Listing - Reuters</td>    <td>BRIEF-Genetic Technologies Says Nasdaq Hearing Panel Grants Full Extension For Continued Listing  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-genetic-technologies-says-nasdaq-h/brief-genetic-technologies-says-nasdaq-hearing-panel-grants-full-extension-for-continued-listing-idUSFWN2CZ03H">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 06:00:00 GMT</td>    <td>BRIEF-Genetic Technologies Announces USD 8 Million Capital Raising - Reuters</td>    <td>BRIEF-Genetic Technologies Announces USD 8 Million Capital Raising  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-genetic-technologies-announces-usd/brief-genetic-technologies-announces-usd-8-million-capital-raising-idUSFWN2D80XR">Link</a></td>  </tr></table><h3>287. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GNFT">Genfit S.A.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 20:13:52 GMT</td>    <td>GENFIT: Announces Results from Interim Analysis of RESOLVE-IT Phase 3 Trial of Elafibranor in Adults with NASH and Fibrosis - GlobeNewswire</td>    <td>GENFIT: Announces Results from Interim Analysis of RESOLVE-IT Phase 3 Trial of Elafibranor in Adults with NASH and Fibrosis  GlobeNewswireWhy Genfit Is Cratering Today  Motley FoolHepatitis Treatment: Genfit Stock Craters On Failure, Boosting Intercept  Investor's Business DailyGenfit's NASH hopes are dashed by phase 3 trial fail -  pharmaphorumDiverging NASH Stories: CymaBay On Track To Restart, GenFit's Drug Flunks Late-Stage Study  BenzingaView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031418/0/en/GENFIT-Announces-Results-from-Interim-Analysis-of-RESOLVE-IT-Phase-3-Trial-of-Elafibranor-in-Adults-with-NASH-and-Fibrosis.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>GNFT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Genfit SA and Encourages Investors to Contact the Firm - Yahoo Finance</td>    <td>GNFT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Genfit SA and Encourages Investors to Contact the Firm  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/gnft-investor-alert-bronstein-gewirtz-150300478.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings - Benzinga</td>    <td>The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/general/biotech/20/05/16008416/the-daily-biotech-pulse-nash-disappointment-for-genfit-novavax-lands-384m-cepi-funding-for-corona">Link</a></td>  </tr></table><h3>288. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GMAB">Genmab A/S</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 20:38:15 GMT</td>    <td>Genmab A/S : US FDA Extends Review of sBLA, Submitted by Novartis, for Ofatumumab in Relapsing Multiple Sclerosis - marketscreener.com</td>    <td>Genmab A/S : US FDA Extends Review of sBLA, Submitted by Novartis, for Ofatumumab in Relapsing Multiple Sclerosis  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/GENMAB-A-S-63733191/news/Genmab-A-S-U-S-FDA-Extends-Review-of-sBLA-Submitted-by-Novartis-for-Ofatumumab-in-Relapsing-Mul-30711983/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 19:57:00 GMT</td>    <td>Grant of Restricted Stock Units and Warrants to Employees in Genmab - Yahoo Finance UK</td>    <td>Grant of Restricted Stock Units and Warrants to Employees in Genmab  Yahoo Finance UK</td>    <td><a target="_blank" href="https://uk.finance.yahoo.com/news/grant-restricted-stock-units-warrants-195700035.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 14:48:23 GMT</td>    <td>Genmab A/S (GMAB) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Genmab A/S (GMAB) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/07/genmab-as-gmab-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr></table><h3>289. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GNCA">Genocea Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 21:34:17 GMT</td>    <td>Genocea Introduces GEN-011, a Transformational T cell Therapy Designed to Improve on Current Limitations of TIL Therapy - GlobeNewswire</td>    <td>Genocea Introduces GEN-011, a Transformational T cell Therapy Designed to Improve on Current Limitations of TIL Therapy  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032313/0/en/Genocea-Introduces-GEN-011-a-Transformational-T-cell-Therapy-Designed-to-Improve-on-Current-Limitations-of-TIL-Therapy.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 11:37:39 GMT</td>    <td>Genocea Announces Material Transfer and License Option Agreement with Shionogi for Proprietary GEN-003 HSV-2 Antigens - GlobeNewswire</td>    <td>Genocea Announces Material Transfer and License Option Agreement with Shionogi for Proprietary GEN-003 HSV-2 Antigens  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/19/2035543/0/en/Genocea-Announces-Material-Transfer-and-License-Option-Agreement-with-Shionogi-for-Proprietary-GEN-003-HSV-2-Antigens.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 22:03:11 GMT</td>    <td>Genocea to Present Long-term Follow-up Data from GEN-009 Neoantigen Vaccine at Virtual ASCO 2020 - GlobeNewswire</td>    <td>Genocea to Present Long-term Follow-up Data from GEN-009 Neoantigen Vaccine at Virtual ASCO 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033098/0/en/Genocea-to-Present-Long-term-Follow-up-Data-from-GEN-009-Neoantigen-Vaccine-at-Virtual-ASCO-2020.html">Link</a></td>  </tr></table><h3>290. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GNPX">Genprex, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 19:23:32 GMT</td>    <td>Genprex forms global licensing deal with MD Anderson for its cancer drug Oncoprex - Proactive Investors USA & Canada</td>    <td>Genprex forms global licensing deal with MD Anderson for its cancer drug Oncoprex  Proactive Investors USA & Canada</td>    <td><a target="_blank" href="https://www.proactiveinvestors.com/companies/news/919638/genprex-forms-global-licensing-deal-with-md-anderson-for-its-cancer-drug-oncoprex-919638.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies - Business Wire</td>    <td>Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200505005133/en/Genprex-Enters-Exclusive-Worldwide-Patent-Technology-License">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Genprex strikes deal with MD Anderson, adds to momentum in cancer fight - Austin Business Journal</td>    <td>Genprex strikes deal with MD Anderson, adds to momentum in cancer fight  Austin Business Journal</td>    <td><a target="_blank" href="https://www.bizjournals.com/austin/news/2020/05/08/genprex-strikes-deal-with-md-anderson-cancer.html">Link</a></td>  </tr></table><h3>291. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GERN">Geron Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 20:33:27 GMT</td>    <td>Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants - GlobeNewswire</td>    <td>Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039761/0/en/Geron-Corporation-Announces-the-Closing-of-its-Public-Offering-of-Common-Stock-and-Warrants.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 20:16:21 GMT</td>    <td>Geron Corporation Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Geron Corporation Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040550/0/en/Geron-Corporation-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 20:05:30 GMT</td>    <td>Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants - GlobeNewswire</td>    <td>Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037263/0/en/Geron-Corporation-Announces-Proposed-Public-Offering-of-Common-Stock-and-Warrants.html">Link</a></td>  </tr></table><h3>292. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GILD">Gilead Sciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 03:49:34 GMT</td>    <td>Is Gilead Sciences a Great Dividend Stock? - The Motley Fool</td>    <td>Is Gilead Sciences a Great Dividend Stock?  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/17/is-gilead-sciences-a-great-dividend-stock.aspx">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:48:00 GMT</td>    <td>Gilead Upgraded With Covid Sales Seen Reaching $7.7 Billion - Yahoo Finance</td>    <td>Gilead Upgraded With Covid Sales Seen Reaching $7.7 Billion  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/gilead-loses-skeptic-remdesivir-sales-122824770.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 07:00:00 GMT</td>    <td>Hedge Funds Piled Into Gilead Sciences, Inc. (GILD) During The Crash - Yahoo Finance</td>    <td>Hedge Funds Piled Into Gilead Sciences, Inc. (GILD) During The Crash  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-piled-gilead-sciences-171038895.html">Link</a></td>  </tr></table><h3>293. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GBT">Global Blood Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:00:00 GMT</td>    <td>GBT Announces New Employment Inducement Grants Nasdaq:GBT - GlobeNewswire</td>    <td>GBT Announces New Employment Inducement Grants Nasdaq:GBT  GlobeNewswire</td>    <td><a target="_blank" href="http://www.globenewswire.com/news-release/2020/06/03/2042844/0/en/GBT-Announces-New-Employment-Inducement-Grants.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Global Blood Therapeutics Reports Q1 Beat, Impressive Oxbryta Sales - Yahoo Finance</td>    <td>Global Blood Therapeutics Reports Q1 Beat, Impressive Oxbryta Sales  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/global-blood-therapeutics-reports-q1-094834661.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Global Blood Therapeutics (GBT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance</td>    <td>Global Blood Therapeutics (GBT) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/global-blood-therapeutics-gbt-reports-213509023.html">Link</a></td>  </tr></table><h3>294. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GLYC">GlycoMimetics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 13:00:00 GMT</td>    <td>GlycoMimetics to Present at Upcoming Jefferies Virtual Healthcare Conference - Business Wire</td>    <td>GlycoMimetics to Present at Upcoming Jefferies Virtual Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200529005296/en/GlycoMimetics-Present-Upcoming-Jefferies-Virtual-Healthcare-Conference">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>GlycoMimetics to Present New Preclinical Data Highlighting Biomarkers and Potential Expanded Pipeline Opportunities at Virtual AACR Annual Meeting 2020 - Business Wire</td>    <td>GlycoMimetics to Present New Preclinical Data Highlighting Biomarkers and Potential Expanded Pipeline Opportunities at Virtual AACR Annual Meeting 2020  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200515005324/en/GlycoMimetics-Present-New-Preclinical-Data-Highlighting-Biomarkers">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>GlycoMimetics Announces Change to Virtual Meeting Format for 2020 Annual Meeting of Shareholders - Business Wire</td>    <td>GlycoMimetics Announces Change to Virtual Meeting Format for 2020 Annual Meeting of Shareholders  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200508005232/en/GlycoMimetics-Announces-Change-Virtual-Meeting-Format-2020">Link</a></td>  </tr></table><h3>295. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GOSS">Gossamer Bio</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 11:35:00 GMT</td>    <td>Gossamer Bio Announces Participation in Upcoming Investor Conferences - Business Wire</td>    <td>Gossamer Bio Announces Participation in Upcoming Investor Conferences  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200601005175/en/Gossamer-Bio-Announces-Participation-Upcoming-Investor-Conferences">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update - Business Wire</td>    <td>Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005809/en/Gossamer-Bio-Announces-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:07:00 GMT</td>    <td>Gossamer Bio Announces Early Encouraging Safety and Biomarker Data from Phase 1/2 Study of GB1275 at American Society of Clinical Oncology 2020 Virtual Scientific Program - Business Wire</td>    <td>Gossamer Bio Announces Early Encouraging Safety and Biomarker Data from Phase 1/2 Study of GB1275 at American Society of Clinical Oncology 2020 Virtual Scientific Program  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200529005079/en/Gossamer-Bio-Announces-Early-Encouraging-Safety-Biomarker">Link</a></td>  </tr></table><h3>296. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GRFS">Grifols, S.A.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 05:40:08 GMT</td>    <td>What Kind Of Investor Owns Most Of Grifols, S.A. (BME:GRF)? - Simply Wall St</td>    <td>What Kind Of Investor Owns Most Of Grifols, S.A. (BME:GRF)?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/what-kind-of-investor-owns-most-of-grifols-s-a-bmegrf/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 19:07:45 GMT</td>    <td>Haemophilia Market Analysis 2020 With Top Companies Profile | Grifols SA, CSL Limited, Octapharma, Novo Nordisk A/S, Kedrion SpA, Pfizer Inc., Bayer AG - Cole of Duty</td>    <td>Haemophilia Market Analysis 2020 With Top Companies Profile | Grifols SA, CSL Limited, Octapharma, Novo Nordisk A/S, Kedrion SpA, Pfizer Inc., Bayer AG  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/06/03/haemophilia-market-5/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Grifols Procleix Panther System with Automation Ready Technology (ART) receives FDA Approval - PRNewswire</td>    <td>Grifols Procleix Panther System with Automation Ready Technology (ART) receives FDA Approval  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/grifols-procleix-panther-system-with-automation-ready-technology-art-receives-fda-approval-301054914.html">Link</a></td>  </tr></table><h3>297. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GRTS">Gritstone Oncology, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights - BioSpace</td>    <td>Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/gritstone-oncology-reports-first-quarter-financial-results-and-recent-highlights/">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>Analysts Have Made A Financial Statement On Gritstone Oncology, Inc.'s (NASDAQ:GRTS) First-Quarter Report - Yahoo Finance</td>    <td>Analysts Have Made A Financial Statement On Gritstone Oncology, Inc.'s (NASDAQ:GRTS) First-Quarter Report  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-made-financial-statement-gritstone-141416480.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 13:15:00 GMT</td>    <td>Gritstone Oncology (GRTS): Strong Industry, Solid Earnings Estimate Revisions - Yahoo Finance</td>    <td>Gritstone Oncology (GRTS): Strong Industry, Solid Earnings Estimate Revisions  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/gritstone-oncology-grts-strong-industry-131501966.html">Link</a></td>  </tr></table><h3>298. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GTXI">GTx, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>GTx: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>GTx: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/GTx-1Q-Earnings-Snapshot-15253464.php">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 19:39:33 GMT</td>    <td>University of Michigan dean chosen as new University of Alabama provost - MLive.com</td>    <td>University of Michigan dean chosen as new University of Alabama provost  MLive.com</td>    <td><a target="_blank" href="https://www.mlive.com/news/ann-arbor/2020/05/university-of-michigan-dean-chosen-as-new-university-of-alabama-provost.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 09:49:11 GMT</td>    <td>Garrett Motion Inc. (GTX) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Garrett Motion Inc. (GTX) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/garrett-motion-inc-gtx-q1-2020-earnings-call-trans.aspx">Link</a></td>  </tr></table><h3>299. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GHSI">Guardion Health Sciences</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update - Yahoo Finance</td>    <td>Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/guardion-health-sciences-reports-first-110010195.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Market cap of Guardion Health Sciences Inc. [GHSI] reaches 44.55M – now what? - The DBT News</td>    <td>Market cap of Guardion Health Sciences Inc. [GHSI] reaches 44.55M – now what?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/05/22/market-cap-of-guardion-health-sciences-inc-ghsi-reaches-44-55m-now-what/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:40:00 GMT</td>    <td>Risks You Need To Know Before Getting in Guardion Health Sciences Inc. (NASDAQ:GHSI) - State Reviewer</td>    <td>Risks You Need To Know Before Getting in Guardion Health Sciences Inc. (NASDAQ:GHSI)  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/01/risks-you-need-to-know-before-getting-in-guardion-health-sciences-inc-nasdaqghsi-2/">Link</a></td>  </tr></table><h3>300. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GWPH">GW Pharmaceuticals Plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>GW Pharmaceuticals plc Reports First Quarter 2020 Financial Results and Operational Progress - GlobeNewswire</td>    <td>GW Pharmaceuticals plc Reports First Quarter 2020 Financial Results and Operational Progress  GlobeNewswireEpidiolex Growth Fuels GW Pharma Revenue Above Expectations to...  New Cannabis VenturesGW Pharmaceuticals PLC (GWPH) Q1 2020 Earnings Call Transcript  The Motley FoolGW Pharmaceuticals sells more of CBD-derived epilepsy drug than expected, stock rises  MarketWatchGW Pharmaceuticals PLC (GWPH) CEO Justin Gover on Q1 2020 Results - Earnings Call Transcript  Seeking AlphaView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031373/0/en/GW-Pharmaceuticals-plc-Reports-First-Quarter-2020-Financial-Results-and-Operational-Progress.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>What's in Store for GW Pharmaceuticals (GWPH) in Q1 Earnings? - Yahoo Finance</td>    <td>What's in Store for GW Pharmaceuticals (GWPH) in Q1 Earnings?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/whats-store-gw-pharmaceuticals-gwph-151703402.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 11:00:00 GMT</td>    <td>GW Pharmaceuticals to Present at the Goldman Sachs 41st Annual Global Healthcare Conference - Yahoo Finance</td>    <td>GW Pharmaceuticals to Present at the Goldman Sachs 41st Annual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/gw-pharmaceuticals-present-goldman-sachs-110010857.html">Link</a></td>  </tr></table><h3>301. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HALO">Halozyme Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Halozyme Therapeutics: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Halozyme Therapeutics: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Halozyme-Therapeutics-1Q-Earnings-Snapshot-15262540.php">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Halozyme To Receive $15 Million Milestone Payment From Janssen - PRNewswire</td>    <td>Halozyme To Receive $15 Million Milestone Payment From Janssen  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/halozyme-to-receive-15-million-milestone-payment-from-janssen-301059642.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 14:28:00 GMT</td>    <td>Is Halozyme Therapeutics (HALO) a Smart Long-term Buy? - Yahoo Finance</td>    <td>Is Halozyme Therapeutics (HALO) a Smart Long-term Buy?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/halozyme-therapeutics-halo-smart-long-142820265.html">Link</a></td>  </tr></table><h3>302. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HAPP">Happiness Biotech Group Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 25 May 2020 11:57:00 GMT</td>    <td>Are Happiness Biotech Group Limited’s (NASDAQ:HAPP) High Returns Really That Great? - Yahoo Finance</td>    <td>Are Happiness Biotech Group Limited’s (NASDAQ:HAPP) High Returns Really That Great?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/happiness-biotech-group-limited-nasdaq-115758706.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Happiness Biotech Announced the Sales of Epidemic Prevention Products Have Exceeded RMB45 million - PRNewswire</td>    <td>Happiness Biotech Announced the Sales of Epidemic Prevention Products Have Exceeded RMB45 million  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/happiness-biotech-announced-the-sales-of-epidemic-prevention-products-have-exceeded-rmb45-million-301054525.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Happiness Biotech Announced Innovative Cultivation Technology of Lucidum - PRNewswire</td>    <td>Happiness Biotech Announced Innovative Cultivation Technology of Lucidum  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/happiness-biotech-announced-innovative-cultivation-technology-of-lucidum-301058394.html">Link</a></td>  </tr></table><h3>303. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HARP">Harpoon Therapeutics, Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Harpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Harpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028842/0/en/Harpoon-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:12:16 GMT</td>    <td>Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose Escalation Trial for the PSMA-targeting TriTAC® HPN424 at the ASCO20 Virtual Scientific Program - GlobeNewswire</td>    <td>Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose Escalation Trial for the PSMA-targeting TriTAC® HPN424 at the ASCO20 Virtual Scientific Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040877/0/en/Harpoon-Therapeutics-Presents-Interim-Phase-1-Data-from-an-Ongoing-Dose-Escalation-Trial-for-the-PSMA-targeting-TriTAC-HPN424-at-the-ASCO20-Virtual-Scientific-Program.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Analysts Are Much More Bearish On Harpoon Therapeutics, Inc. (NASDAQ:HARP) Than They Used To Be - Yahoo Finance</td>    <td>Analysts Are Much More Bearish On Harpoon Therapeutics, Inc. (NASDAQ:HARP) Than They Used To Be  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-much-more-bearish-harpoon-103549651.html">Link</a></td>  </tr></table><h3>304. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HBIO">Harvard Bioscience, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 21:22:08 GMT</td>    <td>Harvard Bioscience, Inc. Issues Letter to Shareholders - GlobeNewswire</td>    <td>Harvard Bioscience, Inc. Issues Letter to Shareholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038987/0/en/Harvard-Bioscience-Inc-Issues-Letter-to-Shareholders.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 11:03:43 GMT</td>    <td>Harvard Bioscience Announces First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Harvard Bioscience Announces First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027383/0/en/Harvard-Bioscience-Announces-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Harvard Bioscience announces salary reductions, job cuts - MetroWest Daily News</td>    <td>Harvard Bioscience announces salary reductions, job cuts  MetroWest Daily News</td>    <td><a target="_blank" href="https://www.metrowestdailynews.com/news/20200506/harvard-bioscience-announces-salary-reductions-job-cuts">Link</a></td>  </tr></table><h3>305. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HTBX">Heat Biologics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 10:15:00 GMT</td>    <td>HTBX: The Antigen Chaperone: gp96 - Yahoo Finance</td>    <td>HTBX: The Antigen Chaperone: gp96  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/htbx-antigen-chaperone-gp96-101500247.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 12:00:00 GMT</td>    <td>Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine - Yahoo Finance</td>    <td>Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/heat-biologics-announces-collaboration-waisman-120000346.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 18:42:00 GMT</td>    <td>BRIEF-Heat Biologics Inc says It Had Cash, Cash Equivalents And Short-Term Investments Of $35.5 Million As Of June 1, 2020 - Reuters</td>    <td>BRIEF-Heat Biologics Inc says It Had Cash, Cash Equivalents And Short-Term Investments Of $35.5 Million As Of June 1, 2020  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-heat-biologics-inc-says-it-had-cas/brief-heat-biologics-inc-says-it-had-cash-cash-equivalents-and-short-term-investments-of-355-million-as-of-june-1-2020-idUSFWN2DE0V4">Link</a></td>  </tr></table><h3>306. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HSDT">Helius Medical Technologies, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 11:15:38 GMT</td>    <td>Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis - GlobeNewswire</td>    <td>Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031783/0/en/Helius-Medical-Technologies-Inc-Announces-FDA-Has-Granted-the-PoNS-Device-Breakthrough-Device-Designation-for-the-Treatment-of-Gait-Deficits-Due-to-Symptoms-of-Multiple-Sclerosis.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:12:22 GMT</td>    <td>Helius Medical Technologies, Inc. Reports First Quarter of Full Year 2020 Financial Results; Updates Full Year 2020 Outlook - GlobeNewswire</td>    <td>Helius Medical Technologies, Inc. Reports First Quarter of Full Year 2020 Financial Results; Updates Full Year 2020 Outlook  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029858/0/en/Helius-Medical-Technologies-Inc-Reports-First-Quarter-of-Full-Year-2020-Financial-Results-Updates-Full-Year-2020-Outlook.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 20:00:03 GMT</td>    <td>Helius Medical Technologies, Inc. (NASDAQ:HSDT) has great growth outlook for 2020 - Marketing Sentinel</td>    <td>Helius Medical Technologies, Inc. (NASDAQ:HSDT) has great growth outlook for 2020  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/03/helius-medical-technologies-inc-nasdaqhsdt-has-great-growth-outlook-for-2020/">Link</a></td>  </tr></table><h3>307. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HRTX">Heron Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Heron Therapeutics Inc. (HRTX) Soars 1.57% on June 03 - Equities.com</td>    <td>Heron Therapeutics Inc. (HRTX) Soars 1.57% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/heron-therapeutics-inc-hrtx-soars-1-57-on-june-03">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain - PRNewswire</td>    <td>Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/heron-therapeutics-announces-initiation-of-phase-1b2-clinical-study-of-htx-034-for-the-treatment-of-postoperative-pain-301060550.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 12:52:28 GMT</td>    <td>Have Insiders Been Buying Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares? - Simply Wall St</td>    <td>Have Insiders Been Buying Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrtx/heron-therapeutics/news/have-insiders-been-buying-heron-therapeutics-inc-nasdaqhrtx-shares/">Link</a></td>  </tr></table><h3>308. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HSKA">Heska Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Heska Corporation Reports First Quarter 2020 Results - Yahoo Finance</td>    <td>Heska Corporation Reports First Quarter 2020 Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/heska-corporation-reports-first-quarter-120000685.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Heska Corporation (HSKA) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Heska Corporation (HSKA) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/heska-corporation-hska-q1-2020-earnings-call-trans.aspx">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:49:17 GMT</td>    <td>Veterinary Point of Care Blood Gas Analyzers Market, 2028 | Abaxis, Inc., Edan Instruments, Inc., Heska Corporation, IDEXX Laboratories, Inc., LifeHealth - Azizsalon News</td>    <td>Veterinary Point of Care Blood Gas Analyzers Market, 2028 | Abaxis, Inc., Edan Instruments, Inc., Heska Corporation, IDEXX Laboratories, Inc., LifeHealth  Azizsalon News</td>    <td><a target="_blank" href="https://azizsalon.com/veterinary-point-of-care-blood-gas-analyzers-market-2028-abaxis-inc-edan-instruments-inc-heska-corporation-idexx-laboratories-inc-lifehealth/">Link</a></td>  </tr></table><h3>309. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-FIXX">Homology Medicines, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 12:12:54 GMT</td>    <td>Homology Medicines Announces Presentations on its In Vivo Gene Therapy and Gene Editing Programs and Commercial Manufacturing Platform at the American Society of Gene & Cell Therapy Annual Meeting - GlobeNewswire</td>    <td>Homology Medicines Announces Presentations on its In Vivo Gene Therapy and Gene Editing Programs and Commercial Manufacturing Platform at the American Society of Gene & Cell Therapy Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031853/0/en/Homology-Medicines-Announces-Presentations-on-its-In-Vivo-Gene-Therapy-and-Gene-Editing-Programs-and-Commercial-Manufacturing-Platform-at-the-American-Society-of-Gene-Cell-Therapy-.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:11:29 GMT</td>    <td>Homology Medicines Reports First Quarter 2020 Financial Results and Recent Highlights - GlobeNewswire</td>    <td>Homology Medicines Reports First Quarter 2020 Financial Results and Recent Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029894/0/en/Homology-Medicines-Reports-First-Quarter-2020-Financial-Results-and-Recent-Highlights.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 18:12:59 GMT</td>    <td>Homology Medicines Announces Peer-Reviewed Publication Describing Molecular Characterization of Precise In Vivo Nuclease-Free Gene Editing with PKU Program - GlobeNewswire</td>    <td>Homology Medicines Announces Peer-Reviewed Publication Describing Molecular Characterization of Precise In Vivo Nuclease-Free Gene Editing with PKU Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038883/0/en/Homology-Medicines-Announces-Peer-Reviewed-Publication-Describing-Molecular-Characterization-of-Precise-In-Vivo-Nuclease-Free-Gene-Editing-with-PKU-Program.html">Link</a></td>  </tr></table><h3>310. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HOOK">HOOKIPA Pharma</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 11:12:03 GMT</td>    <td>HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update - GlobeNewswire</td>    <td>HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033394/0/en/HOOKIPA-Pharma-Reports-First-Quarter-2020-Financial-Results-and-Provides-a-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 11:33:46 GMT</td>    <td>HOOKIPA Pharma to Present at Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>HOOKIPA Pharma to Present at Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038533/0/en/HOOKIPA-Pharma-to-Present-at-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>HOOKIPA Pharma Inc (HOOK) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance</td>    <td>HOOKIPA Pharma Inc (HOOK) Reports Q1 Loss, Misses Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hookipa-pharma-inc-hook-reports-121512068.html">Link</a></td>  </tr></table><h3>311. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HZNP">Horizon Pharma plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 21:16:08 GMT</td>    <td>May 07, 2020 - Horizon Therapeutics Plc (HZNP) EVP, CFO Paul W. Hoelscher Sold $4 million of Shares - GuruFocus.com</td>    <td>May 07, 2020 - Horizon Therapeutics Plc (HZNP) EVP, CFO Paul W. Hoelscher Sold $4 million of Shares  GuruFocus.com</td>    <td><a target="_blank" href="https://www.gurufocus.com/news/1129899/horizon-therapeutics-plc-hznp-evp-cfo-paul-w-hoelscher-sold-4-million-of-shares">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 21:19:42 GMT</td>    <td>May 12, 2020 - Horizon Therapeutics Plc (HZNP) EVP and Chief Medical Officer Jeffrey W Sherman Sold $1.5 million of Shares - GuruFocus.com</td>    <td>May 12, 2020 - Horizon Therapeutics Plc (HZNP) EVP and Chief Medical Officer Jeffrey W Sherman Sold $1.5 million of Shares  GuruFocus.com</td>    <td><a target="_blank" href="https://www.gurufocus.com/news/1134434/horizon-therapeutics-plc-hznp-evp-and-chief-medical-officer-jeffrey-w-sherman-sold-15-million-of-shares">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 06:01:11 GMT</td>    <td>Osteoarthritis Drugs Market: Anti-Nerve Growth Therapy Promises a New Avenue for Growth - BioSpace</td>    <td>Osteoarthritis Drugs Market: Anti-Nerve Growth Therapy Promises a New Avenue for Growth  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/osteoarthritis-drugs-market-anti-nerve-growth-therapy-promises-a-new-avenue-for-growth/">Link</a></td>  </tr></table><h3>312. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HOTH">Hoth Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:00:00 GMT</td>    <td>Hoth Therapeutics Provides Shareholder Update on Therapeutics Pipeline - PRNewswire</td>    <td>Hoth Therapeutics Provides Shareholder Update on Therapeutics Pipeline  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/hoth-therapeutics-provides-shareholder-update-on-therapeutics-pipeline-301069716.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:49:00 GMT</td>    <td>BRIEF-Hoth Therapeutics Preparing To Begin Biolexa Platform First Trial In Humans Later This Year - Reuters</td>    <td>BRIEF-Hoth Therapeutics Preparing To Begin Biolexa Platform First Trial In Humans Later This Year  Reuters</td>    <td><a target="_blank" href="https://uk.reuters.com/article/brief-hoth-therapeutics-preparing-to-beg/brief-hoth-therapeutics-preparing-to-begin-biolexa-platform-first-trial-in-humans-later-this-year-idUKFWN2DG09H">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 17:50:00 GMT</td>    <td>Hoth Therapeutics Announces Closing of Public Offering of Common Stock - PRNewswire</td>    <td>Hoth Therapeutics Announces Closing of Public Offering of Common Stock  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-closing-of-public-offering-of-common-stock-301066324.html">Link</a></td>  </tr></table><h3>313. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HTGM">HTG Molecular Diagnostics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:15:19 GMT</td>    <td>HTG EdgeSeq Technology Highlighted in Several Posters at ASCO - GlobeNewswire</td>    <td>HTG EdgeSeq Technology Highlighted in Several Posters at ASCO  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042177/0/en/HTG-EdgeSeq-Technology-Highlighted-in-Several-Posters-at-ASCO.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 20:26:42 GMT</td>    <td>HTG Molecular Diagnostics Reports First Quarter 2020 Results - GlobeNewswire</td>    <td>HTG Molecular Diagnostics Reports First Quarter 2020 Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032985/0/en/HTG-Molecular-Diagnostics-Reports-First-Quarter-2020-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>HTG Molecular Diagnostics Inc (HTGM) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance</td>    <td>HTG Molecular Diagnostics Inc (HTGM) Reports Q1 Loss, Misses Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/htg-molecular-diagnostics-inc-htgm-212509637.html">Link</a></td>  </tr></table><h3>314. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-HCM">Hutchison China MediTech Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 06:08:58 GMT</td>    <td>Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab - GlobeNewswire</td>    <td>Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038329/0/en/Chi-Med-and-BeiGene-Enter-into-Clinical-Collaboration-to-Evaluate-Combinations-of-Surufatinib-and-Fruquintinib-with-Tislelizumab.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Chi-Med Highlights Clinical Data to be Presented at the Upcoming ASCO20 Virtual Scientific Program - GlobeNewswire</td>    <td>Chi-Med Highlights Clinical Data to be Presented at the Upcoming ASCO20 Virtual Scientific Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033215/0/en/Chi-Med-Highlights-Clinical-Data-to-be-Presented-at-the-Upcoming-ASCO20-Virtual-Scientific-Program.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 06:20:40 GMT</td>    <td>Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA - GlobeNewswire</td>    <td>Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041263/0/en/Chi-Med-Plans-to-Submit-NDA-for-Surufatinib-Following-Pre-NDA-Meeting-with-the-U-S-FDA.html">Link</a></td>  </tr></table><h3>315. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ICLR">ICON plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 10:00:00 GMT</td>    <td>ICON plc to Present at Jefferies Virtual Healthcare Conference - Business Wire</td>    <td>ICON plc to Present at Jefferies Virtual Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200527005387/en/ICON-plc-Present-Jefferies-Virtual-Healthcare-Conference">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 14:57:26 GMT</td>    <td>Company of the Month April 2020: ICON plc’s Q1 figures indicate strong growth - Business & Finance</td>    <td>Company of the Month April 2020: ICON plc’s Q1 figures indicate strong growth  Business & Finance</td>    <td><a target="_blank" href="https://businessandfinance.com/company-of-the-month-april-2020-icon-plcs-q1-figures-indicate-strong-growth/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:50:00 GMT</td>    <td>Contract Research Organization (CROs) Services Market 2020 Will Experience An Impressive Growth | Leading... - Azizsalon News</td>    <td>Contract Research Organization (CROs) Services Market 2020 Will Experience An Impressive Growth | Leading...  Azizsalon News</td>    <td><a target="_blank" href="https://azizsalon.com/contract-research-organization-cros-services-market-2020-will-experience-an-impressive-growth-leading-players-icon-plc-laboratory-corporation-of-america-holdings-covance-inc-parexel-interna/">Link</a></td>  </tr></table><h3>316. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IDYA">IDEAYA Biosciences</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>IDEAYA Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update - PRNewswire</td>    <td>IDEAYA Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/ideaya-biosciences-inc-reports-first-quarter-2020-financial-results-and-provides-business-update-301057256.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>IDEAYA Biosciences Announces AACR Abstracts for IDE196 Targeting GNAQ/11 Tumors and Preclinical MAT2A Synthetic Lethality Program - PRNewswire</td>    <td>IDEAYA Biosciences Announces AACR Abstracts for IDE196 Targeting GNAQ/11 Tumors and Preclinical MAT2A Synthetic Lethality Program  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-aacr-abstracts-for-ide196-targeting-gnaq11-tumors-and-preclinical-mat2a-synthetic-lethality-program-301059878.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:39:00 GMT</td>    <td>BRIEF-Ideaya Biosciences Files For Mixed Shelf Of Up To $250 Mln – SEC Filing - Reuters</td>    <td>BRIEF-Ideaya Biosciences Files For Mixed Shelf Of Up To $250 Mln – SEC Filing  Reuters</td>    <td><a target="_blank" href="https://uk.reuters.com/article/brief-ideaya-biosciences-files-for-mixed/brief-ideaya-biosciences-files-for-mixed-shelf-of-up-to-250-mln-sec-filing-idUKFWN2DE0XO">Link</a></td>  </tr></table><h3>317. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IDRA">Idera Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:32:15 GMT</td>    <td>Idera Pharmaceuticals Announces Preliminary Data From and Planned Continuation of the ILLUMINATE-206 Trial for the Treatment of Micro-Satellite Stable Colorectal Cancer - GlobeNewswire</td>    <td>Idera Pharmaceuticals Announces Preliminary Data From and Planned Continuation of the ILLUMINATE-206 Trial for the Treatment of Micro-Satellite Stable Colorectal Cancer  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042214/0/en/Idera-Pharmaceuticals-Announces-Preliminary-Data-From-and-Planned-Continuation-of-the-ILLUMINATE-206-Trial-for-the-Treatment-of-Micro-Satellite-Stable-Colorectal-Cancer.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Idera Pharmaceuticals Inc. (IDRA) Plunges 5.66% on June 03 - Equities.com</td>    <td>Idera Pharmaceuticals Inc. (IDRA) Plunges 5.66% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/idera-pharmaceuticals-inc-idra-plunges-5-66-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 20:00:03 GMT</td>    <td>Idera Pharmaceuticals, Inc. (IDRA): What is good about stock? - Marketing Sentinel</td>    <td>Idera Pharmaceuticals, Inc. (IDRA): What is good about stock?  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/02/idera-pharmaceuticals-inc-idra-what-is-good-about-stock/">Link</a></td>  </tr></table><h3>318. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IDXX">IDEXX Laboratories, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 21:00:00 GMT</td>    <td>IDEXX Laboratories Provides US Companion Animal Market Trends Update - PRNewswire</td>    <td>IDEXX Laboratories Provides US Companion Animal Market Trends Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/idexx-laboratories-provides-us-companion-animal-market-trends-update-301065549.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>IDEXX Laboratories to Present at Stifel Conference - Yahoo Finance</td>    <td>IDEXX Laboratories to Present at Stifel Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/idexx-laboratories-present-stifel-conference-173000498.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 11:29:00 GMT</td>    <td>Veterinary Urinalysis Product Market By Top Keyplayers IDEXX Laboratories, Inc - BіоPhаrmа Dіvе</td>    <td>Veterinary Urinalysis Product Market By Top Keyplayers IDEXX Laboratories, Inc  BіоPhаrmа Dіvе</td>    <td><a target="_blank" href="https://www.biopharmapress.com/veterinary-urinalysis-product-market-by-top-keyplayers-idexx-laboratories-inc/">Link</a></td>  </tr></table><h3>319. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IGMS">IGM Biosciences</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>IGM Biosciences Announces First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>IGM Biosciences Announces First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029852/0/en/IGM-Biosciences-Announces-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Atreca, BeiGene, and IGM Biosciences - Genetic Engineering & Biotechnology News</td>    <td>Atreca, BeiGene, and IGM Biosciences  Genetic Engineering & Biotechnology News</td>    <td><a target="_blank" href="https://www.genengnews.com/covid-19-candidates/covid-19-too-soon-to-tell/atreca-beigene-and-igm-biosciences/">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 11:00:00 GMT</td>    <td>IGM Biosciences to Present at the Jefferies 2020 Healthcare Conference - Yahoo Finance</td>    <td>IGM Biosciences to Present at the Jefferies 2020 Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/igm-biosciences-present-jefferies-2020-110010368.html">Link</a></td>  </tr></table><h3>320. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ILMN">Illumina, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Here's Why You Should Hold on to Illumina (ILMN) Stock for Now - Yahoo Finance</td>    <td>Here's Why You Should Hold on to Illumina (ILMN) Stock for Now  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/heres-why-hold-illumina-ilmn-100310366.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 08:05:00 GMT</td>    <td>Four clues to the quality of Illumina Inc (NSQ:ILMN) - Stockopedia</td>    <td>Four clues to the quality of Illumina Inc (NSQ:ILMN)  Stockopedia</td>    <td><a target="_blank" href="https://www.stockopedia.com/articles/four-clues-to-the-quality-of-illumina-inc-nsqilmn-49958/">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Natera and Illumina Settle Patent Dispute - Yahoo Finance</td>    <td>Natera and Illumina Settle Patent Dispute  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/natera-illumina-settle-patent-dispute-130300588.html">Link</a></td>  </tr></table><h3>321. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IMAB">I-Mab </a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 13:50:00 GMT</td>    <td>I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm - FierceBiotech</td>    <td>I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm  FierceBiotech</td>    <td><a target="_blank" href="https://www.fiercebiotech.com/research/i-mab-advances-repositioned-ra-drug-early-trial-to-treat-covid-19-cytokine-storm">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors - PRNewswire</td>    <td>First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/first-patient-dosed-with-i-mabs-cd73-antibody-tjd5-in-phase-12-clinical-trial-in-china-for-advanced-solid-tumors-301058413.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:00:00 GMT</td>    <td>I-Mab Announces Upcoming Participation at June Conferences - Herald-Mail Media</td>    <td>I-Mab Announces Upcoming Participation at June Conferences  Herald-Mail Media</td>    <td><a target="_blank" href="https://www.heraldmailmedia.com/news/state/i-mab-announces-upcoming-participation-at-june-conferences/article_6957ef39-4afd-5f99-85e6-09452b910060.html">Link</a></td>  </tr></table><h3>322. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IMAC">IMAC Holdings, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:00:00 GMT</td>    <td>IMAC Holdings Inc. to Present at the June 2020 Virtual Summer Investor Summit - GlobeNewswire</td>    <td>IMAC Holdings Inc. to Present at the June 2020 Virtual Summer Investor Summit  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042871/0/en/IMAC-Holdings-Inc-to-Present-at-the-June-2020-Virtual-Summer-Investor-Summit.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 20:16:03 GMT</td>    <td>IMAC Holdings Reports First Quarter 2020 Financial Results, Including 19% Growth of Patient Services Revenue Compared to 2019 - GlobeNewswire</td>    <td>IMAC Holdings Reports First Quarter 2020 Financial Results, Including 19% Growth of Patient Services Revenue Compared to 2019  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033862/0/en/IMAC-Holdings-Reports-First-Quarter-2020-Financial-Results-Including-19-Growth-of-Patient-Services-Revenue-Compared-to-2019.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>BRIEF-IMAC Holdings Says Submitted IND With FDA For Proposed Study To Evaluate Umbilical Cord-Derived Stem Cells Use For Treating Bradykinesia - Reuters</td>    <td>BRIEF-IMAC Holdings Says Submitted IND With FDA For Proposed Study To Evaluate Umbilical Cord-Derived Stem Cells Use For Treating Bradykinesia  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-imac-holdings-says-submitted-ind-w/brief-imac-holdings-says-submitted-ind-with-fda-for-proposed-study-to-evaluate-umbilical-cord-derived-stem-cells-use-for-treating-bradykinesia-idUSFWN2CX11C">Link</a></td>  </tr></table><h3>323. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ICCC">ImmuCell Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 16:12:31 GMT</td>    <td>ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020 - GlobeNewswire</td>    <td>ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029696/0/en/ImmuCell-to-Announce-Unaudited-Financial-Results-for-First-Quarter-of-2020.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 12:42:00 GMT</td>    <td>ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders - GlobeNewswire</td>    <td>ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033518/0/en/ImmuCell-to-Hold-Virtual-Only-Annual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 20:26:53 GMT</td>    <td>ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020 - GlobeNewswire</td>    <td>ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032979/0/en/ImmuCell-Announces-Unaudited-Financial-Results-for-the-First-Quarter-Ended-March-31-2020.html">Link</a></td>  </tr></table><h3>324. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IMDZ">Immune Design Corp.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 11:21:06 GMT</td>    <td>Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD - BioSpace</td>    <td>Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/sutro-biopharma-adds-two-exceptional-leaders-to-advisory-boards-carlos-paya-md-phd-and-lainie-martin-md/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 20:46:00 GMT</td>    <td>The Economic Impact of Coronavirus on Metastatic Ovarian Cancer Drug Market Projected to Experience Major Revenue Boost During the Period Between 2019-2026 - Jewish Life News</td>    <td>The Economic Impact of Coronavirus on Metastatic Ovarian Cancer Drug Market Projected to Experience Major Revenue Boost During the Period Between 2019-2026  Jewish Life News</td>    <td><a target="_blank" href="https://jewishlifenews.com/uncategorized/the-economic-impact-of-coronavirus-on-metastatic-ovarian-cancer-drug-market-projected-to-experience-major-revenue-boost-during-the-period-between-2019-2026/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 20:30:49 GMT</td>    <td>Potential Impact of COVID-19 on Ready To Use Toll Like Receptor 4 Market Global Industry Analysis, size, share and Forecast 2019-2022 - Cole of Duty</td>    <td>Potential Impact of COVID-19 on Ready To Use Toll Like Receptor 4 Market Global Industry Analysis, size, share and Forecast 2019-2022  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/military-news/2020/06/02/potential-impact-of-covid-19-on-ready-to-use-toll-like-receptor-4-market-global-industry-analysis-size-share-and-forecast-2019-2022/">Link</a></td>  </tr></table><h3>325. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IMGN">ImmunoGen, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>ImmunoGen Inc. (IMGN) Plunges 7.8% on June 03 - Equities.com</td>    <td>ImmunoGen Inc. (IMGN) Plunges 7.8% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/immunogen-inc-imgn-plunges-7-8-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 12:00:00 GMT</td>    <td>ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire</td>    <td>ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005271/en/ImmunoGen-Announces-Inducement-Grants-Nasdaq-Listing-Rule">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:01:28 GMT</td>    <td>ImmunoGen Announces Virtual 2020 Annual Meeting of Shareholders | Business, Finance & Technology - Kankakee Daily Journal</td>    <td>ImmunoGen Announces Virtual 2020 Annual Meeting of Shareholders | Business, Finance & Technology  Kankakee Daily Journal</td>    <td><a target="_blank" href="https://www.daily-journal.com/business/immunogen-announces-virtual-2020-annual-meeting-of-shareholders/article_d1a2a2d8-0c4a-52d5-b557-7b06a81cffe5.html">Link</a></td>  </tr></table><h3>326. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IMMU">Immunomedics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 22:34:00 GMT</td>    <td>Shareholder Alert: Robbins LLP Announces Shareholder Class Action Against Immunomedics, Inc. (IMMU) Survives Motion to Dismiss - Business Wire</td>    <td>Shareholder Alert: Robbins LLP Announces Shareholder Class Action Against Immunomedics, Inc. (IMMU) Survives Motion to Dismiss  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005977/en/Shareholder-Alert-Robbins-LLP-Announces-Shareholder-Class">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Immunomedics Inc. (IMMU) Plunges 5.77% on June 03 - Equities.com</td>    <td>Immunomedics Inc. (IMMU) Plunges 5.77% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/immunomedics-inc-immu-plunges-5-77-on-june-03">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 20:14:05 GMT</td>    <td>Immunomedics Announces Leadership Change and Provides Business Update Amid COVID-19 - GlobeNewswire</td>    <td>Immunomedics Announces Leadership Change and Provides Business Update Amid COVID-19  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039705/0/en/Immunomedics-Announces-Leadership-Change-and-Provides-Business-Update-Amid-COVID-19.html">Link</a></td>  </tr></table><h3>327. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IMRN">Immuron Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 06:21:00 GMT</td>    <td>Latest Update 2020: Alcoholic Hepatitis Therapeutic Market by COVID19 Impact Analysis And Top Manufacturers: Alkermes, Conatus pharmaceuticals, Dainippon sumitomo pharma, Generon corporation, Immuron limited, etc. | InForGrowth - 3rd Watch News</td>    <td>Latest Update 2020: Alcoholic Hepatitis Therapeutic Market by COVID19 Impact Analysis And Top Manufacturers: Alkermes, Conatus pharmaceuticals, Dainippon sumitomo pharma, Generon corporation, Immuron limited, etc. | InForGrowth  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/market/1145623/latest-update-2020-alcoholic-hepatitis-therapeutic-market-by-covid19-impact-analysis-and-top-manufacturers-alkermes-conatus-pharmaceuticals-dainippon-sumitomo-pharma-generon-corporation-immuron/">Link</a></td>  </tr><tr>    <td>Mon, 03 Feb 2020 08:00:00 GMT</td>    <td>Immuron's Technology Platform of Treatments in the Age of the Coronavirus Outbreak - GlobeNewswire</td>    <td>Immuron's Technology Platform of Treatments in the Age of the Coronavirus Outbreak  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/02/03/1978650/0/en/Immuron-s-Technology-Platform-of-Treatments-in-the-Age-of-the-Coronavirus-Outbreak.html">Link</a></td>  </tr><tr>    <td>Mon, 20 Apr 2020 10:16:15 GMT</td>    <td>Immuron North American Travelan® Sales Up 95%, Global Sales Up 60% - GlobeNewswire</td>    <td>Immuron North American Travelan® Sales Up 95%, Global Sales Up 60%  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/04/20/2018457/0/en/Immuron-North-American-Travelan-Sales-Up-95-Global-Sales-Up-60.html">Link</a></td>  </tr></table><h3>328. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IMMP">Immutep Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 00:18:08 GMT</td>    <td>Immutep Global Webcast to Present New Data from 2020 ASCO Annual Meeting - GlobeNewswire</td>    <td>Immutep Global Webcast to Present New Data from 2020 ASCO Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039032/0/en/Immutep-Global-Webcast-to-Present-New-Data-from-2020-ASCO-Annual-Meeting.html">Link</a></td>  </tr><tr>    <td>Sun, 31 May 2020 23:53:25 GMT</td>    <td>Immutep Announces Improving Data from the Phase II TACTI-002 Study - GlobeNewswire</td>    <td>Immutep Announces Improving Data from the Phase II TACTI-002 Study  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/31/2041240/0/en/Immutep-Announces-Improving-Data-from-the-Phase-II-TACTI-002-Study.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 18:01:00 GMT</td>    <td>How Hedge Funds Traded Immutep Limited (IMMP) During The Crash - Yahoo Finance</td>    <td>How Hedge Funds Traded Immutep Limited (IMMP) During The Crash  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-traded-immutep-limited-180102684.html">Link</a></td>  </tr></table><h3>329. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IMMY">Imprimis Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Harrow Health (HROW) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance</td>    <td>Harrow Health (HROW) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/harrow-health-hrow-reports-q1-225510661.html">Link</a></td>  </tr><tr>    <td>Mon, 31 Dec 2018 08:00:00 GMT</td>    <td>Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc. - GlobeNewswire</td>    <td>Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc.  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2018/12/31/1679147/0/en/Imprimis-Pharmaceuticals-Inc-Completes-Name-Change-to-Harrow-Health-Inc.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 17:20:55 GMT</td>    <td>Pre & Post COVID-19 Impact Analysis on Global Lead Poisoning Treatment Market 2020 | Major Players are Akorn, Incorporated, Amerigen Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd, Mylan NV - Cole of Duty</td>    <td>Pre & Post COVID-19 Impact Analysis on Global Lead Poisoning Treatment Market 2020 | Major Players are Akorn, Incorporated, Amerigen Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd, Mylan NV  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/05/26/pre-post-covid-19-impact-analysis-on-global-lead-poisoning-treatment-market-2020-major-players-are-akorn-incorporated-amerigen-pharmaceuticals-limited-teva-pharmaceutical-industries-ltd-my-3/">Link</a></td>  </tr></table><h3>330. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IMV">IMV Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>IMV Inc. Provides Clinical and Operational Update and Announces First Quarter 2020 Financial Results - Business Wire</td>    <td>IMV Inc. Provides Clinical and Operational Update and Announces First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200515005219/en/IMV-Clinical-Operational-Update-Announces-Quarter-2020">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>IMV Inc. Announces Closing of $25.1 Million Private Placement - Business Wire</td>    <td>IMV Inc. Announces Closing of $25.1 Million Private Placement  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005653/en/IMV-Announces-Closing-25.1-Million-Private-Placement">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:44:00 GMT</td>    <td>Form 6-K IMV Inc. For: Jun 02 - StreetInsider.com</td>    <td>Form 6-K IMV Inc. For: Jun 02  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/SEC+Filings/Form+6-K+IMV+Inc.+For%3A+Jun+02/16966552.html">Link</a></td>  </tr></table><h3>331. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-INCY">Incyte Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 08:00:00 GMT</td>    <td>Here's How One Should Trade Incyte Corporation (INCY) Now - The News Heater</td>    <td>Here's How One Should Trade Incyte Corporation (INCY) Now  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/heres-how-one-should-trade-incyte-corporation-incy-now/">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Incyte (INCY) Misses Q1 Earnings Estimates, Beats on Revenues - Yahoo Finance</td>    <td>Incyte (INCY) Misses Q1 Earnings Estimates, Beats on Revenues  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/incyte-incy-misses-q1-earnings-152403787.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Incyte Corporation (INCY) CEO Hervé Hoppenot on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Incyte Corporation (INCY) CEO Hervé Hoppenot on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4343257-incyte-corporation-incy-ceo-herv-hoppenot-on-q1-2020-results-earnings-call-transcript">Link</a></td>  </tr></table><h3>332. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-INFI">Infinity Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Infinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial Results - BioSpace</td>    <td>Infinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial Results  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/infinity-pharmaceuticals-provides-company-update-and-first-quarter-2020-financial-results/">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance</td>    <td>Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/infinity-pharmaceuticals-infi-reports-q1-125512563.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4346421-infinity-pharmaceuticals-inc-infi-ceo-adelene-perkins-on-q1-2020-results-earnings-call">Link</a></td>  </tr></table><h3>333. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IFRX">InflaRx N.V.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 11:31:24 GMT</td>    <td>InflaRx Reports Q1 2020 Financial & Operating Results - GlobeNewswire</td>    <td>InflaRx Reports Q1 2020 Financial & Operating Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2036942/0/en/InflaRx-Reports-Q1-2020-Financial-Operating-Results.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:12:21 GMT</td>    <td>Stock Alert: InflaRx N.V Continues To Trend Higher - Nasdaq</td>    <td>Stock Alert: InflaRx N.V Continues To Trend Higher  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/stock-alert%3A-inflarx-n.v-continues-to-trend-higher-2020-05-22">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:10:00 GMT</td>    <td>Analysts Turn Mixed On Big 5 Sporting Goods Corporation (NASDAQ:BGFV), InflaRx N.V. (NASDAQ:IFRX) - State Reviewer</td>    <td>Analysts Turn Mixed On Big 5 Sporting Goods Corporation (NASDAQ:BGFV), InflaRx N.V. (NASDAQ:IFRX)  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/analysts-turn-mixed-on-big-5-sporting-goods-corporation-nasdaqbgfv-inflarx-n-v-nasdaqifrx/">Link</a></td>  </tr></table><h3>334. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IPHA">Innate Pharma SA</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sun, 31 May 2020 03:01:30 GMT</td>    <td>Is Innate Pharma S.A. (IPHA) A Good Stock To Buy? - Yahoo Finance</td>    <td>Is Innate Pharma S.A. (IPHA) A Good Stock To Buy?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/innate-pharma-ipha-good-stock-024727954.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Innate Pharma First Quarter 2020 Report Paris Stock Exchange:IPH - GlobeNewswire</td>    <td>Innate Pharma First Quarter 2020 Report Paris Stock Exchange:IPH  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031605/0/en/Innate-Pharma-First-Quarter-2020-Report.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Does Innate Pharma S.A.'s (EPA:IPH) CEO Salary Compare Well With Others? - Yahoo Finance</td>    <td>Does Innate Pharma S.A.'s (EPA:IPH) CEO Salary Compare Well With Others?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/does-innate-pharma-epa-iph-095617453.html">Link</a></td>  </tr></table><h3>335. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-INNT">Innovate Biopharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 04:05:45 GMT</td>    <td>While small businesses waited, publicly-traded NC companies collected PPP loans - WCNC.com</td>    <td>While small businesses waited, publicly-traded NC companies collected PPP loans  WCNC.com</td>    <td><a target="_blank" href="https://www.wcnc.com/article/news/health/coronavirus/while-small-businesses-waited-publicly-traded-nc-companies-collected-ppp-loans/275-5d92269c-2ff9-44ad-9691-9deee405f659">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:01:00 GMT</td>    <td>$NMTR 9 Meters Biopharma Files Prospectus Relates To Resale From Time To Time By Selling Stockholders Of Up To 84.6 Mln Shares Of Common Stock - CML News</td>    <td>$NMTR 9 Meters Biopharma Files Prospectus Relates To Resale From Time To Time By Selling Stockholders Of Up To 84.6 Mln Shares Of Common Stock  CML News</td>    <td><a target="_blank" href="https://www.cmlviz.com/recent-development/2020/06/01/NMTR/9-meters-biopharma-files-prospectus-relates-to-resale-from-time-to-time-by-selling-stockholders-of-up-to-84-6-mln-shares-of-common-stock">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:27:58 GMT</td>    <td>What's driving the Peptide Hormones Market Growth? Prominent Players BioPartners, Boehringer Ingelheim GmbH, Eli Lily and Company, Innovate Biopharmaceuticals - Medic Insider</td>    <td>What's driving the Peptide Hormones Market Growth? Prominent Players BioPartners, Boehringer Ingelheim GmbH, Eli Lily and Company, Innovate Biopharmaceuticals  Medic Insider</td>    <td><a target="_blank" href="https://medicinsider.com/whats-driving-the-peptide-hormones-market-growth-prominent-players-biopartners-boehringer-ingelheim-gmbh-eli-lily-and-company-innovate-biopharmaceuticals/">Link</a></td>  </tr></table><h3>336. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-INVA">Innoviva, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:50:00 GMT</td>    <td>Innoviva (INVA) Gains But Lags Market: What You Should Know - Yahoo Finance</td>    <td>Innoviva (INVA) Gains But Lags Market: What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/innoviva-inva-gains-lags-market-215009177.html">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>Were Hedge Funds Right About Innoviva, Inc. (INVA)? - Yahoo Finance</td>    <td>Were Hedge Funds Right About Innoviva, Inc. (INVA)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/were-hedge-funds-innoviva-inc-191923268.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 20:05:00 GMT</td>    <td>Innoviva Names Pavel Raifeld as Chief Executive Officer - BioSpace</td>    <td>Innoviva Names Pavel Raifeld as Chief Executive Officer  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/innoviva-names-pavel-raifeld-as-chief-executive-officer/">Link</a></td>  </tr></table><h3>337. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-INSM">Insmed, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 19:10:00 GMT</td>    <td>Analysts Turn Mixed On Insmed Incorporated (NASDAQ:INSM), Cleveland-Cliffs Inc. (NYSE:CLF) - State Reviewer</td>    <td>Analysts Turn Mixed On Insmed Incorporated (NASDAQ:INSM), Cleveland-Cliffs Inc. (NYSE:CLF)  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/analysts-turn-mixed-on-insmed-incorporated-nasdaqinsm-cleveland-cliffs-inc-nyseclf/">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 21:09:00 GMT</td>    <td>Insmed Inc. (INSM) Soars 1.95% on May 26 - Equities.com</td>    <td>Insmed Inc. (INSM) Soars 1.95% on May 26  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/insmed-inc-insm-soars-1-95-on-may-26">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Insmed Inc. (INSM) Soars 1.62% on May 22 - Equities.com</td>    <td>Insmed Inc. (INSM) Soars 1.62% on May 22  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/insmed-inc-insm-soars-1-62-on-may-22">Link</a></td>  </tr></table><h3>338. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-INSY">Insys Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 07:09:21 GMT</td>    <td>Medicinal Cannabis Market Size: Opportunities, Current Trends And Industry Analysis by 2028 | Tilray,... - Azizsalon News</td>    <td>Medicinal Cannabis Market Size: Opportunities, Current Trends And Industry Analysis by 2028 | Tilray,...  Azizsalon News</td>    <td><a target="_blank" href="https://azizsalon.com/medicinal-cannabis-market-size-opportunities-current-trends-and-industry-analysis-by-2028-tilray-medreleaf-corporation-aurora-cannabis-inc-canopy-growth-corporation-insys-therapeutics-inc/">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Shareholders Ink Deal With Ex-Insys Exec Over Fraud Claims - Law360</td>    <td>Shareholders Ink Deal With Ex-Insys Exec Over Fraud Claims  Law360</td>    <td><a target="_blank" href="https://www.law360.com/articles/1272029/shareholders-ink-deal-with-ex-insys-exec-over-fraud-claims">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 08:35:00 GMT</td>    <td>Cannabis Pharmaceuticals Market Size Worth $5.8 Billion by 2027: Grand View Research, Inc. - P&T Community</td>    <td>Cannabis Pharmaceuticals Market Size Worth $5.8 Billion by 2027: Grand View Research, Inc.  P&T Community</td>    <td><a target="_blank" href="https://www.ptcommunity.com/wire/cannabis-pharmaceuticals-market-size-worth-58-billion-2027-grand-view-research-inc">Link</a></td>  </tr></table><h3>339. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NTEC">Intec Pharma Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 12:00:00 GMT</td>    <td>Intec Pharma to Present at Jefferies Virtual Healthcare Conference - PRNewswire</td>    <td>Intec Pharma to Present at Jefferies Virtual Healthcare Conference  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/il/news-releases/intec-pharma-to-present-at-jefferies-virtual-healthcare-conference-301066816.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Intec Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update - Yahoo Finance</td>    <td>Intec Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/intec-pharma-reports-first-quarter-201500395.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 14:03:00 GMT</td>    <td>Implied Volatility Surging for Intec Pharma (NTEC) Stock Options - Yahoo Finance</td>    <td>Implied Volatility Surging for Intec Pharma (NTEC) Stock Options  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/implied-volatility-surging-intec-pharma-140302181.html">Link</a></td>  </tr></table><h3>340. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NTLA">Intellia Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 15:46:00 GMT</td>    <td>Here's Why Intellia Therapeutics Gained as Much as 18.0% Today - Motley Fool</td>    <td>Here's Why Intellia Therapeutics Gained as Much as 18.0% Today  Motley FoolRegeneron to expand development deal with Intellia Therapeutics  MarketWatchIntellia Therapeutics Announces Proposed Public Offering of Common Stock  GlobeNewswireRegeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments  PRNewswireRegeneron and Intellia Therapeutics Expand Collaboration  Citybizlist Real EstateView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/06/01/heres-why-intellia-therapeutics-gained-as-much-as.aspx">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 01:17:57 GMT</td>    <td>Intellia Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewswire</td>    <td>Intellia Therapeutics Announces Pricing of Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042633/0/en/Intellia-Therapeutics-Announces-Pricing-of-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 21:13:00 GMT</td>    <td>Intellia Therapeutics Inc. (NTLA) Breaks into New 52-Week High on June 03 Session - Equities.com</td>    <td>Intellia Therapeutics Inc. (NTLA) Breaks into New 52-Week High on June 03 Session  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/intellia-therapeutics-inc-ntla-breaks-into-new-52-week-high-on-june-03-session">Link</a></td>  </tr></table><h3>341. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IPCI">Intellipharmaceutics International Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 21:20:00 GMT</td>    <td>Intellipharmaceutics Announces First Quarter 2020 Results - Yahoo Finance</td>    <td>Intellipharmaceutics Announces First Quarter 2020 Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/intellipharmaceutics-announces-first-quarter-2020-212000920.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 02:44:14 GMT</td>    <td>Life Sciences Court Report & COVID-19 Impact on District Court Filings - JD Supra</td>    <td>Life Sciences Court Report & COVID-19 Impact on District Court Filings  JD Supra</td>    <td><a target="_blank" href="https://www.jdsupra.com/legalnews/life-sciences-court-report-covid-19-39897/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 14:39:25 GMT</td>    <td>COVID-19 Impact on Depression Therapeutics Market Increasing Popularity to Boost Growth By 2026 by Top Key Players Pfizer, Inc., Eli, Lilly and Company, AstraZeneca, Plc, Allergan Plc, GlaxoSmithKline Plc, Intellipharmaceutics International, Inc., Takeda Pharmaceutical Company Limited. - Surfacing Magazine</td>    <td>COVID-19 Impact on Depression Therapeutics Market Increasing Popularity to Boost Growth By 2026 by Top Key Players Pfizer, Inc., Eli, Lilly and Company, AstraZeneca, Plc, Allergan Plc, GlaxoSmithKline Plc, Intellipharmaceutics International, Inc., Takeda Pharmaceutical Company Limited.  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/covid-19-impact-on-depression-therapeutics-market-increasing-popularity-to-boost-growth-by-2026-by-top-key-players-pfizer-inc-eli-lilly-and-company-astrazeneca-plc-allergan-plc-glaxosmithkline/">Link</a></td>  </tr></table><h3>342. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ICPT">Intercept Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Why Intercept Pharmaceuticals Is Plunging Today - Motley Fool</td>    <td>Why Intercept Pharmaceuticals Is Plunging Today  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/22/why-intercept-pharmaceuticals-is-plunging-today.aspx">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 22:29:32 GMT</td>    <td>SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT - GlobeNewswire</td>    <td>SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041829/0/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Intercept-Pharmaceuticals-Inc-ICPT.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Intercept Pharmaceuticals Inc (ICPT) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Intercept Pharmaceuticals Inc (ICPT) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/11/intercept-pharmaceuticals-inc-icpt-q1-2020-earning.aspx">Link</a></td>  </tr></table><h3>343. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ITCI">Intra-Cellular Therapies Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 20:27:16 GMT</td>    <td>Intra-Cellular Therapies to Host Virtual Annual Meeting of Stockholders - GlobeNewswire</td>    <td>Intra-Cellular Therapies to Host Virtual Annual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033000/0/en/Intra-Cellular-Therapies-to-Host-Virtual-Annual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 11:50:22 GMT</td>    <td>Intra-Cellular Therapies Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Intra-Cellular Therapies Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029339/0/en/Intra-Cellular-Therapies-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:50:00 GMT</td>    <td>Why Intra-Cellular Therapies, Inc. (ITCI) Is in Such attractive Condition: Rise 2.68% - The News Heater</td>    <td>Why Intra-Cellular Therapies, Inc. (ITCI) Is in Such attractive Condition: Rise 2.68%  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/why-intra-cellular-therapies-inc-itci-is-in-such-attractive-condition-rise-2-68/">Link</a></td>  </tr></table><h3>344. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XON">Intrexon Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 02 Jan 2020 08:00:00 GMT</td>    <td>Intrexon Begins 2020 With a New CEO and Name Change - BioSpace</td>    <td>Intrexon Begins 2020 With a New CEO and Name Change  BioSpaceIntrexon To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To Precigen To Reflect Healthcare Focus  PRNewswireIs Intrexon Corporation (NASDAQ:XON) Excessively Paying Its CEO?  Yahoo FinanceIntrexon (XON) Appoints Helen Sabzevari, PhD, as New President and CEO, to Change Name, Sell Non-healthcare Assets  StreetInsider.comIntrexon: New CEO, New Name and New Focus To Start the New Year  Equities.comView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.biospace.com/article/intrexon-changes-name-to-precigen-taps-new-ceo/">Link</a></td>  </tr><tr>    <td>Sat, 30 May 2020 11:42:40 GMT</td>    <td>Remarkable Stocks Buzz: M&T; Bank Corporation (NYSE:MTB), American Tower Corp (NYSE:AMT), Intrexon Corp (NYSE:XON) - Stocks Newswire</td>    <td>Remarkable Stocks Buzz: M&T Bank Corporation (NYSE:MTB), American Tower Corp (NYSE:AMT), Intrexon Corp (NYSE:XON)  Stocks Newswire</td>    <td><a target="_blank" href="https://stocksnewswire.com/2020/05/30/remarkable-stocks-buzz-m-bank-corporation-nysemtb-american-tower-corp-nyseamt-intrexon-corp-nysexon/">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 00:36:00 GMT</td>    <td>Agriculture: An Uber Moment For Entrepreneurs - Forbes</td>    <td>Agriculture: An Uber Moment For Entrepreneurs  Forbes</td>    <td><a target="_blank" href="https://www.forbes.com/sites/tomtaulli/2020/05/19/agriculture-an-uber-moment-for-entrepreneurs/">Link</a></td>  </tr></table><h3>345. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IONS">Ionis Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 20:05:00 GMT</td>    <td>Ionis Pharmaceuticals to host 2020 virtual annual meeting of stockholders - PRNewswire</td>    <td>Ionis Pharmaceuticals to host 2020 virtual annual meeting of stockholders  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/ionis-pharmaceuticals-to-host-2020-virtual-annual-meeting-of-stockholders-301067195.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Ionis Pharmaceuticals, Inc. (IONS) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Ionis Pharmaceuticals, Inc. (IONS) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/07/ionis-pharmaceuticals-inc-ions-q1-2020-earnings-ca.aspx">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Ionis Pharmaceuticals: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Ionis Pharmaceuticals: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Ionis-Pharmaceuticals-1Q-Earnings-Snapshot-15250220.php">Link</a></td>  </tr></table><h3>346. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IOVA">Iovance Biotherapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 13:20:00 GMT</td>    <td>Hedge Funds Aren’t Done Buying Iovance Biotherapeutics, Inc. (IOVA) - Yahoo Finance</td>    <td>Hedge Funds Aren’t Done Buying Iovance Biotherapeutics, Inc. (IOVA)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-aren-t-done-132015433.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 17:28:00 GMT</td>    <td>Iovance Biotherapeutics Couples Data Release With Stock Offering - Motley Fool</td>    <td>Iovance Biotherapeutics Couples Data Release With Stock Offering  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/28/iovance-biotherapeutics-couples-data-release-with.aspx">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 21:01:00 GMT</td>    <td>Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma - GlobeNewswire</td>    <td>Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033047/0/en/Iovance-Biotherapeutics-Announces-Clinical-Data-Updates-for-Lifileucel-in-Advanced-Melanoma.html">Link</a></td>  </tr></table><h3>347. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IRIX">IRIDEX Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>IRIDEX Corporation (IRIX) Plunges 11.63% on June 03 - Equities.com</td>    <td>IRIDEX Corporation (IRIX) Plunges 11.63% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/iridex-corporation-irix-plunges-11-63-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>IRIDEX Corporation (IRIX) Soars 34.38% on June 02 - Equities.com</td>    <td>IRIDEX Corporation (IRIX) Soars 34.38% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/iridex-corporation-irix-soars-34-38-on-june-02">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>IRIDEX Announces First Quarter 2020 Financial Results Nasdaq:IRIX - GlobeNewswire</td>    <td>IRIDEX Announces First Quarter 2020 Financial Results Nasdaq:IRIX  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031443/0/en/IRIDEX-Announces-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>348. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-IRWD">Ironwood Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 13:04:00 GMT</td>    <td>Ironwood Pharmaceuticals (IRWD) Looks Good: Stock Adds 7.6% in Session - Nasdaq</td>    <td>Ironwood Pharmaceuticals (IRWD) Looks Good: Stock Adds 7.6% in Session  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/ironwood-pharmaceuticals-irwd-looks-good%3A-stock-adds-7.6-in-session-2020-06-03">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:30:00 GMT</td>    <td>Ironwood Pharmaceuticals Inc. [IRWD] Is Currently 7.56 below its 200 Period Moving Avg: What Dose This Mean? - The DBT News</td>    <td>Ironwood Pharmaceuticals Inc. [IRWD] Is Currently 7.56 below its 200 Period Moving Avg: What Dose This Mean?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/ironwood-pharmaceuticals-inc-irwd-is-currently-7-56-below-its-200-period-moving-avg-what-dose-this-mean/">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Ironwood Pharmaceuticals Reports First Quarter 2020 Results and Provides Update on Impact of COVID-19 Pandemic - Business Wire</td>    <td>Ironwood Pharmaceuticals Reports First Quarter 2020 Results and Provides Update on Impact of COVID-19 Pandemic  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506005986/en/Ironwood-Pharmaceuticals-Reports-Quarter-2020-Results-Update">Link</a></td>  </tr></table><h3>349. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ITRM">Iterum Therapeutics plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 13:51:34 GMT</td>    <td>Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - GlobeNewswire</td>    <td>Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2043025/0/en/Iterum-Therapeutics-Announces-5-Million-Registered-Direct-Offering-Priced-At-the-Market-under-Nasdaq-Rules.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:51:00 GMT</td>    <td>Iterum Therapeutics Plc (ITRM) Announces $5 Million Registered Direct Offering of Ordinary Shares, Warrants - StreetInsider.com</td>    <td>Iterum Therapeutics Plc (ITRM) Announces $5 Million Registered Direct Offering of Ordinary Shares, Warrants  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Iterum+Therapeutics+Plc+%28ITRM%29+Announces+%245+Million+Registered+Direct+Offering+of+Ordinary+Shares%2C+Warrants/16966283.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:48:16 GMT</td>    <td>Iterum Therapeutics Announces Topline Results for a Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection - GlobeNewswire</td>    <td>Iterum Therapeutics Announces Topline Results for a Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041474/0/en/Iterum-Therapeutics-Announces-Topline-Results-for-a-Phase-3-Clinical-Trial-of-Oral-and-IV-Sulopenem-in-Complicated-Urinary-Tract-Infection.html">Link</a></td>  </tr></table><h3>350. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-JAGX">Jaguar Health, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Jaguar Health Reports Voting Results from May 15, 2020 Annual Meeting of Stockholders - Yahoo Finance</td>    <td>Jaguar Health Reports Voting Results from May 15, 2020 Annual Meeting of Stockholders  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/jaguar-health-reports-voting-results-201500851.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Jaguar Health Announces Exercise of Warrants for $4.45 Million Gross Proceeds - Yahoo Finance</td>    <td>Jaguar Health Announces Exercise of Warrants for $4.45 Million Gross Proceeds  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/jaguar-health-announces-exercise-warrants-130000377.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Jaguar Health to Host Investor Call May 15th at 8:30 a.m. Eastern Regarding Q1 2020 Financials & Business Updates - Yahoo Finance</td>    <td>Jaguar Health to Host Investor Call May 15th at 8:30 a.m. Eastern Regarding Q1 2020 Financials & Business Updates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/jaguar-health-host-investor-call-154500258.html">Link</a></td>  </tr></table><h3>351. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-JAZZ">Jazz Pharmaceuticals plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 18:34:25 GMT</td>    <td>Is Jazz Pharmaceuticals PLC (JAZZ) A Winner in the Healthcare Sector? - InvestorsObserver</td>    <td>Is Jazz Pharmaceuticals PLC (JAZZ) A Winner in the Healthcare Sector?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-jazz-pharmaceuticals-plc-jazz-a-winner-in-the-healthcare-sector">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 20:05:00 GMT</td>    <td>Jazz Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences - PRNewswire</td>    <td>Jazz Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-participation-at-two-upcoming-virtual-investor-conferences-301066362.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 17:13:07 GMT</td>    <td>Jazz Pharmaceuticals: Pandemic Leaves The Leading Drug In A Catch 22 - Seeking Alpha</td>    <td>Jazz Pharmaceuticals: Pandemic Leaves The Leading Drug In A Catch 22  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4351312-jazz-pharmaceuticals-pandemic-leaves-leading-drug-in-catch-22">Link</a></td>  </tr></table><h3>352. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-JNCE">Jounce Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:16:53 GMT</td>    <td>Jounce Therapeutics to Hold Virtual Meeting of Stockholders - GlobeNewswire</td>    <td>Jounce Therapeutics to Hold Virtual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042156/0/en/Jounce-Therapeutics-to-Hold-Virtual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 10:45:27 GMT</td>    <td>Jounce Therapeutics Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Jounce Therapeutics Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028250/0/en/Jounce-Therapeutics-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Jounce Therapeutics, Inc. (JNCE) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Jounce Therapeutics, Inc. (JNCE) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/06/jounce-therapeutics-inc-jnce-q1-2020-earnings-call.aspx">Link</a></td>  </tr></table><h3>353. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KALA">Kala Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Kala Pharmaceuticals to Present at BofA Securities 2020 Health Care Conference - Business Wire</td>    <td>Kala Pharmaceuticals to Present at BofA Securities 2020 Health Care Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506005011/en/Kala-Pharmaceuticals-Present-BofA-Securities-2020-Health">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 22:10:00 GMT</td>    <td>Should You Buy Kala Pharmaceuticals Inc. (NASDAQ:KALA) Right Now? Here’s How to Decide - State Reviewer</td>    <td>Should You Buy Kala Pharmaceuticals Inc. (NASDAQ:KALA) Right Now? Here’s How to Decide  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/should-you-buy-kala-pharmaceuticals-inc-nasdaqkala-right-now-heres-how-to-decide/">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:00:00 GMT</td>    <td>Kala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye Disease - Business Wire</td>    <td>Kala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye Disease  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200526005191/en/Kala-Pharmaceuticals-Announces-FDA-Acceptance-New-Drug">Link</a></td>  </tr></table><h3>354. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KLDO">Kaleido Biosciences</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 01:47:57 GMT</td>    <td>Kaleido Biosciences Announces Pricing of Public Offering of Common Stock - GlobeNewswire</td>    <td>Kaleido Biosciences Announces Pricing of Public Offering of Common Stock  GlobeNewswireKaleido Biosciences readies equity offering  Seeking Alpha$KLDO Kaleido Biosciences Intends To Sell $30 Mln Of Common Shares In Offering  CML NewsView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2041866/0/en/Kaleido-Biosciences-Announces-Pricing-of-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 20:30:19 GMT</td>    <td>Kaleido Biosciences Announces Proposed Public Offering of Common Stock - GlobeNewswire</td>    <td>Kaleido Biosciences Announces Proposed Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041764/0/en/Kaleido-Biosciences-Announces-Proposed-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 18:30:23 GMT</td>    <td>Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Kaleido Biosciences Shares Plunge - Benzinga</td>    <td>Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Kaleido Biosciences Shares Plunge  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/news/earnings/20/06/16162742/mid-afternoon-market-update-crude-oil-rises-over-3-kaleido-biosciences-shares-plunge">Link</a></td>  </tr></table><h3>355. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KALV">KalVista Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 11:30:00 GMT</td>    <td>KalVista Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference - Business Wire</td>    <td>KalVista Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200528005106/en/KalVista-Pharmaceuticals-Present-Jefferies-Virtual-Healthcare-Conference">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 14:02:11 GMT</td>    <td>Should You Worry About KalVista Pharmaceuticals, Inc.’s (NASDAQ:KALV) CEO Salary Level? - Simply Wall St</td>    <td>Should You Worry About KalVista Pharmaceuticals, Inc.’s (NASDAQ:KALV) CEO Salary Level?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kalv/kalvista-pharmaceuticals/news/should-you-worry-about-kalvista-pharmaceuticals-inc-s-nasdaqkalv-ceo-salary-level/">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>82 Biggest Movers From Yesterday - Benzinga</td>    <td>82 Biggest Movers From Yesterday  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/news/20/05/16061963/82-biggest-movers-from-yesterday">Link</a></td>  </tr></table><h3>356. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KMDA">Kamada Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 11:07:51 GMT</td>    <td>Kamada to Announce First Quarter Ended March 31, 2020 Financial Results and Host Conference Call on May 18, 2020 - GlobeNewswire</td>    <td>Kamada to Announce First Quarter Ended March 31, 2020 Financial Results and Host Conference Call on May 18, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030940/0/en/Kamada-to-Announce-First-Quarter-Ended-March-31-2020-Financial-Results-and-Host-Conference-Call-on-May-18-2020.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Kamada Ltd (KMDA) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Kamada Ltd (KMDA) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/18/kamada-ltd-kmda-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 11:14:16 GMT</td>    <td>Kamada Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Progress - GlobeNewswire</td>    <td>Kamada Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Progress  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2034845/0/en/Kamada-Reports-First-Quarter-2020-Financial-Results-and-Highlights-Recent-Corporate-Progress.html">Link</a></td>  </tr></table><h3>357. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KRTX">Karuna Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 10:30:00 GMT</td>    <td>Karuna Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference - Business Wire</td>    <td>Karuna Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200603005124/en/Karuna-Therapeutics-Present-Goldman-Sachs-41st-Annual">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Karuna Therapeutics Reports First Quarter 2020 Financial Results and Provides General Business Update - Business Wire</td>    <td>Karuna Therapeutics Reports First Quarter 2020 Financial Results and Provides General Business Update  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005191/en/Karuna-Therapeutics-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 10:30:00 GMT</td>    <td>Karuna Therapeutics to Present Additional Data from the Phase 2 Clinical Trial of KarXT for the Treatment of Psychosis in Patients with Schizophrenia at the American Society of Clinical Psychopharmacology 2020 Annual Meeting - Business Wire</td>    <td>Karuna Therapeutics to Present Additional Data from the Phase 2 Clinical Trial of KarXT for the Treatment of Psychosis in Patients with Schizophrenia at the American Society of Clinical Psychopharmacology 2020 Annual Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200527005178/en/Karuna-Therapeutics-Present-Additional-Data-Phase-2">Link</a></td>  </tr></table><h3>358. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KPTI">Karyopharm Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 20:06:41 GMT</td>    <td>Karyopharm to Participate at Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>Karyopharm to Participate at Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038918/0/en/Karyopharm-to-Participate-at-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:28:00 GMT</td>    <td>Are Options Traders Betting on a Big Move in Karyopharm Therapeutics (KPTI) Stock? - Nasdaq</td>    <td>Are Options Traders Betting on a Big Move in Karyopharm Therapeutics (KPTI) Stock?  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-karyopharm-therapeutics-kpti-stock-2020-06-03">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Things Look Grim For Karyopharm Therapeutics Inc. (NASDAQ:KPTI) After Today's Downgrade - Yahoo Finance</td>    <td>Things Look Grim For Karyopharm Therapeutics Inc. (NASDAQ:KPTI) After Today's Downgrade  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/things-look-grim-karyopharm-therapeutics-120715401.html">Link</a></td>  </tr></table><h3>359. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KMPH">KemPharm, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 May 2020 11:37:28 GMT</td>    <td>KemPharm Receives Day-74 Letter for KP415 NDA - GlobeNewswire</td>    <td>KemPharm Receives Day-74 Letter for KP415 NDA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/19/2035553/0/en/KemPharm-Receives-Day-74-Letter-for-KP415-NDA.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 20:07:49 GMT</td>    <td>KemPharm Reports First Quarter 2020 Financial Results Nasdaq:KMPH - GlobeNewswire</td>    <td>KemPharm Reports First Quarter 2020 Financial Results Nasdaq:KMPH  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032254/0/en/KemPharm-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:22:02 GMT</td>    <td>KemPharm to Report First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>KemPharm to Report First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028865/0/en/KemPharm-to-Report-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>360. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KROS">Keros Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 11:21:50 GMT</td>    <td>Keros Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Keros Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/22/2037506/0/en/Keros-Therapeutics-Reports-Recent-Business-Highlights-and-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 11:08:43 GMT</td>    <td>Keros Therapeutics To Present At The Jefferies 2020 Virtual Healthcare Conference - GlobeNewswire</td>    <td>Keros Therapeutics To Present At The Jefferies 2020 Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040093/0/en/Keros-Therapeutics-To-Present-At-The-Jefferies-2020-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 11:18:00 GMT</td>    <td>BRIEF-Keros Therapeutics Reports Qtrly Loss Per Share Of $5.11 - Reuters</td>    <td>BRIEF-Keros Therapeutics Reports Qtrly Loss Per Share Of $5.11  Reuters</td>    <td><a target="_blank" href="https://uk.reuters.com/article/brief-keros-therapeutics-reports-qtrly-l/brief-keros-therapeutics-reports-qtrly-loss-per-share-of-511-idUKASA00RBE">Link</a></td>  </tr></table><h3>361. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KZR">Kezar Life Sciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:07:52 GMT</td>    <td>Kezar Provides Data Update from MISSION Study of KZR-616 - GlobeNewswire</td>    <td>Kezar Provides Data Update from MISSION Study of KZR-616  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2043242/0/en/Kezar-Provides-Data-Update-from-MISSION-Study-of-KZR-616.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire</td>    <td>Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029820/0/en/Kezar-Life-Sciences-Reports-First-Quarter-2020-Financial-Results-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 23:25:53 GMT</td>    <td>Stocks Making Big Moves After Hours: Kezar Life Sciences, Smartsheet, Cloudera, Zuora - Nasdaq</td>    <td>Stocks Making Big Moves After Hours: Kezar Life Sciences, Smartsheet, Cloudera, Zuora  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/stocks-making-big-moves-after-hours%3A-kezar-life-sciences-smartsheet-cloudera-zuora-2020-06">Link</a></td>  </tr></table><h3>362. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KIN">Kindred Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 14:14:08 GMT</td>    <td>Our Take On Kindred Biosciences, Inc.’s (NASDAQ:KIN) CEO Salary - Simply Wall St</td>    <td>Our Take On Kindred Biosciences, Inc.’s (NASDAQ:KIN) CEO Salary  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kin/kindred-biosciences/news/our-take-on-kindred-biosciences-inc-s-nasdaqkin-ceo-salary/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Kindred Biosciences Announces First Quarter 2020 Financial Results - PRNewswire</td>    <td>Kindred Biosciences Announces First Quarter 2020 Financial Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/kindred-biosciences-announces-first-quarter-2020-financial-results-301055077.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart - Yahoo Finance</td>    <td>Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/kindred-biosciences-announces-covid-19-115800972.html">Link</a></td>  </tr></table><h3>363. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KNSA">Kiniksa Pharmaceuticals, Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 20:05:25 GMT</td>    <td>Kiniksa Pharmaceuticals, Ltd. Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewswire</td>    <td>Kiniksa Pharmaceuticals, Ltd. Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2035233/0/en/Kiniksa-Pharmaceuticals-Ltd-Announces-Closing-of-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 21:26:01 GMT</td>    <td>Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering - GlobeNewswire</td>    <td>Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033063/0/en/Kiniksa-Pharmaceuticals-Ltd-Announces-Proposed-Public-Offering.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>How Kiniksa Pharmaceuticals (KNSA) Stock Stands Out in a Strong Industry - Yahoo Finance</td>    <td>How Kiniksa Pharmaceuticals (KNSA) Stock Stands Out in a Strong Industry  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/kiniksa-pharmaceuticals-knsa-stock-stands-125612639.html">Link</a></td>  </tr></table><h3>364. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KTOV">Kitov Pharma Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 11:40:58 GMT</td>    <td>Kitov Announces US Commercial Launch of Consensi™ Tel Aviv Stock Exchange:KTOV.TA - GlobeNewswire</td>    <td>Kitov Announces US Commercial Launch of Consensi™ Tel Aviv Stock Exchange:KTOV.TA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036300/0/en/Kitov-Announces-U-S-Commercial-Launch-of-Consensi.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 20:04:25 GMT</td>    <td>Kitov Closes $10 Million Registered Direct Offering Tel Aviv Stock Exchange:KTOV.TA - GlobeNewswire</td>    <td>Kitov Closes $10 Million Registered Direct Offering Tel Aviv Stock Exchange:KTOV.TA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030545/0/en/Kitov-Closes-10-Million-Registered-Direct-Offering.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 12:28:29 GMT</td>    <td>Kitov Announces $10 million Registered Direct Offering Tel Aviv Stock Exchange:KTOV.TA - GlobeNewswire</td>    <td>Kitov Announces $10 million Registered Direct Offering Tel Aviv Stock Exchange:KTOV.TA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028385/0/en/Kitov-Announces-10-million-Registered-Direct-Offering.html">Link</a></td>  </tr></table><h3>365. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KOD">Kodiak Sciences Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference - PRNewswire</td>    <td>Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-the-bank-of-america-merrill-lynch-health-care-conference-301056969.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Kodiak Sciences Announces First Quarter 2020 Financial Results and Recent Business Highlights - PRNewswire</td>    <td>Kodiak Sciences Announces First Quarter 2020 Financial Results and Recent Business Highlights  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/kodiak-sciences-announces-first-quarter-2020-financial-results-and-recent-business-highlights-301056387.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 12:22:00 GMT</td>    <td>Kodiak Sciences to Present at Upcoming Conferences - PRNewswire</td>    <td>Kodiak Sciences to Present at Upcoming Conferences  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-upcoming-conferences-301066790.html">Link</a></td>  </tr></table><h3>366. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KRYS">Krystal Biotech, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Krystal Biotech Announces Proposed Public Offering of Common Stock - BioSpace</td>    <td>Krystal Biotech Announces Proposed Public Offering of Common Stock  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/krystal-biotech-announces-proposed-public-offering-of-common-stock/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 12:06:38 GMT</td>    <td>Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial of KB105 in Patients with TGM1-related Autosomal Recessive Congenital Ichthyosis (ARCI) - GlobeNewswire</td>    <td>Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial of KB105 in Patients with TGM1-related Autosomal Recessive Congenital Ichthyosis (ARCI)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033459/0/en/Krystal-Biotech-Announces-Positive-Interim-Results-from-Phase-1-2-Clinical-Trial-of-KB105-in-Patients-with-TGM1-related-Autosomal-Recessive-Congenital-Ichthyosis-ARCI.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>BRIEF-Krystal Biotech Says Phase 2 Study In 4-6 Pediatric Patients Anticipated To Start In H2 2020 - Reuters</td>    <td>BRIEF-Krystal Biotech Says Phase 2 Study In 4-6 Pediatric Patients Anticipated To Start In H2 2020  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-krystal-biotech-says-phase-2-study/brief-krystal-biotech-says-phase-2-study-in-4-6-pediatric-patients-anticipated-to-start-in-h2-2020-idUSASA00Q80">Link</a></td>  </tr></table><h3>367. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-KURA">Kura Oncology, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Kura Oncology Announces Commencement of Public Offering of Common Stock - GlobeNewswire</td>    <td>Kura Oncology Announces Commencement of Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027873/0/en/Kura-Oncology-Announces-Commencement-of-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 16:47:50 GMT</td>    <td>Kura Oncology, Inc. (KURA) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Kura Oncology, Inc. (KURA) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/05/kura-oncology-inc-kura-q1-2020-earnings-call-trans.aspx">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 13:25:37 GMT</td>    <td>Kura Oncology Announces Pricing of $125 Million Public Offering of Common Stock - GlobeNewswire</td>    <td>Kura Oncology Announces Pricing of $125 Million Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028474/0/en/Kura-Oncology-Announces-Pricing-of-125-Million-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr></table><h3>368. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LJPC">La Jolla Pharmaceutical Company</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>La Jolla Pharmaceutical Company (LJPC) Soars 9.01% on June 02 - Equities.com</td>    <td>La Jolla Pharmaceutical Company (LJPC) Soars 9.01% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/la-jolla-pharmaceutical-company-ljpc-soars-9-01-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:07:02 GMT</td>    <td>La Jolla Pharmaceutical Company (LJPC) EPS growth this year is 45.20%: Get Prepared for Trading Lift Off - News Daemon</td>    <td>La Jolla Pharmaceutical Company (LJPC) EPS growth this year is 45.20%: Get Prepared for Trading Lift Off  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/03/la-jolla-pharmaceutical-company-ljpc-eps-growth-this-year-is-45-20-get-prepared-for-trading-lift-off/">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>La Jolla Pharmaceutical Company (NASDAQ:LJPC) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Yahoo Finance</td>    <td>La Jolla Pharmaceutical Company (NASDAQ:LJPC) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/la-jolla-pharmaceutical-company-nasdaq-124132553.html">Link</a></td>  </tr></table><h3>369. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LNTH">Lantheus Holdings, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference - Yahoo Finance</td>    <td>Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/lantheus-holdings-present-jefferies-virtual-203000785.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 18:40:00 GMT</td>    <td>Analysts Have Mixed Ratings On OneMain Holdings Inc. (NYSE:OMF), Lantheus Holdings Inc. (NASDAQ:LNTH) - State Reviewer</td>    <td>Analysts Have Mixed Ratings On OneMain Holdings Inc. (NYSE:OMF), Lantheus Holdings Inc. (NASDAQ:LNTH)  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/05/28/analysts-have-mixed-ratings-on-onemain-holdings-inc-nyseomf-lantheus-holdings-inc-nasdaqlnth/">Link</a></td>  </tr><tr>    <td>Mon, 06 Apr 2020 07:00:00 GMT</td>    <td>Lantheus Holdings, Inc. to Hold 2020 Annual Meeting of Stockholders Virtually - Business Wire</td>    <td>Lantheus Holdings, Inc. to Hold 2020 Annual Meeting of Stockholders Virtually  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200406005219/en/Lantheus-Holdings-Hold-2020-Annual-Meeting-Stockholders">Link</a></td>  </tr></table><h3>370. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LPTX">LEAP THERAPEUTICS, INC.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:00:00 GMT</td>    <td>Leap Therapeutics Inc. [LPTX] Stock trading around $2.84 per share: What’s Next? - The DBT News</td>    <td>Leap Therapeutics Inc. [LPTX] Stock trading around $2.84 per share: What’s Next?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/leap-therapeutics-inc-lptx-stock-trading-around-2-84-per-share-whats-next/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Leap Therapeutics Reports First Quarter 2020 Financial Results - BioSpace</td>    <td>Leap Therapeutics Reports First Quarter 2020 Financial Results  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/leap-therapeutics-reports-first-quarter-2020-financial-results/">Link</a></td>  </tr><tr>    <td>Sat, 16 May 2020 07:00:00 GMT</td>    <td>Analyst Estimates: Here's What Brokers Think Of Leap Therapeutics, Inc. (NASDAQ:LPTX) After Its First-Quarter Report - Yahoo Finance</td>    <td>Analyst Estimates: Here's What Brokers Think Of Leap Therapeutics, Inc. (NASDAQ:LPTX) After Its First-Quarter Report  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analyst-estimates-heres-brokers-think-142311226.html">Link</a></td>  </tr></table><h3>371. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LXRX">Lexicon Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 14:00:05 GMT</td>    <td>Here is a bargain stock you should look at : Lexicon Pharmaceuticals, Inc. (LXRX) - Marketing Sentinel</td>    <td>Here is a bargain stock you should look at : Lexicon Pharmaceuticals, Inc. (LXRX)  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/02/here-is-a-bargain-stock-you-should-look-at-lexicon-pharmaceuticals-inc-lxrx/">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 21:44:30 GMT</td>    <td>Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl's Antiproliferative Effects Against Various Cancer Cell Lines - GlobeNewswire</td>    <td>Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl's Antiproliferative Effects Against Various Cancer Cell Lines  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2033081/0/en/Lexicon-Pharmaceuticals-Announces-Preclinical-Efficacy-Data-on-Telotristat-Ethyl-s-Antiproliferative-Effects-Against-Various-Cancer-Cell-Lines.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 11:05:50 GMT</td>    <td>Lexicon Pharmaceuticals to Present at Upcoming Investor Conference - GlobeNewswire</td>    <td>Lexicon Pharmaceuticals to Present at Upcoming Investor Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039229/0/en/Lexicon-Pharmaceuticals-to-Present-at-Upcoming-Investor-Conference.html">Link</a></td>  </tr></table><h3>372. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LFVN">Lifevantage Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Lifevantage Corporation (LFVN) Soars 1.66% on June 03 - Equities.com</td>    <td>Lifevantage Corporation (LFVN) Soars 1.66% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/lifevantage-corporation-lfvn-soars-1-66-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 20:16:19 GMT</td>    <td>LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2020 - GlobeNewswire</td>    <td>LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027906/0/en/LifeVantage-Announces-Financial-Results-for-the-Third-Quarter-of-Fiscal-2020.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 15:47:04 GMT</td>    <td>Lifevantage Corp (LFVN) Q3 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Lifevantage Corp (LFVN) Q3 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/06/lifevantage-corp-lfvn-q3-2020-earnings-call-transc.aspx">Link</a></td>  </tr></table><h3>373. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LGND">Ligand Pharmaceuticals Incorporated</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 21:10:21 GMT</td>    <td>Ligand Pharmaceuticals Incorporated : CEO Issues Letter to Captisol Customers - Marketscreener.com</td>    <td>Ligand Pharmaceuticals Incorporated : CEO Issues Letter to Captisol Customers  Marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/LIGAND-PHARMACEUTICALS-IN-17306/news/Ligand-Pharmaceuticals-Incorporated-CEO-Issues-Letter-to-Captisol-Customers-30706414/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Ligand Pharmaceuticals Incorporated (LGND) Soars 8.34% on June 02 - Equities.com</td>    <td>Ligand Pharmaceuticals Incorporated (LGND) Soars 8.34% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/ligand-pharmaceuticals-incorporated-lgnd-soars-8-34-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:30:00 GMT</td>    <td>Ride Out The Next Market Storm With Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Colony Credit Real Estate Inc. (NYSE:CLNC) - State Reviewer</td>    <td>Ride Out The Next Market Storm With Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Colony Credit Real Estate Inc. (NYSE:CLNC)  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/ride-out-the-next-market-storm-with-ligand-pharmaceuticals-incorporated-nasdaqlgnd-colony-credit-real-estate-inc-nyseclnc/">Link</a></td>  </tr></table><h3>374. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LPCN">Lipocine Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Lipocine Announces Presentations on TLANDO™ at AUA Virtual Experience 2020 - PRNewswire</td>    <td>Lipocine Announces Presentations on TLANDO™ at AUA Virtual Experience 2020  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/lipocine-announces-presentations-on-tlando-at-aua-virtual-experience-2020-301059647.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:10:00 GMT</td>    <td>What Lipocine Inc. (LPCN) Doesn’t Want You to Know - The News Heater</td>    <td>What Lipocine Inc. (LPCN) Doesn’t Want You to Know  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/what-lipocine-inc-lpcn-doesnt-want-you-to-know/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Lipocine Announces First Quarter 2020 Financial and Operational Results - PRNewswire</td>    <td>Lipocine Announces First Quarter 2020 Financial and Operational Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/lipocine-announces-first-quarter-2020-financial-and-operational-results-301054618.html">Link</a></td>  </tr></table><h3>375. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LQDA">Liquidia Technologies, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031393/0/en/Liquidia-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 22:43:20 GMT</td>    <td>Liquidia to Report First Quarter 2020 Financial Results and Provide Corporate Update on May 11, 2020 - GlobeNewswire</td>    <td>Liquidia to Report First Quarter 2020 Financial Results and Provide Corporate Update on May 11, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028981/0/en/Liquidia-to-Report-First-Quarter-2020-Financial-Results-and-Provide-Corporate-Update-on-May-11-2020.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Why Liquidia Technologies (LQDA) Stock Might be a Great Pick? - Yahoo Finance</td>    <td>Why Liquidia Technologies (LQDA) Stock Might be a Great Pick?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-liquidia-technologies-lqda-stock-140102848.html">Link</a></td>  </tr></table><h3>376. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LIVN">LivaNova PLC</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 13:01:25 GMT</td>    <td>LivaNova to Present at the Jefferies Virtual Healthcare Conference - Valdosta Daily Times</td>    <td>LivaNova to Present at the Jefferies Virtual Healthcare Conference  Valdosta Daily Times</td>    <td><a target="_blank" href="https://www.valdostadailytimes.com/news/business/livanova-to-present-at-the-jefferies-virtual-healthcare-conference/article_03b49733-ab6e-58f4-8ada-8c9b46660914.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 19:50:57 GMT</td>    <td>Wearable Heart Monitoring Devices Market : LivaNova PLC, Abbott, Medtronic, Integra Lifesciences Holdings Corporation, Stryker – Medic Reports - Medic Insider</td>    <td>Wearable Heart Monitoring Devices Market : LivaNova PLC, Abbott, Medtronic, Integra Lifesciences Holdings Corporation, Stryker – Medic Reports  Medic Insider</td>    <td><a target="_blank" href="https://medicinsider.com/wearable-heart-monitoring-devices-market-livanova-plc-abbott-medtronic-integra-lifesciences-holdings-corporation-stryker/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 04:42:51 GMT</td>    <td>Cardiopulmonary Bypass Equipment Market Global Outlook, Research, Trends and Forecast to 2028 | Medtronic... - Azizsalon News</td>    <td>Cardiopulmonary Bypass Equipment Market Global Outlook, Research, Trends and Forecast to 2028 | Medtronic...  Azizsalon News</td>    <td><a target="_blank" href="https://azizsalon.com/cardiopulmonary-bypass-equipment-market-global-outlook-research-trends-and-forecast-to-2028-medtronic-plc-livanova-plc-maquet-holding-b-v-co-kg-terumo-corporation-braile-biomedica-ti/">Link</a></td>  </tr></table><h3>377. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LVGO">Livongo Health</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 30 May 2020 14:48:51 GMT</td>    <td>Is Livongo Health Stock a Buy? - The Motley Fool</td>    <td>Is Livongo Health Stock a Buy?  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/30/is-livongo-health-stock-a-buy.aspx">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 20:05:00 GMT</td>    <td>Why Livongo Health Stock Is Jumping Today - Motley Fool</td>    <td>Why Livongo Health Stock Is Jumping Today  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/28/why-livongo-health-stock-is-jumping-today.aspx">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 12:48:00 GMT</td>    <td>Should You Buy Livongo Health? - The Motley Fool</td>    <td>Should You Buy Livongo Health?  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/09/should-you-buy-livongo-health.aspx">Link</a></td>  </tr></table><h3>378. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LOGC">LogicBio Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 20:10:00 GMT</td>    <td>LogicBio Therapeutics to Present New Data on GeneRide™ Platform and Next Generation Capsid Development Program at the American Society of Gene & Cell Therapy 2020 Annual Meeting - GlobeNewswire</td>    <td>LogicBio Therapeutics to Present New Data on GeneRide™ Platform and Next Generation Capsid Development Program at the American Society of Gene & Cell Therapy 2020 Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031452/0/en/LogicBio-Therapeutics-to-Present-New-Data-on-GeneRide-Platform-and-Next-Generation-Capsid-Development-Program-at-the-American-Society-of-Gene-Cell-Therapy-2020-Annual-Meeting.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 11:08:13 GMT</td>    <td>LogicBio Therapeutics to Present at the Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>LogicBio Therapeutics to Present at the Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040080/0/en/LogicBio-Therapeutics-to-Present-at-the-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>LogicBio Therapeutics: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>LogicBio Therapeutics: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/LogicBio-Therapeutics-1Q-Earnings-Snapshot-15262500.php">Link</a></td>  </tr></table><h3>379. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LOXO">Loxo Oncology, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Eli Lilly's $8 Billion Oncology Bet Gets Its Chance to Succeed - Nasdaq</td>    <td>Eli Lilly's $8 Billion Oncology Bet Gets Its Chance to Succeed  NasdaqLilly wins approval for first Loxo-sourced asset, Retevmo  BioWorld OnlineFDA Approves First Therapy for Patients with Lung and Thyroid Cancers with a Certain Genetic Mutation or Fusion  PRNewswireFDA approves Eli Lilly drug for thyroid, lung cancers driven by a genetic mutation  ETHealthworld.comView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/eli-lillys-%248-billion-oncology-bet-gets-its-chance-to-succeed-2020-05-09">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Biotech ETFs to Gain From Latest Advancements in Cancer Drugs - Yahoo Finance</td>    <td>Biotech ETFs to Gain From Latest Advancements in Cancer Drugs  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/biotech-etfs-gain-latest-advancements-212609132.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 18:41:00 GMT</td>    <td>Global Pontine Glioma Drug Market (2020-2026) | Latest COVID19 Impact Analysis | Know About Brand Players: Arog Pharmaceuticals, Inc., Burzynski Research Institute, Inc., Loxo Oncology, etc - Jewish Life News</td>    <td>Global Pontine Glioma Drug Market (2020-2026) | Latest COVID19 Impact Analysis | Know About Brand Players: Arog Pharmaceuticals, Inc., Burzynski Research Institute, Inc., Loxo Oncology, etc  Jewish Life News</td>    <td><a target="_blank" href="https://jewishlifenews.com/uncategorized/global-pontine-glioma-drug-market-2020-2026-latest-covid19-impact-analysis-know-about-brand-players-arog-pharmaceuticals-inc-burzynski-research-institute-inc-loxo-oncology-etc/">Link</a></td>  </tr></table><h3>380. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LUNA">Luna Innovations Incorporated</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Luna Innovations Reports Strong First-Quarter 2020 Results - Business Wire</td>    <td>Luna Innovations Reports Strong First-Quarter 2020 Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005919/en/Luna-Innovations-Reports-Strong-First-Quarter-2020-Results">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Does Luna Innovations Incorporated's (NASDAQ:LUNA) CEO Pay Matter? - Yahoo Finance</td>    <td>Does Luna Innovations Incorporated's (NASDAQ:LUNA) CEO Pay Matter?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/does-luna-innovations-incorporateds-nasdaq-130546428.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Luna Innovations Inc (Old) (LUNA) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Luna Innovations Inc (Old) (LUNA) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/luna-innovations-inc-old-luna-q1-2020-earnings-cal.aspx">Link</a></td>  </tr></table><h3>381. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-LYRA">Lyra Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Lyra Therapeutics to Present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference - Business Wire</td>    <td>Lyra Therapeutics to Present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200508005540/en/Lyra-Therapeutics-Present-Bank-America-Merrill-Lynch">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 20:16:32 GMT</td>    <td>Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040541/0/en/Lyra-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 22:32:00 GMT</td>    <td>BRIEF-Perceptive Advisors Llc Reports 24.9% Stake In Lyra Therapeutics As Of May 5, 2020 - Reuters</td>    <td>BRIEF-Perceptive Advisors Llc Reports 24.9% Stake In Lyra Therapeutics As Of May 5, 2020  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-perceptive-advisors-llc-reports-24/brief-perceptive-advisors-llc-reports-249-stake-in-lyra-therapeutics-as-of-may-5-2020-idUSFWN2DE0VK">Link</a></td>  </tr></table><h3>382. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MGNX">MacroGenics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 20:15:54 GMT</td>    <td>MacroGenics Provides Update on Corporate Progress and First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>MacroGenics Provides Update on Corporate Progress and First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027866/0/en/MacroGenics-Provides-Update-on-Corporate-Progress-and-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 20:08:07 GMT</td>    <td>MacroGenics Announces Publication in Science Translational Medicine Supporting Flotetuzumab Pivotal Study in Patients with Refractory Acute Myeloid Leukemia - GlobeNewswire</td>    <td>MacroGenics Announces Publication in Science Translational Medicine Supporting Flotetuzumab Pivotal Study in Patients with Refractory Acute Myeloid Leukemia  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2043253/0/en/MacroGenics-Announces-Publication-in-Science-Translational-Medicine-Supporting-Flotetuzumab-Pivotal-Study-in-Patients-with-Refractory-Acute-Myeloid-Leukemia.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 11:46:04 GMT</td>    <td>MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive Metastatic Breast Cancer - GlobeNewswire</td>    <td>MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive Metastatic Breast Cancer  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040109/0/en/MacroGenics-Provides-Update-on-FDA-Review-of-Margetuximab-for-HER2-Positive-Metastatic-Breast-Cancer.html">Link</a></td>  </tr></table><h3>383. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MDGL">Madrigal Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 10:52:16 GMT</td>    <td>Madrigal Pharmaceuticals Reports 2020 First Quarter Financial Results and Highlights - GlobeNewswire</td>    <td>Madrigal Pharmaceuticals Reports 2020 First Quarter Financial Results and Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029253/0/en/Madrigal-Pharmaceuticals-Reports-2020-First-Quarter-Financial-Results-and-Highlights.html">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>Was The Smart Money Right About Madrigal Pharmaceuticals (MDGL)? - Yahoo Finance</td>    <td>Was The Smart Money Right About Madrigal Pharmaceuticals (MDGL)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/smart-money-madrigal-pharmaceuticals-mdgl-191858986.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 09:24:00 GMT</td>    <td>Oppenheimer Gives a Buy Rating to Madrigal Pharmaceuticals (MDGL) - Smarter Analyst</td>    <td>Oppenheimer Gives a Buy Rating to Madrigal Pharmaceuticals (MDGL)  Smarter Analyst</td>    <td><a target="_blank" href="https://www.smarteranalyst.com/new-blurbs/oppenheimer-gives-a-buy-rating-to-madrigal-pharmaceuticals-mdgl/">Link</a></td>  </tr></table><h3>384. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MGTA">Magenta Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Magenta Therapeutics Reports Recent Business Highlights and First Quarter Financial Results - Business Wire</td>    <td>Magenta Therapeutics Reports Recent Business Highlights and First Quarter Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005472/en/Magenta-Therapeutics-Reports-Business-Highlights-Quarter-Financial">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Magenta Therapeutics and AVROBIO Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies - Business Wire</td>    <td>Magenta Therapeutics and AVROBIO Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506005272/en/Magenta-Therapeutics-AVROBIO-Announce-Collaboration-Evaluate-Targeted">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>BRIEF-Magenta Therapeutics And Avrobio Collaborate To Evaluate Targeted Antibody-Drug Conjugate - Reuters</td>    <td>BRIEF-Magenta Therapeutics And Avrobio Collaborate To Evaluate Targeted Antibody-Drug Conjugate  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-magenta-therapeutics-and-avrobio-c/brief-magenta-therapeutics-and-avrobio-collaborate-to-evaluate-targeted-antibody-drug-conjugate-idUSFWN2CO0G6">Link</a></td>  </tr></table><h3>385. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MNKD">MannKind Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>MannKind Corporation Reports 2020 First Quarter Financial Results - Yahoo Finance</td>    <td>MannKind Corporation Reports 2020 First Quarter Financial Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/mannkind-corporation-reports-2020-first-200010318.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:00:00 GMT</td>    <td>MannKind Corporation [MNKD] Is Currently 0.00 below its 200 Period Moving Avg: What Dose This Mean? - The DBT News</td>    <td>MannKind Corporation [MNKD] Is Currently 0.00 below its 200 Period Moving Avg: What Dose This Mean?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/mannkind-corporation-mnkd-is-currently-0-00-below-its-200-period-moving-avg-what-dose-this-mean/">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 21:09:00 GMT</td>    <td>MannKind Corporation (MNKD) Soars 1.34% on May 29 - Equities.com</td>    <td>MannKind Corporation (MNKD) Soars 1.34% on May 29  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/mannkind-corporation-mnkd-soars-1-34-on-may-29">Link</a></td>  </tr></table><h3>386. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MRNS">Marinus Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 20:11:56 GMT</td>    <td>Marinus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewswire</td>    <td>Marinus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042545/0/en/Marinus-Pharmaceuticals-Announces-Closing-of-46-Million-Public-Offering-of-Common-Stock-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 20:15:42 GMT</td>    <td>Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock - GlobeNewswire</td>    <td>Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040531/0/en/Marinus-Pharmaceuticals-Announces-Proposed-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 11:10:00 GMT</td>    <td>Market Analysts see Marinus Pharmaceuticals Inc. [MRNS] gaining to $4.50. Time to buy? - The DBT News</td>    <td>Market Analysts see Marinus Pharmaceuticals Inc. [MRNS] gaining to $4.50. Time to buy?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/01/market-analysts-see-marinus-pharmaceuticals-inc-mrns-gaining-to-4-50-time-to-buy/">Link</a></td>  </tr></table><h3>387. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MRKR">Marker Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Marker Therapeutics Reports First Quarter 2020 Operating and Financial Results - PRNewswire</td>    <td>Marker Therapeutics Reports First Quarter 2020 Operating and Financial Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/marker-therapeutics-reports-first-quarter-2020-operating-and-financial-results-301056928.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 14:14:10 GMT</td>    <td>When Will Marker Therapeutics, Inc. (NASDAQ:MRKR) Become Profitable? - Simply Wall St</td>    <td>When Will Marker Therapeutics, Inc. (NASDAQ:MRKR) Become Profitable?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrkr/marker-therapeutics/news/when-will-marker-therapeutics-inc-nasdaqmrkr-become-profitable/">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:00:00 GMT</td>    <td>Marker Therapeutics Reports Interim Results of its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting - PRNewswire</td>    <td>Marker Therapeutics Reports Interim Results of its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/marker-therapeutics-reports-interim-results-of-its-multitaa-specific-t-cell-therapy-in-patients-with-pancreatic-adenocarcinoma-at-the-2020-american-society-of-clinical-oncology-asco-virtual-annual-meeting-301067451.html">Link</a></td>  </tr></table><h3>388. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MASI">Masimo Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 10:45:49 GMT</td>    <td>After A Massive 60% Rise Since March Lows, Has Masimo Stock Run Its Course? - Forbes</td>    <td>After A Massive 60% Rise Since March Lows, Has Masimo Stock Run Its Course?  Forbes</td>    <td><a target="_blank" href="https://www.forbes.com/sites/greatspeculations/2020/06/03/after-a-massive-60-rise-since-march-lows-has-masimo-stock-run-its-course/">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 00:00:00 GMT</td>    <td>Masimo Corporation's Acquisition Of A Business Facility In Neuchâtel, Switzerland - Global Legal Chronicle</td>    <td>Masimo Corporation's Acquisition Of A Business Facility In Neuchâtel, Switzerland  Global Legal Chronicle</td>    <td><a target="_blank" href="https://www.globallegalchronicle.com/masimo-corporations-acquisition-of-a-business-facility-in-neuchatel-switzerland/">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Masimo Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting - Business Wire</td>    <td>Masimo Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200520005901/en/Masimo-Announces-2020-Annual-Meeting-Stockholders-Held">Link</a></td>  </tr></table><h3>389. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MNOV">MediciNova, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>MediciNova Inc. (MNOV) Soars 2.77% on June 02 - Equities.com</td>    <td>MediciNova Inc. (MNOV) Soars 2.77% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/medicinova-inc-mnov-soars-2-77-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 05:43:50 GMT</td>    <td>Pulmonary Fibrosis Drug Market Global Research and Clinical Survey 2020 to 2026 - Cole of Duty</td>    <td>Pulmonary Fibrosis Drug Market Global Research and Clinical Survey 2020 to 2026  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/06/03/pulmonary-fibrosis-drug-market-global-research-and-clinical-survey-2020-to-2026/">Link</a></td>  </tr><tr>    <td>Wed, 08 Apr 2020 10:22:41 GMT</td>    <td>MediciNova Announces Plans to Initiate a Clinical Trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) - GlobeNewswire</td>    <td>MediciNova Announces Plans to Initiate a Clinical Trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/04/08/2013412/0/en/MediciNova-Announces-Plans-to-Initiate-a-Clinical-Trial-of-MN-166-ibudilast-for-COVID-19-Acute-Respiratory-Distress-Syndrome-ARDS.html">Link</a></td>  </tr></table><h3>390. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MEDP">Medpace Holdings, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 07:00:00 GMT</td>    <td>Medpace Holdings, Inc. to Present at Two Upcoming Investor Conferences - Olean Times Herald</td>    <td>Medpace Holdings, Inc. to Present at Two Upcoming Investor Conferences  Olean Times Herald</td>    <td><a target="_blank" href="http://www.oleantimesherald.com/business/medpace-holdings-inc-to-present-at-two-upcoming-investor-conferences/article_23218e5b-848e-5f70-93fa-87d901dab540.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 22:23:49 GMT</td>    <td>Tag: Medpace Holdings. - Cole of Duty</td>    <td>Tag: Medpace Holdings.  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/tag/medpace-holdings/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>The COVID-19 Crisis Can’t Sink Medpace (MEDP) Stock - Yahoo Finance</td>    <td>The COVID-19 Crisis Can’t Sink Medpace (MEDP) Stock  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/covid-19-crisis-t-sink-125816822.html">Link</a></td>  </tr></table><h3>391. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MEIP">MEI Pharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:28:00 GMT</td>    <td>What You Need To Know About The MEI Pharma, Inc. (NASDAQ:MEIP) Analyst Downgrade Today - Yahoo Finance</td>    <td>What You Need To Know About The MEI Pharma, Inc. (NASDAQ:MEIP) Analyst Downgrade Today  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/know-mei-pharma-inc-nasdaq-112845416.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:00:00 GMT</td>    <td>MEI Pharma to Host Investor and Analyst Video Webcast Following ASCO20 Virtual Scientific Program - Yahoo Finance</td>    <td>MEI Pharma to Host Investor and Analyst Video Webcast Following ASCO20 Virtual Scientific Program  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/mei-pharma-host-investor-analyst-120000590.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>How MEI Pharma (MEIP) Stock Stands Out in a Strong Industry - Yahoo Finance</td>    <td>How MEI Pharma (MEIP) Stock Stands Out in a Strong Industry  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/mei-pharma-meip-stock-stands-123612292.html">Link</a></td>  </tr></table><h3>392. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MGTX">MeiraGTx Holdings plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 20:47:08 GMT</td>    <td>MeiraGTx Reports First Quarter 2020 Financial Results Nasdaq:MGTX - GlobeNewswire</td>    <td>MeiraGTx Reports First Quarter 2020 Financial Results Nasdaq:MGTX  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029993/0/en/MeiraGTx-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:34:13 GMT</td>    <td>MeiraGTx Announces Move to Virtual-Only Format for 2020 Annual General Meeting of Shareholders - GlobeNewswire</td>    <td>MeiraGTx Announces Move to Virtual-Only Format for 2020 Annual General Meeting of Shareholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038631/0/en/MeiraGTx-Announces-Move-to-Virtual-Only-Format-for-2020-Annual-General-Meeting-of-Shareholders.html">Link</a></td>  </tr><tr>    <td>Sun, 17 May 2020 13:53:05 GMT</td>    <td>This Insider Has Just Sold Shares In MeiraGTx Holdings plc (NASDAQ:MGTX) - Simply Wall St</td>    <td>This Insider Has Just Sold Shares In MeiraGTx Holdings plc (NASDAQ:MGTX)  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/this-insider-has-just-sold-shares-in-meiragtx-holdings-plc-nasdaqmgtx/">Link</a></td>  </tr></table><h3>393. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MLNT">Melinta Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>BRIEF-Tetraphase Pharmaceuticals Says Got Revised Proposal From Melinta Therapeutics - Reuters</td>    <td>BRIEF-Tetraphase Pharmaceuticals Says Got Revised Proposal From Melinta Therapeutics  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-tetraphase-pharmaceuticals-says-go/brief-tetraphase-pharmaceuticals-says-got-revised-proposal-from-melinta-therapeutics-idUSFWN2D30SC">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 20:51:00 GMT</td>    <td>Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx - Yahoo Finance</td>    <td>Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/tetraphase-announces-receipt-amended-melinta-205100465.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 22:50:00 GMT</td>    <td>AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase - PRNewswire</td>    <td>AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-it-will-not-further-revise-its-offer-to-acquire-tetraphase-301070465.html">Link</a></td>  </tr></table><h3>394. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MNLO">Menlo Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:15:12 GMT</td>    <td>Menlo Therapeutics Announces Positive Results from Phase 2 Trial of FCD105 for the Treatment of Moderate-to-Severe Acne Vulgaris - GlobeNewswire</td>    <td>Menlo Therapeutics Announces Positive Results from Phase 2 Trial of FCD105 for the Treatment of Moderate-to-Severe Acne Vulgaris  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042185/0/en/Menlo-Therapeutics-Announces-Positive-Results-from-Phase-2-Trial-of-FCD105-for-the-Treatment-of-Moderate-to-Severe-Acne-Vulgaris.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 12:43:00 GMT</td>    <td>Menlo Therapeutics (MNLO) Catches Eye: Stock Jumps 7.1% - Yahoo Finance</td>    <td>Menlo Therapeutics (MNLO) Catches Eye: Stock Jumps 7.1%  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/menlo-therapeutics-mnlo-catches-eye-124312715.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 15:50:51 GMT</td>    <td>Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea - GlobeNewswire</td>    <td>Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2041047/0/en/Menlo-Therapeutics-Receives-FDA-Approval-of-ZILXI-minocycline-topical-foam-1-5-the-First-Topical-Minocycline-Treatment-for-Rosacea.html">Link</a></td>  </tr></table><h3>395. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VIVO">Meridian Bioscience Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 12:07:31 GMT</td>    <td>Meridian Bioscience Announces It Will Supply Reagents for the Manufacturing of Tens of Millions of COVID-19 Antibody Tests Per Month - GlobeNewswire</td>    <td>Meridian Bioscience Announces It Will Supply Reagents for the Manufacturing of Tens of Millions of COVID-19 Antibody Tests Per Month  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038572/0/en/Meridian-Bioscience-Announces-It-Will-Supply-Reagents-for-the-Manufacturing-of-Tens-of-Millions-of-COVID-19-Antibody-Tests-Per-Month.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 20:32:34 GMT</td>    <td>Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics - GlobeNewswire</td>    <td>Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036691/0/en/Meridian-Bioscience-Promotes-Tony-Serafini-Lamanna-to-Executive-Vice-President-of-Diagnostics.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 14:49:45 GMT</td>    <td>A Rising Share Price Has Us Looking Closely At Meridian Bioscience, Inc.’s (NASDAQ:VIVO) P/E Ratio - Simply Wall St</td>    <td>A Rising Share Price Has Us Looking Closely At Meridian Bioscience, Inc.’s (NASDAQ:VIVO) P/E Ratio  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/healthcare/nasdaq-vivo/meridian-bioscience/news/a-rising-share-price-has-us-looking-closely-at-meridian-bioscience-inc-s-nasdaqvivo-p-e-ratio/">Link</a></td>  </tr></table><h3>396. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MACK">Merrimack Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 21:18:04 GMT</td>    <td>MERRIMACK PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K) - marketscreener.com</td>    <td>MERRIMACK PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)  marketscreener.com</td>    <td><a target="_blank" href="https://m.marketscreener.com/MERRIMACK-PHARMACEUTICALS-37705478/news/MERRIMACK-PHARMACEUTICALS-INC-Submission-of-Matters-to-a-Vote-of-Security-Holders-form-8-K-30689622/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Merrimack Pharmaceuticals : Reports First Quarter 2020 Financial Results - marketscreener.com</td>    <td>Merrimack Pharmaceuticals : Reports First Quarter 2020 Financial Results  marketscreener.com</td>    <td><a target="_blank" href="https://m.marketscreener.com/MERRIMACK-PHARMACEUTICALS-37705478/news/Merrimack-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results-30563143/">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 21:09:00 GMT</td>    <td>Merrimack Pharmaceuticals Inc. (MACK) Soars 1.8% on May 29 - Equities.com</td>    <td>Merrimack Pharmaceuticals Inc. (MACK) Soars 1.8% on May 29  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/merrimack-pharmaceuticals-inc-mack-soars-1-8-on-may-29">Link</a></td>  </tr></table><h3>397. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MRSN">Mersana Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 05:05:12 GMT</td>    <td>Mersana Therapeutics Stock (MRSN): Should I Buy It Now? - Pulse 2.0</td>    <td>Mersana Therapeutics Stock (MRSN): Should I Buy It Now?  Pulse 2.0</td>    <td><a target="_blank" href="https://pulse2.com/mersana-therapeutics-stock-mrsn-buy/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:38:34 GMT</td>    <td>Mersana Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewswire</td>    <td>Mersana Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042605/0/en/Mersana-Therapeutics-Announces-Closing-of-Public-Offering-of-Common-Stock-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 10:11:02 GMT</td>    <td>Mersana Therapeutics Reports Positive Interim Data from the Expansion Portion of the XMT-1536 Phase 1 Study - GlobeNewswire</td>    <td>Mersana Therapeutics Reports Positive Interim Data from the Expansion Portion of the XMT-1536 Phase 1 Study  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039179/0/en/Mersana-Therapeutics-Reports-Positive-Interim-Data-from-the-Expansion-Portion-of-the-XMT-1536-Phase-1-Study.html">Link</a></td>  </tr></table><h3>398. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MRUS">Merus N.V.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 20:49:53 GMT</td>    <td>Merus Announces Financial Results for the First Quarter and Provides Business Update - GlobeNewswire</td>    <td>Merus Announces Financial Results for the First Quarter and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031492/0/en/Merus-Announces-Financial-Results-for-the-First-Quarter-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 13:15:58 GMT</td>    <td>Merus Announces the Acceptance of Six Abstracts at Upcoming Medical Conferences and Provides Program Updates - GlobeNewswire</td>    <td>Merus Announces the Acceptance of Six Abstracts at Upcoming Medical Conferences and Provides Program Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033581/0/en/Merus-Announces-the-Acceptance-of-Six-Abstracts-at-Upcoming-Medical-Conferences-and-Provides-Program-Updates.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Merus NV (MRUS) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance</td>    <td>Merus NV (MRUS) Reports Q1 Loss, Misses Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/merus-nv-mrus-reports-q1-231511438.html">Link</a></td>  </tr></table><h3>399. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MESO">Mesoblast Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sun, 31 May 2020 03:01:30 GMT</td>    <td>Is Mesoblast Limited (MESO) A Good Stock To Buy? - Yahoo Finance</td>    <td>Is Mesoblast Limited (MESO) A Good Stock To Buy?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/mesoblast-limited-meso-good-stock-024902863.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 16:48:20 GMT</td>    <td>Mesoblast Limited (MESO) Q3 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Mesoblast Limited (MESO) Q3 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/28/mesoblast-limited-meso-q3-2020-earnings-call-trans.aspx">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Who Has Been Buying Mesoblast Limited (ASX:MSB) Shares? - Yahoo Finance</td>    <td>Who Has Been Buying Mesoblast Limited (ASX:MSB) Shares?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/buying-mesoblast-limited-asx-msb-000352096.html">Link</a></td>  </tr></table><h3>400. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MBOT">Microbot Medical Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 16:18:15 GMT</td>    <td>Microbot Medical Inc Will stock surge before Earnings results? - Stock Market Daily</td>    <td>Microbot Medical Inc Will stock surge before Earnings results?  Stock Market Daily</td>    <td><a target="_blank" href="https://stockmarketdaily.co/2020/06/03/microbot-medical-inc-will-stock-surge-before-earnings-results/">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 15:17:26 GMT</td>    <td>Has Microbot Medical Inc (MBOT) Stock's Performance Changed Wall Street's View? - InvestorsObserver</td>    <td>Has Microbot Medical Inc (MBOT) Stock's Performance Changed Wall Street's View?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/has-microbot-medical-inc-mbot-stocks-performance-changed-wall-streets-view">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 15:15:00 GMT</td>    <td>Microbot Medical Inc How Have the Numbers Shaped Up for - Stock Market Daily</td>    <td>Microbot Medical Inc How Have the Numbers Shaped Up for  Stock Market Daily</td>    <td><a target="_blank" href="https://stockmarketdaily.co/2020/05/27/microbot-medical-inc-how-have-the-numbers-shaped-up-for/">Link</a></td>  </tr></table><h3>401. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MTP">Midatech Pharma PLC</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Midatech Pharma PLC Announces US$3.0 Million Registered Direct Offering - Yahoo Finance</td>    <td>Midatech Pharma PLC Announces US$3.0 Million Registered Direct Offering  Yahoo FinanceMidatech Pharma raises £4.3mln combined in the UK and US  Proactive Investors UKMidatech Pharma To Report Narrowed Loss For 2019 On Lower Expenses  MorningstarMidatech Pharma raises £4.3m from share, ADS issuance, 18 May 2020 14:54  Shares magazineView Full Coverage on Google News</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/midatech-pharma-plc-announces-us-134000926.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Midatech Pharma PLC Announces Rule 2.9 Announcement - Yahoo Finance</td>    <td>Midatech Pharma PLC Announces Rule 2.9 Announcement  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/midatech-pharma-plc-announces-rule-060100847.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Midatech Pharma PLC - Correction: UK Placing to Raise £1.8 million - Yahoo Finance</td>    <td>Midatech Pharma PLC - Correction: UK Placing to Raise £1.8 million  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/midatech-pharma-plc-correction-uk-111500667.html">Link</a></td>  </tr></table><h3>402. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MIST">Milestone Pharmaceuticals</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update - BioSpace</td>    <td>Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/milestone-pharmaceuticals-reports-first-quarter-2020-financial-results-and-provides-clinical-and-corporate-update/">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 11:00:00 GMT</td>    <td>Milestone Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference - PRNewswire</td>    <td>Milestone Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-the-jefferies-2020-healthcare-conference-301065669.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 23:10:00 GMT</td>    <td>Milestone Pharmaceuticals Inc. (MIST) Tending Lower: Checkout the Key Metrics - State Reviewer</td>    <td>Milestone Pharmaceuticals Inc. (MIST) Tending Lower: Checkout the Key Metrics  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/milestone-pharmaceuticals-inc-mist-tending-lower-checkout-the-key-metrics/">Link</a></td>  </tr></table><h3>403. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MLND">Millendo Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results - Business Wire</td>    <td>Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200508005043/en/Millendo-Therapeutics-Reports-Quarter-2020-Operating-Financial">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 22:10:00 GMT</td>    <td>At Millendo Therapeutics Inc. (NASDAQ:MLND), Share Price Got a Bit Ahead of the Fundamentals - State Reviewer</td>    <td>At Millendo Therapeutics Inc. (NASDAQ:MLND), Share Price Got a Bit Ahead of the Fundamentals  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/at-millendo-therapeutics-inc-nasdaqmlnd-share-price-got-a-bit-ahead-of-the-fundamentals/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:33:59 GMT</td>    <td>Does Millendo Therapeutics Inc (MLND) Stock Beat its Rivals in Biotechnology? - InvestorsObserver</td>    <td>Does Millendo Therapeutics Inc (MLND) Stock Beat its Rivals in Biotechnology?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/does-millendo-therapeutics-inc-mlnd-stock-beat-its-rivals-in-biotechnology">Link</a></td>  </tr></table><h3>404. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NERV">Minerva Neurosciences, Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 13:00:00 GMT</td>    <td>How Minerva Neurosciences (NERV) Stock Stands Out in a Strong Industry - Yahoo Finance</td>    <td>How Minerva Neurosciences (NERV) Stock Stands Out in a Strong Industry  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/minerva-neurosciences-nerv-stock-stands-130001745.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 18:15:00 GMT</td>    <td>Why Minerva Neurosciences Is Heading Higher Today - Motley Fool</td>    <td>Why Minerva Neurosciences Is Heading Higher Today  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/06/01/why-minerva-neurosciences-is-heading-higher-today.aspx">Link</a></td>  </tr><tr>    <td>Sat, 30 May 2020 14:46:38 GMT</td>    <td>Here's Why Minerva Neurosciences Collapsed Today - The Motley Fool</td>    <td>Here's Why Minerva Neurosciences Collapsed Today  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/29/heres-why-minerva-neurosciences-collapsed-today.aspx">Link</a></td>  </tr></table><h3>405. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MRTX">Mirati Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 01:08:11 GMT</td>    <td>Hedge Funds Are Nibbling On Mirati Therapeutics, Inc. (MRTX) - Yahoo Finance</td>    <td>Hedge Funds Are Nibbling On Mirati Therapeutics, Inc. (MRTX)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-nibbling-mirati-therapeutics-005942069.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Mirati Therapeutics To Present Preclinical Data From Investigational Pipeline Of Novel Therapeutics At 2020 American Association For Cancer Research Virtual Annual Meeting II - PRNewswire</td>    <td>Mirati Therapeutics To Present Preclinical Data From Investigational Pipeline Of Novel Therapeutics At 2020 American Association For Cancer Research Virtual Annual Meeting II  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/mirati-therapeutics-to-present-preclinical-data-from-investigational-pipeline-of-novel-therapeutics-at-2020-american-association-for-cancer-research-virtual-annual-meeting-ii-301059990.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Mirati Therapeutics Appoints Joseph A. Leveque, M.D. As Chief Medical Officer - Yahoo Finance</td>    <td>Mirati Therapeutics Appoints Joseph A. Leveque, M.D. As Chief Medical Officer  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/mirati-therapeutics-appoints-joseph-leveque-201500530.html">Link</a></td>  </tr></table><h3>406. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MIRM">Mirum Pharmaceuticals</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 14:05:00 GMT</td>    <td>Mirum Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference - Yahoo Finance</td>    <td>Mirum Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/mirum-pharmaceuticals-present-jefferies-2020-140500321.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire</td>    <td>Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200511005944/en/Mirum-Pharmaceuticals-Reports-Inducement-Grants-Nasdaq-Listing">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 12:30:00 GMT</td>    <td>Mirum's Maralixibat Demonstrates Transplant-Free Survival for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis - Business Wire</td>    <td>Mirum's Maralixibat Demonstrates Transplant-Free Survival for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005312/en/Mirum%E2%80%99s-Maralixibat-Demonstrates-Transplant-Free-Survival-Pediatric-Patients">Link</a></td>  </tr></table><h3>407. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MRNA">Moderna, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 11:30:00 GMT</td>    <td>Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Third Annual Science Day - Business Wire</td>    <td>Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Third Annual Science Day  Business WireModerna Doses First Participants In Phase 2 Study Of Coronavirus Vaccine  BenzingaModerna Embarks On Phase 2 Study Of Covid-19 Candidate; Shares Pop 11%  Yahoo FinanceModerna's coronavirus vaccine announcement set off a frenzy on Wall Street. Now some are calling for an investigation  CNNCordenPharma signs deal to work on COVID vaccine  The Daily CameraView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005212/en/Moderna-Highlights-Advances-Platform-Science-Innovative-Vaccine">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 23:32:59 GMT</td>    <td>HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Announces Investigation into Moderna, Inc. (MRNA) for Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm - GlobeNewswire</td>    <td>HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Announces Investigation into Moderna, Inc. (MRNA) for Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042621/0/en/HAGENS-BERMAN-NATIONAL-TRIAL-ATTORNEYS-Announces-Investigation-into-Moderna-Inc-MRNA-for-Possible-Securities-Fraud-and-Insider-Trading-Encourages-Investors-with-Significant-Losses-.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>'Significant findings' in COVID-19 vaccine trial by Moderna Inc - World Economic Forum</td>    <td>'Significant findings' in COVID-19 vaccine trial by Moderna Inc  World Economic Forum</td>    <td><a target="_blank" href="https://www.weforum.org/agenda/2020/05/coronavirus-vaccine-moderna">Link</a></td>  </tr></table><h3>408. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MTEM">Molecular Templates, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 11:21:17 GMT</td>    <td>New Data on Molecular Templates' Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting II - GlobeNewswire</td>    <td>New Data on Molecular Templates' Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting II  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034132/0/en/New-Data-on-Molecular-Templates-Engineered-Toxin-Bodies-to-be-Presented-at-the-American-Association-of-Cancer-Research-AACR-Virtual-Annual-Meeting-II.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 20:34:08 GMT</td>    <td>Molecular Templates, Inc. Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Molecular Templates, Inc. Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031488/0/en/Molecular-Templates-Inc-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Molecular Templates, Inc. Announces that the 2020 Annual Meeting of Stockholders Will be Held in Virtual Format - Yahoo Finance</td>    <td>Molecular Templates, Inc. Announces that the 2020 Annual Meeting of Stockholders Will be Held in Virtual Format  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/molecular-templates-inc-announces-2020-203010193.html">Link</a></td>  </tr></table><h3>409. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MBRX">Moleculin Biotech, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 23:01:00 GMT</td>    <td>Houston biotech firms resume trading after weeks-long suspensions - New York Business Journal</td>    <td>Houston biotech firms resume trading after weeks-long suspensions  New York Business Journal</td>    <td><a target="_blank" href="https://www.bizjournals.com/houston/news/2020/05/28/moleculin-biotech-cns-pharmaceuticals-nasdaq-sec.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 12:52:55 GMT</td>    <td>Nasdaq Halts Moleculin Biotech Inc. Nasdaq:NDAQ - GlobeNewswire</td>    <td>Nasdaq Halts Moleculin Biotech Inc. Nasdaq:NDAQ  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2034962/0/en/Nasdaq-Halts-Moleculin-Biotech-Inc.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:30:00 GMT</td>    <td>Market cap of Moleculin Biotech Inc. [MBRX] reaches 61.29M – now what? - The DBT News</td>    <td>Market cap of Moleculin Biotech Inc. [MBRX] reaches 61.29M – now what?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/market-cap-of-moleculin-biotech-inc-mbrx-reaches-61-29m-now-what/">Link</a></td>  </tr></table><h3>410. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MNTA">Momenta Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:08:00 GMT</td>    <td>Is Momenta Pharmaceuticals' Stock a Buy? - Motley Fool</td>    <td>Is Momenta Pharmaceuticals' Stock a Buy?  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/06/03/is-momenta-pharmaceuticals-stock-a-buy.aspx">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 13:58:00 GMT</td>    <td>Hedge Funds Aren’t Done Buying Momenta Pharmaceuticals, Inc. (MNTA) - Yahoo Finance</td>    <td>Hedge Funds Aren’t Done Buying Momenta Pharmaceuticals, Inc. (MNTA)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-aren-t-done-135820818.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 11:09:45 GMT</td>    <td>Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results - GlobeNewswire</td>    <td>Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029291/0/en/Momenta-Pharmaceuticals-Reports-First-Quarter-2020-Financial-and-Operating-Results.html">Link</a></td>  </tr></table><h3>411. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MNPR">Monopar Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 13:07:21 GMT</td>    <td>Monopar Therapeutics Reports First Quarter 2020 Financial Results and Business Updates - GlobeNewswire</td>    <td>Monopar Therapeutics Reports First Quarter 2020 Financial Results and Business Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029483/0/en/Monopar-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Business-Updates.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 13:57:40 GMT</td>    <td>We Think Monopar Therapeutics (NASDAQ:MNPR) Can Easily Afford To Drive Business Growth - Simply Wall St</td>    <td>We Think Monopar Therapeutics (NASDAQ:MNPR) Can Easily Afford To Drive Business Growth  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnpr/monopar-therapeutics/news/we-think-monopar-therapeutics-nasdaqmnpr-can-easily-afford-to-drive-business-growth/">Link</a></td>  </tr><tr>    <td>Fri, 08 Nov 2019 08:00:00 GMT</td>    <td>Monopar Therapeutics puts the brakes on IPO, again - FierceBiotech</td>    <td>Monopar Therapeutics puts the brakes on IPO, again  FierceBiotech</td>    <td><a target="_blank" href="https://www.fiercebiotech.com/biotech/monopar-therapeutics-puts-brakes-ipo-again">Link</a></td>  </tr></table><h3>412. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MORF">Morphic Holding</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sun, 31 May 2020 14:57:55 GMT</td>    <td>Have Insiders Sold Morphic Holding, Inc. (NASDAQ:MORF) Shares Recently? - Simply Wall St</td>    <td>Have Insiders Sold Morphic Holding, Inc. (NASDAQ:MORF) Shares Recently?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-morf/morphic-holding/news/have-insiders-sold-morphic-holding-inc-nasdaqmorf-shares-recently/">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Earnings Release: Here's Why Analysts Cut Their Morphic Holding, Inc. (NASDAQ:MORF) Price Target To US$29.67 - Yahoo Finance</td>    <td>Earnings Release: Here's Why Analysts Cut Their Morphic Holding, Inc. (NASDAQ:MORF) Price Target To US$29.67  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/earnings-release-heres-why-analysts-143942660.html">Link</a></td>  </tr><tr>    <td>Tue, 17 Dec 2019 08:00:00 GMT</td>    <td>Morphic Holding Tabbed as Likely to Develop Blockbuster Drug - Yahoo Finance</td>    <td>Morphic Holding Tabbed as Likely to Develop Blockbuster Drug  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/morphic-holding-tabbed-likely-develop-203203369.html">Link</a></td>  </tr></table><h3>413. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MOR">MorphoSys AG</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 17:25:00 GMT</td>    <td>MorphoSys AG Reports Outcome of Annual General Meeting 2020 - Yahoo Finance</td>    <td>MorphoSys AG Reports Outcome of Annual General Meeting 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/morphosys-ag-reports-outcome-annual-172500127.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 20:22:53 GMT</td>    <td>MorphoSys to Present at Upcoming Virtual Investor Conferences (news with additional features) - PharmiWeb.com</td>    <td>MorphoSys to Present at Upcoming Virtual Investor Conferences (news with additional features)  PharmiWeb.com</td>    <td><a target="_blank" href="https://www.pharmiweb.com/press-release/2020-06-02/morphosys-to-present-at-upcoming-virtual-investor-conferences-news-with-additional-features">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>MorphoSys AG - Consensus Indicates Potential 34.7% Upside - DirectorsTalk Interviews</td>    <td>MorphoSys AG - Consensus Indicates Potential 34.7% Upside  DirectorsTalk Interviews</td>    <td><a target="_blank" href="https://www.directorstalkinterviews.com/morphosys-ag-consensus-indicates-potential-34-7-upside/412820657">Link</a></td>  </tr></table><h3>414. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MTFB">Motif Bio plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 06:51:00 GMT</td>    <td>BRIEF-Motif Bio Appoints Peel Hunt As Strategic Adviser - Reuters</td>    <td>BRIEF-Motif Bio Appoints Peel Hunt As Strategic Adviser  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-motif-bio-appoints-peel-hunt-as-st/brief-motif-bio-appoints-peel-hunt-as-strategic-adviser-idUSFWN2DB15G">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Cash shell Motif Bio raises capital for balance sheet, working capital, 5 May 2020 09:04 - Shares magazine</td>    <td>Cash shell Motif Bio raises capital for balance sheet, working capital, 5 May 2020 09:04  Shares magazine</td>    <td><a target="_blank" href="https://www.sharesmagazine.co.uk/news/market/6906297/Cash-shell-Motif-Bio-raises-capital-for-balance-sheet-working-capital">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 09:10:41 GMT</td>    <td>Motif Bio jolted back to life by appointment of Peel Hunt as strategic adviser - Proactive Investors UK</td>    <td>Motif Bio jolted back to life by appointment of Peel Hunt as strategic adviser  Proactive Investors UK</td>    <td><a target="_blank" href="https://proactiveinvestors.co.uk/companies/news/920804/motif-bio-jolted-back-to-life-by-appointment-of-peel-hunt-as-strategic-adviser-920804.html">Link</a></td>  </tr></table><h3>415. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MBIO">Mustang Bio, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Mustang Bio Reports First Quarter 2020 Financial Results and Recent Corporate Highlights - Yahoo Finance</td>    <td>Mustang Bio Reports First Quarter 2020 Financial Results and Recent Corporate Highlights  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/mustang-bio-reports-first-quarter-202010268.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 12:15:09 GMT</td>    <td>Mustang Bio Announces Presentations at 23rd Annual Meeting of the American Society of Gene & Cell Therapy - GlobeNewswire</td>    <td>Mustang Bio Announces Presentations at 23rd Annual Meeting of the American Society of Gene & Cell Therapy  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031873/0/en/Mustang-Bio-Announces-Presentations-at-23rd-Annual-Meeting-of-the-American-Society-of-Gene-Cell-Therapy.html">Link</a></td>  </tr><tr>    <td>Mon, 25 May 2020 07:00:00 GMT</td>    <td>Trade Alert: The President Of Mustang Bio, Inc. (NASDAQ:MBIO), Manuel Litchman, Has Just Spent US$533k Buying 545% More Shares - Yahoo Finance</td>    <td>Trade Alert: The President Of Mustang Bio, Inc. (NASDAQ:MBIO), Manuel Litchman, Has Just Spent US$533k Buying 545% More Shares  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/trade-alert-president-mustang-bio-103958662.html">Link</a></td>  </tr></table><h3>416. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MYL">Mylan N.V.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 15:32:00 GMT</td>    <td>Here is How Hedge Funds Traded Mylan N.V. (MYL) Recently - Yahoo Finance</td>    <td>Here is How Hedge Funds Traded Mylan N.V. (MYL) Recently  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-traded-mylan-n-153253487.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>BRIEF-Mylan NV Exec Says In A Strong Position To Cater To Epipen Demand Ahead Of Back-To-School Season Conf. Call - Reuters</td>    <td>BRIEF-Mylan NV Exec Says In A Strong Position To Cater To Epipen Demand Ahead Of Back-To-School Season Conf. Call  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-mylan-nv-exec-says-in-a-strong-pos/brief-mylan-nv-exec-says-in-a-strong-position-to-cater-to-epipen-demand-ahead-of-back-to-school-season-conf-call-idUSFWN2CT111">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:06:00 GMT</td>    <td>Mylan NV (MYL) Rises 3.22% for June 01 - Equities.com</td>    <td>Mylan NV (MYL) Rises 3.22% for June 01  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/mylan-n-v-myl-rises-3-22-for-june-01">Link</a></td>  </tr></table><h3>417. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MYOK">MyoKardia, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 01:08:11 GMT</td>    <td>MyoKardia, Inc. (MYOK): Hedge Funds Are Snapping Up - Yahoo Finance</td>    <td>MyoKardia, Inc. (MYOK): Hedge Funds Are Snapping Up  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/myokardia-inc-myok-hedge-funds-005026048.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Peninsula heart drug maker soars on positive late-stage clinical trial - San Francisco Business Times</td>    <td>Peninsula heart drug maker soars on positive late-stage clinical trial  San Francisco Business Times</td>    <td><a target="_blank" href="https://www.bizjournals.com/sanfrancisco/news/2020/05/11/myokardia-heart-hcm-hypertrophic-cardiomyopathy.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>MyoKardia Reports First Quarter 2020 Financial Results Nasdaq:MYOK - GlobeNewswire</td>    <td>MyoKardia Reports First Quarter 2020 Financial Results Nasdaq:MYOK  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028825/0/en/MyoKardia-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>418. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MYOS">MYOS RENS Technology Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 12:00:00 GMT</td>    <td>MYOS RENS Partners with GetHealthy.store to Promote MYOS Longevity's Clinically-Backed Nutrition Products - PRNewswire</td>    <td>MYOS RENS Partners with GetHealthy.store to Promote MYOS Longevity's Clinically-Backed Nutrition Products  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/myos-rens-partners-with-gethealthystore-to-promote-myos-longevitys-clinically-backed-nutrition-products-301063522.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>MYOS RENS Technology Reports First Quarter 2020 Financial Results Including a 95% Increase in Net Revenues - PRNewswire</td>    <td>MYOS RENS Technology Reports First Quarter 2020 Financial Results Including a 95% Increase in Net Revenues  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/myos-rens-technology-reports-first-quarter-2020-financial-results-including-a-95-increase-in-net-revenues-301055728.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>MYOS RENS Enters into Agreement with Victor Medical to Distribute MYOS Canine Muscle Formula® Across Western United States - PRNewswire</td>    <td>MYOS RENS Enters into Agreement with Victor Medical to Distribute MYOS Canine Muscle Formula® Across Western United States  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/myos-rens-enters-into-agreement-with-victor-medical-to-distribute-myos-canine-muscle-formula-across-western-united-states-301059064.html">Link</a></td>  </tr></table><h3>419. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MYGN">Myriad Genetics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 20:16:09 GMT</td>    <td>Myriad Genetics Reports Fiscal Third-Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Myriad Genetics Reports Fiscal Third-Quarter 2020 Financial Results  GlobeNewswireMyriad Genetics Inc (MYGN) Q3 2020 Earnings Call Transcript  Motley FoolMyriad Genetics, Inc. (MYGN) CEO Bryan Riggsbee on Q3 2020 Results - Earnings Call Transcript  Seeking AlphaMyriad Genetics Posts Adj. Loss In Q3 - Quick Facts  NasdaqMyriad Genetics (MYGN) Misses Q3 EPS by 10c  StreetInsider.comView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027912/0/en/Myriad-Genetics-Reports-Fiscal-Third-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 11:08:51 GMT</td>    <td>Myriad Genetics Appoints Daniel K. Spiegelman to the Board of Directors and Announces Upcoming Retirement of John T. Henderson, M.D. - GlobeNewswire</td>    <td>Myriad Genetics Appoints Daniel K. Spiegelman to the Board of Directors and Announces Upcoming Retirement of John T. Henderson, M.D.  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040097/0/en/Myriad-Genetics-Appoints-Daniel-K-Spiegelman-to-the-Board-of-Directors-and-Announces-Upcoming-Retirement-of-John-T-Henderson-M-D.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 11:34:29 GMT</td>    <td>Cerecor and Myriad Genetics Announce that Levels of LIGHT, a Novel Cytokine, Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker Study - BioSpace</td>    <td>Cerecor and Myriad Genetics Announce that Levels of LIGHT, a Novel Cytokine, Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker Study  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/cerecor-and-myriad-genetics-announce-that-levels-of-light-a-novel-cytokine-were-highly-correlated-with-disease-severity-and-mortality-in-covid-19-ards-biomarker-study/">Link</a></td>  </tr></table><h3>420. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NBRV">Nabriva Therapeutics plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 23:42:46 GMT</td>    <td>Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - GlobeNewswire</td>    <td>Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2041207/0/en/Nabriva-Therapeutics-Announces-38-Million-Registered-Direct-Offering-Priced-At-the-Market-under-Nasdaq-Rules.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:40:00 GMT</td>    <td>Implied Volatility Surging for Nabriva (NBRV) Stock Options - Yahoo Finance</td>    <td>Implied Volatility Surging for Nabriva (NBRV) Stock Options  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/implied-volatility-surging-nabriva-nbrv-124012496.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 11:00:00 GMT</td>    <td>Nabriva Therapeutics to Present at the BofA Securities 2020 Virtual Health Care Conference - Yahoo Finance</td>    <td>Nabriva Therapeutics to Present at the BofA Securities 2020 Virtual Health Care Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/nabriva-therapeutics-present-bofa-securities-110010574.html">Link</a></td>  </tr></table><h3>421. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NSTG">NanoString Technologies, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>NanoString to Present at the Bank of America Health Care Conference - Yahoo Finance</td>    <td>NanoString to Present at the Bank of America Health Care Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/nanostring-present-bank-america-health-100000220.html">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4345597-nanostring-technologies-inc-nstg-ceo-brad-gray-on-q1-2020-results-earnings-call-transcript">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research - Business Wire</td>    <td>Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005325/en/Publications-Demonstrate-Performance-GeoMx-DSP-Establish-New">Link</a></td>  </tr></table><h3>422. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NK">NantKwest, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 01:22:20 GMT</td>    <td>Hedge Funds Cashing Out Of Nantkwest Inc (NK) - Yahoo Finance</td>    <td>Hedge Funds Cashing Out Of Nantkwest Inc (NK)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-cashing-nantkwest-inc-011327950.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 13:30:00 GMT</td>    <td>NantKwest and ImmunityBio to Present at the Jefferies Virtual Healthcare Conference - Business Wire</td>    <td>NantKwest and ImmunityBio to Present at the Jefferies Virtual Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200526005121/en/NantKwest-ImmunityBio-Present-Jefferies-Virtual-Healthcare-Conference">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>NantKwest and ImmunityBio to Initiate a Phase 2 Study of Immunotherapy for Metastatic Pancreatic Cancer - Business Wire</td>    <td>NantKwest and ImmunityBio to Initiate a Phase 2 Study of Immunotherapy for Metastatic Pancreatic Cancer  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200514005857/en/NantKwest-ImmunityBio-Initiate-Phase-2-Study-Immunotherapy">Link</a></td>  </tr></table><h3>423. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NRC">National Research Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 21:17:51 GMT</td>    <td>National Research Corporation Announces First Quarter 2020 Results - GlobeNewswire</td>    <td>National Research Corporation Announces First Quarter 2020 Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027979/0/en/National-Research-Corporation-Announces-First-Quarter-2020-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 16:48:44 GMT</td>    <td>How Much Are National Research Corporation (NASDAQ:NRC) Insiders Taking Off The Table? - Simply Wall St</td>    <td>How Much Are National Research Corporation (NASDAQ:NRC) Insiders Taking Off The Table?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/healthcare/nasdaq-nrc/national-research/news/how-much-are-national-research-corporation-nasdaqnrc-insiders-taking-off-the-table/">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>National Research Corporation (NRC) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>National Research Corporation (NRC) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/06/national-research-corporation-nrc-q1-2020-earnings.aspx">Link</a></td>  </tr></table><h3>424. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NATR">Nature's Sunshine Products, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Nature's Sunshine Products Inc. (NATR) Soars 5.24% on June 03 - Equities.com</td>    <td>Nature's Sunshine Products Inc. (NATR) Soars 5.24% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/nature-s-sunshine-products-inc-natr-soars-5-24-on-june-03">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 20:13:41 GMT</td>    <td>Nature's Sunshine Products Reports First Quarter 2020 Financial Results With Margin Improvement - GlobeNewswire</td>    <td>Nature's Sunshine Products Reports First Quarter 2020 Financial Results With Margin Improvement  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031426/0/en/Nature-s-Sunshine-Products-Reports-First-Quarter-2020-Financial-Results-With-Margin-Improvement.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Natures Sunshine Products, Inc. (NATR) CEO Terrence Moorehead on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Natures Sunshine Products, Inc. (NATR) CEO Terrence Moorehead on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4346459-natures-sunshine-products-inc-natr-ceo-terrence-moorehead-on-q1-2020-results-earnings-call">Link</a></td>  </tr></table><h3>425. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-BABY">Natus Medical Incorporated</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Were Hedge Funds Right About Natus Medical Incorporated (NTUS)? - Yahoo Finance</td>    <td>Were Hedge Funds Right About Natus Medical Incorporated (NTUS)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/were-hedge-funds-natus-medical-181438238.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 04:05:13 GMT</td>    <td>Wearable EEG Devices Market SWOT Analysis 2027 | ANT Neuro, Natus Medical Incorporated, Brain Products GmbH, Compumedics Neuroscan - Cole of Duty</td>    <td>Wearable EEG Devices Market SWOT Analysis 2027 | ANT Neuro, Natus Medical Incorporated, Brain Products GmbH, Compumedics Neuroscan  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/military-news/2020/06/03/wearable-eeg-devices-market-swot-analysis-2027-ant-neuro-natus-medical-incorporated-brain-products-gmbh-compumedics-neuroscan/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 13:34:33 GMT</td>    <td>Natus partners with Holberg EEG to advance the diagnosis of Epilepsy - GlobeNewswire</td>    <td>Natus partners with Holberg EEG to advance the diagnosis of Epilepsy  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032013/0/en/Natus-partners-with-Holberg-EEG-to-advance-the-diagnosis-of-Epilepsy.html">Link</a></td>  </tr></table><h3>426. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NKTR">Nektar Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Nektar Therapeutics (NKTR) Soars 3.81% on June 03 - Equities.com</td>    <td>Nektar Therapeutics (NKTR) Soars 3.81% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/nektar-therapeutics-nktr-soars-3-81-on-june-03">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:10:00 GMT</td>    <td>Nektar Therapeutics [NKTR] moved up 0.79: Why It’s Important - The DBT News</td>    <td>Nektar Therapeutics [NKTR] moved up 0.79: Why It’s Important  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/nektar-therapeutics-nktr-moved-up-0-79-why-its-important/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Nektar Therapeutics Reports First Quarter 2020 Financial Results - PRNewswire</td>    <td>Nektar Therapeutics Reports First Quarter 2020 Financial Results  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/nektar-therapeutics-reports-first-quarter-2020-financial-results-301055246.html">Link</a></td>  </tr></table><h3>427. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NEOG">Neogen Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 13:35:00 GMT</td>    <td>Neogen Corporation's (NASDAQ:NEOG) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? - Yahoo Finance</td>    <td>Neogen Corporation's (NASDAQ:NEOG) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/neogen-corporations-nasdaq-neog-had-133511125.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 16:54:51 GMT</td>    <td>Neogen Launches Enhanced Igenity® Beef Genomic Profile - Drovers Magazine</td>    <td>Neogen Launches Enhanced Igenity® Beef Genomic Profile  Drovers Magazine</td>    <td><a target="_blank" href="https://www.drovers.com/article/neogen-launches-enhanced-igenityr-beef-genomic-profile">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:51:36 GMT</td>    <td>Agricultural Surface Disinfectant Market Will Grow Pervasively by Prominent Players The Chemours Company, Zoetis, Nufarm Limited, Stepan Company, The DOW Chemical Company, Neogen Corporation Etc - Cole of Duty</td>    <td>Agricultural Surface Disinfectant Market Will Grow Pervasively by Prominent Players The Chemours Company, Zoetis, Nufarm Limited, Stepan Company, The DOW Chemical Company, Neogen Corporation Etc  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/technology/2020/06/03/agricultural-surface-disinfectant-market-will-grow-pervasively-by-prominent-players-the-chemours-company-zoetis-nufarm-limited-stepan-company-the-dow-chemical-company-neogen-corporation-etc/">Link</a></td>  </tr></table><h3>428. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NTGN">Neon Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>BioNTech Completes Acquisition of Neon Therapeutics - Yahoo Finance</td>    <td>BioNTech Completes Acquisition of Neon Therapeutics  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/biontech-completes-acquisition-neon-therapeutics-201510285.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 20:01:03 GMT</td>    <td>PERSONALIZED CANCER VACCINES MARKET ANALYSIS WITH COMPETITIVE LANDSCAPE | NEON THERAPEUTICS, MODERNA, INC., GRITSTONE ONCOLOGY – Cole Reports - Cole of Duty</td>    <td>PERSONALIZED CANCER VACCINES MARKET ANALYSIS WITH COMPETITIVE LANDSCAPE | NEON THERAPEUTICS, MODERNA, INC., GRITSTONE ONCOLOGY – Cole Reports  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/military-news/2020/06/03/personalized-cancer-vaccines-market-analysis-with-competitive-landscape-neon-therapeutics-moderna-inc-gritstone-oncology/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>BioNTech's $97 Million Acquisition of Neon Therapeutics – Global Legal Chronicle - Global Legal Chronicle</td>    <td>BioNTech's $97 Million Acquisition of Neon Therapeutics – Global Legal Chronicle  Global Legal Chronicle</td>    <td><a target="_blank" href="https://www.globallegalchronicle.com/biontechs-97-million-acquisition-of-neon-therapeutics/">Link</a></td>  </tr></table><h3>429. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NEOS">Neos Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Neos Therapeutics Inc. (NEOS) Soars 1.58% on June 03 - Equities.com</td>    <td>Neos Therapeutics Inc. (NEOS) Soars 1.58% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/neos-therapeutics-inc-neos-soars-1-58-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:00:00 GMT</td>    <td>Neos Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference - Yahoo Finance</td>    <td>Neos Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/neos-therapeutics-present-jefferies-virtual-120010689.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Neos Therapeutics Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Neos Therapeutics Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031395/0/en/Neos-Therapeutics-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>430. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NEPT">Neptune Wellness Solutions Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Neptune Announces $16.5 Million Extraction Partnership for Hemp Processing at Sherbrooke Facility - PRNewswire</td>    <td>Neptune Announces $16.5 Million Extraction Partnership for Hemp Processing at Sherbrooke Facility  PRNewswireNeptune Wellness Solutions (NEPT) Reports $16.5M Extraction Partnership for Hemp Processing at Sherbrooke Facility  StreetInsider.comWhy Neptune Wellness Solutions Shares Rose Almost 9% Today  NasdaqNeptune Wellness Signs $16.5M Extraction Partnership  BenzingaNeptune Wellness Solutions Inc.  MENAFN.COMView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/neptune-announces-16-5-million-extraction-partnership-for-hemp-processing-at-sherbrooke-facility-301061389.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 11:00:00 GMT</td>    <td>Neptune Appoints Robert DiPede as Senior Vice President of Biodroga and Health & Wellness Innovation - PRNewswire</td>    <td>Neptune Appoints Robert DiPede as Senior Vice President of Biodroga and Health & Wellness Innovation  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/neptune-appoints-robert-dipede-as-senior-vice-president-of-biodroga-and-health--wellness-innovation-301068848.html">Link</a></td>  </tr><tr>    <td>Mon, 25 May 2020 12:53:32 GMT</td>    <td>Neptune Wellness Solutions Inc (NASDAQ:NEPT) Expects To Post Revenues Of $22 Million In Q1 2021: Introduces Non-Contact Infrared Thermometer – Neptune Air - MMJObserver | Medical Marijuana, Cannabis, & Hemp News - MMJ Observer</td>    <td>Neptune Wellness Solutions Inc (NASDAQ:NEPT) Expects To Post Revenues Of $22 Million In Q1 2021: Introduces Non-Contact Infrared Thermometer – Neptune Air - MMJObserver | Medical Marijuana, Cannabis, & Hemp News  MMJ Observer</td>    <td><a target="_blank" href="https://www.mmjobserver.com/neptune-wellness-solutions-inc-nasdaqnept-expects-to-post-revenues-of-22-million-in-q1-2021-introduces-non-contact-infrared-thermometer-neptune-air/33610/">Link</a></td>  </tr></table><h3>431. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-CUR">Neuralstem, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 10:30:00 GMT</td>    <td>Form 10-Q Seneca Biopharma, Inc. For: Mar 31 - StreetInsider.com</td>    <td>Form 10-Q Seneca Biopharma, Inc. For: Mar 31  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/SEC+Filings/Form+10-Q+Seneca+Biopharma%2C+Inc.+For%3A+Mar+31/16889361.html">Link</a></td>  </tr><tr>    <td>Tue, 29 Oct 2019 07:00:00 GMT</td>    <td>Local biopharma rebrands as part of commercialization strategy - Washington Business Journal</td>    <td>Local biopharma rebrands as part of commercialization strategy  Washington Business Journal</td>    <td><a target="_blank" href="https://www.bizjournals.com/washington/news/2019/10/29/local-biopharma-rebrands-as-part-of.html">Link</a></td>  </tr><tr>    <td>Mon, 25 May 2020 09:16:53 GMT</td>    <td>Ceramic Orthodontic Retainer Market Climbs on Positive Outlook of Booming Sales - Bandera County Courier</td>    <td>Ceramic Orthodontic Retainer Market Climbs on Positive Outlook of Booming Sales  Bandera County Courier</td>    <td><a target="_blank" href="https://www.bccourier.com/ceramic-orthodontic-retainer-market-climbs-on-positive-outlook-of-booming-sales/">Link</a></td>  </tr></table><h3>432. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NBIX">Neurocrine Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 17:38:00 GMT</td>    <td>Should You Avoid Neurocrine Biosciences, Inc. (NBIX)? - Yahoo Finance</td>    <td>Should You Avoid Neurocrine Biosciences, Inc. (NBIX)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/avoid-neurocrine-biosciences-inc-nbix-173839642.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Neurocrine Biosciences Exercises Option to License Idorsia's Novel Treatment for Rare Pediatric Epilepsy - Yahoo Finance</td>    <td>Neurocrine Biosciences Exercises Option to License Idorsia's Novel Treatment for Rare Pediatric Epilepsy  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/neurocrine-biosciences-exercises-option-license-200100711.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 14:21:03 GMT</td>    <td>Neurocrine Biosciences, Inc.’s (NASDAQ:NBIX) Stock Is Going Strong: Is the Market Following Fundamentals? - Simply Wall St</td>    <td>Neurocrine Biosciences, Inc.’s (NASDAQ:NBIX) Stock Is Going Strong: Is the Market Following Fundamentals?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-inc-s-nasdaqnbix-stock-is-going-strong-is-the-market-following-fundamentals/">Link</a></td>  </tr></table><h3>433. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NTRP">Neurotrope, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company - PRNewswire</td>    <td>Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/neurotrope-and-metuchen-pharmaceuticals-announce-merger-agreement-to-form-petros-pharmaceuticals-a-mens-health-company-301060769.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Neurotrope, Metuchen Pharmaceuticals Merge to Form Petros Pharmaceuticals - njbmagazine.com</td>    <td>Neurotrope, Metuchen Pharmaceuticals Merge to Form Petros Pharmaceuticals  njbmagazine.com</td>    <td><a target="_blank" href="https://njbmagazine.com/njb-news-now/neurotrope-metuchen-pharmaceuticals-merge-to-form-petros-pharmaceuticals/">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 13:00:00 GMT</td>    <td>Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer's Disease - PRNewswire</td>    <td>Neurotrope Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer's Disease  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/neurotrope-launches-new-long-term-clinical-trial-of-bryostatin-with-the-national-institutes-of-health-for-the-treatment-of-patients-with-alzheimers-disease-301066973.html">Link</a></td>  </tr></table><h3>434. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NLNK">NewLink Genetics Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 20:15:38 GMT</td>    <td>Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities - GlobeNewswire</td>    <td>Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040534/0/en/Lumos-Pharma-Reports-First-Quarter-2020-Results-and-Provides-Update-on-Clinical-and-Corporate-Activities.html">Link</a></td>  </tr><tr>    <td>Wed, 18 Mar 2020 12:02:32 GMT</td>    <td>NewLink Genetics Stockholders Approve Merger with Lumos Pharma - GlobeNewswire</td>    <td>NewLink Genetics Stockholders Approve Merger with Lumos Pharma  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/03/18/2002543/0/en/NewLink-Genetics-Stockholders-Approve-Merger-with-Lumos-Pharma.html">Link</a></td>  </tr><tr>    <td>Fri, 28 Feb 2020 08:00:00 GMT</td>    <td>NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/02/28/1992734/0/en/NewLink-Genetics-Reports-Fourth-Quarter-and-Full-Year-2019-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr></table><h3>435. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NXTC">NextCure</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 21:26:58 GMT</td>    <td>NextCure Reports First Quarter 2020 Financial Results Nasdaq:NXTC - GlobeNewswire</td>    <td>NextCure Reports First Quarter 2020 Financial Results Nasdaq:NXTC  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2030029/0/en/NextCure-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:12:50 GMT</td>    <td>NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting - GlobeNewswire</td>    <td>NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040908/0/en/NextCure-Presents-Biomarker-Data-and-Updated-Clinical-Results-from-Phase-1-Portion-of-its-NC318-Clinical-Trial-at-the-2020-Virtual-American-Society-of-Clinical-Oncology-Annual-Meet.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 12:29:37 GMT</td>    <td>NextCure to Present at BofA Securities Virtual Health Care Conference - GlobeNewswire</td>    <td>NextCure to Present at BofA Securities Virtual Health Care Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028395/0/en/NextCure-to-Present-at-BofA-Securities-Virtual-Health-Care-Conference.html">Link</a></td>  </tr></table><h3>436. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NGM">NGM Biopharmaceuticals</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 20:26:38 GMT</td>    <td>NGM Bio Provides Business Update and Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>NGM Bio Provides Business Update and Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032988/0/en/NGM-Bio-Provides-Business-Update-and-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>NGM Biopharmaceuticals: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>NGM Biopharmaceuticals: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/NGM-Biopharmaceuticals-1Q-Earnings-Snapshot-15268074.php">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 16:34:10 GMT</td>    <td>Did You Miss NGM Biopharmaceuticals’ (NASDAQ:NGM) 46% Share Price Gain? - Simply Wall St</td>    <td>Did You Miss NGM Biopharmaceuticals’ (NASDAQ:NGM) 46% Share Price Gain?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ngm/ngm-biopharmaceuticals/news/did-you-miss-ngm-biopharmaceuticals-nasdaqngm-46-share-price-gain/">Link</a></td>  </tr></table><h3>437. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NITE">Nightstar Therapeutics plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 07 Jun 2019 07:00:00 GMT</td>    <td>Nightstar Therapeutics PLC Completion of Acquisition by Biogen - GlobeNewswire</td>    <td>Nightstar Therapeutics PLC Completion of Acquisition by Biogen  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/06/07/1865786/0/en/Nightstar-Therapeutics-PLC-Completion-of-Acquisition-by-Biogen.html">Link</a></td>  </tr><tr>    <td>Mon, 04 Mar 2019 08:00:00 GMT</td>    <td>Nightstar Therapeutics plc reaches agreement to be acquired by Biogen - GlobeNewswire</td>    <td>Nightstar Therapeutics plc reaches agreement to be acquired by Biogen  GlobeNewswireNightstar Therapeutics' stock rockets on Biogen buyout deal valued at $877 million  MarketWatchBiogen to buy Nightstar Therapeutics in $800 mln cash deal  ReutersStock Market Today: Biogen Buys Gene Therapy Company Nightstar Therapeutics  The Motley FoolBiogen Buys Gene Therapy for Rare Eye Disease  The Wall Street JournalView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/03/04/1745685/0/en/Nightstar-Therapeutics-plc-reaches-agreement-to-be-acquired-by-Biogen.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 11:27:40 GMT</td>    <td>Global Ophthalmology Drugs Market Opportunities and Strategies (2019 to 2030) - COVID-19 Impact and Recovery - GlobeNewswire</td>    <td>Global Ophthalmology Drugs Market Opportunities and Strategies (2019 to 2030) - COVID-19 Impact and Recovery  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040100/0/en/Global-Ophthalmology-Drugs-Market-Opportunities-and-Strategies-2019-to-2030-COVID-19-Impact-and-Recovery.html">Link</a></td>  </tr></table><h3>438. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NOVN">Novan, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 17:30:00 GMT</td>    <td>Novan, Inc. (NOVN): Share Tumbled 0.37% last week: What Happened? - The News Heater</td>    <td>Novan, Inc. (NOVN): Share Tumbled 0.37% last week: What Happened?  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/02/novan-inc-novn-share-tumbled-0-37-last-week-what-happened/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 09:20:00 GMT</td>    <td>Piper Jaffray slashes price target on Novan Inc. [NOVN] – find out why. - The DBT News</td>    <td>Piper Jaffray slashes price target on Novan Inc. [NOVN] – find out why.  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/02/piper-jaffray-slashes-price-target-on-novan-inc-novn-find-out-why-2/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:40:00 GMT</td>    <td>Killer Stocks to Buy That No One Knows About: Novan Inc. (NASDAQ:NOVN), Coeur Mining Inc. (NYSE:CDE) - State Reviewer</td>    <td>Killer Stocks to Buy That No One Knows About: Novan Inc. (NASDAQ:NOVN), Coeur Mining Inc. (NYSE:CDE)  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/killer-stocks-to-buy-that-no-one-knows-about-novan-inc-nasdaqnovn-coeur-mining-inc-nysecde/">Link</a></td>  </tr></table><h3>439. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NVAX">Novavax, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:00:00 GMT</td>    <td>Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine - Yahoo Finance</td>    <td>Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine  Yahoo FinanceNovavax partners with contract drugmaker for COVID-19 vaccine manufacturing  Financial PostNovavax Selects AGC Biologics To Manufacture Novel COVID-19 Vax  Contract PharmaNovavax (NVAX) Selects AGC Biologics to Manufacture Matrix-M Adjuvant for Novel COVID-19 Vaccine  StreetInsider.comView Full Coverage on Google News</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/novavax-selects-agc-biologics-manufacture-110000414.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 12:39:00 GMT</td>    <td>Novavax buys Czech manufacturing plant to boost production of coronavirus vaccine candidate - Washington Business Journal</td>    <td>Novavax buys Czech manufacturing plant to boost production of coronavirus vaccine candidate  Washington Business JournalNovavax Jumps After Starting Covid-19 Vaccine Study  BloombergNovavax Analyst Sees Leading Contender In Coronavirus Vaccine Race  BenzingaNovavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine  GlobeNewswireNovavax Buys Praha Vaccines for $167 Million to Boost COVID-19 Vaccine Production  The New York TimesView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.bizjournals.com/washington/news/2020/05/28/novavax-buys-praha-vaccines.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Novavax Inc. (NVAX) Plunges 10.86% on June 03 - Equities.com</td>    <td>Novavax Inc. (NVAX) Plunges 10.86% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/novavax-inc-nvax-plunges-10-86-on-june-03">Link</a></td>  </tr></table><h3>440. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NVLN">Novelion Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 10:57:56 GMT</td>    <td>Potential Impact of Covid-19 Outbreak On HIV-Associated Lipodystrophy Treatment Market Size, Share, Geographic Segmentation and Forecast to 2027 | Theratechnologies Inc., GlaxoSmithKline plc, Novelion Therapeutics Inc., AstraZeneca plc, AbbVie Inc - Cole of Duty</td>    <td>Potential Impact of Covid-19 Outbreak On HIV-Associated Lipodystrophy Treatment Market Size, Share, Geographic Segmentation and Forecast to 2027 | Theratechnologies Inc., GlaxoSmithKline plc, Novelion Therapeutics Inc., AstraZeneca plc, AbbVie Inc  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/06/01/potential-impact-of-covid-19-outbreak-on-hiv-associated-lipodystrophy-treatment-market-size-share-geographic-segmentation-and-forecast-to-2027-theratechnologies-inc-glaxosmithkline-plc-novelion/">Link</a></td>  </tr><tr>    <td>Fri, 03 Jan 2020 08:00:00 GMT</td>    <td>Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters - GlobeNewswire</td>    <td>Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/01/03/1966000/0/en/Novelion-Therapeutics-Provides-Updates-on-Voluntary-Liquidation-and-Other-Matters.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Movers & Shakers, May 22 | BioSpace - BioSpace</td>    <td>Movers & Shakers, May 22 | BioSpace  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/biospace-movers-and-shakers-may-22/">Link</a></td>  </tr></table><h3>441. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NVUS">Novus Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:30:00 GMT</td>    <td>Novus Therapeutics Announces Topline Results of Phase 2a Clinical Trial of OP0201 in Acute Otitis Media - Business Wire</td>    <td>Novus Therapeutics Announces Topline Results of Phase 2a Clinical Trial of OP0201 in Acute Otitis Media  Business WireNovus Therapeutics stock loses nearly half its value after disappointing drug trial results  MarketWatchNovus Therapeutics, Inc. (NVUS): What is good about stock?  Marketing SentinelNovus Therapeutics Inc. (NVUS) moved down -53.55%: Novus Therapeutics Inc. Price Paint Picture of volatility  State ReviewerNovus Therapeutics down big on failed ear infection study  Seeking AlphaView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200601005267/en/Novus-Therapeutics-Announces-Topline-Results-Phase-2a">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Novus Therapeutics Reports First Quarter 2020 Financial Results - Business Wire</td>    <td>Novus Therapeutics Reports First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200515005049/en/Novus-Therapeutics-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Sat, 30 May 2020 22:39:00 GMT</td>    <td>Hedge Funds Watching Novus Therapeutics, Inc. (NVUS) From Afar - Yahoo Finance</td>    <td>Hedge Funds Watching Novus Therapeutics, Inc. (NVUS) From Afar  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-watching-novus-therapeutics-223935318.html">Link</a></td>  </tr></table><h3>442. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NCNA">NuCana plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:59:00 GMT</td>    <td>Why NuCana (NCNA) Stock Might be a Great Pick - Yahoo Finance</td>    <td>Why NuCana (NCNA) Stock Might be a Great Pick  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-nucana-ncna-stock-might-125912864.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>NuCana Announces Re-Opening of Global Phase III Study of Acelarin Plus Cisplatin in Patients with Biliary Tract Cancer (NuTide:121) - GlobeNewswire</td>    <td>NuCana Announces Re-Opening of Global Phase III Study of Acelarin Plus Cisplatin in Patients with Biliary Tract Cancer (NuTide:121)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027874/0/en/NuCana-Announces-Re-Opening-of-Global-Phase-III-Study-of-Acelarin-Plus-Cisplatin-in-Patients-with-Biliary-Tract-Cancer-NuTide-121.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 11:14:22 GMT</td>    <td>NuCana Announces the Re-Opening of Enrollment in Multiple Clinical Studies After Temporary Pause Due to COVID-19 Pandemic - GlobeNewswire</td>    <td>NuCana Announces the Re-Opening of Enrollment in Multiple Clinical Studies After Temporary Pause Due to COVID-19 Pandemic  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2034839/0/en/NuCana-Announces-the-Re-Opening-of-Enrollment-in-Multiple-Clinical-Studies-After-Temporary-Pause-Due-to-COVID-19-Pandemic.html">Link</a></td>  </tr></table><h3>443. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NXTM">NxStage Medical, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:33:00 GMT</td>    <td>Kidney Dialysis Centers Market 2020 Business Scenario – B. Braun Melsungen Ag, Baxter International Inc., Fresenius Medical Care Ag & Co. Kgaa, Davita Inc., Nipro Corporation, Diaverum, Asahi Kasei Corporation, Nikkiso Co., Ltd, Medivators Inc., Nxstage Medical, Inc. - 3rd Watch News</td>    <td>Kidney Dialysis Centers Market 2020 Business Scenario – B. Braun Melsungen Ag, Baxter International Inc., Fresenius Medical Care Ag & Co. Kgaa, Davita Inc., Nipro Corporation, Diaverum, Asahi Kasei Corporation, Nikkiso Co., Ltd, Medivators Inc., Nxstage Medical, Inc.  3rd Watch NewsGLOBAL HEMODIALYSIS EQUIPMENTS MARKET ANALYSIS REPORT PROMISING INDUSTRY BRIGHT FUTURE A REPORT BY FRESENIUS MEDICAL CARE AG & CO. KGAA , DAVITA INC., BAXTER INTERNATIONAL, INC., B. BRAUN MELSUNGEN AG  Jewish Life NewsHemodialysis and Peritoneal Dialysis Market Growth Trends Analysis and Dynamic Demand, Forecast 2017 to 2025  Cole of DutyHemodialysis Catheter Market New Era Of Industry and Forecast 2017-2025 – Medic Reports  Medic InsiderView Full Coverage on Google News</td>    <td><a target="_blank" href="https://3wnews.org/industry/1156358/kidney-dialysis-centers-market-2020-business-scenario-b-braun-melsungen-ag-baxter-international-inc-fresenius-medical-care-ag-co-kgaa-davita-inc-nipro-corporation-diaverum-as/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 11:05:00 GMT</td>    <td>Impact of Corona virus on Kidney Dialysis Equipment Market by 2027 | Top Key Players Nipro Corporation, B. Braun Melsungen AG, Nikkiso Co, Ltd., Asahi Kasei Corporation, NxStage Medical, Inc - Surfacing Magazine</td>    <td>Impact of Corona virus on Kidney Dialysis Equipment Market by 2027 | Top Key Players Nipro Corporation, B. Braun Melsungen AG, Nikkiso Co, Ltd., Asahi Kasei Corporation, NxStage Medical, Inc  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/impact-of-corona-virus-on-kidney-dialysis-equipment-market-by-2027-top-key-players-nipro-corporation-b-braun-melsungen-ag-nikkiso-co-ltd-asahi-kasei-corporation-nxstage-medical-inc/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 22:38:21 GMT</td>    <td>Hemodialysis and Peritoneal Dialysis Market 2020 Analysis, Demand And Growth Forecast | By Industry Players Like B. Braun Melsungen AG, Diaverum, Nipro, Nxstage Medical, Inc., Nikkiso Co., Ltd. - Bulletin Line</td>    <td>Hemodialysis and Peritoneal Dialysis Market 2020 Analysis, Demand And Growth Forecast | By Industry Players Like B. Braun Melsungen AG, Diaverum, Nipro, Nxstage Medical, Inc., Nikkiso Co., Ltd.  Bulletin Line</td>    <td><a target="_blank" href="https://bulletinline.com/2020/06/03/hemodialysis-and-peritoneal-dialysis-market/">Link</a></td>  </tr></table><h3>444. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-NYMX">Nymox Pharmaceutical Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91% - Yahoo Finance</td>    <td>If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91%  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/had-bought-nymox-pharmaceutical-nasdaq-130814072.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 11:56:06 GMT</td>    <td>Should You Worry About Nymox Pharmaceutical Corporation’s (NASDAQ:NYMX) CEO Pay? - Simply Wall St</td>    <td>Should You Worry About Nymox Pharmaceutical Corporation’s (NASDAQ:NYMX) CEO Pay?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/should-you-worry-about-nymox-pharmaceutical-corporations-nasdaqnymx-ceo-pay/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 05:41:55 GMT</td>    <td>Benign Prostatic Hyperplasia Testing Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: AEternaZentaris, Astellas Pharma, Eli Lilly and Company, IntelGenx Technologies Corp, Nymox Pharmaceutical Corporation, etc. | InForGrowth - News Distinct</td>    <td>Benign Prostatic Hyperplasia Testing Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: AEternaZentaris, Astellas Pharma, Eli Lilly and Company, IntelGenx Technologies Corp, Nymox Pharmaceutical Corporation, etc. | InForGrowth  News Distinct</td>    <td><a target="_blank" href="https://www.newsdistinct.com/benign-prostatic-hyperplasia-testing-market-2020-know-the-latest-covid19-impact-analysis-and-strategies-of-key-players-aeternazentaris-astellas-pharma-eli-lilly-and-company-intelgenx-technologie/">Link</a></td>  </tr></table><h3>445. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OASM">Oasmia Pharmaceutical AB</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>BRIEF-Oasmia Pharmaceutical: Outcome Of Strategic Review To Deliver Long-Term, Profitable Growth As A Specialty Pharma Company - Reuters</td>    <td>BRIEF-Oasmia Pharmaceutical: Outcome Of Strategic Review To Deliver Long-Term, Profitable Growth As A Specialty Pharma Company  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-oasmia-pharmaceutical-outcome-of-s/brief-oasmia-pharmaceutical-outcome-of-strategic-review-to-deliver-long-term-profitable-growth-as-a-specialty-pharma-company-idUSFWN2CV092">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:50:00 GMT</td>    <td>Global Estrogen Receptor Beta market 2019 ? 2025 analysis examined in new market research report - Jewish Life News</td>    <td>Global Estrogen Receptor Beta market 2019 ? 2025 analysis examined in new market research report  Jewish Life News</td>    <td><a target="_blank" href="https://jewishlifenews.com/uncategorized/global-estrogen-receptor-beta-market-2019-2025-analysis-examined-in-new-market-research-report/">Link</a></td>  </tr><tr>    <td>Mon, 30 Dec 2019 08:00:00 GMT</td>    <td>Oasmia Pharmaceutical AB (publ) Interim report for the period May 1 – October 31, 2019 - GlobeNewswire</td>    <td>Oasmia Pharmaceutical AB (publ) Interim report for the period May 1 – October 31, 2019  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/12/30/1964781/0/en/Oasmia-Pharmaceutical-AB-publ-Interim-report-for-the-period-May-1-October-31-2019.html">Link</a></td>  </tr></table><h3>446. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OBSV">ObsEva SA</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 05:15:20 GMT</td>    <td>ObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020 - GlobeNewswire</td>    <td>ObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040652/0/en/ObsEva-SA-to-present-at-the-Jefferies-Virtual-Healthcare-Conference-June-3rd-2020.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 20:44:44 GMT</td>    <td>ObsEva Annual General Meeting 2020 Nasdaq:OBSV - GlobeNewswire</td>    <td>ObsEva Annual General Meeting 2020 Nasdaq:OBSV  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030584/0/en/ObsEva-Annual-General-Meeting-2020.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 08:40:31 GMT</td>    <td>ObsEva Announces First Quarter 2020 Financial Results and Business Update - GlobeNewswire</td>    <td>ObsEva Announces First Quarter 2020 Financial Results and Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027284/0/en/ObsEva-Announces-First-Quarter-2020-Financial-Results-and-Business-Update.html">Link</a></td>  </tr></table><h3>447. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OCUL">Ocular Therapeutix, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock - Business Wire</td>    <td>Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200519005934/en/Ocular-Therapeutix%E2%84%A2-Announces-Proposed-Public-Offering-Common">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Ocular Therapeutix™ Announces Pricing of Public Offering of Common Stock - Yahoo Finance</td>    <td>Ocular Therapeutix™ Announces Pricing of Public Offering of Common Stock  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/ocular-therapeutix-announces-pricing-public-113000795.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Ocular Therapeutix(TM) To Present New Data at the American Society of Cataract and Refractive Surgery (ASCRS) 2020 Virtual Annual Meeting - Stockhouse</td>    <td>Ocular Therapeutix(TM) To Present New Data at the American Society of Cataract and Refractive Surgery (ASCRS) 2020 Virtual Annual Meeting  Stockhouse</td>    <td><a target="_blank" href="https://stockhouse.com/news/press-releases/2020/05/11/ocular-therapeutix-tm-to-present-new-data-at-the-american-society-of-cataract">Link</a></td>  </tr></table><h3>448. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ODT">Odonate Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 12:31:02 GMT</td>    <td>Odonate Therapeutics to Present at the Jefferies Virtual Healthcare Conference - Valdosta Daily Times</td>    <td>Odonate Therapeutics to Present at the Jefferies Virtual Healthcare Conference  Valdosta Daily Times</td>    <td><a target="_blank" href="https://www.valdostadailytimes.com/news/business/odonate-therapeutics-to-present-at-the-jefferies-virtual-healthcare-conference/article_f00ce548-8129-507e-a922-fe48ab2e336b.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Were Hedge Funds Right About Odonate Therapeutics, Inc. (ODT)? - Yahoo Finance</td>    <td>Were Hedge Funds Right About Odonate Therapeutics, Inc. (ODT)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/were-hedge-funds-odonate-therapeutics-140453855.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 11:53:27 GMT</td>    <td>Why Odonate Therapeutics (ODT) Stock Might be a Great Pick - Zacks.com</td>    <td>Why Odonate Therapeutics (ODT) Stock Might be a Great Pick  Zacks.com</td>    <td><a target="_blank" href="https://www.zacks.com/stock/news/949012/why-odonate-therapeutics-odt-stock-might-be-a-great-pick">Link</a></td>  </tr></table><h3>449. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OHRP">Ohr Pharmaceutical, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 25 May 2020 03:25:14 GMT</td>    <td>Global Fibroblast Growth Factor 2 Market 2020 to Witness Huge Growth by 2020 | ID Pharma Co Ltd, Kringle Pharma Inc, Ohr Pharmaceutical Inc, Ribomic Inc | Impact of COVID-19 - Bandera County Courier</td>    <td>Global Fibroblast Growth Factor 2 Market 2020 to Witness Huge Growth by 2020 | ID Pharma Co Ltd, Kringle Pharma Inc, Ohr Pharmaceutical Inc, Ribomic Inc | Impact of COVID-19  Bandera County Courier</td>    <td><a target="_blank" href="https://www.bccourier.com/global-fibroblast-growth-factor-2-market-2020-to-witness-huge-growth-by-2020-id-pharma-co-ltd-kringle-pharma-inc-ohr-pharmaceutical-inc-ribomic-inc-impact-of-covid-19/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 04:38:00 GMT</td>    <td>Global Fibroblast Growth Factor 2 Market 2020 Industry Dynamics – ID Pharma Co Ltd, Ribomic Inc, Kringle Pharma Inc - Jewish Life News</td>    <td>Global Fibroblast Growth Factor 2 Market 2020 Industry Dynamics – ID Pharma Co Ltd, Ribomic Inc, Kringle Pharma Inc  Jewish Life News</td>    <td><a target="_blank" href="https://jewishlifenews.com/uncategorized/global-fibroblast-growth-factor-2-market-2020-industry-dynamics-id-pharma-co-ltd-ribomic-inc-kringle-pharma-inc/">Link</a></td>  </tr><tr>    <td>Wed, 10 Jul 2019 07:00:00 GMT</td>    <td>Ohr Pharmaceutical, Inc. Announces Stockholder Approval of Merger Agreement with NeuBase Therapeutics, Inc. - GlobeNewswire</td>    <td>Ohr Pharmaceutical, Inc. Announces Stockholder Approval of Merger Agreement with NeuBase Therapeutics, Inc.  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/07/10/1881037/0/en/Ohr-Pharmaceutical-Inc-Announces-Stockholder-Approval-of-Merger-Agreement-with-NeuBase-Therapeutics-Inc.html">Link</a></td>  </tr></table><h3>450. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OMER">Omeros Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 20:02:00 GMT</td>    <td>Omeros Corporation Reports First Quarter 2020 Financial Results - Business Wire</td>    <td>Omeros Corporation Reports First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200511005841/en/Omeros-Corporation-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Omeros Corporation Announces Presentation of Narsoplimab Pivotal Trial Data at Upcoming European Hematology Association Annual Congress - Yahoo Finance</td>    <td>Omeros Corporation Announces Presentation of Narsoplimab Pivotal Trial Data at Upcoming European Hematology Association Annual Congress  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/omeros-corporation-announces-presentation-narsoplimab-130000063.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Omeros Corporation to Announce First Quarter Financial Results on May 11, 2020 - Yahoo Finance</td>    <td>Omeros Corporation to Announce First Quarter Financial Results on May 11, 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/omeros-corporation-announce-first-quarter-110000029.html">Link</a></td>  </tr></table><h3>451. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ONCY">Oncolytics Biotech Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Oncolytics Biotech® Reports 2020 First Quarter Financial Results and Operational Highlights - BioSpace</td>    <td>Oncolytics Biotech® Reports 2020 First Quarter Financial Results and Operational Highlights  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/oncolytics-biotech-reports-2020-first-quarter-financial-results-and-operational-highlights/">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 11:34:29 GMT</td>    <td>Oncolytics Biotech® Presents Clinical Data Supporting a Predictive Biomarker of Pelareorep Response in Breast Cancer at the ESMO Breast Cancer Virtual Meeting - BioSpace</td>    <td>Oncolytics Biotech® Presents Clinical Data Supporting a Predictive Biomarker of Pelareorep Response in Breast Cancer at the ESMO Breast Cancer Virtual Meeting  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/oncolytics-biotech-presents-clinical-data-supporting-a-predictive-biomarker-of-pelareorep-response-in-breast-cancer-at-the-esmo-breast-cancer-virtual-meeting/">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Oncolytics Biotech® to Present at the RBC Global Healthcare Conference - Yahoo Finance</td>    <td>Oncolytics Biotech® to Present at the RBC Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/oncolytics-biotech-present-rbc-global-110000896.html">Link</a></td>  </tr></table><h3>452. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OMED">OncoMed Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 10:40:58 GMT</td>    <td>Research on Bispecific Antibodies Market (impact of COVID-19) with Top Players: AbbVie, Janssen Biotech, Amgen, Inc., Bayer AG, Immunocore Limited, Celgene, Ganymed Pharmaceuticals, OncoMed Pharmaceuticals, and Others - WaterCloud News</td>    <td>Research on Bispecific Antibodies Market (impact of COVID-19) with Top Players: AbbVie, Janssen Biotech, Amgen, Inc., Bayer AG, Immunocore Limited, Celgene, Ganymed Pharmaceuticals, OncoMed Pharmaceuticals, and Others  WaterCloud News</td>    <td><a target="_blank" href="https://news.watercloudsolutions.com/news/257267/research-on-bispecific-antibodies-market-impact-of-covid-19-with-top-players-abbvie-janssen-biotech-amgen-inc-bayer-ag-immunocore-limited-celgene-ganymed-pharmaceuticals-oncomed-pharmaceut/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Atara Biotherapeutics Names Cell Therapy & Oncology Leader Jakob Dupont, M.D. as Global Head of Research & Development - Business Wire</td>    <td>Atara Biotherapeutics Names Cell Therapy & Oncology Leader Jakob Dupont, M.D. as Global Head of Research & Development  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200514005828/en/%C2%A0Atara-Biotherapeutics-Names-Cell-Therapy-Oncology-Leader">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 12:01:00 GMT</td>    <td>Cowden Syndrome Treatment Market Share, Growth, Trend Analysis and Forecast from 2020-2026; Consumption Capacity by Volume and Production Value - Weekly Wall</td>    <td>Cowden Syndrome Treatment Market Share, Growth, Trend Analysis and Forecast from 2020-2026; Consumption Capacity by Volume and Production Value  Weekly Wall</td>    <td><a target="_blank" href="https://weeklywall.com/cowden-syndrome-treatment-market-share-growth-trend-analysis-and-forecast-from-2020-2026-consumption-capacity-by-volume-and-production-value/">Link</a></td>  </tr></table><h3>453. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ONTX">Onconova Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 20:16:00 GMT</td>    <td>Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033864/0/en/Onconova-Therapeutics-Provides-Corporate-Update-and-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 12:09:43 GMT</td>    <td>Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders - GlobeNewswire</td>    <td>Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031041/0/en/Onconova-Therapeutics-Announces-Virtual-Format-for-2020-Annual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 12:11:26 GMT</td>    <td>Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020 - GlobeNewswire</td>    <td>Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029360/0/en/Onconova-Therapeutics-to-Provide-Corporate-Update-and-First-Quarter-2020-Earnings-on-May-14-2020.html">Link</a></td>  </tr></table><h3>454. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ONCS">OncoSec Medical Incorporated</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>OncoSec's TAVO™ Receives ATMP Certification from European Medicines Agency to Support Marketing Authorization Application in Metastatic Melanoma - PRNewswire</td>    <td>OncoSec's TAVO™ Receives ATMP Certification from European Medicines Agency to Support Marketing Authorization Application in Metastatic Melanoma  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/oncosecs-tavo-receives-atmp-certification-from-european-medicines-agency-to-support-marketing-authorization-application-in-metastatic-melanoma-301058550.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>OncoSec to Present Two Late-Breaking Pre-Clinical Abstracts on TAVO-PLUS at the American Association for Cancer Research (AACR) Virtual Annual Meeting II - Yahoo Finance</td>    <td>OncoSec to Present Two Late-Breaking Pre-Clinical Abstracts on TAVO-PLUS at the American Association for Cancer Research (AACR) Virtual Annual Meeting II  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/oncosec-present-two-breaking-pre-130000081.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 14:37:59 GMT</td>    <td>Can We See Significant Institutional Ownership On The OncoSec Medical Incorporated (NASDAQ:ONCS) Share Register? - Simply Wall St</td>    <td>Can We See Significant Institutional Ownership On The OncoSec Medical Incorporated (NASDAQ:ONCS) Share Register?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/can-we-see-significant-institutional-ownership-on-the-oncosec-medical-incorporated-nasdaqoncs-share-register/">Link</a></td>  </tr></table><h3>455. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OPHT">Ophthotech Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 04:31:02 GMT</td>    <td>A Global Digital Media Network - Digital Journal</td>    <td>A Global Digital Media Network  Digital Journal</td>    <td><a target="_blank" href="http://m.digitaljournal.com/pr/4700918">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 14:14:36 GMT</td>    <td>Covid 19 Analysis: Aptamers Market 2026 Focus On Research Methodology, Market Dynamics | Top Key Players Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, SomaLogic, Inc., NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies and Vivonics Inc. - Surfacing Magazine</td>    <td>Covid 19 Analysis: Aptamers Market 2026 Focus On Research Methodology, Market Dynamics | Top Key Players Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, SomaLogic, Inc., NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies and Vivonics Inc.  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/covid-19-analysis-aptamers-market-2026-focus-on-research-methodology-market-dynamics-top-key-players-ophthotech-corporation-aptamer-sciences-inc-novartis-ag-somalogic-inc-neoneuro-sas-apt/">Link</a></td>  </tr><tr>    <td>Tue, 16 Apr 2019 07:00:00 GMT</td>    <td>Ophthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases and Changes Name to IVERIC bio - Business Wire</td>    <td>Ophthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases and Changes Name to IVERIC bio  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20190416005282/en/Ophthotech-Transitions-Gene-Therapy-Focused-Company-Developing">Link</a></td>  </tr></table><h3>456. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OPK">Opko Health, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:15:00 GMT</td>    <td>OPKO Health, Inc. (OPK) Management Presents at Jefferies Virtual Healthcare Conference (Transcript) - Seeking Alpha</td>    <td>OPKO Health, Inc. (OPK) Management Presents at Jefferies Virtual Healthcare Conference (Transcript)  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4351815-opko-health-inc-opk-management-presents-jefferies-virtual-healthcare-conference-transcript">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:57:00 GMT</td>    <td>Here's Why You Should Invest in OPKO Health (OPK) Stock Now - Yahoo Finance</td>    <td>Here's Why You Should Invest in OPKO Health (OPK) Stock Now  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/heres-why-invest-opko-health-125712809.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 12:50:00 GMT</td>    <td>How OPKO Health (OPK) Stock Stands Out in a Strong Industry - Yahoo Finance</td>    <td>How OPKO Health (OPK) Stock Stands Out in a Strong Industry  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/opko-health-opk-stock-stands-125012030.html">Link</a></td>  </tr></table><h3>457. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OPTN">OptiNose, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 20:33:18 GMT</td>    <td>Optinose to Host its Annual Meeting of Stockholders in Virtual Format - GlobeNewswire</td>    <td>Optinose to Host its Annual Meeting of Stockholders in Virtual Format  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039764/0/en/Optinose-to-Host-its-Annual-Meeting-of-Stockholders-in-Virtual-Format.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>OptiNose, Inc. (OPTN) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>OptiNose, Inc. (OPTN) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/optinose-inc-optn-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>OptiNose, Inc. (OPTN) CEO Peter Miller on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>OptiNose, Inc. (OPTN) CEO Peter Miller on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4345801-optinose-inc-optn-ceo-peter-miller-on-q1-2020-results-earnings-call-transcript">Link</a></td>  </tr></table><h3>458. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ORMP">Oramed Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Oramed Pharmaceuticals to Present at the 80th American Diabetes Association Scientific Session, to be Held Virtually This Year in June - PRNewswire</td>    <td>Oramed Pharmaceuticals to Present at the 80th American Diabetes Association Scientific Session, to be Held Virtually This Year in June  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/oramed-pharmaceuticals-to-present-at-the-80th-american-diabetes-association-scientific-session-to-be-held-virtually-this-year-in-june-301052801.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 14:58:43 GMT</td>    <td>Imagine Owning Oramed Pharmaceuticals (NASDAQ:ORMP) While The Price Tanked 60% - Simply Wall St</td>    <td>Imagine Owning Oramed Pharmaceuticals (NASDAQ:ORMP) While The Price Tanked 60%  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ormp/oramed-pharmaceuticals/news/imagine-owning-oramed-pharmaceuticals-nasdaqormp-while-the-price-tanked-60/">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 13:51:27 GMT</td>    <td>Should You Take Comfort From Insider Transactions At Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)? - Simply Wall St</td>    <td>Should You Take Comfort From Insider Transactions At Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/should-you-take-comfort-from-insider-transactions-at-oramed-pharmaceuticals-inc-nasdaqormp/">Link</a></td>  </tr></table><h3>459. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ORTX">Orchard Therapeutics plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Were Hedge Funds Right About Orchard Therapeutics plc (ORTX)? - Yahoo Finance</td>    <td>Were Hedge Funds Right About Orchard Therapeutics plc (ORTX)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/were-hedge-funds-orchard-therapeutics-131443591.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Orchard Therapeutics: Q1 Earnings Insights - Benzinga</td>    <td>Orchard Therapeutics: Q1 Earnings Insights  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/news/earnings/20/05/15978663/orchard-therapeutics-q1-earnings-insights">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 10:01:00 GMT</td>    <td>Orchard Therapeutics Plc (ORTX) Highlights New Interim Data from OTL-203 Proof-of-Concept Study for MPS-I - StreetInsider.com</td>    <td>Orchard Therapeutics Plc (ORTX) Highlights New Interim Data from OTL-203 Proof-of-Concept Study for MPS-I  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Orchard+Therapeutics+Plc+%28ORTX%29+Highlights+New+Interim+Data+from+OTL-203+Proof-of-Concept+Study+for+MPS-I/16888667.html">Link</a></td>  </tr></table><h3>460. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ORGO">Organogenesis Holdings Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 20:13:59 GMT</td>    <td>Organogenesis Holdings Inc. Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Organogenesis Holdings Inc. Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031412/0/en/Organogenesis-Holdings-Inc-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Organogenesis Holdings Inc (ORGO) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Organogenesis Holdings Inc (ORGO) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/organogenesis-holdings-inc-orgo-q1-2020-earnings-c.aspx">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Organogenesis Holdings, Inc. (ORGO) CEO Gary Gillheeney on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Organogenesis Holdings, Inc. (ORGO) CEO Gary Gillheeney on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4346471-organogenesis-holdings-inc-orgo-ceo-gary-gillheeney-on-q1-2020-results-earnings-call">Link</a></td>  </tr></table><h3>461. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ONVO">Organovo Holdings, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Organovo Holdings Inc. (ONVO) Soars 2.16% on June 03 - Equities.com</td>    <td>Organovo Holdings Inc. (ONVO) Soars 2.16% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/organovo-holdings-inc-onvo-soars-2-16-on-june-03">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:20:00 GMT</td>    <td>Market cap of Organovo Holdings Inc. [ONVO] reaches 96.00M – now what? - The DBT News</td>    <td>Market cap of Organovo Holdings Inc. [ONVO] reaches 96.00M – now what?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/market-cap-of-organovo-holdings-inc-onvo-reaches-96-00m-now-what/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:09:00 GMT</td>    <td>Organovo Holdings Inc. (ONVO) Soars 9.06% on June 01 - Equities.com</td>    <td>Organovo Holdings Inc. (ONVO) Soars 9.06% on June 01  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/organovo-holdings-inc-onvo-soars-9-06-on-june-01">Link</a></td>  </tr></table><h3>462. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ORGS">Orgenesis Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 11:48:00 GMT</td>    <td>Orgenesis First Quarter 2020 Revenue Increases 348% to $1.9 Million Reflecting Success of CGT Biotech Platform - GlobeNewswire</td>    <td>Orgenesis First Quarter 2020 Revenue Increases 348% to $1.9 Million Reflecting Success of CGT Biotech Platform  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030989/0/en/Orgenesis-First-Quarter-2020-Revenue-Increases-348-to-1-9-Million-Reflecting-Success-of-CGT-Biotech-Platform.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Orgenesis sees 1Q revenue rocket driven by its Cell and Gene Therapy Biotech platform - Proactive Investors USA & Canada</td>    <td>Orgenesis sees 1Q revenue rocket driven by its Cell and Gene Therapy Biotech platform  Proactive Investors USA & Canada</td>    <td><a target="_blank" href="https://www.proactiveinvestors.com/companies/news/919275/orgenesis-sees-1q-revenue-rocket-driven-by-its-cell-and-gene-therapy-biotech-platform-919275.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 13:44:15 GMT</td>    <td>Orgenesis unveils plans to repurchase up to $10 million in stock - Proactive Investors USA & Canada</td>    <td>Orgenesis unveils plans to repurchase up to $10 million in stock  Proactive Investors USA & Canada</td>    <td><a target="_blank" href="https://www.proactiveinvestors.com/companies/news/919726/orgenesis-unveils-plans-to-repurchase-up-to-10-million-in-stock-919726.html">Link</a></td>  </tr></table><h3>463. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ORIC">Oric Pharmaceuticals</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 20:32:28 GMT</td>    <td>ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results - GlobeNewswire</td>    <td>ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036686/0/en/ORIC-Pharmaceuticals-Reports-First-Quarter-2020-Financial-and-Operational-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 10:30:00 GMT</td>    <td>ORIC Pharmaceuticals Announces Five Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting II - GlobeNewswire</td>    <td>ORIC Pharmaceuticals Announces Five Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting II  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039199/0/en/ORIC-Pharmaceuticals-Announces-Five-Presentations-at-the-2020-American-Association-for-Cancer-Research-Virtual-Annual-Meeting-II.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 10:32:15 GMT</td>    <td>ORIC Pharmaceuticals to Present at the Jefferies 2020 Global Healthcare Conference - GlobeNewswire</td>    <td>ORIC Pharmaceuticals to Present at the Jefferies 2020 Global Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038451/0/en/ORIC-Pharmaceuticals-to-Present-at-the-Jefferies-2020-Global-Healthcare-Conference.html">Link</a></td>  </tr></table><h3>464. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OSIR">Osiris Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 07:12:51 GMT</td>    <td>GLOBAL STEM CELL MARKET 2020-2026 | LEADING PLAYERS ADVANCED CELL TECHNOLOGY INC, OSIRIS THERAPEUTICS INC, CELGENE CORPORATION, BIOTIME, INC., CYNATA, STEMCELL TECHNOLOGIES INC., CELLULAR ENGINEERING TECHNOLOGIES INC – Distinct Analysis & Reports - News Distinct</td>    <td>GLOBAL STEM CELL MARKET 2020-2026 | LEADING PLAYERS ADVANCED CELL TECHNOLOGY INC, OSIRIS THERAPEUTICS INC, CELGENE CORPORATION, BIOTIME, INC., CYNATA, STEMCELL TECHNOLOGIES INC., CELLULAR ENGINEERING TECHNOLOGIES INC – Distinct Analysis & Reports  News DistinctCOVID-19 UPDATE: STEM CELL MANUFACTURING MARKET 2020 FUTURE GROWTH WITH TOP PLAYERS THERMO FISHER SCIENTIFIC. MERCK GROUP, BECTON, DICKINSON AND COMPANY. HOLOSTEM ADVANCED THERAPIES  Medic InsiderStem Cell Therapy Market Analysis and Demand 2017 – 2025  Cole of DutyCOVID-19 Impact on Regenerative Medicine Market: Outlook, Growth, Key Driving Players and Industry Analysis Report 2026  3rd Watch NewsAdvancement in Research and Development Activities to Induce Growth Rate Of Regenerative Medicine Market  TMR Research BlogView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.newsdistinct.com/global-stem-cell-market-2020-2026-leading-players-advanced-cell-technology-inc-osiris-therapeutics-inc-celgene-corporation-biotime-inc-cynata-stemcell-technologies-inc-cellular-engineering/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 19:16:19 GMT</td>    <td>Active Wound Care Market 2020 Future Outlook || Key Companies Profile : Molyncke Healthcare, Smith and Nephew, Osiris Therapeutics Inc., Medline Industries, Inc., Avita Medical - Cole of Duty</td>    <td>Active Wound Care Market 2020 Future Outlook || Key Companies Profile : Molyncke Healthcare, Smith and Nephew, Osiris Therapeutics Inc., Medline Industries, Inc., Avita Medical  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/06/03/active-wound-care-market-2/">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 10:49:00 GMT</td>    <td>Global Stem Cell Market 2020-2026 | Leading Players Advanced Cell Technology Inc, Osiris Therapeutics Inc, Celgene Corporation, Biotime, Inc., Cynata, Stemcell Technologies Inc., Cellular Engineering Technologies Inc - 3rd Watch News</td>    <td>Global Stem Cell Market 2020-2026 | Leading Players Advanced Cell Technology Inc, Osiris Therapeutics Inc, Celgene Corporation, Biotime, Inc., Cynata, Stemcell Technologies Inc., Cellular Engineering Technologies Inc  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/998277/global-stem-cell-market-2020-2026-leading-players-advanced-cell-technology-inc-osiris-therapeutics-inc-celgene-corporation-biotime-inc-cynata-stemcell-technologies-inc-cellular-engineering/">Link</a></td>  </tr></table><h3>465. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OSMT">Osmotica Pharmaceuticals plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 20:08:04 GMT</td>    <td>Osmotica Pharmaceuticals plc Reports First Quarter 2020 Results and Provides Business Updates - GlobeNewswire</td>    <td>Osmotica Pharmaceuticals plc Reports First Quarter 2020 Results and Provides Business Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032243/0/en/Osmotica-Pharmaceuticals-plc-Reports-First-Quarter-2020-Results-and-Provides-Business-Updates.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 17:33:13 GMT</td>    <td>Osmotica Pharmaceuticals plc to Provide First Quarter 2020 Business and Financial Update on May 12, 2020 - GlobeNewswire</td>    <td>Osmotica Pharmaceuticals plc to Provide First Quarter 2020 Business and Financial Update on May 12, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030509/0/en/Osmotica-Pharmaceuticals-plc-to-Provide-First-Quarter-2020-Business-and-Financial-Update-on-May-12-2020.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 20:30:00 GMT</td>    <td>Osmotica Pharmaceuticals plc Announces Result of Proposal 3 at Annual General Meeting - Yahoo Finance</td>    <td>Osmotica Pharmaceuticals plc Announces Result of Proposal 3 at Annual General Meeting  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/osmotica-pharmaceuticals-plc-announces-result-203000877.html">Link</a></td>  </tr></table><h3>466. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OTIC">Otonomy, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:50:19 GMT</td>    <td>Otonomy Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Otonomy Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029341/0/en/Otonomy-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Otonomy Inc. (OTIC) Soars 2.99% on June 02 - Equities.com</td>    <td>Otonomy Inc. (OTIC) Soars 2.99% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/otonomy-inc-otic-soars-2-99-on-june-02">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 12:15:25 GMT</td>    <td>Otonomy and AGTC Present Preclinical Results Supporting Selection of Product Candidate for GJB2 Gene Therapy Hearing Loss Program - GlobeNewswire</td>    <td>Otonomy and AGTC Present Preclinical Results Supporting Selection of Product Candidate for GJB2 Gene Therapy Hearing Loss Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031864/0/en/Otonomy-and-AGTC-Present-Preclinical-Results-Supporting-Selection-of-Product-Candidate-for-GJB2-Gene-Therapy-Hearing-Loss-Program.html">Link</a></td>  </tr></table><h3>467. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OTLK">Outlook Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:16:15 GMT</td>    <td>Outlook Therapeutics Announces Closing of $16.0 Million Private Placement - GlobeNewswire</td>    <td>Outlook Therapeutics Announces Closing of $16.0 Million Private Placement  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042890/0/en/Outlook-Therapeutics-Announces-Closing-of-16-0-Million-Private-Placement.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:08:19 GMT</td>    <td>Outlook Therapeutics Announces $16.0 Million Private Placement to Advance the Development of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) - GlobeNewswire</td>    <td>Outlook Therapeutics Announces $16.0 Million Private Placement to Advance the Development of ONS-5010 / LYTENAVA™ (bevacizumab-vikg)  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038606/0/en/Outlook-Therapeutics-Announces-16-0-Million-Private-Placement-to-Advance-the-Development-of-ONS-5010-LYTENAVA-bevacizumab-vikg.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Some Analysts Just Cut Their Outlook Therapeutics, Inc. (NASDAQ:OTLK) Estimates - Yahoo Finance</td>    <td>Some Analysts Just Cut Their Outlook Therapeutics, Inc. (NASDAQ:OTLK) Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-just-cut-outlook-therapeutics-123901687.html">Link</a></td>  </tr></table><h3>468. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OVID">Ovid Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 12:09:49 GMT</td>    <td>Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029398/0/en/Ovid-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:00:00 GMT</td>    <td>Ovid Therapeutics Inc. [OVID] moved up 3.56: Why It’s Important - The DBT News</td>    <td>Ovid Therapeutics Inc. [OVID] moved up 3.56: Why It’s Important  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/ovid-therapeutics-inc-ovid-moved-up-3-56-why-its-important/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 12:15:02 GMT</td>    <td>Ovid Therapeutics Announces Participation in the 2020 RBC Capital Markets Virtual Global Healthcare Conference - GlobeNewswire</td>    <td>Ovid Therapeutics Announces Participation in the 2020 RBC Capital Markets Virtual Global Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031824/0/en/Ovid-Therapeutics-Announces-Participation-in-the-2020-RBC-Capital-Markets-Virtual-Global-Healthcare-Conference.html">Link</a></td>  </tr></table><h3>469. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OXFD">Oxford Immunotec Global PLC</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Oxford Immunotec Global PLC (OXFD) Soars 1.23% on June 03 - Equities.com</td>    <td>Oxford Immunotec Global PLC (OXFD) Soars 1.23% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/oxford-immunotec-global-plc-oxfd-soars-1-23-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Oxford Immunotec Global PLC (OXFD) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Oxford Immunotec Global PLC (OXFD) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/05/oxford-immunotec-global-plc-oxfd-q1-2020-earnings.aspx">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 11:03:47 GMT</td>    <td>Oxford Immunotec Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Oxford Immunotec Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027381/0/en/Oxford-Immunotec-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>470. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-OYST">Oyster Point Pharma</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 15:39:00 GMT</td>    <td>Is Oyster Point Pharma, Inc. (OYST) A Good Stock To Buy? - Yahoo Finance</td>    <td>Is Oyster Point Pharma, Inc. (OYST) A Good Stock To Buy?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/oyster-point-pharma-inc-oyst-153945003.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 20:52:00 GMT</td>    <td>Oyster Point Pharma Proposed Public Offering of Common Stock - GlobeNewswire</td>    <td>Oyster Point Pharma Proposed Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032269/0/en/Oyster-Point-Pharma-Proposed-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 10:06:27 GMT</td>    <td>Oyster Point Pharma Reports First Quarter 2020 Financial Results and Recent Business Highlights - GlobeNewswire</td>    <td>Oyster Point Pharma Reports First Quarter 2020 Financial Results and Recent Business Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030873/0/en/Oyster-Point-Pharma-Reports-First-Quarter-2020-Financial-Results-and-Recent-Business-Highlights.html">Link</a></td>  </tr></table><h3>471. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PACB">Pacific Biosciences of California, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Pacific Biosciences of California, Inc. Announces First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Pacific Biosciences of California, Inc. Announces First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028807/0/en/Pacific-Biosciences-of-California-Inc-Announces-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Pacific Biosciences of California Inc (PACB) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Pacific Biosciences of California Inc (PACB) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/07/pacific-biosciences-of-california-inc-pacb-q1-2020.aspx">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Personal Genomics, Inc. Files Patent Infringement Complaint Against Pacific Biosciences of California, Inc. in China - PRNewswire</td>    <td>Personal Genomics, Inc. Files Patent Infringement Complaint Against Pacific Biosciences of California, Inc. in China  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/personal-genomics-inc-files-patent-infringement-complaint-against-pacific-biosciences-of-california-inc-in-china-301062867.html">Link</a></td>  </tr></table><h3>472. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PCRX">Pacira Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Pacira: 1Q Earnings Snapshot - Yahoo Finance</td>    <td>Pacira: 1Q Earnings Snapshot  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/pacira-1q-earnings-snapshot-121311908.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 10:30:00 GMT</td>    <td>Concise Report 2020: 3D Printed Drugs Market Competitive Landscape and Industrial Growth| The Impact of COVID-19 Disruption During 2029 - 3rd Watch News</td>    <td>Concise Report 2020: 3D Printed Drugs Market Competitive Landscape and Industrial Growth| The Impact of COVID-19 Disruption During 2029  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/1150024/concise-report-2020-3d-printed-drugs-market-competitive-landscape-and-industrial-growth-the-impact-of-covid-19-disruption-during-2029/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 06:13:18 GMT</td>    <td>Postoperative Pain Therapeutics Service Market Overview With Detailed Analysis, Competitive Landscape, Forecast to 2026 - Cole of Duty</td>    <td>Postoperative Pain Therapeutics Service Market Overview With Detailed Analysis, Competitive Landscape, Forecast to 2026  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/market-reports/2020/06/03/postoperative-pain-therapeutics-service-market-overview-with-detailed-analysis-competitive-landscape-forecast-to-2026/">Link</a></td>  </tr></table><h3>473. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PTIE">Pain Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 06:13:18 GMT</td>    <td>Postoperative Pain Therapeutics Service Market Overview With Detailed Analysis, Competitive Landscape, Forecast to 2026 - Cole of Duty</td>    <td>Postoperative Pain Therapeutics Service Market Overview With Detailed Analysis, Competitive Landscape, Forecast to 2026  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/market-reports/2020/06/03/postoperative-pain-therapeutics-service-market-overview-with-detailed-analysis-competitive-landscape-forecast-to-2026/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 19:58:00 GMT</td>    <td>Antibe Therapeutics to Host Conference Call to Discuss Positive Results of Phase 2B Dose-Ranging, Efficacy Study for ATB-346 - Business Wire</td>    <td>Antibe Therapeutics to Host Conference Call to Discuss Positive Results of Phase 2B Dose-Ranging, Efficacy Study for ATB-346  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005908/en/Antibe-Therapeutics-Host-Conference-Call-Discuss-Positive">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 10:30:31 GMT</td>    <td>Karuna Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference - Valdosta Daily Times</td>    <td>Karuna Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference  Valdosta Daily Times</td>    <td><a target="_blank" href="https://www.valdostadailytimes.com/news/business/karuna-therapeutics-to-present-at-the-goldman-sachs-41st-annual-global-healthcare-conference/article_abe4b6a8-af7a-53fd-ac86-4402e49e4dd0.html">Link</a></td>  </tr></table><h3>474. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRTK">Paratek Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 12:50:48 GMT</td>    <td>Paratek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of Stockholders - GlobeNewswire</td>    <td>Paratek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of Stockholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040926/0/en/Paratek-Pharmaceuticals-Announces-Change-to-Time-of-2020-Annual-Meeting-of-Stockholders.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 10:47:55 GMT</td>    <td>Paratek Pharmaceuticals Announces First Quarter 2020 Total Revenues of $7.9 Million including NUZYRA® (omadacycline) Net Sales of $7.3 Million - GlobeNewswire</td>    <td>Paratek Pharmaceuticals Announces First Quarter 2020 Total Revenues of $7.9 Million including NUZYRA® (omadacycline) Net Sales of $7.3 Million  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030900/0/en/Paratek-Pharmaceuticals-Announces-First-Quarter-2020-Total-Revenues-of-7-9-Million-including-NUZYRA-omadacycline-Net-Sales-of-7-3-Million.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:09:00 GMT</td>    <td>Paratek Pharmaceuticals Inc. (PRTK) Soars 3.15% on June 01 - Equities.com</td>    <td>Paratek Pharmaceuticals Inc. (PRTK) Soars 3.15% on June 01  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/paratek-pharmaceuticals-inc-prtk-soars-3-15-on-june-01">Link</a></td>  </tr></table><h3>475. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PASG">Passage BIO</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:50:24 GMT</td>    <td>Passage Bio Announces Expansion of Gene Therapy Collaboration with University of Pennsylvania - GlobeNewswire</td>    <td>Passage Bio Announces Expansion of Gene Therapy Collaboration with University of Pennsylvania  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029337/0/en/Passage-Bio-Announces-Expansion-of-Gene-Therapy-Collaboration-with-University-of-Pennsylvania.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Passage Bio Reports First Quarter 2020 Financial Results and Recent Business Highlights - BioSpace</td>    <td>Passage Bio Reports First Quarter 2020 Financial Results and Recent Business Highlights  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/passage-bio-reports-first-quarter-2020-financial-results-and-recent-business-highlights/">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Philadelphia gene therapy company gets FDA designation that could be worth big money - Philadelphia Business Journal</td>    <td>Philadelphia gene therapy company gets FDA designation that could be worth big money  Philadelphia Business Journal</td>    <td><a target="_blank" href="https://www.bizjournals.com/philadelphia/news/2020/05/22/passage-bio-gene-therapy-fda-rare-disease-gm1.html">Link</a></td>  </tr></table><h3>476. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PDLI">PDL BioPharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders - PRNewswire</td>    <td>PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/pdl-biopharma-completes-distribution-of-evofem-biosciences-common-stock-to-pdl-stockholders-301063876.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 18:24:01 GMT</td>    <td>Does The PDL BioPharma, Inc. (NASDAQ:PDLI) Share Price Tend To Follow The Market? - Simply Wall St</td>    <td>Does The PDL BioPharma, Inc. (NASDAQ:PDLI) Share Price Tend To Follow The Market?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pdli/pdl-biopharma/news/does-the-pdl-biopharma-inc-nasdaqpdli-share-price-tend-to-follow-the-market/">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 13:48:57 GMT</td>    <td>PDL Biopharma Inc (PDLI) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>PDL Biopharma Inc (PDLI) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/pdl-biopharma-inc-pdli-q1-2020-earnings-call-trans.aspx">Link</a></td>  </tr></table><h3>477. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PTX">Pernix Therapeutics Holdings, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 Feb 2019 08:00:00 GMT</td>    <td>Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management - GlobeNewswire</td>    <td>Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/02/19/1734397/0/en/Pernix-Therapeutics-Holdings-Inc-Enters-into-Asset-Purchase-Agreement-with-Certain-Funds-Managed-by-Highbridge-Capital-Management.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Apr 2019 07:00:00 GMT</td>    <td>Delisting of Securities of Pernix Therapeutics Holdings, Inc., Priority Technology Holdings, Inc. (Warrant and Unit only), Windstream Holdings, Inc., Simplicity Esports and Gaming Company, PHI, Inc. from The Nasdaq Stock Market - GlobeNewswire</td>    <td>Delisting of Securities of Pernix Therapeutics Holdings, Inc., Priority Technology Holdings, Inc. (Warrant and Unit only), Windstream Holdings, Inc., Simplicity Esports and Gaming Company, PHI, Inc. from The Nasdaq Stock Market  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/04/01/1794658/0/en/Delisting-of-Securities-of-Pernix-Therapeutics-Holdings-Inc-Priority-Technology-Holdings-Inc-Warrant-and-Unit-only-Windstream-Holdings-Inc-Simplicity-Esports-and-Gaming-Company-PHI.html">Link</a></td>  </tr><tr>    <td>Tue, 05 Feb 2019 08:00:00 GMT</td>    <td>What Kind Of Shareholders Own Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX)? - Simply Wall St</td>    <td>What Kind Of Shareholders Own Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX)?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ptx/pernix-therapeutics-holdings/news/what-kind-of-shareholders-own-pernix-therapeutics-holdings-inc-nasdaqptx/">Link</a></td>  </tr></table><h3>478. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PSNL">Personalis, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 15:08:00 GMT</td>    <td>Personalis, Inc. Announces New Data to be Presented at ASCO Virtual Scientific Meeting - Business Wire</td>    <td>Personalis, Inc. Announces New Data to be Presented at ASCO Virtual Scientific Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200529005485/en/Personalis-Announces-New-Data-Presented-ASCO-Virtual">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 18:41:00 GMT</td>    <td>PSNL Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Personalis, Inc. and Encourages Investors to Contact the Firm - PRNewswire</td>    <td>PSNL Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Personalis, Inc. and Encourages Investors to Contact the Firm  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/psnl-investor-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-personalis-inc-and-encourages-investors-to-contact-the-firm-301069540.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Personalis, Inc. Appoints Industry Veteran Stephen Moore as General Counsel - Business Wire</td>    <td>Personalis, Inc. Appoints Industry Veteran Stephen Moore as General Counsel  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200505005867/en/Personalis-Appoints-Industry-Veteran-Stephen-Moore-General">Link</a></td>  </tr></table><h3>479. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PHAS">PhaseBio Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 20:01:00 GMT</td>    <td>PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients - Business Wire</td>    <td>PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients  Business WirePhaseBio Gets FDA Nod to Begin Study for Coronavirus Treatment  Yahoo FinancePhasebio Launches Clinical Trial for Covid-19 Treatment  Bloomberg LawThe FDA’s Newest Nod for a Coronavirus Treatment Trial  24/7 Wall St.PhaseBio (PHAS) Launches Clinical Trial to Evaluate PB1046 as Treatment for Hospitalized COVID-19 Patients  StreetInsider.comView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200527005882/en/PhaseBio-Launches-Clinical-Trial-Evaluate-PB1046-Treatment">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:07:02 GMT</td>    <td>PhaseBio Pharmaceuticals Inc. (PHAS) move up 103.85% from 52 week low: Right on the Precipice - News Daemon</td>    <td>PhaseBio Pharmaceuticals Inc. (PHAS) move up 103.85% from 52 week low: Right on the Precipice  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/03/phasebio-pharmaceuticals-inc-phas-move-up-103-85-from-52-week-low-right-on-the-precipice/">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 12:24:57 GMT</td>    <td>The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer - Benzinga</td>    <td>The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/general/biotech/20/05/16125282/the-daily-biotech-pulse-phasebio-to-start-potential-pivotal-covid-19-trial-immunomedics-ceo-quits">Link</a></td>  </tr></table><h3>480. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PHAT">Phathom Pharmaceuticals</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 20:35:39 GMT</td>    <td>Phathom Pharmaceuticals to Present at Upcoming Investor Conferences - GlobeNewswire</td>    <td>Phathom Pharmaceuticals to Present at Upcoming Investor Conferences  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040578/0/en/Phathom-Pharmaceuticals-to-Present-at-Upcoming-Investor-Conferences.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Phathom Pharmaceuticals Reports First Quarter 2020 Results - BioSpace</td>    <td>Phathom Pharmaceuticals Reports First Quarter 2020 Results  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/phathom-pharmaceuticals-reports-first-quarter-2020-results/">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>BRIEF-Phathom Pharma On May 5, Entered Into A Commercial Supply Agreement With Takeda Pharmaceutical Company Limited - Reuters</td>    <td>BRIEF-Phathom Pharma On May 5, Entered Into A Commercial Supply Agreement With Takeda Pharmaceutical Company Limited  Reuters</td>    <td><a target="_blank" href="https://uk.reuters.com/article/brief-phathom-pharma-on-may-5-entered-in/brief-phathom-pharma-on-may-5-entered-into-a-commercial-supply-agreement-with-takeda-pharmaceutical-company-limited-idUKFWN2CN130">Link</a></td>  </tr></table><h3>481. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PAHC">Phibro Animal Health Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Phibro Animal Health Corporation Reports Third Quarter Results - Business Wire</td>    <td>Phibro Animal Health Corporation Reports Third Quarter Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005762/en/Phibro-Animal-Health-Corporation-Reports-Quarter-Results">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q3 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q3 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4345018-phibro-animal-health-corporation-pahc-ceo-jack-bendheim-on-q3-2020-results-earnings-call">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Phibro Animal Health (PAHC) Q3 2020 Earnings Call Transcript - Motley Fool</td>    <td>Phibro Animal Health (PAHC) Q3 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/09/phibro-animal-health-pahc-q3-2020-earnings-call-tr.aspx">Link</a></td>  </tr></table><h3>482. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PHIO">Phio Pharmaceuticals Corp.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 22:07:00 GMT</td>    <td>BRIEF-Phio Pharmaceuticals Files Prospectus Related To Selling Stockholders Offering Upto 1.8 Million Shares Of Co - Reuters</td>    <td>BRIEF-Phio Pharmaceuticals Files Prospectus Related To Selling Stockholders Offering Upto 1.8 Million Shares Of Co  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-phio-pharmaceuticals-files-prospec/brief-phio-pharmaceuticals-files-prospectus-related-to-selling-stockholders-offering-upto-18-million-shares-of-co-idUSFWN2DF0PP">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:00:00 GMT</td>    <td>Phio Announces Positive In Vivo Data on the Intratumoral Use of INTASYL Compounds Showing Strong Antitumor Activity - Yahoo Finance</td>    <td>Phio Announces Positive In Vivo Data on the Intratumoral Use of INTASYL Compounds Showing Strong Antitumor Activity  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/phio-announces-positive-vivo-data-120000514.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:10:00 GMT</td>    <td>Analysts Turn Mixed On Leap Therapeutics Inc. (NASDAQ:LPTX), Phio Pharmaceuticals Corp. (NASDAQ:PHIO) - State Reviewer</td>    <td>Analysts Turn Mixed On Leap Therapeutics Inc. (NASDAQ:LPTX), Phio Pharmaceuticals Corp. (NASDAQ:PHIO)  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/analysts-turn-mixed-on-leap-therapeutics-inc-nasdaqlptx-phio-pharmaceuticals-corp-nasdaqphio/">Link</a></td>  </tr></table><h3>483. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PIRS">Pieris Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Pieris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update - Yahoo Finance</td>    <td>Pieris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/pieris-pharmaceuticals-reports-first-quarter-110000108.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Pieris Pharmaceuticals: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Pieris Pharmaceuticals: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Pieris-Pharmaceuticals-1Q-Earnings-Snapshot-15261075.php">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Earnings Update: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance</td>    <td>Earnings Update: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Just Reported And Analysts Are Boosting Their Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/earnings-pieris-pharmaceuticals-inc-nasdaq-142348270.html">Link</a></td>  </tr></table><h3>484. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PSTI">Pluristem Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 15:30:00 GMT</td>    <td>Has Pluristem Therapeutics (PSTI) Outpaced Other Medical Stocks This Year? - Yahoo Finance</td>    <td>Has Pluristem Therapeutics (PSTI) Outpaced Other Medical Stocks This Year?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/pluristem-therapeutics-psti-outpaced-other-153003206.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 11:08:27 GMT</td>    <td>Pluristem Joins Forces with CRISPR-IL National Consortium to Advance Development of Cutting-Edge Genome Editing Solutions for Life Science Products - GlobeNewswire</td>    <td>Pluristem Joins Forces with CRISPR-IL National Consortium to Advance Development of Cutting-Edge Genome Editing Solutions for Life Science Products  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042782/0/en/Pluristem-Joins-Forces-with-CRISPR-IL-National-Consortium-to-Advance-Development-of-Cutting-Edge-Genome-Editing-Solutions-for-Life-Science-Products.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 10:04:24 GMT</td>    <td>U.S. FDA Clears Pluristem's IND Application for Phase II COVID-19 Study - GlobeNewswire</td>    <td>U.S. FDA Clears Pluristem's IND Application for Phase II COVID-19 Study  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030212/0/en/U-S-FDA-Clears-Pluristem-s-IND-Application-for-Phase-II-COVID-19-Study.html">Link</a></td>  </tr></table><h3>485. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PLXP">PLx Pharma Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 10:58:11 GMT</td>    <td>PLx Pharma Inc. Reports First Quarter 2020 Results - GlobeNewswire</td>    <td>PLx Pharma Inc. Reports First Quarter 2020 Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034111/0/en/PLx-Pharma-Inc-Reports-First-Quarter-2020-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 20:42:35 GMT</td>    <td>PLx Pharma Inc. Announces Completion of $8 Million Convertible Preferred Stock Financing - GlobeNewswire</td>    <td>PLx Pharma Inc. Announces Completion of $8 Million Convertible Preferred Stock Financing  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2035262/0/en/PLx-Pharma-Inc-Announces-Completion-of-8-Million-Convertible-Preferred-Stock-Financing.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com</td>    <td>PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)  marketscreener.com</td>    <td><a target="_blank" href="https://m.marketscreener.com/PLX-PHARMA-INC-34619792/news/PLX-PHARMA-MANAGEMENT-S-DISCUSSION-AND-ANALYSIS-OF-FINANCIAL-CONDITION-AND-RESULTS-OF-OPERATIONS--30614272/">Link</a></td>  </tr></table><h3>486. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PTE">PolarityTE, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>PolarityTE Reports First Quarter 2020 Results - Business Wire</td>    <td>PolarityTE Reports First Quarter 2020 Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200511005217/en/PolarityTE-Reports-Quarter-2020-Results">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:29:00 GMT</td>    <td>Edited Transcript of COOL earnings conference call or presentation 11-May-20 12:00pm GMT - Yahoo Finance</td>    <td>Edited Transcript of COOL earnings conference call or presentation 11-May-20 12:00pm GMT  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/edited-transcript-cool-earnings-conference-132956721.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 11:27:36 GMT</td>    <td>EARNINGS SUMMARY: Details of PolarityTE Inc. Q1 Earnings Report - Nasdaq</td>    <td>EARNINGS SUMMARY: Details of PolarityTE Inc. Q1 Earnings Report  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/earnings-summary%3A-details-of-polarityte-inc.-q1-earnings-report-2020-05-11">Link</a></td>  </tr></table><h3>487. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PTLA">Portola Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Portola Pharmaceuticals Announces Virtual 2020 Annual Stockholder Meeting - PRNewswire</td>    <td>Portola Pharmaceuticals Announces Virtual 2020 Annual Stockholder Meeting  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/portola-pharmaceuticals-announces-virtual-2020-annual-stockholder-meeting-301061109.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Portola Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update - BioSpace</td>    <td>Portola Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/portola-pharmaceuticals-reports-first-quarter-2020-financial-results-and-provides-corporate-update/">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Portola Pharmaceuticals: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Portola Pharmaceuticals: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Portola-Pharmaceuticals-1Q-Earnings-Snapshot-15261125.php">Link</a></td>  </tr></table><h3>488. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PPD">PPD</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 14:35:36 GMT</td>    <td>Baseball Expanded Glance - Federal News Network</td>    <td>Baseball Expanded Glance  Federal News Network</td>    <td><a target="_blank" href="https://federalnewsnetwork.com/sports-news/2020/06/baseball-expanded-glance-88/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:35:36 GMT</td>    <td>American League Glance - Federal News Network</td>    <td>American League Glance  Federal News Network</td>    <td><a target="_blank" href="https://federalnewsnetwork.com/sports-news/2020/06/american-league-glance-85/">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 11:10:00 GMT</td>    <td>PPD, Inc. Announces Offering of Senior Notes - Business Wire</td>    <td>PPD, Inc. Announces Offering of Senior Notes  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200521005347/en/PPD-Announces-Offering-Senior-Notes">Link</a></td>  </tr></table><h3>489. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRAH">PRA Health Sciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>PRA Health Sciences Inc. (PRAH) Soars 3.41% on June 03 - Equities.com</td>    <td>PRA Health Sciences Inc. (PRAH) Soars 3.41% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/pra-health-sciences-inc-prah-soars-3-41-on-june-03">Link</a></td>  </tr><tr>    <td>Sat, 30 May 2020 15:31:00 GMT</td>    <td>Why Is PRA Health Sciences (PRAH) Up 7.3% Since Last Earnings Report? - Yahoo Finance</td>    <td>Why Is PRA Health Sciences (PRAH) Up 7.3% Since Last Earnings Report?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-pra-health-sciences-prah-153103373.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 21:09:00 GMT</td>    <td>PRA Health Sciences Inc. (PRAH) Soars 1.6% on May 29 - Equities.com</td>    <td>PRA Health Sciences Inc. (PRAH) Soars 1.6% on May 29  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/pra-health-sciences-inc-prah-soars-1-6-on-may-29">Link</a></td>  </tr></table><h3>490. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRAN">Prana Biotechnology Ltd</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 07:06:34 GMT</td>    <td>Multiple System Atrophy Therapeutics Market 2019 Global Analysis, Research, Review, Applications and Forecast to 2025 - Surfacing Magazine</td>    <td>Multiple System Atrophy Therapeutics Market 2019 Global Analysis, Research, Review, Applications and Forecast to 2025  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/multiple-system-atrophy-therapeutics-market-2019-global-analysis-research-review-applications-and-forecast-to-2025/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 13:05:36 GMT</td>    <td>Huntingtons Disease Therapeutics Market to Record Exponential Growth Owing to High Demand Through COVID 19 Pandemic - Cole of Duty</td>    <td>Huntingtons Disease Therapeutics Market to Record Exponential Growth Owing to High Demand Through COVID 19 Pandemic  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/military-news/2020/06/02/huntingtons-disease-therapeutics-market-to-record-exponential-growth-owing-to-high-demand-through-covid-19-pandemic/">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 05:04:00 GMT</td>    <td>Potential impact of coronavirus outbreak on Multiple System Atrophy Therapeutics Market: Industry Statistics and Facts Helps to Flourish Industry Rapidly – QYR - 3rd Watch News</td>    <td>Potential impact of coronavirus outbreak on Multiple System Atrophy Therapeutics Market: Industry Statistics and Facts Helps to Flourish Industry Rapidly – QYR  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/industry/1014086/potential-impact-of-coronavirus-outbreak-on-multiple-system-atrophy-therapeutics-market-industry-statistics-and-facts-helps-to-flourish-industry-rapidly-qyr/">Link</a></td>  </tr></table><h3>491. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRPO">Precipio, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 21:14:05 GMT</td>    <td>Precipio Announces Q1-2020 Corporate Update Call For Shareholders - GlobeNewswire</td>    <td>Precipio Announces Q1-2020 Corporate Update Call For Shareholders  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032297/0/en/Precipio-Announces-Q1-2020-Corporate-Update-Call-For-Shareholders.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Precipio, Inc. to Host Earnings Call - Yahoo Finance</td>    <td>Precipio, Inc. to Host Earnings Call  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/precipio-inc-host-earnings-call-190000296.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:56:02 GMT</td>    <td>Precipio Inc. (PRPO) is 48.99% away from 50-day simple Moving Average despite all headwinds - News Daemon</td>    <td>Precipio Inc. (PRPO) is 48.99% away from 50-day simple Moving Average despite all headwinds  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/03/precipio-inc-prpo-is-48-99-away-from-50-day-simple-moving-average-despite-all-headwinds/">Link</a></td>  </tr></table><h3>492. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-DTIL">Precision BioSciences, Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Precision BioSciences Reports First Quarter 2020 Financial Results and Provides Business Update - BioSpace</td>    <td>Precision BioSciences Reports First Quarter 2020 Financial Results and Provides Business Update  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/precision-biosciences-reports-first-quarter-2020-financial-results-and-provides-business-update/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 22:17:00 GMT</td>    <td>BRIEF-Precision Biosciences Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing - Reuters</td>    <td>BRIEF-Precision Biosciences Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-precision-biosciences-inc-files-fo/brief-precision-biosciences-inc-files-for-mixed-shelf-of-up-to-200-million-sec-filing-idUSFWN2DE0XZ">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 20:03:14 GMT</td>    <td>Precision BioSciences to Present at Upcoming Investor Conferences - GlobeNewswire</td>    <td>Precision BioSciences to Present at Upcoming Investor Conferences  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038910/0/en/Precision-BioSciences-to-Present-at-Upcoming-Investor-Conferences.html">Link</a></td>  </tr></table><h3>493. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRVL">Prevail Therapeutics Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 21:57:43 GMT</td>    <td>Prevail Therapeutics to Participate in Fireside Chat at Chardan 4th Annual Genetic Medicines Manufacturing Summit - GlobeNewswire</td>    <td>Prevail Therapeutics to Participate in Fireside Chat at Chardan 4th Annual Genetic Medicines Manufacturing Summit  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037352/0/en/Prevail-Therapeutics-to-Participate-in-Fireside-Chat-at-Chardan-4th-Annual-Genetic-Medicines-Manufacturing-Summit.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 11:12:49 GMT</td>    <td>Prevail Therapeutics Reports First Quarter 2020 Financial Results and Business Highlights - GlobeNewswire</td>    <td>Prevail Therapeutics Reports First Quarter 2020 Financial Results and Business Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033366/0/en/Prevail-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Business-Highlights.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Prevail Therapeutics to Present at Bank of America Global Research Virtual Health Care Conference 2020 - Yahoo Finance</td>    <td>Prevail Therapeutics to Present at Bank of America Global Research Virtual Health Care Conference 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/prevail-therapeutics-present-bank-america-200510213.html">Link</a></td>  </tr></table><h3>494. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRNB">Principia Biopharma Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:01:00 GMT</td>    <td>Principia Biopharma to Hold Virtual Analyst Event to Discuss BTK Inhibition: Beyond B Cells and Antibodies - GlobeNewswire</td>    <td>Principia Biopharma to Hold Virtual Analyst Event to Discuss BTK Inhibition: Beyond B Cells and Antibodies  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2043232/0/en/Principia-Biopharma-to-Hold-Virtual-Analyst-Event-to-Discuss-BTK-Inhibition-Beyond-B-Cells-and-Antibodies.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Principia Biopharma Reports First Quarter 2020 Financial Results - Yahoo Finance</td>    <td>Principia Biopharma Reports First Quarter 2020 Financial Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/principia-biopharma-reports-first-quarter-200510838.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:08:17 GMT</td>    <td>Principia Announces Data Presentations of Rilzabrutinib in Patients with Immune Thrombocytopenia (ITP) at Two Upcoming Virtual Medical Meetings - GlobeNewswire</td>    <td>Principia Announces Data Presentations of Rilzabrutinib in Patients with Immune Thrombocytopenia (ITP) at Two Upcoming Virtual Medical Meetings  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038604/0/en/Principia-Announces-Data-Presentations-of-Rilzabrutinib-in-Patients-with-Immune-Thrombocytopenia-ITP-at-Two-Upcoming-Virtual-Medical-Meetings.html">Link</a></td>  </tr></table><h3>495. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PGNX">Progenics Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:50:16 GMT</td>    <td>Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update - GlobeNewswire</td>    <td>Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029344/0/en/Progenics-Pharmaceuticals-Announces-First-Quarter-2020-Financial-Results-and-Business-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 23:53:00 GMT</td>    <td>SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc. - PRNewswire</td>    <td>SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-progenics-pharmaceuticals-inc-301066598.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Progenics Pharmaceuticals Inc. (PGNX) Soars 5.51% on May 20 - Equities.com</td>    <td>Progenics Pharmaceuticals Inc. (PGNX) Soars 5.51% on May 20  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/progenics-pharmaceuticals-inc-pgnx-soars-5-51-on-may-20">Link</a></td>  </tr></table><h3>496. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PGNY">Progyny</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 20:07:46 GMT</td>    <td>Progyny, Inc. Announces First Quarter 2020 Results Nasdaq:PGNY - GlobeNewswire</td>    <td>Progyny, Inc. Announces First Quarter 2020 Results Nasdaq:PGNY  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032256/0/en/Progyny-Inc-Announces-First-Quarter-2020-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Progyny brings in $4M in profits in Q1, beats Wall Street expectations - FierceHealthcare</td>    <td>Progyny brings in $4M in profits in Q1, beats Wall Street expectations  FierceHealthcare</td>    <td><a target="_blank" href="https://www.fiercehealthcare.com/tech/progyny-brings-4m-profits-q1-and-beats-wall-street-revenue-earnings-estimates">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 20:44:16 GMT</td>    <td>Progyny Earnings Due After The Close, As Coronavirus Delays Fertility Services - Investor's Business Daily</td>    <td>Progyny Earnings Due After The Close, As Coronavirus Delays Fertility Services  Investor's Business Daily</td>    <td><a target="_blank" href="https://www.investors.com/news/progyny-earnings-q1-2020-progyny-stock/">Link</a></td>  </tr></table><h3>497. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRPH">ProPhase Labs, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 12:13:35 GMT</td>    <td>ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2020 - GlobeNewswire</td>    <td>ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031840/0/en/ProPhase-Labs-Reports-Financial-Results-for-the-Three-Months-Ended-March-31-2020.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 16:01:29 GMT</td>    <td>Is ProPhase Labs Inc (PRPH) Stock a Great Value? - InvestorsObserver</td>    <td>Is ProPhase Labs Inc (PRPH) Stock a Great Value?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-prophase-labs-inc-prph-stock-a-great-value">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 12:37:00 GMT</td>    <td>PROPHASE LABS, INC. (NASDAQ:PRPH) Files An 8-K Submission of Matters to a Vote of Security Holders - Market Exclusive</td>    <td>PROPHASE LABS, INC. (NASDAQ:PRPH) Files An 8-K Submission of Matters to a Vote of Security Holders  Market Exclusive</td>    <td><a target="_blank" href="https://marketexclusive.com/prophase-labs-inc-nasdaqprph-files-an-8-k-submission-of-matters-to-a-vote-of-security-holders-2/2020/05/">Link</a></td>  </tr></table><h3>498. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRQR">ProQR Therapeutics N.V.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:10:19 GMT</td>    <td>ProQR Announces First Quarter 2020 Operating and Financial Results - GlobeNewswire</td>    <td>ProQR Announces First Quarter 2020 Operating and Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029269/0/en/ProQR-Announces-First-Quarter-2020-Operating-and-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:55:00 GMT</td>    <td>How ProQR (PRQR) Stock Stands Out in a Strong Industry - Yahoo Finance</td>    <td>How ProQR (PRQR) Stock Stands Out in a Strong Industry  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/proqr-prqr-stock-stands-strong-125512388.html">Link</a></td>  </tr><tr>    <td>Mon, 25 May 2020 07:00:00 GMT</td>    <td>ProQR Announces Annual Meeting of Shareholders - Yahoo Finance</td>    <td>ProQR Announces Annual Meeting of Shareholders  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/proqr-announces-annual-meeting-shareholders-110000349.html">Link</a></td>  </tr></table><h3>499. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PTGX">Protagonist Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sun, 10 May 2020 11:49:23 GMT</td>    <td>Protagonist Therapeutics, Inc. Common Stock (PTGX) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Protagonist Therapeutics, Inc. Common Stock (PTGX) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/10/protagonist-therapeutics-inc-common-stock-ptgx-q1.aspx">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Protagonist Therapeutics Reports First Quarter Financial Results and Provides Corporate Update - PRNewswire</td>    <td>Protagonist Therapeutics Reports First Quarter Financial Results and Provides Corporate Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/protagonist-therapeutics-reports-first-quarter-financial-results-and-provides-corporate-update-301055215.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Why Did Protagonist Therapeutics (PTGX) Soar 83.7% Today? - Yahoo Finance</td>    <td>Why Did Protagonist Therapeutics (PTGX) Soar 83.7% Today?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-did-protagonist-therapeutics-ptgx-212309643.html">Link</a></td>  </tr></table><h3>500. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRTO">Proteon Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 23 Sep 2019 07:00:00 GMT</td>    <td>Proteon Therapeutics and ArTara Therapeutics Agree to Combine - GlobeNewswire</td>    <td>Proteon Therapeutics and ArTara Therapeutics Agree to Combine  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/09/23/1919503/0/en/Proteon-Therapeutics-and-ArTara-Therapeutics-Agree-to-Combine.html">Link</a></td>  </tr><tr>    <td>Thu, 09 Jan 2020 08:00:00 GMT</td>    <td>ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics - GlobeNewswire</td>    <td>ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/01/09/1968639/0/en/ArTara-Therapeutics-Completes-Merger-Transaction-with-Proteon-Therapeutics.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 12:29:58 GMT</td>    <td>Hemodialysis Vascular Grafts Market Size, Industry Analysis and Forecast Report to 2026 - Cole of Duty</td>    <td>Hemodialysis Vascular Grafts Market Size, Industry Analysis and Forecast Report to 2026  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/06/02/hemodialysis-vascular-grafts-market-size-industry-analysis-and-forecast-report-to-2026/">Link</a></td>  </tr></table><h3>501. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PTI">Proteostasis Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Proteostasis Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - PRNewswire</td>    <td>Proteostasis Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/proteostasis-therapeutics-reports-first-quarter-2020-financial-results-and-provides-corporate-update-301060214.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 11:00:00 GMT</td>    <td>Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19 - PRNewswire</td>    <td>Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/proteostasis-therapeutics-announces-in-vitro-data-for-pti-129-as-potential-treatment-candidate-for-covid-19-301068350.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Proteostasis Therapeutics to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference - PRNewswire</td>    <td>Proteostasis Therapeutics to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/proteostasis-therapeutics-to-present-at-the-2020-rbc-capital-markets-global-healthcare-virtual-conference-301058479.html">Link</a></td>  </tr></table><h3>502. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRTA">Prothena Corporation plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Prothena Corporation plc (PRTA) Soars 5.69% on June 02 - Equities.com</td>    <td>Prothena Corporation plc (PRTA) Soars 5.69% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/prothena-corporation-plc-prta-soars-5-69-on-june-02">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Industry Analysts Just Upgraded Their Prothena Corporation plc (NASDAQ:PRTA) Revenue Forecasts By 92% - Yahoo Finance</td>    <td>Industry Analysts Just Upgraded Their Prothena Corporation plc (NASDAQ:PRTA) Revenue Forecasts By 92%  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/industry-analysts-just-upgraded-prothena-112620349.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:20:55 GMT</td>    <td>Prothena Reports First Quarter 2020 Financial Results and Provides R&D Update and Updated Financial Guidance - GlobeNewswire</td>    <td>Prothena Reports First Quarter 2020 Financial Results and Provides R&D Update and Updated Financial Guidance  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028816/0/en/Prothena-Reports-First-Quarter-2020-Financial-Results-and-Provides-R-D-Update-and-Updated-Financial-Guidance.html">Link</a></td>  </tr></table><h3>503. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PRVB">Provention Bio, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Provention Bio and Vactech Announce Publication of Proof-of-Concept Data for a Preclinical Prototype of Coxsackievirus B Vaccine - PRNewswire</td>    <td>Provention Bio and Vactech Announce Publication of Proof-of-Concept Data for a Preclinical Prototype of Coxsackievirus B Vaccine  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/provention-bio-and-vactech-announce-publication-of-proof-of-concept-data-for-a-preclinical-prototype-of-coxsackievirus-b-vaccine-301060612.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 20:04:00 GMT</td>    <td>Oppenheimer Starts Provention Bio Inc. (PRVB) at Outperform - StreetInsider.com</td>    <td>Oppenheimer Starts Provention Bio Inc. (PRVB) at Outperform  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Analyst+Comments/Oppenheimer+Starts+Provention+Bio+Inc.+%28PRVB%29+at+Outperform/16967801.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Provention Bio Announces Changes to its Board of Directors - PRNewswire</td>    <td>Provention Bio Announces Changes to its Board of Directors  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/provention-bio-announces-changes-to-its-board-of-directors-301062264.html">Link</a></td>  </tr></table><h3>504. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PTCT">PTC Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:00:00 GMT</td>    <td>PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals - PRNewswire</td>    <td>PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/ptc-therapeutics-successfully-completes-acquisition-of-censa-pharmaceuticals-301068302.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>PTC Therapeutics to Acquire Censa Pharmaceuticals - PRNewswire</td>    <td>PTC Therapeutics to Acquire Censa Pharmaceuticals  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/ptc-therapeutics-to-acquire-censa-pharmaceuticals-301054298.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 23:04:00 GMT</td>    <td>PTC Therapeutics, Inc. to Hold Virtual 2020 Annual Meeting of Stockholders - Yahoo Finance</td>    <td>PTC Therapeutics, Inc. to Hold Virtual 2020 Annual Meeting of Stockholders  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/ptc-therapeutics-inc-hold-virtual-230400333.html">Link</a></td>  </tr></table><h3>505. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PULM">Pulmatrix, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Pulmatrix Reports Q1 2020 Results - BioSpace</td>    <td>Pulmatrix Reports Q1 2020 Results  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/pulmatrix-reports-q1-2020-results/">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 13:00:00 GMT</td>    <td>Pulmatrix to Host 2020 Annual Meeting of Stockholders Virtually - PRNewswire</td>    <td>Pulmatrix to Host 2020 Annual Meeting of Stockholders Virtually  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/pulmatrix-to-host-2020-annual-meeting-of-stockholders-virtually-301066034.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Pulmatrix Inc. [PULM] Stock trading around $1.72 per share: What’s Next? - The DBT News</td>    <td>Pulmatrix Inc. [PULM] Stock trading around $1.72 per share: What’s Next?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/05/20/pulmatrix-inc-pulm-stock-trading-around-1-72-per-share-whats-next/">Link</a></td>  </tr></table><h3>506. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-PBYI">Puma Biotechnology Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:15:00 GMT</td>    <td>Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire</td>    <td>Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005900/en/Puma-Biotechnology-Reports-Inducement-Awards-Nasdaq-Listing">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Puma Biotechnology Licensing Partner CANbridge Pharmaceuticals Receives Marketing Approval in Mainland China for NERLYNX® (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer - Business Wire</td>    <td>Puma Biotechnology Licensing Partner CANbridge Pharmaceuticals Receives Marketing Approval in Mainland China for NERLYNX® (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005358/en/Puma-Biotechnology-Licensing-Partner-CANbridge-Pharmaceuticals-Receives">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:30:00 GMT</td>    <td>Riding the Trend or Protecting Profits: Puma Biotechnology, Inc. (PBYI) - The News Heater</td>    <td>Riding the Trend or Protecting Profits: Puma Biotechnology, Inc. (PBYI)  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/riding-the-trend-or-protecting-profits-puma-biotechnology-inc-pbyi/">Link</a></td>  </tr></table><h3>507. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-QGEN">Qiagen N.V.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 14:22:00 GMT</td>    <td>QIAGEN Sales Grow on Coronavirus Solutions Ahead of Selloff - Yahoo Finance</td>    <td>QIAGEN Sales Grow on Coronavirus Solutions Ahead of Selloff  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/qiagen-sales-grow-coronavirus-solutions-142202902.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>QIAGEN Reports Full Results for First Quarter of 2020 - BioSpace</td>    <td>QIAGEN Reports Full Results for First Quarter of 2020  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/qiagen-reports-full-results-for-first-quarter-of-2020/">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>QIAGEN Announces Publication of Reasoned Position Statement for Proposed Acquisition by Thermo Fisher and Date for Annual General Meeting - Business Wire</td>    <td>QIAGEN Announces Publication of Reasoned Position Statement for Proposed Acquisition by Thermo Fisher and Date for Annual General Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200518005232/en/QIAGEN-Announces-Publication-Reasoned-Position-Statement-Proposed">Link</a></td>  </tr></table><h3>508. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-QTRX">Quanterix Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Quanterix Corporation Releases Operating Results for First Quarter 2020 - Business Wire</td>    <td>Quanterix Corporation Releases Operating Results for First Quarter 2020  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200505005988/en/%C2%A0Quanterix-Corporation-Releases-Operating-Results-Quarter-2020">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Quanterix' Simoa Technology Sets New Standard in Protein Detection - Business Wire</td>    <td>Quanterix' Simoa Technology Sets New Standard in Protein Detection  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200513005437/en/%C2%A0Quanterix%E2%80%99-Simoa-Technology-Sets-New-Standard-Protein">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Quanterix Corporation (NASDAQ:QTRX) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance</td>    <td>Quanterix Corporation (NASDAQ:QTRX) Just Reported And Analysts Have Been Cutting Their Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/quanterix-corporation-nasdaq-qtrx-just-131414628.html">Link</a></td>  </tr></table><h3>509. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-QDEL">Quidel Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Quidel Corporation (QDEL) Plunges 5.17% on June 03 - Equities.com</td>    <td>Quidel Corporation (QDEL) Plunges 5.17% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/quidel-corporation-qdel-plunges-5-17-on-june-03">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay - Business Wire</td>    <td>Quidel Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay  Business WireEx-FDA Chief Calls New Covid-19 Antigen Test a ‘Game-Changer’  BloombergQuidel : Receives Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay  Marketscreener.comFDA grants emergency use authorization to Quidel for first antigen test for COVID-19  ReutersQuidel's antigen test OK'ed with promise of fast COVID checks  The Detroit NewsView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200508005553/en/Quidel-Receives-Emergency-Authorization-Rapid-Antigen-COVID-19">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 20:10:00 GMT</td>    <td>Quidel to Present Virtually at William Blair 40th Annual Growth Stock Conference - Business Wire</td>    <td>Quidel to Present Virtually at William Blair 40th Annual Growth Stock Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200526005787/en/Quidel-Present-Virtually-William-Blair-40th-Annual">Link</a></td>  </tr></table><h3>510. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-QTNT">Quotient Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 20:42:23 GMT</td>    <td>Quotient Limited to Participate in the Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>Quotient Limited to Participate in the Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038944/0/en/Quotient-Limited-to-Participate-in-the-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:03:59 GMT</td>    <td>Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call - GlobeNewswire</td>    <td>Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038597/0/en/Quotient-Limited-to-Report-Fiscal-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Host-Conference-Call.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK - GlobeNewswire</td>    <td>Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030728/0/en/Quotient-Limited-and-hVIVO-Announce-Partnership-to-Support-Wide-Spread-COVID-19-Antibody-Testing-in-the-UK.html">Link</a></td>  </tr></table><h3>511. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RARX">Ra Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 02 Apr 2020 07:00:00 GMT</td>    <td>UCB Completes the Acquisition of Ra Pharmaceuticals - to Deliver Differentiated Therapies to Patients - PRNewswire</td>    <td>UCB Completes the Acquisition of Ra Pharmaceuticals - to Deliver Differentiated Therapies to Patients  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/ucb-completes-the-acquisition-of-ra-pharmaceuticals--to-deliver-differentiated-therapies-to-patients-301034148.html">Link</a></td>  </tr><tr>    <td>Thu, 10 Oct 2019 07:00:00 GMT</td>    <td>Ra Pharma acquired for $2.1B by Belgian firm that vows to grow in Boston - New York Business Journal</td>    <td>Ra Pharma acquired for $2.1B by Belgian firm that vows to grow in Boston  New York Business Journal</td>    <td><a target="_blank" href="https://www.bizjournals.com/boston/news/2019/10/10/ra-pharma-acquired-for-2-1b-by-belgian-firm-that.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 18:40:00 GMT</td>    <td>Targeted Delivery Drugs Market Key Players Immunocore, Keystone Nano, Inc., Lipocine Inc., Mankind Pharma - 3rd Watch News</td>    <td>Targeted Delivery Drugs Market Key Players Immunocore, Keystone Nano, Inc., Lipocine Inc., Mankind Pharma  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/1158869/targeted-delivery-drugs-market/">Link</a></td>  </tr></table><h3>512. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RDUS">Radius Health, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 14:35:03 GMT</td>    <td>Radius Health Inc. (RDUS) poses a Brand-New Opportunity for Investors with beta value of 1.09 - News Daemon</td>    <td>Radius Health Inc. (RDUS) poses a Brand-New Opportunity for Investors with beta value of 1.09  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/03/radius-health-inc-rdus-poses-a-brand-new-opportunity-for-investors-with-beta-value-of-1-09/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:46:21 GMT</td>    <td>Radius Health Announces First Quarter 2020 Operating Results - GlobeNewswire</td>    <td>Radius Health Announces First Quarter 2020 Operating Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029959/0/en/Radius-Health-Announces-First-Quarter-2020-Operating-Results.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Radius Health: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Radius Health: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Radius-Health-1Q-Earnings-Snapshot-15255960.php">Link</a></td>  </tr></table><h3>513. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RAPT">RAPT Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 12:04:40 GMT</td>    <td>RAPT Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference - GlobeNewswire</td>    <td>RAPT Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038588/0/en/RAPT-Therapeutics-to-Present-at-the-Jefferies-Virtual-Global-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 18:38:45 GMT</td>    <td>Is Rapt Therapeutics Inc (RAPT) a Stock to Watch This Week? - InvestorsObserver</td>    <td>Is Rapt Therapeutics Inc (RAPT) a Stock to Watch This Week?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/is-rapt-therapeutics-inc-rapt-a-stock-to-watch-this-week">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 12:15:24 GMT</td>    <td>RAPT Therapeutics to Present at the UBS Virtual Global Healthcare Conference - GlobeNewswire</td>    <td>RAPT Therapeutics to Present at the UBS Virtual Global Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031865/0/en/RAPT-Therapeutics-to-Present-at-the-UBS-Virtual-Global-Healthcare-Conference.html">Link</a></td>  </tr></table><h3>514. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RLM">Realm Therapeutics plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 30 May 2020 12:28:42 GMT</td>    <td>Allergic Conjunctivitis Drug Market Size (COVID-19 Impact) 2020-26: Aldeyra Therapeutics Inc, AlleCures Inc, Allergan Plc - Bandera County Courier</td>    <td>Allergic Conjunctivitis Drug Market Size (COVID-19 Impact) 2020-26: Aldeyra Therapeutics Inc, AlleCures Inc, Allergan Plc  Bandera County Courier</td>    <td><a target="_blank" href="https://www.bccourier.com/allergic-conjunctivitis-drug-market-size-covid-19-impact-2020-26-aldeyra-therapeutics-inc-allecures-inc-allergan-plc/">Link</a></td>  </tr><tr>    <td>Wed, 31 Jul 2019 07:00:00 GMT</td>    <td>ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective - BioSpace</td>    <td>ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/essa-announces-that-the-scheme-of-arrangement-with-realm-therapeutics-has-become-effective/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020 - BioSpace</td>    <td>ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/essa-pharma-provides-corporate-update-and-reports-financial-results-for-fiscal-second-quarter-ended-march-31-2020/">Link</a></td>  </tr></table><h3>515. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RETA">Reata Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Reata Pharmaceuticals, Inc. Announces First Quarter 2020 Financial Results and Provides an Update on Development Programs - GlobeNewswire</td>    <td>Reata Pharmaceuticals, Inc. Announces First Quarter 2020 Financial Results and Provides an Update on Development Programs  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031396/0/en/Reata-Pharmaceuticals-Inc-Announces-First-Quarter-2020-Financial-Results-and-Provides-an-Update-on-Development-Programs.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Reata Pharmaceuticals Inc (RETA) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance</td>    <td>Reata Pharmaceuticals Inc (RETA) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/reata-pharmaceuticals-inc-reta-reports-224510101.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Reata Pharmaceuticals, Inc. (RETA) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Reata Pharmaceuticals, Inc. (RETA) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/reata-pharmaceuticals-inc-reta-q1-2020-earnings-ca.aspx">Link</a></td>  </tr></table><h3>516. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-REPH">Recro Pharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>RECRO PHARMA ALERT: Bragar Eagel & Squire, P.C. is Investigating Recro Pharma, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm - Business Wire</td>    <td>RECRO PHARMA ALERT: Bragar Eagel & Squire, P.C. is Investigating Recro Pharma, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200513005628/en/RECRO-PHARMA-ALERT-Bragar-Eagel-Squire-P.C.">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Recro Pharma Inc (REPH) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Recro Pharma Inc (REPH) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/11/recro-pharma-inc-reph-q1-2020-earnings-call-transc.aspx">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 21:27:27 GMT</td>    <td>Recro Pharma, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton; Investors Who Lost Money Should Contact the Firm - GlobeNewswire</td>    <td>Recro Pharma, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton; Investors Who Lost Money Should Contact the Firm  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031517/0/en/Recro-Pharma-Inc-Investigated-for-Possible-Securities-Laws-Violations-by-Block-Leviton-Investors-Who-Lost-Money-Should-Contact-the-Firm.html">Link</a></td>  </tr></table><h3>517. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RDHL">Redhill Biopharma Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:26:24 GMT</td>    <td>RedHill Biopharma to Present at BIO Digital Tel Aviv Stock Exchange:RDHL.TA - GlobeNewswire</td>    <td>RedHill Biopharma to Present at BIO Digital Tel Aviv Stock Exchange:RDHL.TA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041418/0/en/RedHill-Biopharma-to-Present-at-BIO-Digital.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 11:08:00 GMT</td>    <td>RedHill Biopharma to Present at Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>RedHill Biopharma to Present at Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/28/2040092/0/en/RedHill-Biopharma-to-Present-at-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>RedHill Biopharma to Present at the UBS Virtual Global Healthcare Conference - Yahoo Finance</td>    <td>RedHill Biopharma to Present at the UBS Virtual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/redhill-biopharma-present-ubs-virtual-110010628.html">Link</a></td>  </tr></table><h3>518. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-REGN">Regeneron Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 03:02:00 GMT</td>    <td>Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Regeneron Oncology Investor Event ASCO 2020 Conference (Transcript) - Seeking Alpha</td>    <td>Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Regeneron Oncology Investor Event ASCO 2020 Conference (Transcript)  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4351420-regeneron-pharmaceuticals-inc-regn-management-presents-regeneron-oncology-investor-event-asco">Link</a></td>  </tr><tr>    <td>Sat, 30 May 2020 15:17:00 GMT</td>    <td>Hedge Funds Aren’t Done Buying Regeneron Pharmaceuticals Inc (REGN) - Yahoo Finance</td>    <td>Hedge Funds Aren’t Done Buying Regeneron Pharmaceuticals Inc (REGN)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-aren-t-done-151717060.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:53:00 GMT</td>    <td>Regeneron Pharmaceuticals (REGN) Jumps: Stock Rises 6.3% - Yahoo Finance</td>    <td>Regeneron Pharmaceuticals (REGN) Jumps: Stock Rises 6.3%  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/regeneron-pharmaceuticals-regn-jumps-stock-125312994.html">Link</a></td>  </tr></table><h3>519. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RGNX">REGENXBIO Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>REGENXBIO Inc. (RGNX) Soars 1.9% on June 02 - Equities.com</td>    <td>REGENXBIO Inc. (RGNX) Soars 1.9% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/regenxbio-inc-rgnx-soars-1-9-on-june-02">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Regenxbio Inc. (RGNX) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Regenxbio Inc. (RGNX) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/07/regenxbio-inc-rgnx-q1-2020-earnings-call-transcrip.aspx">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 15:23:08 GMT</td>    <td>Does REGENXBIO Inc. (NASDAQ:RGNX) Have A Volatile Share Price? - Simply Wall St</td>    <td>Does REGENXBIO Inc. (NASDAQ:RGNX) Have A Volatile Share Price?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgnx/regenxbio/news/does-regenxbio-inc-nasdaqrgnx-have-a-volatile-share-price/">Link</a></td>  </tr></table><h3>520. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RGLS">Regulus Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent Updates - Yahoo Finance</td>    <td>Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent Updates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/regulus-therapeutics-reports-first-quarter-200700063.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:50:00 GMT</td>    <td>Is It Right Time to Be Bullish on Regulus Therapeutics Inc. (NASDAQ:RGLS), Companhia Brasileira de Distribuicao (NYSE:CBD)? - State Reviewer</td>    <td>Is It Right Time to Be Bullish on Regulus Therapeutics Inc. (NASDAQ:RGLS), Companhia Brasileira de Distribuicao (NYSE:CBD)?  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/is-it-right-time-to-be-bullish-on-regulus-therapeutics-inc-nasdaqrgls-companhia-brasileira-de-distribuicao-nysecbd/">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 21:09:00 GMT</td>    <td>Regulus Therapeutics Inc. (RGLS) Soars 10.94% on May 28 - Equities.com</td>    <td>Regulus Therapeutics Inc. (RGLS) Soars 10.94% on May 28  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/regulus-therapeutics-inc-rgls-soars-10-94-on-may-28">Link</a></td>  </tr></table><h3>521. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RELV">Reliv' International, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Reliv International Reports First-Quarter Financial Results for 2020 - PRNewswire</td>    <td>Reliv International Reports First-Quarter Financial Results for 2020  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/reliv-international-reports-first-quarter-financial-results-for-2020-301059829.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 09:35:57 GMT</td>    <td>65 Biggest Movers From Yesterday - Benzinga</td>    <td>65 Biggest Movers From Yesterday  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/news/20/05/16135753/65-biggest-movers-from-yesterday">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>50 Stocks Moving In Friday's Mid-Day Session - Benzinga</td>    <td>50 Stocks Moving In Friday's Mid-Day Session  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/news/20/05/16045493/50-stocks-moving-in-fridays-mid-day-session">Link</a></td>  </tr></table><h3>522. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RGEN">Repligen Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Repligen Corporation (RGEN) Soars 2.63% on June 02 - Equities.com</td>    <td>Repligen Corporation (RGEN) Soars 2.63% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/repligen-corporation-rgen-soars-2-63-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 11:46:50 GMT</td>    <td>Repligen Reports First Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance - GlobeNewswire</td>    <td>Repligen Reports First Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028332/0/en/Repligen-Reports-First-Quarter-2020-Financial-Results-and-Updates-Full-Year-2020-Financial-Guidance.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Results: Repligen Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance</td>    <td>Results: Repligen Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/results-repligen-corporation-beat-earnings-142355799.html">Link</a></td>  </tr></table><h3>523. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-REPL">Replimune Group, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:15:00 GMT</td>    <td>Replimune Reports Fiscal Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Replimune Reports Fiscal Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="http://www.globenewswire.com/news-release/2020/06/03/2042803/0/en/Replimune-Reports-Fiscal-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 11:28:37 GMT</td>    <td>Form 8-K Replimune Group, Inc. For: Jun 03 - StreetInsider.com</td>    <td>Form 8-K Replimune Group, Inc. For: Jun 03  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/SEC+Filings/Form+8-K+Replimune+Group%2C+Inc.+For%3A+Jun+03/16965263.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 11:00:00 GMT</td>    <td>Replimune Provides RP1 Data Update from its Phase 2 Cohorts in Melanoma and Non-Melanoma Skin Cancer that Strongly Support Replimune's Ongoing Registration-Directed Clinical Trials with RP1 - GlobeNewswire</td>    <td>Replimune Provides RP1 Data Update from its Phase 2 Cohorts in Melanoma and Non-Melanoma Skin Cancer that Strongly Support Replimune's Ongoing Registration-Directed Clinical Trials with RP1  GlobeNewswire</td>    <td><a target="_blank" href="http://www.globenewswire.com/news-release/2020/06/03/2042778/0/en/Replimune-Provides-RP1-Data-Update-from-its-Phase-2-Cohorts-in-Melanoma-and-Non-Melanoma-Skin-Cancer-that-Strongly-Support-Replimune-s-Ongoing-Registration-Directed-Clinical-Trials.html">Link</a></td>  </tr></table><h3>524. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RSLS">ReShape Lifesciences Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>ReShape Lifesciences Announces First Quarter 2020 Financial and Operational Results - Yahoo Finance</td>    <td>ReShape Lifesciences Announces First Quarter 2020 Financial and Operational Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/reshape-lifesciences-announces-first-quarter-200500818.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:52:57 GMT</td>    <td>Global Implantable Pulse Generators Market Covid-19 Impact Analysis, Future Potential 2026|Dextronix, Inc.; CorMedix Inc.; NeuroPace, Inc.; ReShape Lifesciences, Inc.; Stimwave LLC; IntraPace, Inc.; Integer Holdings Corporation; Impulse Dynamics - Bulletin Line</td>    <td>Global Implantable Pulse Generators Market Covid-19 Impact Analysis, Future Potential 2026|Dextronix, Inc.; CorMedix Inc.; NeuroPace, Inc.; ReShape Lifesciences, Inc.; Stimwave LLC; IntraPace, Inc.; Integer Holdings Corporation; Impulse Dynamics  Bulletin Line</td>    <td><a target="_blank" href="https://bulletinline.com/2020/06/03/global-implantable-pulse-generators-market-covid-19-impact-analysis-future-potential-2026dextronix-inc-cormedix-inc-neuropace-inc-reshape-lifesciences-inc-stimwave-llc-intrapace-inc-i/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:22:48 GMT</td>    <td>COVID-19 UPDATE: Bariatric Surgery Devices Market to Show Tremendous Growth by 2027 | Leading Players-Medtronic plc., Intuitive Surgical Inc., Apollo Endosurgery, Reshape Lifesciences - Medic Insider</td>    <td>COVID-19 UPDATE: Bariatric Surgery Devices Market to Show Tremendous Growth by 2027 | Leading Players-Medtronic plc., Intuitive Surgical Inc., Apollo Endosurgery, Reshape Lifesciences  Medic Insider</td>    <td><a target="_blank" href="https://medicinsider.com/covid-19-update-bariatric-surgery-devices-market-to-show-tremendous-growth-by-2027-leading-players-medtronic-plc-intuitive-surgical-inc-apollo-endosurgery-reshape-lifesciences/">Link</a></td>  </tr></table><h3>525. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TORC">resTORbio, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:21:03 GMT</td>    <td>resTORbio Inc. (TORC) return on Assets touches -81.18: These Shares are Poised for Major Movement - News Daemon</td>    <td>resTORbio Inc. (TORC) return on Assets touches -81.18: These Shares are Poised for Major Movement  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/03/restorbio-inc-torc-return-on-assets-touches-81-18-these-shares-are-poised-for-major-movement/">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 11:50:25 GMT</td>    <td>resTORbio Provides Corporate Update and Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>resTORbio Provides Corporate Update and Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029336/0/en/resTORbio-Provides-Corporate-Update-and-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:35:00 GMT</td>    <td>SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of resTORbio, Inc. (NasdaqGS - TORC) - Yahoo Finance</td>    <td>SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of resTORbio, Inc. (NasdaqGS - TORC)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/shareholder-notice-brodsky-smith-llc-213500385.html">Link</a></td>  </tr></table><h3>526. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RTRX">Retrophin, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Retrophin Inc. (RTRX) Soars 5.72% on June 02 - Equities.com</td>    <td>Retrophin Inc. (RTRX) Soars 5.72% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/retrophin-inc-rtrx-soars-5-72-on-june-02">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Retrophin Reports First Quarter 2020 Financial Results Nasdaq:RTRX - GlobeNewswire</td>    <td>Retrophin Reports First Quarter 2020 Financial Results Nasdaq:RTRX  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031383/0/en/Retrophin-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 20:33:15 GMT</td>    <td>Retrophin to Present at the Jefferies 2020 Virtual Healthcare Conference - GlobeNewswire</td>    <td>Retrophin to Present at the Jefferies 2020 Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039767/0/en/Retrophin-to-Present-at-the-Jefferies-2020-Virtual-Healthcare-Conference.html">Link</a></td>  </tr></table><h3>527. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RVNC">Revance Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 20:05:00 GMT</td>    <td>Revance to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast - Business Wire</td>    <td>Revance to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005781/en/Revance-Present-Goldman-Sachs-41st-Annual-Global">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Revance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices - Business Wire</td>    <td>Revance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200519005316/en/Revance-Announces-Agreement-Acquire-HintMD-Proprietary-Fintech">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:30:00 GMT</td>    <td>Revance and Mylan to Advance Development Program for Biosimilar to BOTOX - BioSpace</td>    <td>Revance and Mylan to Advance Development Program for Biosimilar to BOTOX  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/revance-and-mylan-to-advance-development-program-for-biosimilar-to-botox-/">Link</a></td>  </tr></table><h3>528. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RVMD">Revolution Medicines</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 20:15:56 GMT</td>    <td>Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress - GlobeNewswire</td>    <td>Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033868/0/en/Revolution-Medicines-Reports-First-Quarter-2020-Financial-Results-and-Continued-Corporate-Progress.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 11:37:30 GMT</td>    <td>Revolution Medicines Announces Four Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting II - GlobeNewswire</td>    <td>Revolution Medicines Announces Four Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting II  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/19/2035551/0/en/Revolution-Medicines-Announces-Four-Presentations-at-the-2020-American-Association-for-Cancer-Research-Virtual-Annual-Meeting-II.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>BRIEF-Revolution Medicines Reports Quarterly Loss Per Share Of $0.74 - Reuters</td>    <td>BRIEF-Revolution Medicines Reports Quarterly Loss Per Share Of $0.74  Reuters</td>    <td><a target="_blank" href="https://uk.reuters.com/article/brief-revolution-medicines-reports-quart/brief-revolution-medicines-reports-quarterly-loss-per-share-of-074-idUKASA00QCA">Link</a></td>  </tr></table><h3>529. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RYTM">Rhythm Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 13:00:00 GMT</td>    <td>Rhythm Pharmaceuticals Announces FDA Acceptance of New Drug Application for Setmelanotide for the Treatment of POMC and LEPR Deficiency Obesities - GlobeNewswire</td>    <td>Rhythm Pharmaceuticals Announces FDA Acceptance of New Drug Application for Setmelanotide for the Treatment of POMC and LEPR Deficiency Obesities  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032735/0/en/Rhythm-Pharmaceuticals-Announces-FDA-Acceptance-of-New-Drug-Application-for-Setmelanotide-for-the-Treatment-of-POMC-and-LEPR-Deficiency-Obesities.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:07:27 GMT</td>    <td>Rhythm Pharmaceuticals to Present Virtually at Upcoming Investor Conference in June - GlobeNewswire</td>    <td>Rhythm Pharmaceuticals to Present Virtually at Upcoming Investor Conference in June  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038574/0/en/Rhythm-Pharmaceuticals-to-Present-Virtually-at-Upcoming-Investor-Conference-in-June.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 12:02:36 GMT</td>    <td>Rhythm Pharmaceuticals to Present Virtually at 2020 BofA Securities Health Care Conference - GlobeNewswire</td>    <td>Rhythm Pharmaceuticals to Present Virtually at 2020 BofA Securities Health Care Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027450/0/en/Rhythm-Pharmaceuticals-to-Present-Virtually-at-2020-BofA-Securities-Health-Care-Conference.html">Link</a></td>  </tr></table><h3>530. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RIGL">Rigel Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Rigel Pharmaceuticals Inc. (RIGL) Plunges 5.08% on June 03 - Equities.com</td>    <td>Rigel Pharmaceuticals Inc. (RIGL) Plunges 5.08% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/rigel-pharmaceuticals-inc-rigl-plunges-5-08-on-june-03">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:00:10 GMT</td>    <td>Short term estimates and forecasts for Rigel Pharmaceuticals, Inc. (RIGL) - Marketing Sentinel</td>    <td>Short term estimates and forecasts for Rigel Pharmaceuticals, Inc. (RIGL)  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/03/short-term-estimates-and-forecasts-for-rigel-pharmaceuticals-inc-rigl/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 11:30:00 GMT</td>    <td>Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress - PRNewswire</td>    <td>Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/rigel-to-present-four-posters-highlighting-irak14-inhibitor-at-the-eular-2020-e-congress-301069832.html">Link</a></td>  </tr></table><h3>531. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RIOT">Riot Blockchain, Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:45:00 GMT</td>    <td>Riot Blockchain Continues to Increase Production Efficiencies and Aggressive Expansion of Bitcoin Hash Rate, Reaching 567 PH/s with Latest Purchase - PRNewswire</td>    <td>Riot Blockchain Continues to Increase Production Efficiencies and Aggressive Expansion of Bitcoin Hash Rate, Reaching 567 PH/s with Latest Purchase  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/riot-blockchain-continues-to-increase-production-efficiencies-and-aggressive-expansion-of-bitcoin-hash-rate-reaching-567-phs-with-latest-purchase-301070373.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Riot Blockchain Announces April 2020 Production Update - PRNewswire</td>    <td>Riot Blockchain Announces April 2020 Production Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/riot-blockchain-announces-april-2020-production-update-301053379.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 18:00:00 GMT</td>    <td>How Hedge Funds Traded Riot Blockchain, Inc (RIOT) During The Crash - Yahoo Finance</td>    <td>How Hedge Funds Traded Riot Blockchain, Inc (RIOT) During The Crash  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-traded-riot-blockchain-180017359.html">Link</a></td>  </tr></table><h3>532. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RTTR">Ritter Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 16:45:33 GMT</td>    <td>Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc. - GlobeNewswire</td>    <td>Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/22/2037739/0/en/Ritter-Pharmaceuticals-Inc-Announces-Expected-Closing-of-Merger-Transaction-with-Qualigen-Inc.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special Meeting - Yahoo Finance</td>    <td>Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special Meeting  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/ritter-pharmaceuticals-inc-announces-adjournment-181310762.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Ritter Pharmaceuticals Regains Compliance with Nasdaq's Stockholders' Equity Requirement for Continued Listing - GlobeNewswire</td>    <td>Ritter Pharmaceuticals Regains Compliance with Nasdaq's Stockholders' Equity Requirement for Continued Listing  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031044/0/en/ritter-pharmaceuticals-regains-compliance-with-nasdaq-s-stockholders-equity-requirement-for-continued-listing.html">Link</a></td>  </tr></table><h3>533. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RCKT">Rocket Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Rocket Pharmaceuticals Presents Positive Updates on FA and LAD-I Gene Therapy Programs at the 23rd Annual Meeting of the American Society of Gene and Cell Therapy - Business Wire</td>    <td>Rocket Pharmaceuticals Presents Positive Updates on FA and LAD-I Gene Therapy Programs at the 23rd Annual Meeting of the American Society of Gene and Cell Therapy  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005280/en/Rocket-Pharmaceuticals-Presents-Positive-Updates-FA-LAD-I">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Rocket Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Progress - Business Wire</td>    <td>Rocket Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Progress  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506005270/en/Rocket-Pharmaceuticals-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>Was The Smart Money Right About Rocket Pharmaceuticals (RCKT)? - Yahoo Finance</td>    <td>Was The Smart Money Right About Rocket Pharmaceuticals (RCKT)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/smart-money-rocket-pharmaceuticals-rckt-023923527.html">Link</a></td>  </tr></table><h3>534. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RMTI">Rockwell Medical, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 11:11:24 GMT</td>    <td>Rockwell Medical, Inc. Files New Drug Submission with Health Canada for Marketing Approval of Triferic® AVNU™ - GlobeNewswire</td>    <td>Rockwell Medical, Inc. Files New Drug Submission with Health Canada for Marketing Approval of Triferic® AVNU™  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038503/0/en/Rockwell-Medical-Inc-Files-New-Drug-Submission-with-Health-Canada-for-Marketing-Approval-of-Triferic-AVNU.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 20:13:25 GMT</td>    <td>Rockwell Medical, Inc. Provides First Quarter 2020 Financial and Operational Update and Top-line Real-World Triferic Data - GlobeNewswire</td>    <td>Rockwell Medical, Inc. Provides First Quarter 2020 Financial and Operational Update and Top-line Real-World Triferic Data  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031438/0/en/Rockwell-Medical-Inc-Provides-First-Quarter-2020-Financial-and-Operational-Update-and-Top-line-Real-World-Triferic-Data.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Rockwell Medical Inc. (RMTI) Soars 1.44% on June 02 - Equities.com</td>    <td>Rockwell Medical Inc. (RMTI) Soars 1.44% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/rockwell-medical-inc-rmti-soars-1-44-on-june-02">Link</a></td>  </tr></table><h3>535. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RUBY">Rubius Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 12:10:21 GMT</td>    <td>Rubius Therapeutics Reports First Quarter 2020 Financial Results and Provides Operational Update - GlobeNewswire</td>    <td>Rubius Therapeutics Reports First Quarter 2020 Financial Results and Provides Operational Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031034/0/en/Rubius-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Operational-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 20:03:13 GMT</td>    <td>Rubius Therapeutics to Present at Jefferies Virtual 2020 Healthcare Conference - GlobeNewswire</td>    <td>Rubius Therapeutics to Present at Jefferies Virtual 2020 Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038911/0/en/Rubius-Therapeutics-to-Present-at-Jefferies-Virtual-2020-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial of RTX-240, an Allogeneic Cellular Therapy, for the Treatment of Solid Tumors - Yahoo Finance</td>    <td>Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial of RTX-240, an Allogeneic Cellular Therapy, for the Treatment of Solid Tumors  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/rubius-therapeutics-announces-dosing-first-120010295.html">Link</a></td>  </tr></table><h3>536. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SAGE">Sage Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Sage Therapeutics Inc. (SAGE) Soars 3.45% on June 03 - Equities.com</td>    <td>Sage Therapeutics Inc. (SAGE) Soars 3.45% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/sage-therapeutics-inc-sage-soars-3-45-on-june-03">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 10:30:00 GMT</td>    <td>Sage Therapeutics to Present at Goldman Sachs 41st Annual Global Healthcare Conference - Business Wire</td>    <td>Sage Therapeutics to Present at Goldman Sachs 41st Annual Global Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200601005011/en/Sage-Therapeutics-Present-Goldman-Sachs-41st-Annual">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress - Business Wire</td>    <td>Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005952/en/Sage-Therapeutics-Announces-Quarter-2020-Financial-Results">Link</a></td>  </tr></table><h3>537. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SGMO">Sangamo Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Sangamo Therapeutics Announces Virtual Format for 2020 Annual Meeting - Business Wire</td>    <td>Sangamo Therapeutics Announces Virtual Format for 2020 Annual Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507006162/en/Sangamo-Therapeutics-Announces-Virtual-Format-2020-Annual">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results - Business Wire</td>    <td>Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200511005797/en/Sangamo-Therapeutics-Reports-Business-Highlights-Quarter-2020">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Sangamo Therapeutics Announces Participation at the Bank of America 2020 Health Care Conference - Yahoo Finance</td>    <td>Sangamo Therapeutics Announces Participation at the Bank of America 2020 Health Care Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/sangamo-therapeutics-announces-participation-bank-131500780.html">Link</a></td>  </tr></table><h3>538. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-GCVRZ">Sanofi</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 16:12:40 GMT</td>    <td>Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan - GlobeNewswire</td>    <td>Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2043122/0/en/Sanofi-to-launch-Action-2020-a-worldwide-employee-stock-purchase-plan.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 20:16:00 GMT</td>    <td>Sanofi shakes up leadership, brings in 4 new execs - Becker's Hospital Review</td>    <td>Sanofi shakes up leadership, brings in 4 new execs  Becker's Hospital Review</td>    <td><a target="_blank" href="https://www.beckershospitalreview.com/pharmacy/sanofi-shakes-up-leadership-brings-in-4-new-execs.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:13:00 GMT</td>    <td>Sanofi to run consultations over restart of hydroxychloroquine trials - Yahoo Finance</td>    <td>Sanofi to run consultations over restart of hydroxychloroquine trials  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/sanofi-run-consultations-over-restart-171353503.html">Link</a></td>  </tr></table><h3>539. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SRPT">Sarepta Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 01:09:03 GMT</td>    <td>Is Sarepta Therapeutics Inc (SRPT) Going to Burn These Hedge Funds? - Yahoo Finance</td>    <td>Is Sarepta Therapeutics Inc (SRPT) Going to Burn These Hedge Funds?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/sarepta-therapeutics-inc-srpt-going-005721190.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 12:42:31 GMT</td>    <td>Personalis Announces Scientific Collaboration with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics - BioSpace</td>    <td>Personalis Announces Scientific Collaboration with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/personalis-announces-scientific-collaboration-with-sarepta-therapeutics-on-immune-response-to-precision-genetic-therapeutics/">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments - GlobeNewswire</td>    <td>Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028837/0/en/Sarepta-Therapeutics-Announces-First-Quarter-2020-Financial-Results-and-Recent-Corporate-Developments.html">Link</a></td>  </tr></table><h3>540. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-STSA">Satsuma Pharmaceuticals</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 20:07:29 GMT</td>    <td>Satsuma Pharmaceuticals Reports First Quarter 2020 Financial and Business Results - GlobeNewswire</td>    <td>Satsuma Pharmaceuticals Reports First Quarter 2020 Financial and Business Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032227/0/en/Satsuma-Pharmaceuticals-Reports-First-Quarter-2020-Financial-and-Business-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 12:30:00 GMT</td>    <td>Satsuma Pharmaceuticals to To Present at the Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>Satsuma Pharmaceuticals to To Present at the Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039379/0/en/Satsuma-Pharmaceuticals-to-To-Present-at-the-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 20:24:23 GMT</td>    <td>Satsuma Pharmaceuticals Announces Poster Presentations on the American Academy of Neurology 2020 Science Highlights Virtual Platform - GlobeNewswire</td>    <td>Satsuma Pharmaceuticals Announces Poster Presentations on the American Academy of Neurology 2020 Science Highlights Virtual Platform  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2035243/0/en/Satsuma-Pharmaceuticals-Announces-Poster-Presentations-on-the-American-Academy-of-Neurology-2020-Science-Highlights-Virtual-Platform.html">Link</a></td>  </tr></table><h3>541. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SVRA">Savara, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Savara Reports First Quarter 2020 Financial Results and Provides Business Update - Yahoo Finance</td>    <td>Savara Reports First Quarter 2020 Financial Results and Provides Business Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/savara-reports-first-quarter-2020-200500650.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Savara Inc. (NASDAQ:SVRA) Insiders Increased Their Holdings - Simply Wall St</td>    <td>Savara Inc. (NASDAQ:SVRA) Insiders Increased Their Holdings  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/savara-inc-nasdaqsvra-insiders-increased-their-holdings/">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 20:06:52 GMT</td>    <td>Savara to Present at the Jefferies Virtual Healthcare Conference - Valdosta Daily Times</td>    <td>Savara to Present at the Jefferies Virtual Healthcare Conference  Valdosta Daily Times</td>    <td><a target="_blank" href="https://www.valdostadailytimes.com/news/business/savara-to-present-at-the-jefferies-virtual-healthcare-conference/article_1aa61742-0fad-5129-a541-dcc8066c9022.html">Link</a></td>  </tr></table><h3>542. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SRRK">Scholar Rock Holding Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Scholar Rock Holding Corporation (SRRK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance</td>    <td>Scholar Rock Holding Corporation (SRRK) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/scholar-rock-holding-corporation-srrk-010001391.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Scholar Rock Holding Corporation (SRRK) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance</td>    <td>Scholar Rock Holding Corporation (SRRK) May Report Negative Earnings: Know the Trend Ahead of Q1 Release  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/scholar-rock-holding-corporation-srrk-163004424.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Scholar Rock Holding Corp. (SRRK) Adds Tony Kingsley to Board - StreetInsider.com</td>    <td>Scholar Rock Holding Corp. (SRRK) Adds Tony Kingsley to Board  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Scholar+Rock+Holding+Corp.+%28SRRK%29+Adds+Tony+Kingsley+to+Board/16918559.html">Link</a></td>  </tr></table><h3>543. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SDGR">Schrodinger</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 20:00:00 GMT</td>    <td>Schrödinger to Present at the Jefferies 2020 Virtual Healthcare Conference - Business Wire</td>    <td>Schrödinger to Present at the Jefferies 2020 Virtual Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200528005638/en/Schr%C3%B6dinger-Present-Jefferies-2020-Virtual-Healthcare-Conference">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Schrödinger Reports First Quarter 2020 Financial Results and Recent Business Updates - Business Wire</td>    <td>Schrödinger Reports First Quarter 2020 Financial Results and Recent Business Updates  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200513005100/en/Schr%C3%B6dinger-Reports-Quarter-2020-Financial-Results-Business">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Quantum Tunneling Effects, Solving the Schrodinger Equation Bottleneck Recognized as Best Papers by The Journal of Chemical Physics - PRNewswire</td>    <td>Quantum Tunneling Effects, Solving the Schrodinger Equation Bottleneck Recognized as Best Papers by The Journal of Chemical Physics  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/quantum-tunneling-effects-solving-the-schrodinger-equation-bottleneck-recognized-as-best-papers-by-the-journal-of-chemical-physics-301054211.html">Link</a></td>  </tr></table><h3>544. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SCPH">scPharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 12:00:00 GMT</td>    <td>scPharmaceuticals Inc. to Present at Upcoming Investor Conferences - Business Wire</td>    <td>scPharmaceuticals Inc. to Present at Upcoming Investor Conferences  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200528005127/en/scPharmaceuticals-Present-Upcoming-Investor-Conferences">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>scPharmaceuticals Inc. Reports First Quarter 2020 Financial Results and Provides Business Update - Business Wire</td>    <td>scPharmaceuticals Inc. Reports First Quarter 2020 Financial Results and Provides Business Update  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005080/en/scPharmaceuticals-Reports-Quarter-2020-Financial-Results-Business">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 08:21:00 GMT</td>    <td>Scpharmaceuticals Inc (NSQ:SCPH): buy, sell or hold? - Yahoo Finance UK</td>    <td>Scpharmaceuticals Inc (NSQ:SCPH): buy, sell or hold?  Yahoo Finance UK</td>    <td><a target="_blank" href="https://uk.finance.yahoo.com/news/scpharmaceuticals-inc-nsq-scph-buy-082134295.html">Link</a></td>  </tr></table><h3>545. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SCYX">SCYNEXIS, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 13:34:58 GMT</td>    <td>Women's health marketing exec joins Jersey City's Scynexis - NJBIZ</td>    <td>Women's health marketing exec joins Jersey City's Scynexis  NJBIZ</td>    <td><a target="_blank" href="https://njbiz.com/womens-health-marketing-exec-joins-jersey-citys-scynexis/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 17:40:00 GMT</td>    <td>SCYNEXIS Inc. [SCYX] moved up 0.26: Why It’s Important - The DBT News</td>    <td>SCYNEXIS Inc. [SCYX] moved up 0.26: Why It’s Important  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/scynexis-inc-scyx-moved-up-0-26-why-its-important/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 17:10:00 GMT</td>    <td>What SCYNEXIS, Inc. (SCYX) Doesn’t Want You to Know - The News Heater</td>    <td>What SCYNEXIS, Inc. (SCYX) Doesn’t Want You to Know  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/02/what-scynexis-inc-scyx-doesnt-want-you-to-know/">Link</a></td>  </tr></table><h3>546. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SGEN">Seattle Genetics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:00:00 GMT</td>    <td>Seattle Genetics to Present at Goldman Sachs 41st Annual Global Healthcare Conference - Yahoo Finance</td>    <td>Seattle Genetics to Present at Goldman Sachs 41st Annual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/seattle-genetics-present-goldman-sachs-120000986.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Analysts See Seattle Genetics Profitable in 2022 - Yahoo Finance</td>    <td>Analysts See Seattle Genetics Profitable in 2022  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-see-seattle-genetics-profitable-214255041.html">Link</a></td>  </tr><tr>    <td>Sat, 30 May 2020 15:31:00 GMT</td>    <td>Why Is Seattle Genetics (SGEN) Up 14.6% Since Last Earnings Report? - Yahoo Finance</td>    <td>Why Is Seattle Genetics (SGEN) Up 14.6% Since Last Earnings Report?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-seattle-genetics-sgen-14-153103489.html">Link</a></td>  </tr></table><h3>547. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-EYES">Second Sight Medical Products, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 16:00:00 GMT</td>    <td>Second Sight Medical Products (EYES) Upgraded to Buy: Here's What You Should Know - Yahoo Finance</td>    <td>Second Sight Medical Products (EYES) Upgraded to Buy: Here's What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/second-sight-medical-products-eyes-160004555.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 21:09:00 GMT</td>    <td>Second Sight Medical Products Inc. (EYES) Soars 2% on June 03 - Equities.com</td>    <td>Second Sight Medical Products Inc. (EYES) Soars 2% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/second-sight-medical-products-inc-eyes-soars-2-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Second Sight Medical Products Inc. Announces Closing of Public Offering of Common Stock - Yahoo Finance</td>    <td>Second Sight Medical Products Inc. Announces Closing of Public Offering of Common Stock  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/second-sight-medical-products-inc-170800671.html">Link</a></td>  </tr></table><h3>548. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SELB">Selecta Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:50:23 GMT</td>    <td>Selecta Biosciences Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Selecta Biosciences Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029338/0/en/Selecta-Biosciences-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:07:49 GMT</td>    <td>Selecta Biosciences to Present at the Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>Selecta Biosciences to Present at the Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038563/0/en/Selecta-Biosciences-to-Present-at-the-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Selecta Biosciences, Inc. (SELB) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Selecta Biosciences, Inc. (SELB) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/selecta-biosciences-inc-selb-q1-2020-earnings-call.aspx">Link</a></td>  </tr></table><h3>549. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SLS">SELLAS Life Sciences Group, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 20:38:01 GMT</td>    <td>SELLAS Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire</td>    <td>SELLAS Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033910/0/en/SELLAS-Life-Sciences-Reports-First-Quarter-2020-Financial-Results-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 21:22:00 GMT</td>    <td>BRIEF-Sellas Life Sciences Group Files Prospectus Relating To Resale Of Up To 818,900 Shares - Reuters</td>    <td>BRIEF-Sellas Life Sciences Group Files Prospectus Relating To Resale Of Up To 818,900 Shares  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-sellas-life-sciences-group-files-p/brief-sellas-life-sciences-group-files-prospectus-relating-to-resale-of-up-to-818900-shares-idUSFWN2DB16B">Link</a></td>  </tr><tr>    <td>Mon, 25 May 2020 16:36:17 GMT</td>    <td>SELLAS Life Sciences Group, Inc - Consensus Indicates Potential 144.3% Upside - DirectorsTalk Interviews</td>    <td>SELLAS Life Sciences Group, Inc - Consensus Indicates Potential 144.3% Upside  DirectorsTalk Interviews</td>    <td><a target="_blank" href="https://www.directorstalkinterviews.com/sellas-life-sciences-group-inc-consensus-indicates-potential-144-3-upside/412825007">Link</a></td>  </tr></table><h3>550. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MCRB">Seres Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Seres Therapeutics Inc. (MCRB) Plunges 7.02% on June 03 - Equities.com</td>    <td>Seres Therapeutics Inc. (MCRB) Plunges 7.02% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/seres-therapeutics-inc-mcrb-plunges-7-02-on-june-03">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 20:00:00 GMT</td>    <td>Seres Therapeutics to Present at the Goldman Sachs 41st Annual Global Virtual Healthcare Conference - Yahoo Finance</td>    <td>Seres Therapeutics to Present at the Goldman Sachs 41st Annual Global Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/seres-therapeutics-present-goldman-sachs-200000757.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Seres Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates - Business Wire</td>    <td>Seres Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005090/en/Seres-Therapeutics-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr></table><h3>551. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SESN">Sesen Bio, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Sesen Bio Reports Positive Interactions with EMA on Regulatory Pathway for Vicinium® - Business Wire</td>    <td>Sesen Bio Reports Positive Interactions with EMA on Regulatory Pathway for Vicinium®  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507006140/en/Sesen-Bio-Reports-Positive-Interactions-EMA-Regulatory">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 11:00:00 GMT</td>    <td>Sesen Bio to Present at the Jefferies Virtual Healthcare Conference - Business Wire</td>    <td>Sesen Bio to Present at the Jefferies Virtual Healthcare Conference  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200526005065/en/Sesen-Bio-Present-Jefferies-Virtual-Healthcare-Conference">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Sesen Bio Reports First Quarter 2020 Financial Results and Meaningful Progress Towards Demonstrating Analytical Comparability - Business Wire</td>    <td>Sesen Bio Reports First Quarter 2020 Financial Results and Meaningful Progress Towards Demonstrating Analytical Comparability  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200511005145/en/Sesen-Bio-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr></table><h3>552. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SHPG">Shire plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 23:03:00 GMT</td>    <td>Pharmacy Chain Says It Can Rep Class If Lead Is DQ'd - Law360</td>    <td>Pharmacy Chain Says It Can Rep Class If Lead Is DQ'd  Law360</td>    <td><a target="_blank" href="https://www.law360.com/ip/articles/1279346/pharmacy-chain-says-it-can-rep-class-if-lead-is-dq-d">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 15:09:31 GMT</td>    <td>Takeda gets EU green light to keep bowel drug after Shire buy - WHTC News</td>    <td>Takeda gets EU green light to keep bowel drug after Shire buy  WHTC News</td>    <td><a target="_blank" href="https://whtc.com/news/articles/2020/may/28/takeda-gets-eu-green-light-to-keep-bowel-drug-after-shire-buy/1023150/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Takeda Pharma posts full-year operating profit amid Shire consolidation - Reuters</td>    <td>Takeda Pharma posts full-year operating profit amid Shire consolidation  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/takeda-pharma-results/takeda-pharma-posts-full-year-operating-profit-amid-shire-consolidation-idUSL4N2CV188">Link</a></td>  </tr></table><h3>553. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SWAV">ShockWave Medical</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Shockwave Medical: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Shockwave Medical: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Shockwave-Medical-1Q-Earnings-Snapshot-15265312.php">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Shockwave Medical Inc (SWAV) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Shockwave Medical Inc (SWAV) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/13/shockwave-medical-inc-swav-q1-2020-earnings-call-t.aspx">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Shockwave Medical (SWAV) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance</td>    <td>Shockwave Medical (SWAV) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/shockwave-medical-swav-reports-q1-212509822.html">Link</a></td>  </tr></table><h3>554. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SNNA">Sienna Biopharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 12 Dec 2019 08:00:00 GMT</td>    <td>Sienna Biopharmaceuticals to Cease Operations - San Fernando Valley Business Journal</td>    <td>Sienna Biopharmaceuticals to Cease Operations  San Fernando Valley Business Journal</td>    <td><a target="_blank" href="https://www.sfvbj.com/news/2019/dec/12/sienna-biopharmaceuticals-cease-operations/">Link</a></td>  </tr><tr>    <td>Thu, 14 Nov 2019 08:00:00 GMT</td>    <td>Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding Procedures - GlobeNewswire</td>    <td>Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding Procedures  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/11/14/1947575/0/en/Sienna-Biopharmaceuticals-Announces-Court-Approval-of-Chapter-11-Bidding-Procedures.html">Link</a></td>  </tr><tr>    <td>Wed, 18 Sep 2019 07:00:00 GMT</td>    <td>Sienna Biopharmaceuticals Files for Bankruptcy, Delaying Phase III Psoriasis Trial - BioSpace</td>    <td>Sienna Biopharmaceuticals Files for Bankruptcy, Delaying Phase III Psoriasis Trial  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/sienna-biopharmaceuticals-files-chapter-11-delaying-phase-iii-psoriasis-trial/">Link</a></td>  </tr></table><h3>555. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SRRA">Sierra Oncology, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 11:00:00 GMT</td>    <td>Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer - Yahoo Finance</td>    <td>Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/sierra-oncology-appoints-dr-stephen-110000948.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Sierra Oncology Reports First Quarter 2020 Results - Yahoo Finance</td>    <td>Sierra Oncology Reports First Quarter 2020 Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/sierra-oncology-reports-first-quarter-110000721.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 11:00:00 GMT</td>    <td>Sierra Oncology Announces Presentations at Upcoming Investor Conferences - PRNewswire</td>    <td>Sierra Oncology Announces Presentations at Upcoming Investor Conferences  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/sierra-oncology-announces-presentations-at-upcoming-investor-conferences-301065651.html">Link</a></td>  </tr></table><h3>556. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SIGA">SIGA Technologies Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 13:10:12 GMT</td>    <td>SIGA Technologies Announces First International Delivery of Oral TPOXX® - GlobeNewswire</td>    <td>SIGA Technologies Announces First International Delivery of Oral TPOXX®  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041537/0/en/SIGA-Technologies-Announces-First-International-Delivery-of-Oral-TPOXX.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:21:00 GMT</td>    <td>SIGA Technologies, Inc. Reports Financial Results for the First Quarter of 2020 - GlobeNewswire</td>    <td>SIGA Technologies, Inc. Reports Financial Results for the First Quarter of 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028813/0/en/SIGA-Technologies-Inc-Reports-Financial-Results-for-the-First-Quarter-of-2020.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 16:46:44 GMT</td>    <td>Does SIGA Technologies, Inc.’s (NASDAQ:SIGA) CEO Pay Reflect Performance? - Simply Wall St</td>    <td>Does SIGA Technologies, Inc.’s (NASDAQ:SIGA) CEO Pay Reflect Performance?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-siga/siga-technologies/news/does-siga-technologies-inc-s-nasdaqsiga-ceo-pay-reflect-performance/">Link</a></td>  </tr></table><h3>557. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SILK">Silk Road Medical</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Silk Road Medical Announces Full Exercise and Closing of Over-Allotment Option - Yahoo Finance</td>    <td>Silk Road Medical Announces Full Exercise and Closing of Over-Allotment Option  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/silk-road-medical-announces-full-200510711.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 20:05:00 GMT</td>    <td>Silk Road Medical Announces Closing of Follow-on Public Offering - GlobeNewswire</td>    <td>Silk Road Medical Announces Closing of Follow-on Public Offering  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030564/0/en/Silk-Road-Medical-Announces-Closing-of-Follow-on-Public-Offering.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Silk Road Medical Announces Proposed Public Offering of Common Stock - Yahoo Finance</td>    <td>Silk Road Medical Announces Proposed Public Offering of Common Stock  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/silk-road-medical-announces-proposed-202210628.html">Link</a></td>  </tr></table><h3>558. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SVA">Sinovac Biotech, Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:27:37 GMT</td>    <td>Chinese Firm Sinovac Biotech Says It Is 99% Sure that Its COVID-19 Vaccine Will Work - HospiMedica</td>    <td>Chinese Firm Sinovac Biotech Says It Is 99% Sure that Its COVID-19 Vaccine Will Work  HospiMedicaChinese company Sinovac 99% hopeful that its COVID-19 vaccine ‘CoronaVac’ will work  Times NowSinovac 99% Confident that 'CoronaVac' Will Work Effectively Against Coronavirus  Science TimesChinese company Sinovac 99% hopeful that its COVID vaccine CoronaVac would work!  GalattaView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.hospimedica.com/covid-19/articles/294782702/chinese-firm-sinovac-biotech-says-it-is-99-sure-that-its-covid-19-vaccine-will-work.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development - Business Wire</td>    <td>Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200522005096/en/Sinovac-Secures-15-Million-Funding-Accelerate-COVID-19">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 12:30:00 GMT</td>    <td>Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital - Odessa American</td>    <td>Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital  Odessa American</td>    <td><a target="_blank" href="https://www.oaoa.com/news/business/article_82dd95ee-a6da-5498-82e7-04f5594cc785.html">Link</a></td>  </tr></table><h3>559. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SDC">SmileDirectClub</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 13:53:52 GMT</td>    <td>Smile Direct Club Launches Solution For Clear Aligner Patients Ready To Switch To Its Telehealth Platform - GlobeNewswire</td>    <td>Smile Direct Club Launches Solution For Clear Aligner Patients Ready To Switch To Its Telehealth Platform  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/21/2037115/0/en/Smile-Direct-Club-Launches-Solution-For-Clear-Aligner-Patients-Ready-To-Switch-To-Its-Telehealth-Platform.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 13:27:50 GMT</td>    <td>Smile Direct Club Expands SmileShops through Newly Announced Partnership with Watsons in Asia - GlobeNewswire</td>    <td>Smile Direct Club Expands SmileShops through Newly Announced Partnership with Watsons in Asia  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042295/0/en/Smile-Direct-Club-Expands-SmileShops-through-Newly-Announced-Partnership-with-Watsons-in-Asia.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:27:00 GMT</td>    <td>Do Direct-to-Consumer Aligners Like SmileDirectClub Work? - Prevention.com</td>    <td>Do Direct-to-Consumer Aligners Like SmileDirectClub Work?  Prevention.com</td>    <td><a target="_blank" href="https://www.prevention.com/health/a32438930/do-clear-aligners-work/">Link</a></td>  </tr></table><h3>560. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SLNO">Soleno Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 20:07:36 GMT</td>    <td>Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032221/0/en/Soleno-Therapeutics-Provides-Corporate-Update-and-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 12:35:47 GMT</td>    <td>Implied Volatility Surging for Soleno Therapeutics (SLNO) Stock Options - Zacks.com</td>    <td>Implied Volatility Surging for Soleno Therapeutics (SLNO) Stock Options  Zacks.com</td>    <td><a target="_blank" href="https://www.zacks.com/stock/news/956754/implied-volatility-surging-for-soleno-therapeutics-slno-stock-options">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>After a strong run, what's next for investors in Soleno Therapeutics Inc? - Stockopedia</td>    <td>After a strong run, what's next for investors in Soleno Therapeutics Inc?  Stockopedia</td>    <td><a target="_blank" href="https://www.stockopedia.com/articles/after-a-strong-run-whats-next-for-investors-in-soleno-therapeutics-inc-37763">Link</a></td>  </tr></table><h3>561. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SLGL">Sol-Gel Technologies Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 11:12:56 GMT</td>    <td>Sol-Gel Technologies Reports First Quarter 2020 Financial Results and Corporate Update - GlobeNewswire</td>    <td>Sol-Gel Technologies Reports First Quarter 2020 Financial Results and Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033401/0/en/Sol-Gel-Technologies-Reports-First-Quarter-2020-Financial-Results-and-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 20:11:51 GMT</td>    <td>Sol-Gel Technologies to Report First Quarter 2020 Financial Results and Company Updates on May 14, 2020 - GlobeNewswire</td>    <td>Sol-Gel Technologies to Report First Quarter 2020 Financial Results and Company Updates on May 14, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029880/0/en/Sol-Gel-Technologies-to-Report-First-Quarter-2020-Financial-Results-and-Company-Updates-on-May-14-2020.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 12:00:27 GMT</td>    <td>Need To Know: Analysts Are Much More Bullish On Sol-Gel Technologies Ltd. (NASDAQ:SLGL) - Simply Wall St</td>    <td>Need To Know: Analysts Are Much More Bullish On Sol-Gel Technologies Ltd. (NASDAQ:SLGL)  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/need-to-know-analysts-are-much-more-bullish-on-sol-gel-technologies-ltd-nasdaqslgl/">Link</a></td>  </tr></table><h3>562. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SLDB">Solid Biosciences Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 11:21:48 GMT</td>    <td>Solid Biosciences to Hold Virtual Annual Meeting of Stockholders on June 16, 2020 - GlobeNewswire</td>    <td>Solid Biosciences to Hold Virtual Annual Meeting of Stockholders on June 16, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/22/2037508/0/en/Solid-Biosciences-to-Hold-Virtual-Annual-Meeting-of-Stockholders-on-June-16-2020.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 11:28:57 GMT</td>    <td>Solid Biosciences Provides Update regarding SGT-001 Phase I/II Clinical Hold on IGNITE DMD - GlobeNewswire</td>    <td>Solid Biosciences Provides Update regarding SGT-001 Phase I/II Clinical Hold on IGNITE DMD  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029328/0/en/Solid-Biosciences-Provides-Update-regarding-SGT-001-Phase-I-II-Clinical-Hold-on-IGNITE-DMD.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:35:00 GMT</td>    <td>Why Solid Biosciences (SLDB) Stock Might be a Great Pick - Yahoo Finance</td>    <td>Why Solid Biosciences (SLDB) Stock Might be a Great Pick  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-solid-biosciences-sldb-stock-123512016.html">Link</a></td>  </tr></table><h3>563. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SNGX">Soligenix, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results - BioSpace</td>    <td>Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/soligenix-announces-recent-accomplishments-and-first-quarter-2020-financial-results/">Link</a></td>  </tr><tr>    <td>Sun, 17 May 2020 07:00:00 GMT</td>    <td>What You Must Know About Soligenix, Inc.'s (NASDAQ:SNGX) Beta Value - Yahoo Finance</td>    <td>What You Must Know About Soligenix, Inc.'s (NASDAQ:SNGX) Beta Value  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/must-know-soligenix-inc-nasdaq-145944748.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 19:28:00 GMT</td>    <td>How Hedge Funds Traded Soligenix, Inc. (SNGX) During The Crash - Yahoo Finance</td>    <td>How Hedge Funds Traded Soligenix, Inc. (SNGX) During The Crash  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-traded-soligenix-inc-192815054.html">Link</a></td>  </tr></table><h3>564. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SNOA">Sonoma Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 20:30:00 GMT</td>    <td>Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Received Approval to Be Entered Into the Australian Register of Therapeutic Goods (ARTG) for use against COVID-19 - Business Wire</td>    <td>Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Received Approval to Be Entered Into the Australian Register of Therapeutic Goods (ARTG) for use against COVID-19  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200528005780/en/Sonoma-Pharmaceuticals-MicroSafe-Group-Announce-Nanocyn%C2%AE-Disinfectant">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:20:00 GMT</td>    <td>Sonoma Pharmaceuticals stock nearly triples after disinfectant allowed to carry COVID-19 label in Australia - MarketWatch</td>    <td>Sonoma Pharmaceuticals stock nearly triples after disinfectant allowed to carry COVID-19 label in Australia  MarketWatch</td>    <td><a target="_blank" href="http://www.marketwatch.com/story/sonoma-pharmaceuticals-stock-nearly-triples-after-disinfectant-allowed-to-carry-covid-19-label-in-australia-2020-05-29">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 17:28:11 GMT</td>    <td>If You Had Bought Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Five Years Ago, You’d Be Sitting On A 88% Loss, Today - Simply Wall St</td>    <td>If You Had Bought Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Five Years Ago, You’d Be Sitting On A 88% Loss, Today  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-snoa/sonoma-pharmaceuticals/news/if-you-had-bought-sonoma-pharmaceuticals-nasdaqsnoa-stock-five-years-ago-youd-be-sitting-on-a-88-loss-today/">Link</a></td>  </tr></table><h3>565. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SPHS">Sophiris Bio, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Sophiris Bio To Shut Down Operations - PRNewswire</td>    <td>Sophiris Bio To Shut Down Operations  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/sophiris-bio-to-shut-down-operations-301061060.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 04:41:00 GMT</td>    <td>Benign Prostatic Hyperplasia Treatment Equipments Market Size, Opportunities And Forecast Analysis To 2026 - 3rd Watch News</td>    <td>Benign Prostatic Hyperplasia Treatment Equipments Market Size, Opportunities And Forecast Analysis To 2026  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/emerging-trends/1143693/benign-prostatic-hyperplasia-treatment-equipments-market-size-opportunities-and-forecast-analysis-to-2026/">Link</a></td>  </tr><tr>    <td>Tue, 10 Mar 2020 20:17:23 GMT</td>    <td>Sophiris Bio Announces Nasdaq Delisting Nasdaq:SPHS - GlobeNewswire</td>    <td>Sophiris Bio Announces Nasdaq Delisting Nasdaq:SPHS  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/03/10/1998338/0/en/Sophiris-Bio-Announces-Nasdaq-Delisting.html">Link</a></td>  </tr></table><h3>566. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SRNE">Sorrento Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:40:00 GMT</td>    <td>Why Sorrento Therapeutics Shares Are Tumbling Today - Motley Fool</td>    <td>Why Sorrento Therapeutics Shares Are Tumbling Today  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/06/03/why-sorrento-therapeutics-shares-are-tumbling-toda.aspx">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 20:12:26 GMT</td>    <td>SORRENTO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Sorrento Therapeutics, Inc. - GlobeNewswire</td>    <td>SORRENTO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Sorrento Therapeutics, Inc.  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042563/0/en/SORRENTO-THERAPEUTICS-INC-CLASS-ACTION-ALERT-Wolf-Haldenstein-Adler-Freeman-Herz-LLP-reminds-investors-that-a-securities-class-action-lawsuit-has-been-filed-in-the-United-States-Di.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 13:18:00 GMT</td>    <td>Sorrento Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm - Yahoo Finance</td>    <td>Sorrento Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/sorrento-shareholder-notice-faruqi-faruqi-131800309.html">Link</a></td>  </tr></table><h3>567. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ONCE">Spark Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 16:05:00 GMT</td>    <td>Gene Therapy Products Market Outlook : Post Covid Investors Eye Bigger-than-expected | Top key Players –... - Azizsalon News</td>    <td>Gene Therapy Products Market Outlook : Post Covid Investors Eye Bigger-than-expected | Top key Players –...  Azizsalon News</td>    <td><a target="_blank" href="https://azizsalon.com/gene-therapy-products-market-outlook-post-covid-investors-eye-bigger-than-expected-top-key-players-novartis-ag-achieve-life-sciences-inc-spark-therapeutics-inc-abeona-therapeutics/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:15:48 GMT</td>    <td>Gene Therapy for Blood Disorders Market Research Report 2020 - Industry Trend Analysis, Clinical Trial/Pipeline Analysis, and Revenue Forecast Till 2030 | - Medgadget</td>    <td>Gene Therapy for Blood Disorders Market Research Report 2020 - Industry Trend Analysis, Clinical Trial/Pipeline Analysis, and Revenue Forecast Till 2030 |  Medgadget</td>    <td><a target="_blank" href="https://www.medgadget.com/2020/06/gene-therapy-for-blood-disorders-market-research-report-2020-industry-trend-analysis-clinical-trial-pipeline-analysis-and-revenue-forecast-till-2030.html">Link</a></td>  </tr><tr>    <td>Sat, 30 May 2020 18:53:00 GMT</td>    <td>Choroideremia Treatment Market Booming With : Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc - 3rd Watch News</td>    <td>Choroideremia Treatment Market Booming With : Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/1093421/choroideremia-treatment-market/">Link</a></td>  </tr></table><h3>568. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SPPI">Spectrum Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:00:00 GMT</td>    <td>Spectrum Pharmaceuticals Appoints Lyndah K. Dreiling, M.D., MBA, as Senior Vice President, Clinical Development - Business Wire</td>    <td>Spectrum Pharmaceuticals Appoints Lyndah K. Dreiling, M.D., MBA, as Senior Vice President, Clinical Development  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200603005662/en/Spectrum-Pharmaceuticals-Appoints-Lyndah-K.-Dreiling-M.D.">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 11:00:00 GMT</td>    <td>Spectrum Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference 2020 - Business Wire</td>    <td>Spectrum Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference 2020  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200527005070/en/Spectrum-Pharmaceuticals-Present-Jefferies-Virtual-Healthcare-Conference">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Spectrum Pharmaceuticals Reports First Quarter 2020 Financial Results and Pipeline Update - Yahoo Finance</td>    <td>Spectrum Pharmaceuticals Reports First Quarter 2020 Financial Results and Pipeline Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/spectrum-pharmaceuticals-reports-first-quarter-200000225.html">Link</a></td>  </tr></table><h3>569. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SPRO">Spero Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 08 May 2020 12:20:00 GMT</td>    <td>Spero Therapeutics Announces First Quarter 2020 Operating Results and Provides Business Update - GlobeNewswire</td>    <td>Spero Therapeutics Announces First Quarter 2020 Operating Results and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/08/2030335/0/en/Spero-Therapeutics-Announces-First-Quarter-2020-Operating-Results-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Spero Therapeutics, Inc. (SPRO) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Spero Therapeutics, Inc. (SPRO) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/12/spero-therapeutics-inc-spro-q1-2020-earnings-call.aspx">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Spero Therapeutics Inc (SPRO) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance</td>    <td>Spero Therapeutics Inc (SPRO) Reports Q1 Loss, Misses Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/spero-therapeutics-inc-spro-reports-132501443.html">Link</a></td>  </tr></table><h3>570. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SBPH">Spring Bank Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:00:00 GMT</td>    <td>Spring Bank Advances IV SB 11285 Clinical Program - GlobeNewswire</td>    <td>Spring Bank Advances IV SB 11285 Clinical Program  GlobeNewswire</td>    <td><a target="_blank" href="http://www.globenewswire.com/news-release/2020/06/03/2042858/0/en/Spring-Bank-Advances-IV-SB-11285-Clinical-Program.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 11:05:58 GMT</td>    <td>Spring Bank Announces Poster Presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting - GlobeNewswire</td>    <td>Spring Bank Announces Poster Presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036263/0/en/Spring-Bank-Announces-Poster-Presentation-at-the-2020-American-Society-of-Clinical-Oncology-ASCO-Virtual-Annual-Meeting.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 17:18:11 GMT</td>    <td>How Much Of Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) Do Insiders Own? - Simply Wall St</td>    <td>How Much Of Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) Do Insiders Own?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/news/how-much-of-spring-bank-pharmaceuticals-inc-nasdaqsbph-do-insiders-own/">Link</a></td>  </tr></table><h3>571. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SWTX">SpringWorks Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 10:30:00 GMT</td>    <td>SpringWorks Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference - Yahoo Finance</td>    <td>SpringWorks Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/springworks-therapeutics-present-goldman-sachs-103010642.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 11:33:41 GMT</td>    <td>SpringWorks Therapeutics Reports First Quarter 2020 Financial Results and Recent Business Highlights - GlobeNewswire</td>    <td>SpringWorks Therapeutics Reports First Quarter 2020 Financial Results and Recent Business Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031805/0/en/SpringWorks-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Recent-Business-Highlights.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 10:32:16 GMT</td>    <td>SpringWorks Therapeutics Appoints Julie Hambleton, M.D. to its Board of Directors - GlobeNewswire</td>    <td>SpringWorks Therapeutics Appoints Julie Hambleton, M.D. to its Board of Directors  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038450/0/en/SpringWorks-Therapeutics-Appoints-Julie-Hambleton-M-D-to-its-Board-of-Directors.html">Link</a></td>  </tr></table><h3>572. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MITO">Stealth BioTherapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Stealth BioTherapeutics Reports First Quarter 2020 Financial Results and Recent Business Highlights - PRNewswire</td>    <td>Stealth BioTherapeutics Reports First Quarter 2020 Financial Results and Recent Business Highlights  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/stealth-biotherapeutics-reports-first-quarter-2020-financial-results-and-recent-business-highlights-301054483.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Stealth BioTherapeutics to Present at UBS Virtual Global Healthcare Conference - Yahoo Finance</td>    <td>Stealth BioTherapeutics to Present at UBS Virtual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/stealth-biotherapeutics-present-ubs-virtual-123000480.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Stealth BioTherapeutics Corp (MITO) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Stealth BioTherapeutics Corp (MITO) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/stealth-biotherapeutics-corp-mito-q1-2020-earnings.aspx">Link</a></td>  </tr></table><h3>573. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SBOT">Stellar Biotechnologies, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 23:40:00 GMT</td>    <td>Moleculin Biotech Inc. (NASDAQ:MBRX): A Stocks With Stellar Fundamentals? - State Reviewer</td>    <td>Moleculin Biotech Inc. (NASDAQ:MBRX): A Stocks With Stellar Fundamentals?  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/moleculin-biotech-inc-nasdaqmbrx-a-stocks-with-stellar-fundamentals/">Link</a></td>  </tr><tr>    <td>Fri, 07 Jun 2019 07:00:00 GMT</td>    <td>Edesa Biotech and Stellar Biotechnologies Complete Business Combination - PRNewswire</td>    <td>Edesa Biotech and Stellar Biotechnologies Complete Business Combination  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/edesa-biotech-and-stellar-biotechnologies-complete-business-combination-300863843.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>China IPO Stages Stellar Hong Kong Debut Amid Biotech Craze - Yahoo Finance</td>    <td>China IPO Stages Stellar Hong Kong Debut Amid Biotech Craze  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/china-ipo-stages-stellar-hong-025150874.html">Link</a></td>  </tr></table><h3>574. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-STML">Stemline Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:30:00 GMT</td>    <td>Market cap of Stemline Therapeutics Inc. [STML] reaches 625.89M – now what? - The DBT News</td>    <td>Market cap of Stemline Therapeutics Inc. [STML] reaches 625.89M – now what?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/market-cap-of-stemline-therapeutics-inc-stml-reaches-625-89m-now-what/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Why Stemline Therapeutics (STML) Might Surprise This Earnings Season - Yahoo Finance</td>    <td>Why Stemline Therapeutics (STML) Might Surprise This Earnings Season  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/why-stemline-therapeutics-stml-might-133301564.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>SHAREHOLDER ALERT: WeissLaw LLP Investigates Stemline Therapeutics, Inc. - PRNewswire</td>    <td>SHAREHOLDER ALERT: WeissLaw LLP Investigates Stemline Therapeutics, Inc.  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-stemline-therapeutics-inc-301053468.html">Link</a></td>  </tr></table><h3>575. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-STOK">Stoke Therapeutics </a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates - Business Wire</td>    <td>Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200515005050/en/Stoke-Therapeutics-Reports-Quarter-Financial-Results-Business">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Form 10-Q Stoke Therapeutics, Inc. For: Mar 31 - StreetInsider.com</td>    <td>Form 10-Q Stoke Therapeutics, Inc. For: Mar 31  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/SEC+Filings/Form+10-Q+Stoke+Therapeutics%2C+Inc.+For%3A+Mar+31/16889700.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Stoke Therapeutics Presents Preclinical Data That Demonstrate In-Vitro and In-Vivo Target Engagement and Protein Upregulation in OPA1 Protein Deficiency, the Primary Cause of the Most Common Inherited Optic Nerve Disorder - Business Wire</td>    <td>Stoke Therapeutics Presents Preclinical Data That Demonstrate In-Vitro and In-Vivo Target Engagement and Protein Upregulation in OPA1 Protein Deficiency, the Primary Cause of the Most Common Inherited Optic Nerve Disorder  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005237/en/Stoke-Therapeutics-Presents-Preclinical-Data-Demonstrate-In-Vitro">Link</a></td>  </tr></table><h3>576. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SBBP">Strongbridge Biopharma plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 11:30:00 GMT</td>    <td>Strongbridge Biopharma plc to Present at the Jefferies Virtual Healthcare Conference - Yahoo Finance</td>    <td>Strongbridge Biopharma plc to Present at the Jefferies Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/strongbridge-biopharma-plc-present-jefferies-113010882.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 11:46:46 GMT</td>    <td>Strongbridge Biopharma plc Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Strongbridge Biopharma plc Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028335/0/en/Strongbridge-Biopharma-plc-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Strongbridge Biopharma plc Announces Completion of Enrollment of Phase 3 LOGICS Study for RECORLEV® (levoketoconazole) for Endogenous Cushing’s Syndrome - Yahoo Finance</td>    <td>Strongbridge Biopharma plc Announces Completion of Enrollment of Phase 3 LOGICS Study for RECORLEV® (levoketoconazole) for Endogenous Cushing’s Syndrome  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/strongbridge-biopharma-plc-announces-completion-113010532.html">Link</a></td>  </tr></table><h3>577. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SMMT">Summit Therapeutics plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 20:11:47 GMT</td>    <td>Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020 - GlobeNewswire</td>    <td>Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042546/0/en/Summit-Therapeutics-Reports-Financial-Results-and-Operational-Progress-for-the-First-Quarter-and-Three-Months-Ended-March-31-2020.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:45:00 GMT</td>    <td>Summit Therapeutics PLC (SMMT) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance</td>    <td>Summit Therapeutics PLC (SMMT) Outpaces Stock Market Gains: What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/summit-therapeutics-plc-smmt-outpaces-214509996.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Summit Therapeutics PLC (SMMT) Stock Moves -0.43%: What You Should Know - Yahoo Finance</td>    <td>Summit Therapeutics PLC (SMMT) Stock Moves -0.43%: What You Should Know  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/summit-therapeutics-plc-smmt-stock-214509587.html">Link</a></td>  </tr></table><h3>578. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SNDL">Sundial Growers</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sat, 16 May 2020 05:49:02 GMT</td>    <td>Sundial Growers Inc (SNDL) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Sundial Growers Inc (SNDL) Q1 2020 Earnings Call Transcript  The Motley FoolSundial Growers (SNDL) to Sell Bridge Farm Group for $90M  StreetInsider.comSundial Reports First Quarter 2020 Financial Results | News  WFMZ Allentown$SNDL Sundial Growers Reports Qtrly Loss Per Share $0.41  CML NewsSundial Enters Into Agreement to Sell Bridge Farm Group  Yahoo FinanceView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/15/sundial-growers-inc-sndl-q1-2020-earnings-call-tra.aspx">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Sundial Announces Results of its Annual General and Special Meeting of Shareholders and Details of the Share Consolidation - Yahoo Finance</td>    <td>Sundial Announces Results of its Annual General and Special Meeting of Shareholders and Details of the Share Consolidation  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/sundial-announces-results-annual-general-113000946.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Canadian CBD Producer Sundial Growers Allegedly Misled Investors - Bloomberg Law</td>    <td>Canadian CBD Producer Sundial Growers Allegedly Misled Investors  Bloomberg Law</td>    <td><a target="_blank" href="https://news.bloomberglaw.com/securities-law/canadian-cbd-producer-sundial-growers-allegedly-misled-investors">Link</a></td>  </tr></table><h3>579. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SNSS">Sunesis Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 20:12:02 GMT</td>    <td>Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent Highlights - GlobeNewswire</td>    <td>Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029872/0/en/Sunesis-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results-and-Recent-Highlights.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 10:16:00 GMT</td>    <td>Time to Pay a Little Attention to Sunesis Pharmaceuticals, Inc. (SNSS) Again - The News Heater</td>    <td>Time to Pay a Little Attention to Sunesis Pharmaceuticals, Inc. (SNSS) Again  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/02/time-to-pay-a-little-attention-to-sunesis-pharmaceuticals-inc-snss-again/">Link</a></td>  </tr><tr>    <td>Sun, 10 May 2020 07:00:00 GMT</td>    <td>Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Sunesis Pharmaceuticals, Inc. (SNSS) CEO Dayton Misfeldt on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4345780-sunesis-pharmaceuticals-inc-snss-ceo-dayton-misfeldt-on-q1-2020-results-earnings-call">Link</a></td>  </tr></table><h3>580. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SUPN">Supernus Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 09:29:37 GMT</td>    <td>Quality and value are positive signs for Supernus Pharmaceuticals Inc - Stockopedia</td>    <td>Quality and value are positive signs for Supernus Pharmaceuticals Inc  Stockopedia</td>    <td><a target="_blank" href="https://www.stockopedia.com/articles/quality-and-value-are-positive-signs-for-supernus-pharmaceuticals-inc-54798">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>Were Hedge Funds Right About Supernus Pharmaceuticals Inc (SUPN)? - Yahoo Finance</td>    <td>Were Hedge Funds Right About Supernus Pharmaceuticals Inc (SUPN)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/were-hedge-funds-supernus-pharmaceuticals-201722015.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 20:33:02 GMT</td>    <td>Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR® - GlobeNewswire</td>    <td>Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR®  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034498/0/en/Supernus-Announces-Paragraph-IV-ANDA-Filing-for-Oxtellar-XR.html">Link</a></td>  </tr></table><h3>581. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SURF">Surface Oncology, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Surface Oncology Shares Trade Up 40% on Phase 1 Study Plans for SRF617 Combined with Mercks KEYTRUDA - Streetwise Reports</td>    <td>Surface Oncology Shares Trade Up 40% on Phase 1 Study Plans for SRF617 Combined with Mercks KEYTRUDA  Streetwise ReportsSurface Oncology and Merck to Collaborate on Immuno-Oncology Study Evaluating SRF617, Targeting CD39 in Combination with KEYTRUDA® (pembrolizumab) in Solid Tumor Patients  GlobeNewswireSurface Oncology : Shares Rise on Merck Collaboration  Marketscreener.comSurface Oncology (SURF), Merck (MRK) to Collaborate on Immuno-Oncology Study Evaluating SRF617, Targeting CD39 in Combination with KEYTRUDA in Solid Tumor Patients  StreetInsider.comView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.streetwisereports.com/article/2020/05/20/surface-oncology-shares-trade-up-40-on-phase-1-study-plans-for-srf617-combined-with-mercks-keytruda.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Why Surface Oncology's Stock Is Surging Higher - Benzinga</td>    <td>Why Surface Oncology's Stock Is Surging Higher  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/general/biotech/20/05/16076354/why-surface-oncologys-stock-is-surging-higher">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>P/E Ratio Insights for Surface Oncology - Yahoo Finance</td>    <td>P/E Ratio Insights for Surface Oncology  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/p-e-ratio-insights-surface-152810849.html">Link</a></td>  </tr></table><h3>582. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-STRO">Sutro Biopharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD - PRNewswire</td>    <td>Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/sutro-biopharma-adds-two-exceptional-leaders-to-advisory-boards---carlos-paya-md-phd-and-lainie-martin-md-301063319.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Sutro Biopharma Announces Pricing of $85.3 Million Public Offering - BioSpace</td>    <td>Sutro Biopharma Announces Pricing of $85.3 Million Public Offering  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/sutro-biopharma-announces-pricing-of-85-3-million-public-offering/">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Sutro Biopharma Reports First Quarter 2020 Financial Results and Recent Business Highlights and Developments - Yahoo Finance</td>    <td>Sutro Biopharma Reports First Quarter 2020 Financial Results and Recent Business Highlights and Developments  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/sutro-biopharma-reports-first-quarter-201500304.html">Link</a></td>  </tr></table><h3>583. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SNDX">Syndax Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer - PRNewswire</td>    <td>ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/ecog-acrin-provides-syndax-pharmaceuticals-with-results-of-phase-3-e2112-trial-of-entinostat-plus-exemestane-in-patients-with-hr-her2--breast-cancer-301063954.html">Link</a></td>  </tr><tr>    <td>Mon, 25 May 2020 07:00:00 GMT</td>    <td>Does Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Have A Particularly Volatile Share Price? - Yahoo Finance</td>    <td>Does Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Have A Particularly Volatile Share Price?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/does-syndax-pharmaceuticals-inc-nasdaq-191713129.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update - PRNewswire</td>    <td>Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/syndax-pharmaceuticals-reports-first-quarter-2020-financial-results-and-provides-clinical-and-business-update-301055190.html">Link</a></td>  </tr></table><h3>584. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SYNH">Syneos Health, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:38:00 GMT</td>    <td>BRIEF-Syneos Health Inc Sees Q2 Adjusted Earnings Per Share $0.48-$0.52 - Reuters</td>    <td>BRIEF-Syneos Health Inc Sees Q2 Adjusted Earnings Per Share $0.48-$0.52  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-syneos-health-inc-sees-q2-adjusted/brief-syneos-health-inc-sees-q2-adjusted-earnings-per-share-048-052-idUSFWN2DG09G">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:43:00 GMT</td>    <td>$SYNH Syneos Health Inc Sees Q2 Adjusted Earnings Per Share $0.48-$0.52 - CML News</td>    <td>$SYNH Syneos Health Inc Sees Q2 Adjusted Earnings Per Share $0.48-$0.52  CML News</td>    <td><a target="_blank" href="https://www.cmlviz.com/recent-development/2020/06/03/SYNH/syneos-health-inc-sees-q2-adjusted-earnings-per-share-0-48--0-52">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 12:30:00 GMT</td>    <td>Daiichi Sankyo and Syneos Health® Form Strategic Coalition for Development of Daiichi Sankyo's ADC Oncology Pipeline - Business Wire</td>    <td>Daiichi Sankyo and Syneos Health® Form Strategic Coalition for Development of Daiichi Sankyo's ADC Oncology Pipeline  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200528005466/en/Daiichi-Sankyo-Syneos-Health%C2%AE-Form-Strategic-Coalition">Link</a></td>  </tr></table><h3>585. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SGYP">Synergy Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Chronic Idiopathic Constipation (CIC) Treatment Market to See Massive Growth by 2027 | Ironwood Pharmaceuticals, Allergan, Synergy Pharmaceuticals, Inc., Shire plc, and Mallinckrodt plc - Surfacing Magazine</td>    <td>Chronic Idiopathic Constipation (CIC) Treatment Market to See Massive Growth by 2027 | Ironwood Pharmaceuticals, Allergan, Synergy Pharmaceuticals, Inc., Shire plc, and Mallinckrodt plc  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/chronic-idiopathic-constipation-cic-treatment-market-to-see-massive-growth-by-2027-ironwood-pharmaceuticals-allergan-synergy-pharmaceuticals-inc-shire-plc-and-mallinckrodt-plc/">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:10:23 GMT</td>    <td>IRRITABLE BOWEL SYNDROME (IBS) MARKET SIZE 2020: MAJOR PLAYERS ALLERGAN PLC, SUCAMPO PHARMACEUTICALS, IRONWOOD PHARMACEUTICALS, INC., ASTELLAS PHARMA INC - Cole of Duty</td>    <td>IRRITABLE BOWEL SYNDROME (IBS) MARKET SIZE 2020: MAJOR PLAYERS ALLERGAN PLC, SUCAMPO PHARMACEUTICALS, IRONWOOD PHARMACEUTICALS, INC., ASTELLAS PHARMA INC  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/05/20/irritable-bowel-syndrome-ibs-market-size-2020-major-players-allergan-plc-sucampo-pharmaceuticals-ironwood-pharmaceuticals-inc-astellas-pharma-inc-2/">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Constipation Treatment Market by Latest Innovations, Strategic Analysis, Market Challenges of Key Vendors: Takeda Pharmaceutical Company Ltd, Synergy Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc. - 3rd Watch News</td>    <td>Constipation Treatment Market by Latest Innovations, Strategic Analysis, Market Challenges of Key Vendors: Takeda Pharmaceutical Company Ltd, Synergy Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc.  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/770606/constipation-treatment-market-by-latest-innovations-strategic-analysis-market-challenges-of-key-vendors-takeda-pharmaceutical-company-ltd-synergy-pharmaceuticals-inc-ironwood-pharmaceuticals-inc/">Link</a></td>  </tr></table><h3>586. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SYBX">Synlogic, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Synlogic Announces Termination of AbbVie Collaboration Agreement - PRNewswire</td>    <td>Synlogic Announces Termination of AbbVie Collaboration Agreement  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/synlogic-announces-termination-of-abbvie-collaboration-agreement-301063296.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update - PRNewswire</td>    <td>Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/synlogic-reports-first-quarter-2020-financial-results-and-provides-business-update-301055472.html">Link</a></td>  </tr><tr>    <td>Thu, 21 May 2020 07:00:00 GMT</td>    <td>Synlogic to Host Virtual R&D Event - PRNewswire</td>    <td>Synlogic to Host Virtual R&D Event  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/synlogic-to-host-virtual-rd-event-301063863.html">Link</a></td>  </tr></table><h3>587. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-THOR">Synthorx, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 12:03:04 GMT</td>    <td>Sanofi Adds Firepower in Exiting $13 Billion Regeneron Stake - Bloomberg</td>    <td>Sanofi Adds Firepower in Exiting $13 Billion Regeneron Stake  Bloomberg</td>    <td><a target="_blank" href="https://www.bloomberg.com/news/articles/2020-05-25/sanofi-to-sell-regeneron-stake-worth-about-13-billion">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 15:11:00 GMT</td>    <td>Fitch Affirms Sanofi at 'A+'/Stable Following Regeneron Sale - Fitch Ratings</td>    <td>Fitch Affirms Sanofi at 'A+'/Stable Following Regeneron Sale  Fitch Ratings</td>    <td><a target="_blank" href="https://www.fitchratings.com/research/corporate-finance/fitch-affirms-sanofi-at-a-stable-following-regeneron-sale-03-06-2020">Link</a></td>  </tr><tr>    <td>Mon, 09 Dec 2019 08:00:00 GMT</td>    <td>Sanofi buys Synthorx Inc for US$2.35bn - European Biotechnology</td>    <td>Sanofi buys Synthorx Inc for US$2.35bn  European Biotechnology</td>    <td><a target="_blank" href="https://european-biotechnology.com/up-to-date/latest-news/news/sanofi-buys-synthorx-inc-for-us235bn.html">Link</a></td>  </tr></table><h3>588. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-SYRS">Syros Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Syros Pharmaceuticals Inc (SYRS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance</td>    <td>Syros Pharmaceuticals Inc (SYRS) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/syros-pharmaceuticals-inc-syrs-reports-140502841.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Syros Pharmaceuticals, Inc.(SYRS) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Syros Pharmaceuticals, Inc.(SYRS) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/syros-pharmaceuticals-incsyrs-q1-2020-earnings-cal.aspx">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Industry Analysts Just Upgraded Their Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Revenue Forecasts By 20% - Yahoo Finance</td>    <td>Industry Analysts Just Upgraded Their Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Revenue Forecasts By 20%  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/industry-analysts-just-upgraded-syros-143222143.html">Link</a></td>  </tr></table><h3>589. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TLC">Taiwan Liposome Company, Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:20:26 GMT</td>    <td>Economic Impact of Coronavirus on Rhabdomyosarcoma Drug Market Geography Analysis 2020-26 | Taiho Pharmaceutical Co Ltd, Taiwan Liposome Company Ltd, Tarveda Therapeutics Inc - Cole of Duty</td>    <td>Economic Impact of Coronavirus on Rhabdomyosarcoma Drug Market Geography Analysis 2020-26 | Taiho Pharmaceutical Co Ltd, Taiwan Liposome Company Ltd, Tarveda Therapeutics Inc  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/nasa/2020/06/02/economic-impact-of-coronavirus-on-rhabdomyosarcoma-drug-market-geography-analysis-2020-26-taiho-pharmaceutical-co-ltd-taiwan-liposome-company-ltd-tarveda-therapeutics-inc/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 12:09:23 GMT</td>    <td>Potential Demand in Ocular Drug Delivery Technology Market Report Explores Share, Development By Companies Outlook, Growth Prospects And 2027 | Top Key players Clearside Biomedical, INC., Taiwan Liposome Company, Ltd., Novartis, Pfizer Inc., Envisia Therapeutics - Cole of Duty</td>    <td>Potential Demand in Ocular Drug Delivery Technology Market Report Explores Share, Development By Companies Outlook, Growth Prospects And 2027 | Top Key players Clearside Biomedical, INC., Taiwan Liposome Company, Ltd., Novartis, Pfizer Inc., Envisia Therapeutics  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/news/2020/06/02/potential-demand-in-ocular-drug-delivery-technology-market-report-explores-share-development-by-companies-outlook-growth-prospects-and-2027-top-key-players-clearside-biomedical-inc-taiwan-lipos/">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>The Unexpected Growth in Ocular Drug Delivery Technology Market Report 2020 and Forecast Analysis Towards 2027: Taiwan Liposome Company Ltd., Ocular Therapeutix Inc., Graybug Vision Inc. - 3rd Watch News</td>    <td>The Unexpected Growth in Ocular Drug Delivery Technology Market Report 2020 and Forecast Analysis Towards 2027: Taiwan Liposome Company Ltd., Ocular Therapeutix Inc., Graybug Vision Inc.  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/814188/the-unexpected-growth-in-ocular-drug-delivery-technology-market-report-2020-and-forecast-analysis-towards-2027-taiwan-liposome-company-ltd-ocular-therapeutix-inc-graybug-vision-inc/">Link</a></td>  </tr></table><h3>590. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TCRR">TCR2 Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Sun, 24 May 2020 07:00:00 GMT</td>    <td>Tcr2 Therapeutics (NASDAQ:TCRR) Upgraded by BidaskClub N/A to Hold - Stock Market Daily</td>    <td>Tcr2 Therapeutics (NASDAQ:TCRR) Upgraded by BidaskClub N/A to Hold  Stock Market Daily</td>    <td><a target="_blank" href="https://stockmarketdaily.co/2020/05/26/tcr2-therapeutics-nasdaqtcrr-upgraded-by-bidaskclubn-a-to-hold/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 10:56:27 GMT</td>    <td>TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033355/0/en/TCR-Therapeutics-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Tcr2 Therapeutics Inc Earnings : What to expect Stock market Insights & financial analysis - Stock Market Daily</td>    <td>Tcr2 Therapeutics Inc Earnings : What to expect Stock market Insights & financial analysis  Stock Market Daily</td>    <td><a target="_blank" href="https://stockmarketdaily.co/2020/05/11/tcr2-therapeutics-inc-earnings-what-to-expect/">Link</a></td>  </tr></table><h3>591. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TELA">TELA Bio</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 20:08:14 GMT</td>    <td>TELA Bio Announces First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>TELA Bio Announces First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032235/0/en/TELA-Bio-Announces-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 11:07:25 GMT</td>    <td>TELA Bio to Present at the Jefferies Virtual Healthcare Conference - GlobeNewswire</td>    <td>TELA Bio to Present at the Jefferies Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040819/0/en/TELA-Bio-to-Present-at-the-Jefferies-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>BRIEF-Tela Bio Announces Q1 Financial Results - Reuters India</td>    <td>BRIEF-Tela Bio Announces Q1 Financial Results  Reuters India</td>    <td><a target="_blank" href="https://in.reuters.com/article/brief-tela-bio-announces-q1-financial-re/brief-tela-bio-announces-q1-financial-results-idINASA00PS1">Link</a></td>  </tr></table><h3>592. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TLGT">Teligent, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 May 2020 21:09:25 GMT</td>    <td>Teligent, Inc. to Hold Conference Call for First Quarter 2020 Results on Friday May 22nd, 2020 - GlobeNewswire</td>    <td>Teligent, Inc. to Hold Conference Call for First Quarter 2020 Results on Friday May 22nd, 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/19/2036006/0/en/Teligent-Inc-to-Hold-Conference-Call-for-First-Quarter-2020-Results-on-Friday-May-22nd-2020.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 11:44:32 GMT</td>    <td>Teligent, Inc. Announces First Quarter 2020 Results Nasdaq:TLGT - GlobeNewswire</td>    <td>Teligent, Inc. Announces First Quarter 2020 Results Nasdaq:TLGT  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/22/2037535/0/en/Teligent-Inc-Announces-First-Quarter-2020-Results.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Teligent, Inc. to Host Earnings Call - Yahoo Finance</td>    <td>Teligent, Inc. to Host Earnings Call  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/teligent-inc-host-earnings-call-100000993.html">Link</a></td>  </tr></table><h3>593. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TENX">Tenax Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 11:30:00 GMT</td>    <td>Tenax Therapeutics Reports Positive Results from Phase 2 Trial of Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - Business Wire</td>    <td>Tenax Therapeutics Reports Positive Results from Phase 2 Trial of Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF)  Business WireTenax Therapeutics Without Revenue Gets Soaring Stock (NASDAQ: TENX)  Own SnapTenax Therapeutics' Phase II Pulmonary Hypertension Trial Produces Mixed Results  NasdaqTenax Therapeutics Inc. (NASDAQ:TENX): An Opportunity for Fundamental Investors?  State ReviewerPrice Trends About Tenax Therapeutics, Inc. (TENX) You Should Know  The News HeaterView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005359/en/%C2%A0Tenax-Therapeutics-Reports-Positive-Results-Phase-2">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:30:00 GMT</td>    <td>Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire</td>    <td>Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200603005107/en/Tenax-Therapeutics-Regains-Compliance-Nasdaq-Minimum-Bid">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:37:00 GMT</td>    <td>BRIEF-Ziyad Binsalamah Dissolves Share Stake In Tenax Therapeutics - Reuters</td>    <td>BRIEF-Ziyad Binsalamah Dissolves Share Stake In Tenax Therapeutics  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-ziyad-binsalamah-dissolves-share-s/brief-ziyad-binsalamah-dissolves-share-stake-in-tenax-therapeutics-idUSFWN2DF0P9">Link</a></td>  </tr></table><h3>594. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TSRO">TESARO, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Poly Adenosine Diphosphate Ribose Polymerase Market Growth Outlook 2020 | Tesaro Inc., Clovis Oncology, AstraZeneca, Pfizer, Inc., and AbbVie Inc - Surfacing Magazine</td>    <td>Poly Adenosine Diphosphate Ribose Polymerase Market Growth Outlook 2020 | Tesaro Inc., Clovis Oncology, AstraZeneca, Pfizer, Inc., and AbbVie Inc  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/poly-adenosine-diphosphate-ribose-polymerase-market-growth-outlook-2020-tesaro-inc-clovis-oncology-astrazeneca-pfizer-inc-and-abbvie-inc/">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Chemotherapy-Induced Nausea and Vomiting Drugs Market 2020: Merck & Co., Inc., GlaxoSmithKline plc, Tesaro, Inc., Helsinn Group, F. Hoffmann-La Roche Ltd., Heron Therapeutics, Inc. - Cole of Duty</td>    <td>Chemotherapy-Induced Nausea and Vomiting Drugs Market 2020: Merck & Co., Inc., GlaxoSmithKline plc, Tesaro, Inc., Helsinn Group, F. Hoffmann-La Roche Ltd., Heron Therapeutics, Inc.  Cole of Duty</td>    <td><a target="_blank" href="https://coleofduty.com/market-reports/2020/05/18/chemotherapy-induced-nausea-and-vomiting-drugs-market-2020-merck-co-inc-glaxosmithkline-plc-tesaro-inc-helsinn-group-f-hoffmann-la-roche-ltd-heron-therapeutics-inc/">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 10:43:35 GMT</td>    <td>Covid-19 Impact On Poly Adenosine Diphosphate Ribose Polymerase Market worth Observing Growth | Tesaro Inc., Clovis Oncology, AstraZeneca, Pfizer, Inc., and AbbVie Inc - Surfacing Magazine</td>    <td>Covid-19 Impact On Poly Adenosine Diphosphate Ribose Polymerase Market worth Observing Growth | Tesaro Inc., Clovis Oncology, AstraZeneca, Pfizer, Inc., and AbbVie Inc  Surfacing Magazine</td>    <td><a target="_blank" href="https://surfacingmagazine.net/covid-19-impact-on-poly-adenosine-diphosphate-ribose-polymerase-market-worth-observing-growth-tesaro-inc-clovis-oncology-astrazeneca-pfizer-inc-and-abbvie-inc/">Link</a></td>  </tr></table><h3>595. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TTPH">Tetraphase Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 20:51:00 GMT</td>    <td>Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx - Business Wire</td>    <td>Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200601005727/en/Tetraphase-Announces-Receipt-Amended-Melinta-Proposal-Determination">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 21:11:00 GMT</td>    <td>Tetraphase Pharmaceuticals Inc. (TTPH) Plunges 8.2% on June 03 - Equities.com</td>    <td>Tetraphase Pharmaceuticals Inc. (TTPH) Plunges 8.2% on June 03  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/tetraphase-pharmaceuticals-inc-ttph-plunges-8-2-on-june-03">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 13:25:00 GMT</td>    <td>Tetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration - Business Wire</td>    <td>Tetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200527005568/en/Tetraphase-Announces-Amendment-Merger-Agreement-AcelRx-Pharmaceuticals">Link</a></td>  </tr></table><h3>596. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TFFP">TFF Pharmaceuticals</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results - Business Wire</td>    <td>TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200514005819/en/TFF-Pharmaceuticals-Reports-Quarter-2020-Financial-Business">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>TFF Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 14, 2020 - Yahoo Finance</td>    <td>TFF Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 14, 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/tff-pharmaceuticals-announces-first-quarter-200500911.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 11:45:45 GMT</td>    <td>The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs - Benzinga</td>    <td>The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/general/biotech/20/06/16157918/the-daily-biotech-pulse-fda-nod-for-roches-combo-therapy-in-liver-cancer-allena-rips-higher-pfize">Link</a></td>  </tr></table><h3>597. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TGTX">TG Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 11:08:33 GMT</td>    <td>TG Therapeutics to Present at the Jefferies 2020 Healthcare Conference - GlobeNewswire</td>    <td>TG Therapeutics to Present at the Jefferies 2020 Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042091/0/en/TG-Therapeutics-to-Present-at-the-Jefferies-2020-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 11:21:20 GMT</td>    <td>TG Therapeutics Announces Preclinical Data Presentation at the Upcoming American Association for Cancer Research Annual Meeting - GlobeNewswire</td>    <td>TG Therapeutics Announces Preclinical Data Presentation at the Upcoming American Association for Cancer Research Annual Meeting  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/15/2034128/0/en/TG-Therapeutics-Announces-Preclinical-Data-Presentation-at-the-Upcoming-American-Association-for-Cancer-Research-Annual-Meeting.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>TG Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>TG Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031375/0/en/TG-Therapeutics-Provides-Business-Update-and-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>598. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-MDCO">The Medicines Company</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 00:52:22 GMT</td>    <td>Small Richmond-based medicine company gets huge federal contract - The Virginian-Pilot - The Virginian-Pilot</td>    <td>Small Richmond-based medicine company gets huge federal contract - The Virginian-Pilot  The Virginian-PilotDubious history for leader of new made-in-America drug venture  POLITICONew Pharma Company Lands $354 Million Government Contract To Produce Coronavirus Drugs In The U.S.  ForbesTrump takes a first step toward returning medical supply chains to the U.S.  The Washington PostWATCH NOW: Richmond startup awarded $354 million federal contract to make ingredients for COVID-19 drugs  Richmond.comView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.pilotonline.com/news/health/vp-nw-richmond-company-federal-medicine-contract-20200520-yrm6yrdzajdknpmk6a5etnuzye-story.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 10:41:02 GMT</td>    <td>Eli Lilly begins first human tests of an antibody drug against Covid-19 - STAT</td>    <td>Eli Lilly begins first human tests of an antibody drug against Covid-19  STATFirst human trial of potential antibody treatment for Covid-19 begins  CNNEli Lilly starts first-ever trial of a COVID-19 antibody drug, speeding past rivals  BioPharma DiveFirst Human Trial of COVID-19 Drug Set to Begin  EcoWatchView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.statnews.com/2020/06/01/eli-lilly-begins-first-human-tests-of-an-antibody-drug-against-covid-19/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 07:07:00 GMT</td>    <td>Global Hirudin Market 2020 By Segment Forecasts 2026 |New Report Examines by Top Global Key Players: The Medicines Company, Keyken, Minapharm, Abbott, etc - 3rd Watch News</td>    <td>Global Hirudin Market 2020 By Segment Forecasts 2026 |New Report Examines by Top Global Key Players: The Medicines Company, Keyken, Minapharm, Abbott, etc  3rd Watch News</td>    <td><a target="_blank" href="https://3wnews.org/uncategorised/1146490/global-hirudin-market-2020-by-segment-forecasts-2026-new-report-examines-by-top-global-key-players-the-medicines-company-keyken-minapharm-abbott-etc/">Link</a></td>  </tr></table><h3>599. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TXMD">TherapeuticsMD, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 10:50:00 GMT</td>    <td>TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer - Yahoo Finance</td>    <td>TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/therapeuticsmd-announces-appointment-james-c-105000713.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>TherapeuticsMD Inc (TXMD) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>TherapeuticsMD Inc (TXMD) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/07/therapeuticsmd-inc-txmd-q1-2020-earnings-call-tran.aspx">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 16:00:02 GMT</td>    <td>An in-depth look at the TherapeuticsMD, Inc. (TXMD) stock - Marketing Sentinel</td>    <td>An in-depth look at the TherapeuticsMD, Inc. (TXMD) stock  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/01/an-in-depth-look-at-the-therapeuticsmd-inc-txmd-stock/">Link</a></td>  </tr></table><h3>600. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TRPX">Therapix Biosciences Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:15:10 GMT</td>    <td>Pure Capital Demands Replacement of Therapix Biosciences Ltd.'s Board of Directors - GlobeNewswire</td>    <td>Pure Capital Demands Replacement of Therapix Biosciences Ltd.'s Board of Directors  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042187/0/en/Pure-Capital-Demands-Replacement-of-Therapix-Biosciences-Ltd-s-Board-of-Directors.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Therapix Biosciences Closes A Joint Venture Transaction For its Sleep Indication - PRNewswire</td>    <td>Therapix Biosciences Closes A Joint Venture Transaction For its Sleep Indication  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/therapix-biosciences-closes-a-joint-venture-transaction-for-its-sleep-indication-301061696.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 22:07:00 GMT</td>    <td>BRIEF-L.I.A. Pure Capital Ltd Reports 12.58% Stake In Therapix Biosciences As Of May 31 2020 - Reuters</td>    <td>BRIEF-L.I.A. Pure Capital Ltd Reports 12.58% Stake In Therapix Biosciences As Of May 31 2020  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-lia-pure-capital-ltd-reports-1258/brief-lia-pure-capital-ltd-reports-1258-stake-in-therapix-biosciences-as-of-may-31-2020-idUSFWN2DF0PN">Link</a></td>  </tr></table><h3>601. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TBPH">Theravance Biopharma, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Theravance Biopharma, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update - PRNewswire</td>    <td>Theravance Biopharma, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/theravance-biopharma-inc-reports-first-quarter-2020-financial-results-and-provides-business-update-301054281.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Theravance Biopharma Inc (TBPH) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Theravance Biopharma Inc (TBPH) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/theravance-biopharma-inc-tbph-q1-2020-earnings-cal.aspx">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Theravance Biopharma (TBPH) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance</td>    <td>Theravance Biopharma (TBPH) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/theravance-biopharma-tbph-reports-q1-233511690.html">Link</a></td>  </tr></table><h3>602. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TTNP">Titan Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 14:21:02 GMT</td>    <td>Titan Pharmaceuticals Inc. (TTNP) latest performance of 0.58% is not what was on cards - News Daemon</td>    <td>Titan Pharmaceuticals Inc. (TTNP) latest performance of 0.58% is not what was on cards  News Daemon</td>    <td><a target="_blank" href="https://newsdaemon.com/2020/06/03/titan-pharmaceuticals-inc-ttnp-latest-performance-of-0-58-is-not-what-was-on-cards/">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Titan Pharmaceuticals Reports First Quarter 2020 Financial Results - Yahoo Finance</td>    <td>Titan Pharmaceuticals Reports First Quarter 2020 Financial Results  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/titan-pharmaceuticals-reports-first-quarter-124500949.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020 - Yahoo Finance</td>    <td>Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/titan-pharmaceuticals-report-first-quarter-200300462.html">Link</a></td>  </tr></table><h3>603. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TLSA">Tiziana Life Sciences plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 07:29:36 GMT</td>    <td>Tiziana Life Sciences PLC"s chairman discusses the potential for its "crown jewel" Foralumab drug - Proactive Investors USA & Canada</td>    <td>Tiziana Life Sciences PLC"s chairman discusses the potential for its "crown jewel" Foralumab drug  Proactive Investors USA & Canada</td>    <td><a target="_blank" href="https://www.proactiveinvestors.com/companies/news/920902/tiziana-life-sciences-plc-s-chairman-discusses-the-potential-for-its--crown-jewel--foralumab-drug-920902.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 06:06:04 GMT</td>    <td>Tiziana Lifesciences Announces Intention to Demerge Its StemPrintER Genomics-Based Personalized Medicine Business as a Separate Listed Company - GlobeNewswire</td>    <td>Tiziana Lifesciences Announces Intention to Demerge Its StemPrintER Genomics-Based Personalized Medicine Business as a Separate Listed Company  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/22/2037410/0/en/Tiziana-Lifesciences-Announces-Intention-to-Demerge-Its-StemPrintER-Genomics-Based-Personalized-Medicine-Business-as-a-Separate-Listed-Company.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Tiziana Life Sciences to present two studies featuring StemPrintER, a stem cell biology-based Breast Cancer Prognostic Tool during the American Society of Clinical Oncology (ASCO) Virtual Conference - GlobeNewswire</td>    <td>Tiziana Life Sciences to present two studies featuring StemPrintER, a stem cell biology-based Breast Cancer Prognostic Tool during the American Society of Clinical Oncology (ASCO) Virtual Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030726/0/en/Tiziana-Life-Sciences-to-present-two-studies-featuring-StemPrintER-a-stem-cell-biology-based-Breast-Cancer-Prognostic-Tool-during-the-American-Society-of-Clinical-Oncology-ASCO-Vir.html">Link</a></td>  </tr></table><h3>604. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TOCA">Tocagen Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 20:05:00 GMT</td>    <td>Tocagen Announces Change to Virtual Format for Special Meeting of Stockholders - PRNewswire</td>    <td>Tocagen Announces Change to Virtual Format for Special Meeting of Stockholders  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/tocagen-announces-change-to-virtual-format-for-special-meeting-of-stockholders-301067275.html">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Tocagen Inc. [TOCA] Stock trading around $1.57 per share: What’s Next? - The DBT News</td>    <td>Tocagen Inc. [TOCA] Stock trading around $1.57 per share: What’s Next?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/05/19/tocagen-inc-toca-stock-trading-around-1-57-per-share-whats-next/">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Do Traders View Tocagen Inc (TOCA) Stock's Current Trend Positively? - InvestorsObserver</td>    <td>Do Traders View Tocagen Inc (TOCA) Stock's Current Trend Positively?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/do-traders-view-tocagen-inc-toca-stocks-current-trend-positively">Link</a></td>  </tr></table><h3>605. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TNXP">Tonix Pharmaceuticals Holding Corp.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:08:40 GMT</td>    <td>Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences - GlobeNewswire</td>    <td>Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/03/2042772/0/en/Tonix-Pharmaceuticals-to-Participate-in-Two-June-Virtual-Investor-Conferences.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 11:21:06 GMT</td>    <td>Tonix Pharmaceuticals Announces FUJIFILM Diosynth Biotechnologies to be Manufacturing Partner for COVID-19 Vaccine Candidate TNX-1800 - GlobeNewswire</td>    <td>Tonix Pharmaceuticals Announces FUJIFILM Diosynth Biotechnologies to be Manufacturing Partner for COVID-19 Vaccine Candidate TNX-1800  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041355/0/en/Tonix-Pharmaceuticals-Announces-FUJIFILM-Diosynth-Biotechnologies-to-be-Manufacturing-Partner-for-COVID-19-Vaccine-Candidate-TNX-1800.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 11:33:47 GMT</td>    <td>Tonix Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights - GlobeNewswire</td>    <td>Tonix Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031801/0/en/Tonix-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results-and-Operational-Highlights.html">Link</a></td>  </tr></table><h3>606. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TCON">TRACON Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>TRACON Pharmaceuticals believes its ENVASARC trial on envafolimab will enable a quick path to market - Proactive Investors USA & Canada</td>    <td>TRACON Pharmaceuticals believes its ENVASARC trial on envafolimab will enable a quick path to market  Proactive Investors USA & Canada</td>    <td><a target="_blank" href="https://www.proactiveinvestors.com/companies/news/919523/tracon-pharmaceuticals-believes-its-envasarc-trial-on-envafolimab-will-enable-a-quick-path-to-market-919523.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 13:54:23 GMT</td>    <td>TRACON Pharmaceuticals says separate study buoys potential of envafolimab combination to treat sarcoma - Proactive Investors USA & Canada</td>    <td>TRACON Pharmaceuticals says separate study buoys potential of envafolimab combination to treat sarcoma  Proactive Investors USA & Canada</td>    <td><a target="_blank" href="https://www.proactiveinvestors.com/companies/news/920734/tracon-pharmaceuticals-says-separate-study-buoys-potential-of-envafolimab-combination-to-treat-sarcoma-920734.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:46:00 GMT</td>    <td>BRIEF-Tracon Pharmaceuticals Highlights Updated Envafolimab Results In Colorectal Cancer - Reuters</td>    <td>BRIEF-Tracon Pharmaceuticals Highlights Updated Envafolimab Results In Colorectal Cancer  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-tracon-pharmaceuticals-highlights/brief-tracon-pharmaceuticals-highlights-updated-envafolimab-results-in-colorectal-cancer-idUSASA00S16">Link</a></td>  </tr></table><h3>607. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TBIO">Translate Bio, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:41:00 GMT</td>    <td>Will Translate Bio Continue to Surge Higher? - Yahoo Finance</td>    <td>Will Translate Bio Continue to Surge Higher?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/translate-bio-continue-surge-higher-154103600.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Translate Bio Boosted by Sanofi Vaccine Agreement - Yahoo Finance</td>    <td>Translate Bio Boosted by Sanofi Vaccine Agreement  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/translate-bio-boosted-sanofi-vaccine-221606844.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:00:04 GMT</td>    <td>How is the Translate Bio, Inc. (NASDAQ:TBIO) performance outlook for the coming months? - Marketing Sentinel</td>    <td>How is the Translate Bio, Inc. (NASDAQ:TBIO) performance outlook for the coming months?  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/03/how-is-the-translate-bio-inc-nasdaqtbio-performance-outlook-for-the-coming-months/">Link</a></td>  </tr></table><h3>608. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TMDX">TransMedics Group</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 22:52:36 GMT</td>    <td>TransMedics Announces Pricing of Public Offering of Common Stock - GlobeNewswire</td>    <td>TransMedics Announces Pricing of Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2039018/0/en/TransMedics-Announces-Pricing-of-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 07:00:00 GMT</td>    <td>TransMedics proposes public offering following positive OCS Liver Protect trial results - Mass Device</td>    <td>TransMedics proposes public offering following positive OCS Liver Protect trial results  Mass Device</td>    <td><a target="_blank" href="https://www.massdevice.com/transmedics-proposes-public-offering-following-positive-ocs-liver-protect-trial-results/">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>TransMedics Reports First Quarter 2020 Financial Results Nasdaq:TMDX - GlobeNewswire</td>    <td>TransMedics Reports First Quarter 2020 Financial Results Nasdaq:TMDX  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028835/0/en/TransMedics-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>609. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TRVN">Trevena, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:02:00 GMT</td>    <td>Trevena Announces Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co. - GlobeNewswire</td>    <td>Trevena Announces Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co.  GlobeNewswire</td>    <td><a target="_blank" href="http://www.globenewswire.com/news-release/2020/06/03/2042887/0/en/Trevena-Announces-Advancement-of-Oliceridine-Clinical-Development-in-China-by-Jiangsu-Nhwa-Pharmaceutical-Co.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:12:00 GMT</td>    <td>Trevena (TRVN) Reports Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co. - StreetInsider.com</td>    <td>Trevena (TRVN) Reports Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co.  StreetInsider.com</td>    <td><a target="_blank" href="https://www.streetinsider.com/Corporate+News/Trevena+%28TRVN%29+Reports+Advancement+of+Oliceridine+Clinical+Development+in+China+by+Jiangsu+Nhwa+Pharmaceutical+Co./16965600.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 11:09:29 GMT</td>    <td>Trevena Reports First Quarter 2020 Results Nasdaq:TRVN - GlobeNewswire</td>    <td>Trevena Reports First Quarter 2020 Results Nasdaq:TRVN  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029303/0/en/Trevena-Reports-First-Quarter-2020-Results.html">Link</a></td>  </tr></table><h3>610. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TCDA">Tricida, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:39:00 GMT</td>    <td>Tricida Announces that 2020 Annual Meeting Will be Held in Virtual Format - Business Wire</td>    <td>Tricida Announces that 2020 Annual Meeting Will be Held in Virtual Format  Business Wire</td>    <td><a target="_blank" href="http://www.businesswire.com/news/home/20200603005876/en/Tricida-Announces-2020-Annual-Meeting-Held-Virtual">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 14:00:42 GMT</td>    <td>Tricida to Present at the Goldman Sachs Virtual Healthcare Conference - Manchestertimes</td>    <td>Tricida to Present at the Goldman Sachs Virtual Healthcare Conference  Manchestertimes</td>    <td><a target="_blank" href="https://www.manchestertimes.com/news/business/tricida-to-present-at-the-goldman-sachs-virtual-healthcare-conference/article_81624285-c168-596d-97e1-4e03de8557fb.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 04:32:00 GMT</td>    <td>Tricida Prices Offering of $175 Million 3.50% Convertible Senior Notes Due 2027 - Business Wire</td>    <td>Tricida Prices Offering of $175 Million 3.50% Convertible Senior Notes Due 2027  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200519006041/en/Tricida-Prices-Offering-175-Million-3.50-Convertible">Link</a></td>  </tr></table><h3>611. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TRIL">Trillium Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Trillium Therapeutics to Present Data on CD47 Blocker TTI-622 in Advanced Relapsed or Refractory Lymphoma at the ASCO20 Virtual Scientific Program - GlobeNewswire</td>    <td>Trillium Therapeutics to Present Data on CD47 Blocker TTI-622 in Advanced Relapsed or Refractory Lymphoma at the ASCO20 Virtual Scientific Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032571/0/en/Trillium-Therapeutics-to-Present-Data-on-CD47-Blocker-TTI-622-in-Advanced-Relapsed-or-Refractory-Lymphoma-at-the-ASCO20-Virtual-Scientific-Program.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Trillium Therapeutics Announces “At-The-Market” Equity Program - BioSpace</td>    <td>Trillium Therapeutics Announces “At-The-Market” Equity Program  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/trillium-therapeutics-announces-at-the-market-equity-program/">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:12:29 GMT</td>    <td>Trillium Therapeutics Provides Update on the Phase I Dose Escalation Study of Its CD47 Blocker TTI-622 at the ASCO20 Virtual Scientific Program - GlobeNewswire</td>    <td>Trillium Therapeutics Provides Update on the Phase I Dose Escalation Study of Its CD47 Blocker TTI-622 at the ASCO20 Virtual Scientific Program  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040864/0/en/Trillium-Therapeutics-Provides-Update-on-the-Phase-I-Dose-Escalation-Study-of-Its-CD47-Blocker-TTI-622-at-the-ASCO20-Virtual-Scientific-Program.html">Link</a></td>  </tr></table><h3>612. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TRIB">Trinity Biotech plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 14:13:41 GMT</td>    <td>Trinity Biotech Announces Results for Q1, 2020 Nasdaq:TRIB - GlobeNewswire</td>    <td>Trinity Biotech Announces Results for Q1, 2020 Nasdaq:TRIB  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039529/0/en/Trinity-Biotech-Announces-Results-for-Q1-2020.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 11:31:28 GMT</td>    <td>Trinity Biotech plc to Announce First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Trinity Biotech plc to Announce First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033410/0/en/Trinity-Biotech-plc-to-Announce-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 13:00:00 GMT</td>    <td>Trinity Biotech Plc to Host Earnings Call - Yahoo Finance</td>    <td>Trinity Biotech Plc to Host Earnings Call  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/trinity-biotech-plc-host-earnings-130000655.html">Link</a></td>  </tr></table><h3>613. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TROV">TrovaGene, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Trovagene Announces First Quarter 2020 Results and Highlights - PRNewswire</td>    <td>Trovagene Announces First Quarter 2020 Results and Highlights  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/trovagene-announces-first-quarter-2020-results-and-highlights-301055272.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Trovagene Announces Changing of Company Name to Cardiff Oncology and Appointment of Mark Erlander, PhD, as Chief Executive Officer - PRNewswire</td>    <td>Trovagene Announces Changing of Company Name to Cardiff Oncology and Appointment of Mark Erlander, PhD, as Chief Executive Officer  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/trovagene-announces-changing-of-company-name-to-cardiff-oncology-and-appointment-of-mark-erlander-phd-as-chief-executive-officer-301053690.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 03:57:18 GMT</td>    <td>Trovagene Rebrands as Cardiff Oncology, Promotes Longtime Exec to CEO - Xconomy</td>    <td>Trovagene Rebrands as Cardiff Oncology, Promotes Longtime Exec to CEO  Xconomy</td>    <td><a target="_blank" href="https://xconomy.com/san-diego/2020/05/07/trovagene-rebrands-as-cardiff-oncology-promotes-longtime-exec-to-ceo/">Link</a></td>  </tr></table><h3>614. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TPTX">Turning Point Therapeutics</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 13:09:39 GMT</td>    <td>Turning Point Therapeutics to Participate in Goldman Sachs 41st Annual Global Healthcare Conference Webcast - GlobeNewswire</td>    <td>Turning Point Therapeutics to Participate in Goldman Sachs 41st Annual Global Healthcare Conference Webcast  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041504/0/en/Turning-Point-Therapeutics-to-Participate-in-Goldman-Sachs-41st-Annual-Global-Healthcare-Conference-Webcast.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:12:58 GMT</td>    <td>Turning Point Therapeutics Presents Preclinical Data For Novel RET Inhibitor Candidate, TPX-0046 - GlobeNewswire</td>    <td>Turning Point Therapeutics Presents Preclinical Data For Novel RET Inhibitor Candidate, TPX-0046  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040914/0/en/Turning-Point-Therapeutics-Presents-Preclinical-Data-For-Novel-RET-Inhibitor-Candidate-TPX-0046.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 11:14:11 GMT</td>    <td>Turning Point Therapeutics Announces Commencement of Public Offering of Common Stock - GlobeNewswire</td>    <td>Turning Point Therapeutics Announces Commencement of Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2034850/0/en/Turning-Point-Therapeutics-Announces-Commencement-of-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr></table><h3>615. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TWST">Twist Bioscience Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 20:27:30 GMT</td>    <td>Twist Bioscience Announces Proposed Public Offering of Common Stock - Tullahoma News and Guardian</td>    <td>Twist Bioscience Announces Proposed Public Offering of Common Stock  Tullahoma News and Guardian</td>    <td><a target="_blank" href="https://www.tullahomanews.com/news/business/twist-bioscience-announces-proposed-public-offering-of-common-stock/article_10a3bdd9-a840-5e88-a2fc-298303733dfa.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2 - Business Wire</td>    <td>Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200506005337/en/Twist-Bioscience-Identifies-Competitive-Antibodies-SARS-CoV-2">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Twist Bioscience to Participate in the UBS Virtual Global Healthcare Conference - Yahoo Finance</td>    <td>Twist Bioscience to Participate in the UBS Virtual Global Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/twist-bioscience-participate-ubs-virtual-120000970.html">Link</a></td>  </tr></table><h3>616. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-TYME">Tyme Technologies, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Tyme Technologies, Inc. to Host Earnings Call - Yahoo Finance</td>    <td>Tyme Technologies, Inc. to Host Earnings Call  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/tyme-technologies-inc-host-earnings-190000831.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Tyme Technologies to Webcast Conference Call of Fourth Quarter and Fiscal Year 2020 Financial and Operating Results on May 20, 2020 - Business Wire</td>    <td>Tyme Technologies to Webcast Conference Call of Fourth Quarter and Fiscal Year 2020 Financial and Operating Results on May 20, 2020  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005132/en/Tyme-Technologies-Webcast-Conference-Call-Fourth-Quarter">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 12:00:00 GMT</td>    <td>Tyme Technologies to Present at BIO Digital from June 8-12, 2020 - Yahoo Finance</td>    <td>Tyme Technologies to Present at BIO Digital from June 8-12, 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/tyme-technologies-present-bio-digital-120000237.html">Link</a></td>  </tr></table><h3>617. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-RARE">Ultragenyx Pharmaceutical Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 09:28:12 GMT</td>    <td>Brokers upbeat on Ultragenyx Pharmaceutical Inc despite economic uncertainty - Stockopedia</td>    <td>Brokers upbeat on Ultragenyx Pharmaceutical Inc despite economic uncertainty  Stockopedia</td>    <td><a target="_blank" href="https://www.stockopedia.com/articles/brokers-upbeat-on-ultragenyx-pharmaceutical-inc-despite-economic-uncertainty-54368/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Ultragenyx Pharmaceutical Inc. (RARE) Soars 7.89% on June 02 - Equities.com</td>    <td>Ultragenyx Pharmaceutical Inc. (RARE) Soars 7.89% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/ultragenyx-pharmaceutical-inc-rare-soars-7-89-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:03:19 GMT</td>    <td>Ultragenyx Reports First Quarter 2020 Financial Results and Corporate Update - GlobeNewswire</td>    <td>Ultragenyx Reports First Quarter 2020 Financial Results and Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028800/0/en/Ultragenyx-Reports-First-Quarter-2020-Financial-Results-and-Corporate-Update.html">Link</a></td>  </tr></table><h3>618. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-QURE">uniQure N.V.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Uniqure NV Clears Key Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily</td>    <td>Uniqure NV Clears Key Benchmark, Hitting 80-Plus RS Rating  Investor's Business Daily</td>    <td><a target="_blank" href="https://www.investors.com/ibd-data-stories/uniqure-n-v-clears-key-benchmark-hitting-80-plus-rs-rating-2/">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Analysts Have Just Cut Their uniQure N.V. (NASDAQ:QURE) Revenue Estimates By 16% - Yahoo Finance</td>    <td>Analysts Have Just Cut Their uniQure N.V. (NASDAQ:QURE) Revenue Estimates By 16%  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-just-cut-uniqure-n-114932143.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 23:38:00 GMT</td>    <td>Hedge Funds Done Buying Uniqure NV (QURE)? - Yahoo Finance</td>    <td>Hedge Funds Done Buying Uniqure NV (QURE)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-done-buying-uniqure-233802821.html">Link</a></td>  </tr></table><h3>619. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-UTHR">United Therapeutics Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020 - PRNewswire</td>    <td>United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-present-at-the-bofa-securities-virtual-health-care-conference-2020-301053439.html">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 10:00:00 GMT</td>    <td>United Therapeutics Corporation to Present at the Jefferies Virtual Health Care Conference - PRNewswire</td>    <td>United Therapeutics Corporation to Present at the Jefferies Virtual Health Care Conference  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-present-at-the-jefferies-virtual-health-care-conference-301064769.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 16:42:18 GMT</td>    <td>United Therapeutics Corporation (UTHR) Stock: What's Next? - InvestorsObserver</td>    <td>United Therapeutics Corporation (UTHR) Stock: What's Next?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/united-therapeutics-corporation-uthr-stock-whats-next-2">Link</a></td>  </tr></table><h3>620. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-UBX">Unity Biotechnology, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 20:12:21 GMT</td>    <td>UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates - GlobeNewswire</td>    <td>UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029859/0/en/UNITY-Biotechnology-Inc-Reports-First-Quarter-2020-Financial-Results-and-Business-Updates.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:07:00 GMT</td>    <td>Proscia's Concentriq Digital Pathology Software Has Been Deployed By UNITY Biotechnology to Accelerate Research and Development - Business Wire</td>    <td>Proscia's Concentriq Digital Pathology Software Has Been Deployed By UNITY Biotechnology to Accelerate Research and Development  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200603005216/en/Proscia%E2%80%99s-Concentriq-Digital-Pathology-Software-Deployed-UNITY">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 14:00:02 GMT</td>    <td>Should Unity Biotechnology Inc (UBX) Stock be in Your Portfolio? - InvestorsObserver</td>    <td>Should Unity Biotechnology Inc (UBX) Stock be in Your Portfolio?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/should-unity-biotechnology-inc-ubx-stock-be-in-your-portfolio">Link</a></td>  </tr></table><h3>621. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-UMRX">Unum Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 13:54:00 GMT</td>    <td>Is Unum Therapeutics Inc. (UMRX) A Good Stock To Buy? - Yahoo Finance</td>    <td>Is Unum Therapeutics Inc. (UMRX) A Good Stock To Buy?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/unum-therapeutics-inc-umrx-good-135400086.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 20:34:13 GMT</td>    <td>Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates - GlobeNewswire</td>    <td>Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2031484/0/en/Unum-Therapeutics-Reports-First-Quarter-Financial-Results-and-Provides-Corporate-Updates.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Unum Therapeutics Inc (UMRX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance</td>    <td>Unum Therapeutics Inc (UMRX) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/unum-therapeutics-inc-umrx-reports-230511134.html">Link</a></td>  </tr></table><h3>622. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-URGN">UroGen Pharma Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 12:00:00 GMT</td>    <td>UroGen Pharma to Present at Jefferies Virtual Healthcare Conference - Yahoo Finance</td>    <td>UroGen Pharma to Present at Jefferies Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/urogen-pharma-present-jefferies-virtual-120000584.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 13:01:00 GMT</td>    <td>UroGen Pharma Announces First Presentation of Data from Phase 2b Study of UGN-102 in Patients with Difficult to Treat Type of Bladder Cancer - Business Wire</td>    <td>UroGen Pharma Announces First Presentation of Data from Phase 2b Study of UGN-102 in Patients with Difficult to Treat Type of Bladder Cancer  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200515005286/en/UroGen-Pharma-Announces-Presentation-Data-Phase-2b">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 19:55:19 GMT</td>    <td>What Kind Of Shareholder Owns Most UroGen Pharma Ltd. (NASDAQ:URGN) Stock? - Simply Wall St</td>    <td>What Kind Of Shareholder Owns Most UroGen Pharma Ltd. (NASDAQ:URGN) Stock?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-urgn/urogen-pharma/news/what-kind-of-shareholder-owns-most-urogen-pharma-ltd-nasdaqurgn-stock/">Link</a></td>  </tr></table><h3>623. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-UROV">Urovant Sciences Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 12:00:00 GMT</td>    <td>Urovant Sciences Appoints Walt Johnston as Senior Vice President of Commercial, Kenton Stewart as Senior Vice President of Market Access - Business Wire</td>    <td>Urovant Sciences Appoints Walt Johnston as Senior Vice President of Commercial, Kenton Stewart as Senior Vice President of Market Access  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200602005341/en/Urovant-Sciences-Appoints-Walt-Johnston-Senior-Vice">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 12:00:00 GMT</td>    <td>Urovant Sciences to Present at the Jefferies Virtual Healthcare Conference - Yahoo Finance</td>    <td>Urovant Sciences to Present at the Jefferies Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/urovant-sciences-present-jefferies-virtual-120000151.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Urovant Sciences Presents Positive Clinical Efficacy & Safety Data on Lead Drug Candidate Vibegron at Virtual American Urological Association Annual Meeting - Business Wire</td>    <td>Urovant Sciences Presents Positive Clinical Efficacy & Safety Data on Lead Drug Candidate Vibegron at Virtual American Urological Association Annual Meeting  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200514005269/en/Urovant-Sciences-Presents-Positive-Clinical-Efficacy-Safety">Link</a></td>  </tr></table><h3>624. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VCNX">Vaccinex, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Vaccinex Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Vaccinex Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033521/0/en/Vaccinex-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Vaccinex Inc (VCNX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance</td>    <td>Vaccinex Inc (VCNX) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/vaccinex-inc-vcnx-reports-q1-140502442.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Vaccinex Inc (VCNX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance</td>    <td>Vaccinex Inc (VCNX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/vaccinex-inc-vcnx-may-report-163004108.html">Link</a></td>  </tr></table><h3>625. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VNDA">Vanda Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>citybizlist : Washington DC : Vanda Pharmaceuticals Announces Agreement with FDA - Citybizlist Real Estate</td>    <td>citybizlist : Washington DC : Vanda Pharmaceuticals Announces Agreement with FDA  Citybizlist Real Estate</td>    <td><a target="_blank" href="https://dc.citybizlist.com/article/610290/vanda-pharmaceuticals-announces-agreement-with-fda">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 16:00:00 GMT</td>    <td>Oppenheimer Downgrade Vanda Pharmaceuticals Inc. [VNDA]. What else is Wall St. saying? - The DBT News</td>    <td>Oppenheimer Downgrade Vanda Pharmaceuticals Inc. [VNDA]. What else is Wall St. saying?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/oppenheimer-downgrade-vanda-pharmaceuticals-inc-vnda-what-else-is-wall-st-saying/">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Vanda Pharmaceuticals CEO's Proposal on Clinical Trial Data Sharing, COVID-19 and Remdesivir - Yahoo Finance</td>    <td>Vanda Pharmaceuticals CEO's Proposal on Clinical Trial Data Sharing, COVID-19 and Remdesivir  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/vanda-pharmaceuticals-ceos-proposal-clinical-144500525.html">Link</a></td>  </tr></table><h3>626. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VBLT">Vascular Biogenics Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Earnings Update: Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance</td>    <td>Earnings Update: Vascular Biogenics Ltd. (NASDAQ:VBLT) Just Reported And Analysts Are Boosting Their Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/earnings-vascular-biogenics-ltd-nasdaq-131636937.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Vascular Biogenics Ltd.'s Raising Found – Global Legal Chronicle - Global Legal Chronicle</td>    <td>Vascular Biogenics Ltd.'s Raising Found – Global Legal Chronicle  Global Legal Chronicle</td>    <td><a target="_blank" href="https://www.globallegalchronicle.com/vascular-biogenics-ltd-s-raising-found/">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Recap: Vascular Biogenics Q1 Earnings - Yahoo Finance</td>    <td>Recap: Vascular Biogenics Q1 Earnings  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/recap-vascular-biogenics-q1-earnings-123803495.html">Link</a></td>  </tr></table><h3>627. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VXRT">Vaxart, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 12:00:00 GMT</td>    <td>Vaxart to Present at the Jefferies Virtual Healthcare Conference - Yahoo Finance</td>    <td>Vaxart to Present at the Jefferies Virtual Healthcare Conference  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/vaxart-present-jefferies-virtual-healthcare-120010224.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 12:20:34 GMT</td>    <td>Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate - GlobeNewswire</td>    <td>Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/20/2036357/0/en/Vaxart-Announces-Selection-of-its-Oral-COVID-19-Vaccine-Lead-Candidate.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 20:07:30 GMT</td>    <td>Vaxart Announces First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Vaxart Announces First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032226/0/en/Vaxart-Announces-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr></table><h3>628. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VBIV">VBI Vaccines, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance</td>    <td>VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/vbi-vaccines-inc-vbiv-reports-131501448.html">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>Implied Volatility Surging for VBI Vaccines (VBIV) Stock Options - Yahoo Finance</td>    <td>Implied Volatility Surging for VBI Vaccines (VBIV) Stock Options  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/implied-volatility-surging-vbi-vaccines-123512426.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 12:01:00 GMT</td>    <td>VBI Vaccines Secures $50 Million Debt Financing From K2 HealthVentures - Financial Post</td>    <td>VBI Vaccines Secures $50 Million Debt Financing From K2 HealthVentures  Financial Post</td>    <td><a target="_blank" href="https://business.financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/vbi-vaccines-secures-50-million-debt-financing-from-k2-healthventures">Link</a></td>  </tr></table><h3>629. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VSTM">Verastem, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 28 May 2020 11:02:24 GMT</td>    <td>Verastem Oncology to Present at the Jefferies Virtual Healthcare Conference - Olean Times Herald</td>    <td>Verastem Oncology to Present at the Jefferies Virtual Healthcare Conference  Olean Times Herald</td>    <td><a target="_blank" href="http://www.oleantimesherald.com/business/verastem-oncology-to-present-at-the-jefferies-virtual-healthcare-conference/article_b4a14471-cbb0-5ba5-8279-f487f8c9b082.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress - Yahoo Finance</td>    <td>Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/verastem-oncology-reports-first-quarter-200500199.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Are Options Traders Betting on a Big Move in Verastem (VSTM) Stock? - Yahoo Finance</td>    <td>Are Options Traders Betting on a Big Move in Verastem (VSTM) Stock?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/options-traders-betting-big-move-152003042.html">Link</a></td>  </tr></table><h3>630. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VCEL">Vericel Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 13:20:00 GMT</td>    <td>Vericel Corporation [VCEL] Stock trading around $14.89 per share: What’s Next? - The DBT News</td>    <td>Vericel Corporation [VCEL] Stock trading around $14.89 per share: What’s Next?  The DBT News</td>    <td><a target="_blank" href="https://dbtnews.com/2020/06/03/vericel-corporation-vcel-stock-trading-around-14-89-per-share-whats-next/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 13:40:00 GMT</td>    <td>Vericel Corporation (VCEL) Chart Is Flashing Mixed Signals - The News Heater</td>    <td>Vericel Corporation (VCEL) Chart Is Flashing Mixed Signals  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/vericel-corporation-vcel-chart-is-flashing-mixed-signals/">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Vericel Reports First Quarter 2020 Financial Results Nasdaq:VCEL - GlobeNewswire</td>    <td>Vericel Reports First Quarter 2020 Financial Results Nasdaq:VCEL  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027498/0/en/Vericel-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>631. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VRML">Vermillion, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 17:00:04 GMT</td>    <td>How is the Vermillion, Inc. (NASDAQ:VRML) performance outlook for the coming months? - Marketing Sentinel</td>    <td>How is the Vermillion, Inc. (NASDAQ:VRML) performance outlook for the coming months?  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/02/how-is-the-vermillion-inc-nasdaqvrml-performance-outlook-for-the-coming-months/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 11:10:00 GMT</td>    <td>The Futility of Vermillion Inc. (NASDAQ:VRML)’s Fundamentals - State Reviewer</td>    <td>The Futility of Vermillion Inc. (NASDAQ:VRML)’s Fundamentals  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/the-futility-of-vermillion-inc-nasdaqvrmls-fundamentals/">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 17:40:00 GMT</td>    <td>$3.27 – $4.42: is It Good Range to Buy Vermillion, Inc. (VRML)? - The News Heater</td>    <td>$3.27 – $4.42: is It Good Range to Buy Vermillion, Inc. (VRML)?  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/02/3-27-4-42-is-it-good-range-to-buy-vermillion-inc-vrml/">Link</a></td>  </tr></table><h3>632. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VRNA">Verona Pharma plc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:02:24 GMT</td>    <td>Verona Pharma given US regulatory go ahead for phase III programme - Proactive Investors UK</td>    <td>Verona Pharma given US regulatory go ahead for phase III programme  Proactive Investors UK</td>    <td><a target="_blank" href="https://www.proactiveinvestors.co.uk/companies/news/919548/verona-pharma-given-us-regulatory-go-ahead-for-phase-iii-programme-919548.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 12:15:56 GMT</td>    <td>Director/PDMR Shareholding - Grant of Restricted Stock Units, Issue of Equity, Total Voting Rights & PDMR Dealings - GlobeNewswire</td>    <td>Director/PDMR Shareholding - Grant of Restricted Stock Units, Issue of Equity, Total Voting Rights & PDMR Dealings  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2031883/0/en/Director-PDMR-Shareholding-Grant-of-Restricted-Stock-Units-Issue-of-Equity-Total-Voting-Rights-PDMR-Dealings.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>BRIEF-Verona Pharma Announces U.S. FDA Response To End-Of-Phase 2 Briefing Package For Ensifentrine In COPD - Reuters</td>    <td>BRIEF-Verona Pharma Announces U.S. FDA Response To End-Of-Phase 2 Briefing Package For Ensifentrine In COPD  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-verona-pharma-announces-us-fda-res/brief-verona-pharma-announces-us-fda-response-toend-of-phase-2-briefing-package-for-ensifentrine-in-copd-idUSFWN2CW0BH">Link</a></td>  </tr></table><h3>633. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VRCA">Verrica Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 11:09:46 GMT</td>    <td>Verrica Pharmaceuticals Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Verrica Pharmaceuticals Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029290/0/en/Verrica-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 16:00:00 GMT</td>    <td>Verrica Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference - MyChesCo</td>    <td>Verrica Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference  MyChesCo</td>    <td><a target="_blank" href="https://www.mychesco.com/a/news/business/public-companies/verrica-pharmaceuticals-to-present-at-the-jefferies-2020-healthcare-conference/">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 21:19:00 GMT</td>    <td>Hedge Funds Never Been Less Bullish On Verrica Pharmaceuticals Inc. (VRCA) - Yahoo Finance</td>    <td>Hedge Funds Never Been Less Bullish On Verrica Pharmaceuticals Inc. (VRCA)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-never-less-bullish-211902585.html">Link</a></td>  </tr></table><h3>634. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VRTX">Vertex Pharmaceuticals Incorporated</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 17:06:00 GMT</td>    <td>Hedge Funds Have Never Been This Bullish On Vertex Pharmaceuticals (VRTX) - Yahoo Finance</td>    <td>Hedge Funds Have Never Been This Bullish On Vertex Pharmaceuticals (VRTX)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-never-bullish-vertex-170654826.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:02:00 GMT</td>    <td>Vertex Appoints Diana McKenzie to its Board of Directors - Business Wire</td>    <td>Vertex Appoints Diana McKenzie to its Board of Directors  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200603005550/en/Vertex-Appoints-Diana-McKenzie-Board-Directors">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:31:53 GMT</td>    <td>Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply - Nasdaq</td>    <td>Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/zacks.com-featured-highlights-include%3A-vertex-pharmaceuticals-dollar-general-cvs-health">Link</a></td>  </tr></table><h3>635. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VERU">Veru Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 12 May 2020 16:13:42 GMT</td>    <td>Veru Secures FDA Agreement to Initiate Phase 2 Study of VERU-111, Novel Microtubule Depolymerization Drug to Combat COVID-19 - GlobeNewswire</td>    <td>Veru Secures FDA Agreement to Initiate Phase 2 Study of VERU-111, Novel Microtubule Depolymerization Drug to Combat COVID-19  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/12/2032131/0/en/Veru-Secures-FDA-Agreement-to-Initiate-Phase-2-Study-of-VERU-111-Novel-Microtubule-Depolymerization-Drug-to-Combat-COVID-19.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Veru Inc. (NASDAQ:VERU) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance</td>    <td>Veru Inc. (NASDAQ:VERU) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/veru-inc-nasdaq-veru-just-163936036.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>Veru Inc. (VERU) Q2 2020 Earnings Call Transcript - Motley Fool</td>    <td>Veru Inc. (VERU) Q2 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/13/veru-inc-veru-q2-2020-earnings-call-transcript.aspx">Link</a></td>  </tr></table><h3>636. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VICL">Vical Incorporated</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 30 Aug 2019 07:00:00 GMT</td>    <td>Vical Stockholders Approve Reverse Stock Split and Merger with Brickell - GlobeNewswire</td>    <td>Vical Stockholders Approve Reverse Stock Split and Merger with Brickell  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/08/30/1909218/0/en/Vical-Stockholders-Approve-Reverse-Stock-Split-and-Merger-with-Brickell.html">Link</a></td>  </tr><tr>    <td>Mon, 03 Jun 2019 07:00:00 GMT</td>    <td>Vical and Brickell Announce Merger Agreement Nasdaq:VICL - GlobeNewswire</td>    <td>Vical and Brickell Announce Merger Agreement Nasdaq:VICL  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2019/06/03/1862969/0/en/Vical-and-Brickell-Announce-Merger-Agreement.html">Link</a></td>  </tr><tr>    <td>Tue, 03 Sep 2019 07:00:00 GMT</td>    <td>Brickell Biotech Completes Merger with Vical - Yahoo Finance</td>    <td>Brickell Biotech Completes Merger with Vical  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/brickell-biotech-completes-merger-vical-104500083.html">Link</a></td>  </tr></table><h3>637. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VIE">Viela Bio, Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 11:25:43 GMT</td>    <td>Viela Bio Announces Proposed Public Offering of Common Stock - GlobeNewswire</td>    <td>Viela Bio Announces Proposed Public Offering of Common Stock  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038519/0/en/Viela-Bio-Announces-Proposed-Public-Offering-of-Common-Stock.html">Link</a></td>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Some Analysts Just Cut Their Viela Bio, Inc. (NASDAQ:VIE) Estimates - Yahoo Finance</td>    <td>Some Analysts Just Cut Their Viela Bio, Inc. (NASDAQ:VIE) Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/analysts-just-cut-viela-bio-165134022.html">Link</a></td>  </tr><tr>    <td>Wed, 13 May 2020 20:27:17 GMT</td>    <td>Viela Bio Reports First Quarter 2020 Financial Results and Program Highlights - GlobeNewswire</td>    <td>Viela Bio Reports First Quarter 2020 Financial Results and Program Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/13/2032999/0/en/Viela-Bio-Reports-First-Quarter-2020-Financial-Results-and-Program-Highlights.html">Link</a></td>  </tr></table><h3>638. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VRAY">ViewRay, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 23:30:00 GMT</td>    <td>ViewRay Announces Equity Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - PRNewswire</td>    <td>ViewRay Announces Equity Inducement Awards under Nasdaq Listing Rule 5635(c)(4)  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/viewray-announces-equity-inducement-awards-under-nasdaq-listing-rule-5635c4-301070476.html">Link</a></td>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>ViewRay Inc. (VRAY) Soars 3.31% on June 02 - Equities.com</td>    <td>ViewRay Inc. (VRAY) Soars 3.31% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/viewray-inc-vray-soars-3-31-on-june-02">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 11:02:39 GMT</td>    <td>When is ViewRay, Inc. (VRAY) going to be good investment? - Marketing Sentinel</td>    <td>When is ViewRay, Inc. (VRAY) going to be good investment?  Marketing Sentinel</td>    <td><a target="_blank" href="https://marketingsentinel.com/2020/06/03/when-is-viewray-inc-vray-going-to-be-good-investment/">Link</a></td>  </tr></table><h3>639. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VKTX">Viking Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 11:30:00 GMT</td>    <td>Viking Therapeutics to Participate in Upcoming Investor Conferences - PRNewswire</td>    <td>Viking Therapeutics to Participate in Upcoming Investor Conferences  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/viking-therapeutics-to-participate-in-upcoming-investor-conferences-301065714.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Viking Therapeutics Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting - BioSpace</td>    <td>Viking Therapeutics Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/releases/viking-therapeutics-announces-2020-annual-meeting-of-stockholders-to-be-held-as-virtual-meeting/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:30:00 GMT</td>    <td>Viking Therapeutics, Inc. (VKTX) - good time to look at fundamentals - The News Heater</td>    <td>Viking Therapeutics, Inc. (VKTX) - good time to look at fundamentals  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/06/03/viking-therapeutics-inc-vktx-good-time-to-look-at-fundamentals/">Link</a></td>  </tr></table><h3>640. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VIR">Vir Biotechnology</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 16:23:00 GMT</td>    <td>Vir Biotechnology Is Bucking The Biotech COVID-19 Trends, And Stands To Win - Motley Fool</td>    <td>Vir Biotechnology Is Bucking The Biotech COVID-19 Trends, And Stands To Win  Motley FoolVir Biotechnology Inc. [VIR] Revenue clocked in at $10.10 million, up 171.81% YTD: What’s Next?  The DBT NewsWest Bancorp (WTBA) is a Top Dividend Stock Right Now: Should You Buy?  NasdaqView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/06/01/vir-biotechnology-is-bucking-the-biotech-covid-19.aspx">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 02:48:38 GMT</td>    <td>Why Vir Biotechnology Rocketed Higher Today - The Motley Fool</td>    <td>Why Vir Biotechnology Rocketed Higher Today  The Motley FoolIdentification and Characterization of a Potential Therapeutic COVID-19 Antibody by Vir Biotechnology Published in Nature  GlobeNewswireVir Biotechnology Up 31.5%; Findings From Efforts to Develop Therapeutics for Covid-19 Published  Morningstar.comVir Bio bullish on two COVID-19 antibody candidates  Seeking AlphaAntibody that inhibits the new coronavirus discovered in patient who had SARS 17 years ago  Live ScienceView Full Coverage on Google News</td>    <td><a target="_blank" href="https://www.fool.com/investing/2020/05/18/why-vir-biotechnology-rocketed-higher-today.aspx">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:00:00 GMT</td>    <td>Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment - Yahoo Finance</td>    <td>Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/vir-biotechnology-biogen-execute-agreement-120010225.html">Link</a></td>  </tr></table><h3>641. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VTGN">VistaGen Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 20:58:56 GMT</td>    <td>VISTAGEN THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - marketscreener.com</td>    <td>VISTAGEN THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/VISTAGEN-THERAPEUTICS-IN-27506590/news/VISTAGEN-THERAPEUTICS-INC-Regulation-FD-Disclosure-Financial-Statements-and-Exhibits-form-8-K-30706421/">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 23:11:00 GMT</td>    <td>VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Files An 8-K Regulation FD Disclosure - Market Exclusive</td>    <td>VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Files An 8-K Regulation FD Disclosure  Market Exclusive</td>    <td><a target="_blank" href="https://marketexclusive.com/vistagen-therapeutics-inc-nasdaqvtgn-files-an-8-k-regulation-fd-disclosure-8/2020/06/">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Wall Street's Analysis on Vistagen Therapeutics Inc (VTGN) Stock's Recent Behavior - InvestorsObserver</td>    <td>Wall Street's Analysis on Vistagen Therapeutics Inc (VTGN) Stock's Recent Behavior  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/wall-streets-analysis-on-vistagen-therapeutics-inc-vtgn-stocks-recent-behavior">Link</a></td>  </tr></table><h3>642. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VIST">Visterra, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 07:00:00 GMT</td>    <td>Dr. Brian Pereira appointed to AIF's Board - newsindiatimes.com</td>    <td>Dr. Brian Pereira appointed to AIF's Board  newsindiatimes.com</td>    <td><a target="_blank" href="https://www.newsindiatimes.com/dr-brian-pereira-appointed-to-aifs-board/">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Voltron Therapeutics Publishes Letter to Shareholders - PRNewswire</td>    <td>Voltron Therapeutics Publishes Letter to Shareholders  PRNewswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/voltron-therapeutics-publishes-letter-to-shareholders-301061841.html">Link</a></td>  </tr><tr>    <td>Tue, 12 May 2020 07:00:00 GMT</td>    <td>Global Therapeutic Landscape for Bone Marrow Transplant Rejection 2020 - ResearchAndMarkets.com - Business Wire</td>    <td>Global Therapeutic Landscape for Bone Marrow Transplant Rejection 2020 - ResearchAndMarkets.com  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200512005385/en/Global-Therapeutic-Landscape-Bone-Marrow-Transplant-Rejection">Link</a></td>  </tr></table><h3>643. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VTL">Vital Therapies, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 23:08:31 GMT</td>    <td>DHODH enzyme makes catalyst grist for Immunic, others in MS-plus - BioWorld Online</td>    <td>DHODH enzyme makes catalyst grist for Immunic, others in MS-plus  BioWorld Online</td>    <td><a target="_blank" href="https://www.bioworld.com/articles/435543-dhodh-enzyme-makes-catalyst-grist-for-immunic-others-in-ms-plus">Link</a></td>  </tr><tr>    <td>Thu, 28 May 2020 19:47:00 GMT</td>    <td>Active Stocks on the Move: Vital Therapies Inc (NASDAQ:VTL), Marriott Vacations Worldwide Corp (NYSE:VAC), Boston Properties, Inc. (NYSE:BXP) - Stocks Newswire</td>    <td>Active Stocks on the Move: Vital Therapies Inc (NASDAQ:VTL), Marriott Vacations Worldwide Corp (NYSE:VAC), Boston Properties, Inc. (NYSE:BXP)  Stocks Newswire</td>    <td><a target="_blank" href="https://stocksnewswire.com/2020/05/28/active-stocks-on-the-move-vital-therapies-inc-nasdaqvtl-marriott-vacations-worldwide-corp-nysevac-boston-properties-inc-nysebxp/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:45:00 GMT</td>    <td>Artificial Vital Organs and Medical Bionics Market 2020-2026: Key Vendor Landscape By Regional Output, Demand By Countries And Future Growth - Weekly Wall</td>    <td>Artificial Vital Organs and Medical Bionics Market 2020-2026: Key Vendor Landscape By Regional Output, Demand By Countries And Future Growth  Weekly Wall</td>    <td><a target="_blank" href="https://weeklywall.com/artificial-vital-organs-and-medical-bionics-market-2020-2026-key-vendor-landscape-by-regional-output-demand-by-countries-and-future-growth/">Link</a></td>  </tr></table><h3>644. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VIVE">Viveve Medical, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Viveve Reports First Quarter 2020 Financial Results and Provides Corporate Update - Yahoo Finance</td>    <td>Viveve Reports First Quarter 2020 Financial Results and Provides Corporate Update  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/viveve-reports-first-quarter-2020-200100078.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Viveve to Host Conference Call to Provide Corporate Update and First Quarter 2020 Financial Results on May 14, 2020 - Yahoo Finance</td>    <td>Viveve to Host Conference Call to Provide Corporate Update and First Quarter 2020 Financial Results on May 14, 2020  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/viveve-host-conference-call-corporate-122800189.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha</td>    <td>Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2020 Results - Earnings Call Transcript  Seeking Alpha</td>    <td><a target="_blank" href="https://seekingalpha.com/article/4347793-viveve-medical-inc-vive-ceo-scott-durbin-on-q1-2020-results-earnings-call-transcript">Link</a></td>  </tr></table><h3>645. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VVUS">VIVUS, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 11:52:56 GMT</td>    <td>VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P. - GlobeNewswire</td>    <td>VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042123/0/en/VIVUS-Announces-Updated-Agreement-with-Icahn-Enterprises-Holdings-L-P.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 20:20:51 GMT</td>    <td>VIVUS Reports First Quarter 2020 Financial Results Nasdaq:VVUS - GlobeNewswire</td>    <td>VIVUS Reports First Quarter 2020 Financial Results Nasdaq:VVUS  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028819/0/en/VIVUS-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Vivus: 1Q Earnings Snapshot - San Francisco Chronicle</td>    <td>Vivus: 1Q Earnings Snapshot  San Francisco Chronicle</td>    <td><a target="_blank" href="https://www.sfchronicle.com/business/article/Vivus-1Q-Earnings-Snapshot-15252916.php">Link</a></td>  </tr></table><h3>646. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VYGR">Voyager Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 06 May 2020 11:07:16 GMT</td>    <td>Voyager Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates - GlobeNewswire</td>    <td>Voyager Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028287/0/en/Voyager-Therapeutics-Announces-First-Quarter-2020-Financial-Results-and-Corporate-Updates.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Should You Buy Voyager Therapeutics (VYGR) Ahead of Earnings? - Yahoo Finance</td>    <td>Should You Buy Voyager Therapeutics (VYGR) Ahead of Earnings?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/buy-voyager-therapeutics-vygr-ahead-123012463.html">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 21:09:00 GMT</td>    <td>Voyager Therapeutics Inc. (VYGR) Soars 1.07% on June 01 - Equities.com</td>    <td>Voyager Therapeutics Inc. (VYGR) Soars 1.07% on June 01  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/voyager-therapeutics-inc-vygr-soars-1-07-on-june-01">Link</a></td>  </tr></table><h3>647. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-VTVT">vTv Therapeutics Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 07 May 2020 20:47:11 GMT</td>    <td>vTv Therapeutics Announces 2020 First Quarter Financial Results and Update - GlobeNewswire</td>    <td>vTv Therapeutics Announces 2020 First Quarter Financial Results and Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/07/2029990/0/en/vTv-Therapeutics-Announces-2020-First-Quarter-Financial-Results-and-Update.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 20:43:02 GMT</td>    <td>vTv Therapeutics Changes its 2020 Annual Meeting of Stockholders to Virtual Format - GlobeNewswire</td>    <td>vTv Therapeutics Changes its 2020 Annual Meeting of Stockholders to Virtual Format  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/22/2037824/0/en/vTv-Therapeutics-Changes-its-2020-Annual-Meeting-of-Stockholders-to-Virtual-Format.html">Link</a></td>  </tr><tr>    <td>Wed, 27 May 2020 11:31:48 GMT</td>    <td>vTv Therapeutics to Present Full Clinical Study Results from the Positive Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes at the American Diabetes Association's 80th Virtual Scientific Sessions - GlobeNewswire</td>    <td>vTv Therapeutics to Present Full Clinical Study Results from the Positive Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes at the American Diabetes Association's 80th Virtual Scientific Sessions  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039264/0/en/vTv-Therapeutics-to-Present-Full-Clinical-Study-Results-from-the-Positive-Phase-2-Simplici-T1-Study-of-TTP399-Potential-First-in-Class-Oral-Adjunctive-Therapy-for-Patients-with-Typ.html">Link</a></td>  </tr></table><h3>648. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-WVE">WAVE Life Sciences Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 11 May 2020 11:48:16 GMT</td>    <td>Wave Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire</td>    <td>Wave Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030977/0/en/Wave-Life-Sciences-Reports-First-Quarter-2020-Financial-Results-and-Provides-Business-Update.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>WAVE Life Sciences Pte. Ltd. (WVE) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>WAVE Life Sciences Pte. Ltd. (WVE) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/11/wave-life-sciences-pte-ltd-wve-q1-2020-earnings-ca.aspx">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 07:00:00 GMT</td>    <td>Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance</td>    <td>Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/wave-life-sciences-wve-reports-125512083.html">Link</a></td>  </tr></table><h3>649. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XBIT">XBiotech Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 13 May 2020 07:00:00 GMT</td>    <td>XBiotech Inc. (XBIT) Plunges 6.47% on May 13 - Equities.com</td>    <td>XBiotech Inc. (XBIT) Plunges 6.47% on May 13  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/xbiotech-inc-xbit-plunges-6-47-on-may-13">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>XBiotech Inc. (XBIT) Soars 7.28% on May 08 - Equities.com</td>    <td>XBiotech Inc. (XBIT) Soars 7.28% on May 08  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/xbiotech-inc-xbit-soars-7-28-on-may-08">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 07:00:00 GMT</td>    <td>XBiotech Inc. (XBIT) Soars 2.93% on May 20 - Equities.com</td>    <td>XBiotech Inc. (XBIT) Soars 2.93% on May 20  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/xbiotech-inc-xbit-soars-2-93-on-may-20">Link</a></td>  </tr></table><h3>650. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XNCR">Xencor, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 21:09:00 GMT</td>    <td>Xencor Inc. (XNCR) Soars 1.77% on June 02 - Equities.com</td>    <td>Xencor Inc. (XNCR) Soars 1.77% on June 02  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/xencor-inc-xncr-soars-1-77-on-june-02">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Xencor Reports First Quarter 2020 Financial Results - Business Wire</td>    <td>Xencor Reports First Quarter 2020 Financial Results  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507006007/en/Xencor-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Xencor Inc (XNCR) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Xencor Inc (XNCR) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/xencor-inc-xncr-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr></table><h3>651. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XBIO">Xenetic Biosciences, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 19 May 2020 07:00:00 GMT</td>    <td>Xenetic Biosciences, Inc. Announces Research and Development Collaboration with Scripps Research to Advance XCART(TM) Platform - Yahoo Finance</td>    <td>Xenetic Biosciences, Inc. Announces Research and Development Collaboration with Scripps Research to Advance XCART(TM) Platform  Yahoo FinanceXenetic Biosciences (XBIO) Announces Research and Development Collaboration with Scripps Research to Advance XCART Platform  StreetInsider.comXenetic Biosciences Inc. (XBIO) Loss -39.08% YTD: Chances Are, Buyers Will Win the Tug-of-War  State ReviewerDo Analysts Expect Xenetic Biosciences Inc (XBIO) Stock to Rise Next Year?  InvestorsObserverView Full Coverage on Google News</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/xenetic-biosciences-inc-announces-research-113500398.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 07:00:00 GMT</td>    <td>Xenetic Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Corporate Update - BioSpace</td>    <td>Xenetic Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Corporate Update  BioSpace</td>    <td><a target="_blank" href="https://www.biospace.com/article/xenetic-biosciences-inc-reports-first-quarter-2020-financial-results-and-provides-corporate-update/">Link</a></td>  </tr><tr>    <td>Tue, 19 May 2020 11:39:06 GMT</td>    <td>XENETIC BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - marketscreener.com</td>    <td>XENETIC BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/XENETIC-BIOSCIENCES-INC-61112306/news/XENETIC-BIOSCIENCES-INC-Entry-into-a-Material-Definitive-Agreement-Regulation-FD-Disclosure-Fi-30633727/">Link</a></td>  </tr></table><h3>652. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XENE">Xenon Pharmaceuticals Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Mon, 01 Jun 2020 20:30:20 GMT</td>    <td>Xenon Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference - GlobeNewswire</td>    <td>Xenon Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041766/0/en/Xenon-Pharmaceuticals-to-Present-at-the-Jefferies-2020-Virtual-Healthcare-Conference.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 12:23:00 GMT</td>    <td>BRIEF-Xenon Pharmaceuticals Files For Mixed Shelf Of Upto $250 Mln - SEC Filing - Reuters</td>    <td>BRIEF-Xenon Pharmaceuticals Files For Mixed Shelf Of Upto $250 Mln - SEC Filing  Reuters</td>    <td><a target="_blank" href="https://www.reuters.com/article/brief-xenon-pharmaceuticals-files-for-mi/brief-xenon-pharmaceuticals-files-for-mixed-shelf-of-upto-250-mln-sec-filing-idUSFWN2DG095">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Xenon Pharmaceuticals Inc (XENE) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Xenon Pharmaceuticals Inc (XENE) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/22/xenon-pharmaceuticals-inc-xene-q1-2020-earnings-ca.aspx">Link</a></td>  </tr></table><h3>653. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XERS">Xeris Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 07:00:00 GMT</td>    <td>Clinigen Signs Exclusive Agreement with Xeris Pharmaceuticals to Supply and Distribute Gvoke™ Outside the US - b3c newswire</td>    <td>Clinigen Signs Exclusive Agreement with Xeris Pharmaceuticals to Supply and Distribute Gvoke™ Outside the US  b3c newswire</td>    <td><a target="_blank" href="https://www.b3cnewswire.com/202005142069/clinigen-signs-exclusive-agreement-with-xeris-pharmaceuticals-to-supply-and-distribute-gvoke-outside-the-us.html">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Xeris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Updates - Business Wire</td>    <td>Xeris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Updates  Business Wire</td>    <td><a target="_blank" href="https://www.businesswire.com/news/home/20200507005140/en/Xeris-Pharmaceuticals-Reports-Quarter-2020-Financial-Results">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Xeris Pharmaceuticals Inc (XERS) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance</td>    <td>Xeris Pharmaceuticals Inc (XERS) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/xeris-pharmaceuticals-inc-xers-reports-143502830.html">Link</a></td>  </tr></table><h3>654. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XOMA">XOMA Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:23:50 GMT</td>    <td>Introducing XOMA (NASDAQ:XOMA), The Stock That Zoomed 244% In The Last Three Years - Simply Wall St</td>    <td>Introducing XOMA (NASDAQ:XOMA), The Stock That Zoomed 244% In The Last Three Years  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xoma/xoma/news/introducing-xoma-nasdaqxoma-the-stock-that-zoomed-244-in-the-last-three-years/">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 11:42:42 GMT</td>    <td>XOMA Reports First Quarter 2020 Financial Results and Provides COVID-19 Business Update - GlobeNewswire</td>    <td>XOMA Reports First Quarter 2020 Financial Results and Provides COVID-19 Business Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027425/0/en/XOMA-Reports-First-Quarter-2020-Financial-Results-and-Provides-COVID-19-Business-Update.html">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>XOMA CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - marketscreener.com</td>    <td>XOMA CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)  marketscreener.com</td>    <td><a target="_blank" href="https://www.marketscreener.com/XOMA-CORPORATION-31660656/news/XOMA-CORP-Results-of-Operations-and-Financial-Condition-Financial-Statements-and-Exhibits-form-8-30540562/">Link</a></td>  </tr></table><h3>655. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-XTLB">XTL Biopharmaceuticals Ltd.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 26 May 2020 14:52:04 GMT</td>    <td>Should X T L Biopharmaceuticals Ltd (XTLB) Stock be in Your Portfolio? - InvestorsObserver</td>    <td>Should X T L Biopharmaceuticals Ltd (XTLB) Stock be in Your Portfolio?  InvestorsObserver</td>    <td><a target="_blank" href="https://www.investorsobserver.com/news/stock-update/should-x-t-l-biopharmaceuticals-ltd-xtlb-stock-be-in-your-portfolio">Link</a></td>  </tr><tr>    <td>Thu, 01 Nov 2018 07:00:00 GMT</td>    <td>XTL Biopharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Update - PR Newswire</td>    <td>XTL Biopharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Update  PR Newswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/xtl-biopharmaceuticals-reports-third-quarter-2018-financial-results-and-provides-update-300742268.html">Link</a></td>  </tr><tr>    <td>Mon, 27 Nov 2017 08:00:00 GMT</td>    <td>XTL Biopharmaceuticals Reports Third Quarter 2017 Financial Results - PR Newswire</td>    <td>XTL Biopharmaceuticals Reports Third Quarter 2017 Financial Results  PR Newswire</td>    <td><a target="_blank" href="https://www.prnewswire.com/news-releases/xtl-biopharmaceuticals-reports-third-quarter-2017-financial-results-300561834.html">Link</a></td>  </tr></table><h3>656. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-YMAB">Y-mAbs Therapeutics, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 13:10:49 GMT</td>    <td>Y-mAbs Announces U.S. FDA Acceptance of Biologics License Application for Danyelza™ (naxitamab) for the Treatment of Neuroblastoma for Priority Review - GlobeNewswire</td>    <td>Y-mAbs Announces U.S. FDA Acceptance of Biologics License Application for Danyelza™ (naxitamab) for the Treatment of Neuroblastoma for Priority Review  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/02/2042283/0/en/Y-mAbs-Announces-U-S-FDA-Acceptance-of-Biologics-License-Application-for-Danyelza-naxitamab-for-the-Treatment-of-Neuroblastoma-for-Priority-Review.html">Link</a></td>  </tr><tr>    <td>Sat, 09 May 2020 07:00:00 GMT</td>    <td>YmAbs Therapeutics, Inc. (YMAB) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>YmAbs Therapeutics, Inc. (YMAB) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/09/ymabs-therapeutics-inc-ymab-q1-2020-earnings-call.aspx">Link</a></td>  </tr><tr>    <td>Thu, 07 May 2020 07:00:00 GMT</td>    <td>Was The Smart Money Right About Y-mAbs Therapeutics, Inc. (YMAB)? - Yahoo Finance</td>    <td>Was The Smart Money Right About Y-mAbs Therapeutics, Inc. (YMAB)?  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/smart-money-y-mabs-therapeutics-162621197.html">Link</a></td>  </tr></table><h3>657. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ZFGN">Zafgen, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 29 May 2020 12:12:09 GMT</td>    <td>Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics - GlobeNewswire</td>    <td>Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040885/0/en/Chondrial-Therapeutics-and-Zafgen-Complete-Merger-and-Begin-Operating-as-Larimar-Therapeutics.html">Link</a></td>  </tr><tr>    <td>Fri, 22 May 2020 07:00:00 GMT</td>    <td>Zafgen Inc. (ZFGN) Soars 24.93% on May 22 - Equities.com</td>    <td>Zafgen Inc. (ZFGN) Soars 24.93% on May 22  Equities.com</td>    <td><a target="_blank" href="https://www.equities.com/news/zafgen-inc-zfgn-soars-24-93-on-may-22">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 18:20:00 GMT</td>    <td>Understanding the Risk vs Reward for Zafgen, Inc. (ZFGN) - The News Heater</td>    <td>Understanding the Risk vs Reward for Zafgen, Inc. (ZFGN)  The News Heater</td>    <td><a target="_blank" href="https://newsheater.com/2020/05/29/understanding-the-risk-vs-reward-for-zafgen-inc-zfgn/">Link</a></td>  </tr></table><h3>658. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ZLAB">Zai Lab Limited</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 11:31:51 GMT</td>    <td>Zai Lab Announces Presentations at June Conferences - GlobeNewswire</td>    <td>Zai Lab Announces Presentations at June Conferences  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039262/0/en/Zai-Lab-Announces-Presentations-at-June-Conferences.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 11:46:38 GMT</td>    <td>Zai Lab Announces NDA for Omadacycline Granted Priority Review by China's NMPA - GlobeNewswire</td>    <td>Zai Lab Announces NDA for Omadacycline Granted Priority Review by China's NMPA  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/06/2028341/0/en/Zai-Lab-Announces-NDA-for-Omadacycline-Granted-Priority-Review-by-China-s-NMPA.html">Link</a></td>  </tr><tr>    <td>Mon, 18 May 2020 11:32:58 GMT</td>    <td>Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam-Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections - GlobeNewswire</td>    <td>Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam-Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/18/2034874/0/en/Zai-Lab-Announces-First-Chinese-Patient-Dosed-in-the-Global-Phase-3-ATTACK-Trial-of-Sulbactam-Durlobactam-for-Patients-with-Carbapenem-Resistant-Acinetobacter-Infections.html">Link</a></td>  </tr></table><h3>659. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ZEAL">Zealand Pharma A/S</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Fri, 15 May 2020 06:48:14 GMT</td>    <td>Zealand Pharma A/S (ZEAL) Q1 2020 Earnings Call Transcript - The Motley Fool</td>    <td>Zealand Pharma A/S (ZEAL) Q1 2020 Earnings Call Transcript  The Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/14/zealand-pharma-as-zeal-q1-2020-earnings-call-trans.aspx">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 20:12:20 GMT</td>    <td>Zealand Pharma to attend Jefferies and Goldman Sachs Virtual Healthcare Conferences - GlobeNewswire</td>    <td>Zealand Pharma to attend Jefferies and Goldman Sachs Virtual Healthcare Conferences  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/06/01/2041726/0/en/Zealand-Pharma-to-attend-Jefferies-and-Goldman-Sachs-Virtual-Healthcare-Conferences.html">Link</a></td>  </tr><tr>    <td>Thu, 14 May 2020 13:14:54 GMT</td>    <td>Zealand Pharma files New Drug Application with U.S. FDA for dasiglucagon HypoPal® rescue pen, secures DKK 137 million in additional investment, and accelerates readiness of U.S. commercial operations: Interim report for Q1 2020 - GlobeNewswire</td>    <td>Zealand Pharma files New Drug Application with U.S. FDA for dasiglucagon HypoPal® rescue pen, secures DKK 137 million in additional investment, and accelerates readiness of U.S. commercial operations: Interim report for Q1 2020  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033549/0/en/Zealand-Pharma-files-New-Drug-Application-with-U-S-FDA-for-dasiglucagon-HypoPal-rescue-pen-secures-DKK-137-million-in-additional-investment-and-accelerates-readiness-of-U-S-commerc.html">Link</a></td>  </tr></table><h3>660. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ZNTL">Zentalis Pharmaceuticals, LLC </a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 11:07:00 GMT</td>    <td>Is It Too Late to Jump In on Zentalis? - Nasdaq</td>    <td>Is It Too Late to Jump In on Zentalis?  Nasdaq</td>    <td><a target="_blank" href="https://www.nasdaq.com/articles/is-it-too-late-to-jump-in-on-zentalis-2020-06-03">Link</a></td>  </tr><tr>    <td>Mon, 01 Jun 2020 08:53:12 GMT</td>    <td>72 Biggest Movers From Friday - Benzinga</td>    <td>72 Biggest Movers From Friday  Benzinga</td>    <td><a target="_blank" href="https://www.benzinga.com/news/20/06/16147018/72-biggest-movers-from-friday">Link</a></td>  </tr><tr>    <td>Wed, 20 May 2020 11:23:07 GMT</td>    <td>A little-known biotech running low on cash looks to get its own $100M IPO from pandemic market - Endpoints News</td>    <td>A little-known biotech running low on cash looks to get its own $100M IPO from pandemic market  Endpoints News</td>    <td><a target="_blank" href="https://endpts.com/a-little-known-biotech-running-low-on-cash-looks-to-get-its-own-100m-ipo-from-pandemic-market/">Link</a></td>  </tr></table><h3>661. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ZIOP">ZIOPHARM Oncology Inc</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 27 May 2020 20:32:57 GMT</td>    <td>Ziopharm Oncology Announces Management Transition Nasdaq:ZIOP - GlobeNewswire</td>    <td>Ziopharm Oncology Announces Management Transition Nasdaq:ZIOP  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/27/2039747/0/en/Ziopharm-Oncology-Announces-Management-Transition.html">Link</a></td>  </tr><tr>    <td>Fri, 29 May 2020 12:12:00 GMT</td>    <td>Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2020 American Society of Clinical Oncology - GlobeNewswire</td>    <td>Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2020 American Society of Clinical Oncology  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/29/2040894/0/en/Ziopharm-Oncology-Presents-Encouraging-Clinical-Data-for-Controlled-IL-12-for-the-Treatment-of-Recurrent-Glioblastoma-at-the-2020-American-Society-of-Clinical-Oncology.html">Link</a></td>  </tr><tr>    <td>Fri, 08 May 2020 07:00:00 GMT</td>    <td>Ziopharm Oncology Inc (ZIOP) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Ziopharm Oncology Inc (ZIOP) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/08/ziopharm-oncology-inc-ziop-q1-2020-earnings-call-t.aspx">Link</a></td>  </tr></table><h3>662. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ZGNX">Zogenix, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Tue, 02 Jun 2020 13:47:00 GMT</td>    <td>Hedge Funds Are Betting On Zogenix, Inc. (ZGNX) - Yahoo Finance</td>    <td>Hedge Funds Are Betting On Zogenix, Inc. (ZGNX)  Yahoo Finance</td>    <td><a target="_blank" href="https://finance.yahoo.com/news/hedge-funds-betting-zogenix-inc-134743593.html">Link</a></td>  </tr><tr>    <td>Wed, 06 May 2020 07:00:00 GMT</td>    <td>Zogenix Inc (ZGNX) Q1 2020 Earnings Call Transcript - Motley Fool</td>    <td>Zogenix Inc (ZGNX) Q1 2020 Earnings Call Transcript  Motley Fool</td>    <td><a target="_blank" href="https://www.fool.com/earnings/call-transcripts/2020/05/06/zogenix-inc-zgnx-q1-2020-earnings-call-transcript.aspx">Link</a></td>  </tr><tr>    <td>Tue, 05 May 2020 07:00:00 GMT</td>    <td>Zogenix Provides Corporate Update and Reports First Quarter 2020 Financial Results - GlobeNewswire</td>    <td>Zogenix Provides Corporate Update and Reports First Quarter 2020 Financial Results  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/05/2027881/0/en/Zogenix-Provides-Corporate-Update-and-Reports-First-Quarter-2020-Financial-Results.html">Link</a></td>  </tr></table><h3>663. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ZSAN">Zosano Pharma Corporation</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Thu, 14 May 2020 21:14:24 GMT</td>    <td>Zosano Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire</td>    <td>Zosano Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/14/2033926/0/en/Zosano-Pharma-Reports-First-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 23:50:00 GMT</td>    <td>Are Zosano Pharma Corporation (NASDAQ:ZSAN) Prospects Worsening? - State Reviewer</td>    <td>Are Zosano Pharma Corporation (NASDAQ:ZSAN) Prospects Worsening?  State Reviewer</td>    <td><a target="_blank" href="https://statereviewer.com/2020/06/03/are-zosano-pharma-corporation-nasdaqzsan-prospects-worsening/">Link</a></td>  </tr><tr>    <td>Wed, 03 Jun 2020 14:00:03 GMT</td>    <td>Is Zosano Pharma Corporation (NASDAQ:ZSAN) still hot this week? - Stocks Register</td>    <td>Is Zosano Pharma Corporation (NASDAQ:ZSAN) still hot this week?  Stocks Register</td>    <td><a target="_blank" href="https://stocksregister.com/2020/06/03/is-zosano-pharma-corporation-nasdaqzsan-still-hot-this-week/">Link</a></td>  </tr></table><h3>664. <a target="_blank" href="https://www.tradingview.com/symbols/NASDAQ-ZYNE">Zynerba Pharmaceuticals, Inc.</a></h2><table>  <tr>    <th>Date</th>    <th>Title</th>    <th>Description</th>    <th>Url</th>  </tr><tr>    <td>Wed, 03 Jun 2020 15:45:40 GMT</td>    <td>Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE): Are Analysts Optimistic? - Simply Wall St</td>    <td>Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE): Are Analysts Optimistic?  Simply Wall St</td>    <td><a target="_blank" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyne/zynerba-pharmaceuticals/news/zynerba-pharmaceuticals-inc-nasdaqzyne-are-analysts-optimistic/">Link</a></td>  </tr><tr>    <td>Tue, 26 May 2020 10:54:38 GMT</td>    <td>Zynerba Pharmaceuticals Announces New Two-Year Data from Open Label Extension of the Phase 2 FAB-C Trial in Patients with Fragile X at 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session - GlobeNewswire</td>    <td>Zynerba Pharmaceuticals Announces New Two-Year Data from Open Label Extension of the Phase 2 FAB-C Trial in Patients with Fragile X at 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/26/2038467/0/en/Zynerba-Pharmaceuticals-Announces-New-Two-Year-Data-from-Open-Label-Extension-of-the-Phase-2-FAB-C-Trial-in-Patients-with-Fragile-X-at-2020-American-Academy-of-Neurology-AAN-Scienc.html">Link</a></td>  </tr><tr>    <td>Mon, 11 May 2020 11:07:13 GMT</td>    <td>Zynerba Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights - GlobeNewswire</td>    <td>Zynerba Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights  GlobeNewswire</td>    <td><a target="_blank" href="https://www.globenewswire.com/news-release/2020/05/11/2030920/0/en/Zynerba-Pharmaceuticals-Reports-First-Quarter-2020-Financial-Results-and-Operational-Highlights.html">Link</a></td>  </tr></table>
</body>
</html>
